Four Nephrology Myths Debunked

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Four nephrology myths debunked

There are many controversial topics relating to renal disease in hospitalized patients. The aim of this review is to shed light on some important and often debated issues. We will first discuss topics related to electrolytes disorder commonly seen in hospitalized patients (hyponatremia, hyperkalemia, metabolic acidosis) then the use of diuretics in patients with allergy to sulfa containing antibiotics.

Hypothyroidism and Hyponatremia

Hyponatremia is common in hospitalized patients and is associated with worse outcomes.1 It can be seen with a variety of conditions ranging from congestive heart failure to volume depletion. Careful history and physical examination are paramount and the initial work‐up usually includes serum and urine osmolality and urine sodium concentration.

For euvolemic hyponatremia, the differential diagnosis includes the syndrome of inappropriate adenine dinucleotide (ADH) secretion (SIADH), hypoadrenalism, and beer potomania. Additionally, many authorities also include hypothyroidism.

Although the simultaneous finding of hypothyroidism and hyponatremia can occur in patients as both diseases are widely prevalent in the general population, causation has yet to be convincingly demonstrated.

ADH is released in response to effective volume depletion; consequently when hypothyroidism is encountered in the setting of complete pituitary failure there is often hyponatremia.2, 3 Alternatively, with myxedema, the ability of the kidney to handle a water load and concentrate urine can be impaired.4

However, the observation that thyroid hormone administration did not raise sodium values in newborns with congenital hypothyroidism or in adults supports the absence of causal effect.5, 6And in addition, large studies done in the hospital and outpatient setting showed no differences between the serum sodium values of hypothyroid patients and that of controls.7, 8 In the study of outpatients, among those with hypothyroidism, for every increase of 10 mU/L of thyroid‐stimulating hormone (TSH), there was a drop of only 0.14 mmol/L of Na concentration.8 Thus, the elevation of TSH required for a clinically meaningful drop in sodium to occur was considerable.

Hence in patients with hyponatremia, the hospitalist should look for etiologies other than hypothyroidism and should only consider thyroid hypofunction as a culprit in cases of myxedema, or panhypopituitarism.

Sodium Bicarbonate for Hyperkalemia

Hyperkalemia is one of the most feared electrolyte disorders encountered in hospitalized patients and can lead to dire outcomes.9, 10

Potassium (K+) homeostasis is maintained in the body by 2 complimentary systems: a short‐term system that regulates K+ variation by modifying translocation across the cellular membrane and a long‐term system that adjusts overall K+ balance. The translocation system is regulated primarily by insulin and ‐2 stimulation. Overall K+ balance is mainly controlled by the kidney (90‐95%) although the gastrointestinal (GI) tract can have a more preponderant role in anephric patients.

Hyperkalemia can ensue by either a dysregulation of the translocation system (as in diabetic Ketoacidosis secondary to insulin deficiency) or impairment of K+ elimination.

Acid‐base status was previously thought to have a prominent influence on K+ concentration, based on studies that demonstrated that. However, studies looking at metabolic acidosis revealed that contrary to the effect of mineral acidosis (excess of nonmetabolizable anions)11 where there is an inverse correlation between potassium concentration and pH; organic acidosis (excess of metabolizable anions)11 was not associated with hyperkalemia.1214 However, organic acidosis can be seen simultaneously and induced by a same underlying disease (such as organ ischemia with lactic acidosis or insulin deficiency complicated by ketoacidosis). Also, when changes in pH are induced by respiratory variations or with alkalosis, the impact on serum K+ concentration is less remarkable.15 Hence, it seems that it is the nature of the acid‐base disturbance that impacts K+ concentration more than the change in pH itself.

In the kidney, the main site for regulation of K+ balance is the collecting duct. Factors that affect elimination include urinary sodium delivery, urine flow, and aldosterone.16 In order to adequately eliminate K+ these factors must be optimized in conjunction.

Treatment of hyperkalemia includes the sequential administration of agents that stabilize the cardiac membrane (calcium gluconate), shift the potassium intracellularly (insulin, ‐2 agonists), and remove the potassium (diuretics, sodium polystyrene, or dialysis).

The use of sodium bicarbonate for treatment of hyperkalemia has been long advocated.17 It was thought to act by translocation of potassium hence could be used to quickly lower K+ concentration. However, this dogma has been challenged recently.

To assess the true impact of sodium bicarbonate on potassium translocation, studies have been conducted on anephric patients with hyperkalemia. Bicarbonate infusion failed to elicit a significant rapid change in serum K+ concentration despite increase in bicarbonate concentration, arguing against a translocation mechanism.1821 After 60 minutes of treatment, neither isotonic nor hypertonic bicarbonate infusion affected Serum K+ levels in end‐stage renal disease (ESRD) patients.19, 20 On the contrary, hypertonic sodium bicarbonate increased the K+ concentration after 180 minutes of treatment,20 and it took a prolonged infusion of 4 hours to see a significant decrease in K+ concentration (0.6 mmol/L); half of which could be accounted for solely by volume administration. Moreover, this reduction was highly variable.

Rather, sodium bicarbonate seems to enhance potassium elimination by increasing sodium delivery to the distal tubule, increasing urinary pH and negative luminal charge and potentiating the action of diuretics.23 In an elegant study on normovolemic patients, the induction of bicarbonaturia practically doubled potassium excretion.23 However, such an effect is heterogeneous and usually takes place over 4 hours to 6 hours.17

At the cellular level, 2 ion exchange pumps cooperate to handle Na/K/H movement across the cellular membrane: an Na+/H+ exchanger (NHE) and the Na+/K+ ATP‐ase pump (Figure 1). The NHE is normally inactive and is only upregulated in cases of severe intracellular acidosis.24 The infusion of sodium bicarbonate to patients with severe metabolic acidosis could possibly decrease the serum potassium concentration by translocation if the NHE was significantly upregulated. However, this treatment can be associated with a drop in the ionized calcium level, a worsening of the intracellular acidosis, and a decreased peripheral oxygen delivery.25 Thus, the benefits should be balanced with the potential adverse effects and, even in cases of severe metabolic acidosis with hyperkalemia, we would advise the clinician to restrictively administer sodium bicarbonate.

Figure 1
Cellular exchangers.

In addition, in ESRD patients, the administration of sodium bicarbonate can be problematic owing to the osmotic and volume burden it carries. It should also be avoided in patients who are volume overload or in those with decreased ability to eliminate potassium.

When treating hyperkalemic patients, hospitalists should use sodium bicarbonate to potentiate urinary elimination of potassium and should consider administering it either with acetazolamide or a loop diuretic, anticipating a lowering effect after a few hours.26 It should be avoided in patients with volume overload and anuria. Immediate translocation of potassium into cells is best achieved by insulin and ‐2 agonists.

5‐Oxoprolinuria: A Newly Recognized Cause of High Anion Gap Metabolic Acidosis

There are several causes of metabolic high anion gap acidosis in hospitalized patients. However, despite careful investigations, the cause of that disorder is not always apparent.27 Recently, 5‐oxoprolinuria (also called pyroglutamic acidosis) has become increasingly recognized as a potential etiology.2832

The metabolism of glutamate (though the ‐Glutamyl cycle) generates glutathione which provides negative feedback to the ‐Glutamyl‐cysteine synthetase enzyme. The depletion of glutathione increases 5‐oxoproline production owing to the loss of that inhibition (Figures 2 and 3). Low glutathione levels can be seen with liver disease,33 chronic alcohol intake,34 acetaminophen use,35 malnutrition,36 renal dysfunction,29 use of vigabatrim (an antiepileptic that received Food and Drug Administration [FDA] approval for use in April 2009)37 and sepsis.38 Most of the reported cases were female and had more than one risk factor.39

Figure 2
Normal γ glutamyl cycle.
Figure 3
Cycle with glutathione depletion.

Typically, patients present with high anion gap acidosis (often more than 20)28 with normal acetaminophen levels and all usual tests being negative. A history of chronic acetaminophen use with or without other risk factors can frequently be found. The true independent impact of this type of acidosis on outcomes is difficult to determine as all of the reported cases had many confounding factors.

A urinary organic acid level is diagnostic and will reveal increased levels of pyroglutamic acid. Alternatively, the finding of a positive urinary anion gap (UNa +UK UCl) with a positive urinary osmolar gap (Uosmmeasured‐Uosmcalculated) in the appropriate clinical setting (unexplained high anion gap acidosis with negative workup and presence of risk factors for 5‐oxoproliniuria) can point towards the diagnosis.40

A study of patients with unexplained metabolic acidosis did not find any cases of 5‐oxoprolinuria.41 Although this might suggest that the incidence of this disease is low, very few of those patients were actually taking acetaminophen (therefore had a reduced propensity for developing pyroglutamic acidosis).41 Thus, the actual incidence of 5‐oxoprolinuria is hard to determine.

Once recognized, acetaminophen should be withheld and N‐acetylcysteine (NAC) can be used to replete glutathione levels although there is no convincing evidence for this use.42 It is important for hospitalists to be aware of this disorder as it can pose a diagnostic challenge (negative usual work‐up), is easy to treat by stopping acetaminophen, and can (possibly) negatively affect outcomes.

Furosemide and Patients With Sulfa Allergy

Allergic reactions are a common occurrence with sulfa‐containing antibiotics (SCA) and reports estimates the incidence to be approximately 3% to 5%.43, 44

One misbelief is that patients who are allergic to SCAs should not receive sulfa containing diuretics or other sulfa‐containing medications.45 This leads some physicians to substitute commonly used diuretics (such as furosemide or thiazides) for ethacrynic acid. The use of ethacrynic acid has several challenges: the limited supply of the intravenous form, the discontinuation of the oral form, the increased cost, and the risk of permanent ototoxicity.

The evidence for potential allergic cross‐reactivity among medications containing the sulfa moiety has been primarily derived from Case Reports.4649

The molecular structures of sulfamethoxazole and furosemide are shown below. The allergic antigen is most often the N1 component,45 and sometimes N4 but not the sulfa moiety. Both of the incriminated antigens are not present in the furosemide structure (as well as all other sulfa containing diuretics) (Figures 4 and 5).

Figure 4
Sulfamethoxazole (SMX) molecule structure.
Figure 5
Furosemide molecule structure.

Experimental data showed that serum from patients allergic to SCAs did not bind to diuretics.50 In addition, clinical reports failed to demonstrate cross‐reactivity.5153 In a large clinical trial, Strom et al.53 showed that although there was a higher risk for allergic reaction to sulfa containing medications (SCM) in patients allergic to SCA (compared to those who were not), it was lower among patients with an allergy to sulfa antibiotic than among patients with a history of hypersensitivity to penicillins, suggesting this was due to a predisposition to allergic reactions in general rather than true cross‐reactivity. In another report, patients who were receiving ethacrynic acid for many years were successfully and uneventfully switched to furosemide.54

Taken together, these findings suggest that there is no evidence for withholding sulfa nonantibiotics in patients allergic to sulfa containing antibiotics.

Conclusion

Hypothyroidism, unlike myxedema, is not a cause of hyponatremia (although it can be sometimes seen in conjunction with the latter) and additional investigations should be done to determine its etiology. Sodium bicarbonate is effective for treatment of hyperkalemia by enhancing renal potassium elimination, rather than from shifting potassium into cells. The 5‐oxoprolinuria is a newly recognized cause of high anion‐gap metabolic acidosis and should be considered in patients who have taken acetaminophen. Furosemide (and sulfa containing diuretics) can be used safely in patients with an allergy to SCA.

References
  1. Waikar SS,Mount DB,Curhan GC.Mortality after hospitalization with mild, moderate, and severe hyponatremia.Am J Med.2009;122(9):857865.
  2. Kurtulmus N,Yarman S.Hyponatremia as the presenting manifestation of Sheehan's syndrome in elderly patients.Aging Clin Exp Res.2006;18(6):536539.
  3. Pham PC,Pham PA,Pham PT.Sodium and water disturbances in patients with Sheehan's syndrome.Am J Kidney Dis.2001;38(3):E14.
  4. Bai Y,Liu XM,Guo ZS,Dai WX,Shi YF,Zhou XY.Effect of acute water loading on plasma levels of antidiuretic hormone AVP aldosterone, ANP fractional excretion of sodium and plasma and urine osmolalities in myxedema.Chin Med J (Engl).1990;103(9):704708.
  5. Asami T,Uchiyama M.Sodium handling in congenitally hypothyroid neonates.Acta Paediatr.2004;93(1):2224.
  6. Baajafer FS,Hammami MM,Mohamed GE.Prevalence and severity of hyponatremia and hypercreatininemia in short‐term uncomplicated hypothyroidism.J Endocrinol Invest.1999;22(1):3539.
  7. Croal BL,Blake AM,Johnston J,Glen AC,O'Reilly DS.Absence of relation between hyponatraemia and hypothyroidism.Lancet.1997;350(9088):1402.
  8. Warner MH,Holding S,Kilpatrick ES.The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study.Clin Endocrinol (Oxf).2006;64(5):598599.
  9. Gennari FJ.Disorders of potassium homeostasis. Hypokalemia and hyperkalemia.Crit Care Clin.2002;18(2):273288,vi.
  10. Stevens MS,Dunlay RW.Hyperkalemia in hospitalized patients.Int Urol Nephrol.2000;32(2):177180.
  11. Levraut J,Grimaud D.Treatment of metabolic acidosis.Curr Opin Crit Care.2003;9(4):260265.
  12. Orringer CE,Eustace JC,Wunsch CD,Gardner LB.Natural history of lactic acidosis after grand‐mal seizures. A model for the study of an anion‐gap acidosis not associated with hyperkalemia.N Engl J Med.1977;297(15):796799.
  13. Magner PO,Robinson L,Halperin RM,Zettle R,Halperin ML.The plasma potassium concentration in metabolic acidosis: a re‐evaluation.Am J Kidney Dis.1988;11(3):220224.
  14. Adrogue HJ,Lederer ED,Suki WN,Eknoyan G.Determinants of plasma potassium levels in diabetic ketoacidosis.Medicine (Baltimore).1986;65(3):163172.
  15. Adrogue HJ,Madias NE.Changes in plasma potassium concentration during acute acid‐base disturbances.Am J Med.1981;71(3):456467.
  16. Giebisch G,Hebert SC,Wang WH.New aspects of renal potassium transport.Pflugers Arch.2003;446(3):289297.
  17. Fraley DS,Adler S.Correction of hyperkalemia by bicarbonate despite constant blood pH.Kidney Int.1977;12(5):354360.
  18. Blumberg A,Weidmann P,Shaw S,Gnadinger M.Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.Am J Med.1988;85(4):507512.
  19. Allon M,Shanklin N.Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.Am J Kidney Dis.1996;28(4):508514.
  20. Gutierrez R,Schlessinger F,Oster JR,Rietberg B,Perez GO.Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end‐stage renal disease.Miner Electrolyte Metab.1991;17(5):297302.
  21. Kim HJ.Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end‐stage renal disease patients.Nephron.1996;72(3):476482.
  22. Blumberg A,Weidmann P,Ferrari P.Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.Kidney Int.1992;41(2):369374.
  23. Carlisle EJ,Donnelly SM,Ethier JH, et al.Modulation of the secretion of potassium by accompanying anions in humans.Kidney Int.1991;39(6):12061212.
  24. Kamel KS,Wei C.Controversial issues in the treatment of hyperkalaemia.Nephrol Dial Transplant.2003;18(11):22152218.
  25. Forsythe SM,Schmidt GA.Sodium bicarbonate for the treatment of lactic acidosis.Chest.2000;117(1):260267.
  26. Weisberg LS.Management of severe hyperkalemia.Crit Care Med.2008;36(12):32463251.
  27. Mizock BA,Mecher C.Pyroglutamic acid and high anion gap: looking through the keyhole?Crit Care Med.2000;28(6):21402141.
  28. Fenves AZ,Kirkpatrick HM,Patel VV,Sweetman L,Emmett M.Increased anion gap metabolic acidosis as a result of 5‐oxoproline (pyroglutamic acid): a role for acetaminophen.Clin J Am Soc Nephrol.2006;1(3):441447.
  29. Dempsey GA,Lyall HJ,Corke CF,Scheinkestel CD.Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis.Crit Care Med.2000;28(6):18031807.
  30. Humphreys BD,Forman JP,Zandi‐Nejad K,Bazari H,Seifter J,Magee CC.Acetaminophen‐induced anion gap metabolic acidosis and 5‐oxoprolinuria (pyroglutamic aciduria) acquired in hospital.Am J Kidney Dis.2005;46(1):143146.
  31. Yale SH,Mazza JJ.Anion gap acidosis associated with acetaminophen.Ann Intern Med.2000;133(9):752753.
  32. Foot CL,Fraser JF,Mullany DV.Pyroglutamic acidosis in a renal transplant patient.Nephrol Dial Transplant.2005;20(12):28362838.
  33. Altomare E,Vendemiale G,Albano O.Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases.Life Sci.1988;43(12):991998.
  34. Jewell SA,Di Monte D,Gentile A,Guglielmi A,Altomare E,Albano O.Decreased hepatic glutathione in chronic alcoholic patients.J Hepatol.1986;3(1):16.
  35. Jaeschke H,Bajt ML.Intracellular signaling mechanisms of acetaminophen‐induced liver cell death.Toxicol Sci.2006;89(1):3141.
  36. Persaud C,Forrester T,Jackson AA.Urinary excretion of 5‐L‐oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine.J Nutr.1996;126(11):28232830.
  37. Bonham JR,Rattenbury JM,Meeks A,Pollitt RJ.Pyroglutamicaciduria from vigabatrin.Lancet.1989;1(8652):14521453.
  38. Lyons J,Rauh‐Pfeiffer A,Ming‐Yu Y, et al.Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients.Crit Care Med.2001;29(4):870877.
  39. Pitt JJ,Hauser S.Transient 5‐oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects.Clin Chem.1998;44(7):14971503.
  40. Rolleman EJ,Hoorn EJ,Didden P,Zietse R.Guilty as charged: unmeasured urinary anions in a case of pyroglutamic acidosis.Neth J Med.2008;66(8):351353.
  41. Mizock BA,Belyaev S,Mecher C.Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid.Intensive Care Med.2004;30(3):502505.
  42. Martensson J,Gustafsson J,Larsson A.A therapeutic trial with N‐acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5‐oxoprolinuria).J Inherit Metab Dis.1989;12(2):120130.
  43. Gruchalla RS.Diagnosis of allergic reactions to sulfonamides.Allergy.1999;54Suppl 58:2832.
  44. Tilles SA.Practical issues in the management of hypersensitivity reactions: sulfonamides.South Med J.2001;94(8):817824.
  45. Knowles S,Shapiro L,Shear NH.Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of ‘sulfa’ allergy.Drug Saf.2001;24(4):239247.
  46. Bretza JA.Thrombocytopenia due to sulfonamide cross‐sensitivity.Wis Med J.1982;81(6):2123.
  47. Bukhalo M,Zeitouni NC,Cheney RT.Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross‐reaction of a sulfonamide and a sulfonylurea.Cutis.2003;71(3):235238.
  48. Ernst EJ,Egge JA.Celecoxib‐induced erythema multiforme with glyburide cross‐reactivity.Pharmacotherapy.2002;22(5):637640.
  49. Landor M,Rosenstreich DL.Vesiculobullous rash in a patient with systemic lupus erythematosus.Ann Allergy.1993;70(3):196203.
  50. Ahmad A,Ramakrishnan A,McLean MA, et al.Use of optical biosensor technology to study immunological cross‐reactivity between different sulfonamide drugs.Anal Biochem.2002;300(2):177184.
  51. Cribb AE,Lee BL,Trepanier LA,Spielberg SP.Adverse reactions to sulphonamide and sulphonamide‐trimethoprim antimicrobials: clinical syndromes and pathogenesis.Adverse Drug React Toxicol Rev.1996;15(1):950.
  52. Holtzer CD,Flaherty JF,Coleman RL.Cross‐reactivity in HIV‐infected patients switched from trimethoprim‐sulfamethoxazole to dapsone.Pharmacotherapy.1998;18(4):831835.
  53. Strom BL,Schinnar R,Apter AJ, et al.Absence of cross‐reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.N Engl J Med.2003;349(17):16281635.
  54. Earl G,Davenport J,Narula J.Furosemide challenge in patients with heart failure and adverse reactions to sulfa‐containing diuretics.Ann Intern Med.2003;138(4):358359.
Article PDF
Issue
Journal of Hospital Medicine - 6(5)
Page Number
E1-E5
Legacy Keywords
nephrology, myths, hospitalist
Sections
Article PDF
Article PDF

There are many controversial topics relating to renal disease in hospitalized patients. The aim of this review is to shed light on some important and often debated issues. We will first discuss topics related to electrolytes disorder commonly seen in hospitalized patients (hyponatremia, hyperkalemia, metabolic acidosis) then the use of diuretics in patients with allergy to sulfa containing antibiotics.

Hypothyroidism and Hyponatremia

Hyponatremia is common in hospitalized patients and is associated with worse outcomes.1 It can be seen with a variety of conditions ranging from congestive heart failure to volume depletion. Careful history and physical examination are paramount and the initial work‐up usually includes serum and urine osmolality and urine sodium concentration.

For euvolemic hyponatremia, the differential diagnosis includes the syndrome of inappropriate adenine dinucleotide (ADH) secretion (SIADH), hypoadrenalism, and beer potomania. Additionally, many authorities also include hypothyroidism.

Although the simultaneous finding of hypothyroidism and hyponatremia can occur in patients as both diseases are widely prevalent in the general population, causation has yet to be convincingly demonstrated.

ADH is released in response to effective volume depletion; consequently when hypothyroidism is encountered in the setting of complete pituitary failure there is often hyponatremia.2, 3 Alternatively, with myxedema, the ability of the kidney to handle a water load and concentrate urine can be impaired.4

However, the observation that thyroid hormone administration did not raise sodium values in newborns with congenital hypothyroidism or in adults supports the absence of causal effect.5, 6And in addition, large studies done in the hospital and outpatient setting showed no differences between the serum sodium values of hypothyroid patients and that of controls.7, 8 In the study of outpatients, among those with hypothyroidism, for every increase of 10 mU/L of thyroid‐stimulating hormone (TSH), there was a drop of only 0.14 mmol/L of Na concentration.8 Thus, the elevation of TSH required for a clinically meaningful drop in sodium to occur was considerable.

Hence in patients with hyponatremia, the hospitalist should look for etiologies other than hypothyroidism and should only consider thyroid hypofunction as a culprit in cases of myxedema, or panhypopituitarism.

Sodium Bicarbonate for Hyperkalemia

Hyperkalemia is one of the most feared electrolyte disorders encountered in hospitalized patients and can lead to dire outcomes.9, 10

Potassium (K+) homeostasis is maintained in the body by 2 complimentary systems: a short‐term system that regulates K+ variation by modifying translocation across the cellular membrane and a long‐term system that adjusts overall K+ balance. The translocation system is regulated primarily by insulin and ‐2 stimulation. Overall K+ balance is mainly controlled by the kidney (90‐95%) although the gastrointestinal (GI) tract can have a more preponderant role in anephric patients.

Hyperkalemia can ensue by either a dysregulation of the translocation system (as in diabetic Ketoacidosis secondary to insulin deficiency) or impairment of K+ elimination.

Acid‐base status was previously thought to have a prominent influence on K+ concentration, based on studies that demonstrated that. However, studies looking at metabolic acidosis revealed that contrary to the effect of mineral acidosis (excess of nonmetabolizable anions)11 where there is an inverse correlation between potassium concentration and pH; organic acidosis (excess of metabolizable anions)11 was not associated with hyperkalemia.1214 However, organic acidosis can be seen simultaneously and induced by a same underlying disease (such as organ ischemia with lactic acidosis or insulin deficiency complicated by ketoacidosis). Also, when changes in pH are induced by respiratory variations or with alkalosis, the impact on serum K+ concentration is less remarkable.15 Hence, it seems that it is the nature of the acid‐base disturbance that impacts K+ concentration more than the change in pH itself.

In the kidney, the main site for regulation of K+ balance is the collecting duct. Factors that affect elimination include urinary sodium delivery, urine flow, and aldosterone.16 In order to adequately eliminate K+ these factors must be optimized in conjunction.

Treatment of hyperkalemia includes the sequential administration of agents that stabilize the cardiac membrane (calcium gluconate), shift the potassium intracellularly (insulin, ‐2 agonists), and remove the potassium (diuretics, sodium polystyrene, or dialysis).

The use of sodium bicarbonate for treatment of hyperkalemia has been long advocated.17 It was thought to act by translocation of potassium hence could be used to quickly lower K+ concentration. However, this dogma has been challenged recently.

To assess the true impact of sodium bicarbonate on potassium translocation, studies have been conducted on anephric patients with hyperkalemia. Bicarbonate infusion failed to elicit a significant rapid change in serum K+ concentration despite increase in bicarbonate concentration, arguing against a translocation mechanism.1821 After 60 minutes of treatment, neither isotonic nor hypertonic bicarbonate infusion affected Serum K+ levels in end‐stage renal disease (ESRD) patients.19, 20 On the contrary, hypertonic sodium bicarbonate increased the K+ concentration after 180 minutes of treatment,20 and it took a prolonged infusion of 4 hours to see a significant decrease in K+ concentration (0.6 mmol/L); half of which could be accounted for solely by volume administration. Moreover, this reduction was highly variable.

Rather, sodium bicarbonate seems to enhance potassium elimination by increasing sodium delivery to the distal tubule, increasing urinary pH and negative luminal charge and potentiating the action of diuretics.23 In an elegant study on normovolemic patients, the induction of bicarbonaturia practically doubled potassium excretion.23 However, such an effect is heterogeneous and usually takes place over 4 hours to 6 hours.17

At the cellular level, 2 ion exchange pumps cooperate to handle Na/K/H movement across the cellular membrane: an Na+/H+ exchanger (NHE) and the Na+/K+ ATP‐ase pump (Figure 1). The NHE is normally inactive and is only upregulated in cases of severe intracellular acidosis.24 The infusion of sodium bicarbonate to patients with severe metabolic acidosis could possibly decrease the serum potassium concentration by translocation if the NHE was significantly upregulated. However, this treatment can be associated with a drop in the ionized calcium level, a worsening of the intracellular acidosis, and a decreased peripheral oxygen delivery.25 Thus, the benefits should be balanced with the potential adverse effects and, even in cases of severe metabolic acidosis with hyperkalemia, we would advise the clinician to restrictively administer sodium bicarbonate.

Figure 1
Cellular exchangers.

In addition, in ESRD patients, the administration of sodium bicarbonate can be problematic owing to the osmotic and volume burden it carries. It should also be avoided in patients who are volume overload or in those with decreased ability to eliminate potassium.

When treating hyperkalemic patients, hospitalists should use sodium bicarbonate to potentiate urinary elimination of potassium and should consider administering it either with acetazolamide or a loop diuretic, anticipating a lowering effect after a few hours.26 It should be avoided in patients with volume overload and anuria. Immediate translocation of potassium into cells is best achieved by insulin and ‐2 agonists.

5‐Oxoprolinuria: A Newly Recognized Cause of High Anion Gap Metabolic Acidosis

There are several causes of metabolic high anion gap acidosis in hospitalized patients. However, despite careful investigations, the cause of that disorder is not always apparent.27 Recently, 5‐oxoprolinuria (also called pyroglutamic acidosis) has become increasingly recognized as a potential etiology.2832

The metabolism of glutamate (though the ‐Glutamyl cycle) generates glutathione which provides negative feedback to the ‐Glutamyl‐cysteine synthetase enzyme. The depletion of glutathione increases 5‐oxoproline production owing to the loss of that inhibition (Figures 2 and 3). Low glutathione levels can be seen with liver disease,33 chronic alcohol intake,34 acetaminophen use,35 malnutrition,36 renal dysfunction,29 use of vigabatrim (an antiepileptic that received Food and Drug Administration [FDA] approval for use in April 2009)37 and sepsis.38 Most of the reported cases were female and had more than one risk factor.39

Figure 2
Normal γ glutamyl cycle.
Figure 3
Cycle with glutathione depletion.

Typically, patients present with high anion gap acidosis (often more than 20)28 with normal acetaminophen levels and all usual tests being negative. A history of chronic acetaminophen use with or without other risk factors can frequently be found. The true independent impact of this type of acidosis on outcomes is difficult to determine as all of the reported cases had many confounding factors.

A urinary organic acid level is diagnostic and will reveal increased levels of pyroglutamic acid. Alternatively, the finding of a positive urinary anion gap (UNa +UK UCl) with a positive urinary osmolar gap (Uosmmeasured‐Uosmcalculated) in the appropriate clinical setting (unexplained high anion gap acidosis with negative workup and presence of risk factors for 5‐oxoproliniuria) can point towards the diagnosis.40

A study of patients with unexplained metabolic acidosis did not find any cases of 5‐oxoprolinuria.41 Although this might suggest that the incidence of this disease is low, very few of those patients were actually taking acetaminophen (therefore had a reduced propensity for developing pyroglutamic acidosis).41 Thus, the actual incidence of 5‐oxoprolinuria is hard to determine.

Once recognized, acetaminophen should be withheld and N‐acetylcysteine (NAC) can be used to replete glutathione levels although there is no convincing evidence for this use.42 It is important for hospitalists to be aware of this disorder as it can pose a diagnostic challenge (negative usual work‐up), is easy to treat by stopping acetaminophen, and can (possibly) negatively affect outcomes.

Furosemide and Patients With Sulfa Allergy

Allergic reactions are a common occurrence with sulfa‐containing antibiotics (SCA) and reports estimates the incidence to be approximately 3% to 5%.43, 44

One misbelief is that patients who are allergic to SCAs should not receive sulfa containing diuretics or other sulfa‐containing medications.45 This leads some physicians to substitute commonly used diuretics (such as furosemide or thiazides) for ethacrynic acid. The use of ethacrynic acid has several challenges: the limited supply of the intravenous form, the discontinuation of the oral form, the increased cost, and the risk of permanent ototoxicity.

The evidence for potential allergic cross‐reactivity among medications containing the sulfa moiety has been primarily derived from Case Reports.4649

The molecular structures of sulfamethoxazole and furosemide are shown below. The allergic antigen is most often the N1 component,45 and sometimes N4 but not the sulfa moiety. Both of the incriminated antigens are not present in the furosemide structure (as well as all other sulfa containing diuretics) (Figures 4 and 5).

Figure 4
Sulfamethoxazole (SMX) molecule structure.
Figure 5
Furosemide molecule structure.

Experimental data showed that serum from patients allergic to SCAs did not bind to diuretics.50 In addition, clinical reports failed to demonstrate cross‐reactivity.5153 In a large clinical trial, Strom et al.53 showed that although there was a higher risk for allergic reaction to sulfa containing medications (SCM) in patients allergic to SCA (compared to those who were not), it was lower among patients with an allergy to sulfa antibiotic than among patients with a history of hypersensitivity to penicillins, suggesting this was due to a predisposition to allergic reactions in general rather than true cross‐reactivity. In another report, patients who were receiving ethacrynic acid for many years were successfully and uneventfully switched to furosemide.54

Taken together, these findings suggest that there is no evidence for withholding sulfa nonantibiotics in patients allergic to sulfa containing antibiotics.

Conclusion

Hypothyroidism, unlike myxedema, is not a cause of hyponatremia (although it can be sometimes seen in conjunction with the latter) and additional investigations should be done to determine its etiology. Sodium bicarbonate is effective for treatment of hyperkalemia by enhancing renal potassium elimination, rather than from shifting potassium into cells. The 5‐oxoprolinuria is a newly recognized cause of high anion‐gap metabolic acidosis and should be considered in patients who have taken acetaminophen. Furosemide (and sulfa containing diuretics) can be used safely in patients with an allergy to SCA.

There are many controversial topics relating to renal disease in hospitalized patients. The aim of this review is to shed light on some important and often debated issues. We will first discuss topics related to electrolytes disorder commonly seen in hospitalized patients (hyponatremia, hyperkalemia, metabolic acidosis) then the use of diuretics in patients with allergy to sulfa containing antibiotics.

Hypothyroidism and Hyponatremia

Hyponatremia is common in hospitalized patients and is associated with worse outcomes.1 It can be seen with a variety of conditions ranging from congestive heart failure to volume depletion. Careful history and physical examination are paramount and the initial work‐up usually includes serum and urine osmolality and urine sodium concentration.

For euvolemic hyponatremia, the differential diagnosis includes the syndrome of inappropriate adenine dinucleotide (ADH) secretion (SIADH), hypoadrenalism, and beer potomania. Additionally, many authorities also include hypothyroidism.

Although the simultaneous finding of hypothyroidism and hyponatremia can occur in patients as both diseases are widely prevalent in the general population, causation has yet to be convincingly demonstrated.

ADH is released in response to effective volume depletion; consequently when hypothyroidism is encountered in the setting of complete pituitary failure there is often hyponatremia.2, 3 Alternatively, with myxedema, the ability of the kidney to handle a water load and concentrate urine can be impaired.4

However, the observation that thyroid hormone administration did not raise sodium values in newborns with congenital hypothyroidism or in adults supports the absence of causal effect.5, 6And in addition, large studies done in the hospital and outpatient setting showed no differences between the serum sodium values of hypothyroid patients and that of controls.7, 8 In the study of outpatients, among those with hypothyroidism, for every increase of 10 mU/L of thyroid‐stimulating hormone (TSH), there was a drop of only 0.14 mmol/L of Na concentration.8 Thus, the elevation of TSH required for a clinically meaningful drop in sodium to occur was considerable.

Hence in patients with hyponatremia, the hospitalist should look for etiologies other than hypothyroidism and should only consider thyroid hypofunction as a culprit in cases of myxedema, or panhypopituitarism.

Sodium Bicarbonate for Hyperkalemia

Hyperkalemia is one of the most feared electrolyte disorders encountered in hospitalized patients and can lead to dire outcomes.9, 10

Potassium (K+) homeostasis is maintained in the body by 2 complimentary systems: a short‐term system that regulates K+ variation by modifying translocation across the cellular membrane and a long‐term system that adjusts overall K+ balance. The translocation system is regulated primarily by insulin and ‐2 stimulation. Overall K+ balance is mainly controlled by the kidney (90‐95%) although the gastrointestinal (GI) tract can have a more preponderant role in anephric patients.

Hyperkalemia can ensue by either a dysregulation of the translocation system (as in diabetic Ketoacidosis secondary to insulin deficiency) or impairment of K+ elimination.

Acid‐base status was previously thought to have a prominent influence on K+ concentration, based on studies that demonstrated that. However, studies looking at metabolic acidosis revealed that contrary to the effect of mineral acidosis (excess of nonmetabolizable anions)11 where there is an inverse correlation between potassium concentration and pH; organic acidosis (excess of metabolizable anions)11 was not associated with hyperkalemia.1214 However, organic acidosis can be seen simultaneously and induced by a same underlying disease (such as organ ischemia with lactic acidosis or insulin deficiency complicated by ketoacidosis). Also, when changes in pH are induced by respiratory variations or with alkalosis, the impact on serum K+ concentration is less remarkable.15 Hence, it seems that it is the nature of the acid‐base disturbance that impacts K+ concentration more than the change in pH itself.

In the kidney, the main site for regulation of K+ balance is the collecting duct. Factors that affect elimination include urinary sodium delivery, urine flow, and aldosterone.16 In order to adequately eliminate K+ these factors must be optimized in conjunction.

Treatment of hyperkalemia includes the sequential administration of agents that stabilize the cardiac membrane (calcium gluconate), shift the potassium intracellularly (insulin, ‐2 agonists), and remove the potassium (diuretics, sodium polystyrene, or dialysis).

The use of sodium bicarbonate for treatment of hyperkalemia has been long advocated.17 It was thought to act by translocation of potassium hence could be used to quickly lower K+ concentration. However, this dogma has been challenged recently.

To assess the true impact of sodium bicarbonate on potassium translocation, studies have been conducted on anephric patients with hyperkalemia. Bicarbonate infusion failed to elicit a significant rapid change in serum K+ concentration despite increase in bicarbonate concentration, arguing against a translocation mechanism.1821 After 60 minutes of treatment, neither isotonic nor hypertonic bicarbonate infusion affected Serum K+ levels in end‐stage renal disease (ESRD) patients.19, 20 On the contrary, hypertonic sodium bicarbonate increased the K+ concentration after 180 minutes of treatment,20 and it took a prolonged infusion of 4 hours to see a significant decrease in K+ concentration (0.6 mmol/L); half of which could be accounted for solely by volume administration. Moreover, this reduction was highly variable.

Rather, sodium bicarbonate seems to enhance potassium elimination by increasing sodium delivery to the distal tubule, increasing urinary pH and negative luminal charge and potentiating the action of diuretics.23 In an elegant study on normovolemic patients, the induction of bicarbonaturia practically doubled potassium excretion.23 However, such an effect is heterogeneous and usually takes place over 4 hours to 6 hours.17

At the cellular level, 2 ion exchange pumps cooperate to handle Na/K/H movement across the cellular membrane: an Na+/H+ exchanger (NHE) and the Na+/K+ ATP‐ase pump (Figure 1). The NHE is normally inactive and is only upregulated in cases of severe intracellular acidosis.24 The infusion of sodium bicarbonate to patients with severe metabolic acidosis could possibly decrease the serum potassium concentration by translocation if the NHE was significantly upregulated. However, this treatment can be associated with a drop in the ionized calcium level, a worsening of the intracellular acidosis, and a decreased peripheral oxygen delivery.25 Thus, the benefits should be balanced with the potential adverse effects and, even in cases of severe metabolic acidosis with hyperkalemia, we would advise the clinician to restrictively administer sodium bicarbonate.

Figure 1
Cellular exchangers.

In addition, in ESRD patients, the administration of sodium bicarbonate can be problematic owing to the osmotic and volume burden it carries. It should also be avoided in patients who are volume overload or in those with decreased ability to eliminate potassium.

When treating hyperkalemic patients, hospitalists should use sodium bicarbonate to potentiate urinary elimination of potassium and should consider administering it either with acetazolamide or a loop diuretic, anticipating a lowering effect after a few hours.26 It should be avoided in patients with volume overload and anuria. Immediate translocation of potassium into cells is best achieved by insulin and ‐2 agonists.

5‐Oxoprolinuria: A Newly Recognized Cause of High Anion Gap Metabolic Acidosis

There are several causes of metabolic high anion gap acidosis in hospitalized patients. However, despite careful investigations, the cause of that disorder is not always apparent.27 Recently, 5‐oxoprolinuria (also called pyroglutamic acidosis) has become increasingly recognized as a potential etiology.2832

The metabolism of glutamate (though the ‐Glutamyl cycle) generates glutathione which provides negative feedback to the ‐Glutamyl‐cysteine synthetase enzyme. The depletion of glutathione increases 5‐oxoproline production owing to the loss of that inhibition (Figures 2 and 3). Low glutathione levels can be seen with liver disease,33 chronic alcohol intake,34 acetaminophen use,35 malnutrition,36 renal dysfunction,29 use of vigabatrim (an antiepileptic that received Food and Drug Administration [FDA] approval for use in April 2009)37 and sepsis.38 Most of the reported cases were female and had more than one risk factor.39

Figure 2
Normal γ glutamyl cycle.
Figure 3
Cycle with glutathione depletion.

Typically, patients present with high anion gap acidosis (often more than 20)28 with normal acetaminophen levels and all usual tests being negative. A history of chronic acetaminophen use with or without other risk factors can frequently be found. The true independent impact of this type of acidosis on outcomes is difficult to determine as all of the reported cases had many confounding factors.

A urinary organic acid level is diagnostic and will reveal increased levels of pyroglutamic acid. Alternatively, the finding of a positive urinary anion gap (UNa +UK UCl) with a positive urinary osmolar gap (Uosmmeasured‐Uosmcalculated) in the appropriate clinical setting (unexplained high anion gap acidosis with negative workup and presence of risk factors for 5‐oxoproliniuria) can point towards the diagnosis.40

A study of patients with unexplained metabolic acidosis did not find any cases of 5‐oxoprolinuria.41 Although this might suggest that the incidence of this disease is low, very few of those patients were actually taking acetaminophen (therefore had a reduced propensity for developing pyroglutamic acidosis).41 Thus, the actual incidence of 5‐oxoprolinuria is hard to determine.

Once recognized, acetaminophen should be withheld and N‐acetylcysteine (NAC) can be used to replete glutathione levels although there is no convincing evidence for this use.42 It is important for hospitalists to be aware of this disorder as it can pose a diagnostic challenge (negative usual work‐up), is easy to treat by stopping acetaminophen, and can (possibly) negatively affect outcomes.

Furosemide and Patients With Sulfa Allergy

Allergic reactions are a common occurrence with sulfa‐containing antibiotics (SCA) and reports estimates the incidence to be approximately 3% to 5%.43, 44

One misbelief is that patients who are allergic to SCAs should not receive sulfa containing diuretics or other sulfa‐containing medications.45 This leads some physicians to substitute commonly used diuretics (such as furosemide or thiazides) for ethacrynic acid. The use of ethacrynic acid has several challenges: the limited supply of the intravenous form, the discontinuation of the oral form, the increased cost, and the risk of permanent ototoxicity.

The evidence for potential allergic cross‐reactivity among medications containing the sulfa moiety has been primarily derived from Case Reports.4649

The molecular structures of sulfamethoxazole and furosemide are shown below. The allergic antigen is most often the N1 component,45 and sometimes N4 but not the sulfa moiety. Both of the incriminated antigens are not present in the furosemide structure (as well as all other sulfa containing diuretics) (Figures 4 and 5).

Figure 4
Sulfamethoxazole (SMX) molecule structure.
Figure 5
Furosemide molecule structure.

Experimental data showed that serum from patients allergic to SCAs did not bind to diuretics.50 In addition, clinical reports failed to demonstrate cross‐reactivity.5153 In a large clinical trial, Strom et al.53 showed that although there was a higher risk for allergic reaction to sulfa containing medications (SCM) in patients allergic to SCA (compared to those who were not), it was lower among patients with an allergy to sulfa antibiotic than among patients with a history of hypersensitivity to penicillins, suggesting this was due to a predisposition to allergic reactions in general rather than true cross‐reactivity. In another report, patients who were receiving ethacrynic acid for many years were successfully and uneventfully switched to furosemide.54

Taken together, these findings suggest that there is no evidence for withholding sulfa nonantibiotics in patients allergic to sulfa containing antibiotics.

Conclusion

Hypothyroidism, unlike myxedema, is not a cause of hyponatremia (although it can be sometimes seen in conjunction with the latter) and additional investigations should be done to determine its etiology. Sodium bicarbonate is effective for treatment of hyperkalemia by enhancing renal potassium elimination, rather than from shifting potassium into cells. The 5‐oxoprolinuria is a newly recognized cause of high anion‐gap metabolic acidosis and should be considered in patients who have taken acetaminophen. Furosemide (and sulfa containing diuretics) can be used safely in patients with an allergy to SCA.

References
  1. Waikar SS,Mount DB,Curhan GC.Mortality after hospitalization with mild, moderate, and severe hyponatremia.Am J Med.2009;122(9):857865.
  2. Kurtulmus N,Yarman S.Hyponatremia as the presenting manifestation of Sheehan's syndrome in elderly patients.Aging Clin Exp Res.2006;18(6):536539.
  3. Pham PC,Pham PA,Pham PT.Sodium and water disturbances in patients with Sheehan's syndrome.Am J Kidney Dis.2001;38(3):E14.
  4. Bai Y,Liu XM,Guo ZS,Dai WX,Shi YF,Zhou XY.Effect of acute water loading on plasma levels of antidiuretic hormone AVP aldosterone, ANP fractional excretion of sodium and plasma and urine osmolalities in myxedema.Chin Med J (Engl).1990;103(9):704708.
  5. Asami T,Uchiyama M.Sodium handling in congenitally hypothyroid neonates.Acta Paediatr.2004;93(1):2224.
  6. Baajafer FS,Hammami MM,Mohamed GE.Prevalence and severity of hyponatremia and hypercreatininemia in short‐term uncomplicated hypothyroidism.J Endocrinol Invest.1999;22(1):3539.
  7. Croal BL,Blake AM,Johnston J,Glen AC,O'Reilly DS.Absence of relation between hyponatraemia and hypothyroidism.Lancet.1997;350(9088):1402.
  8. Warner MH,Holding S,Kilpatrick ES.The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study.Clin Endocrinol (Oxf).2006;64(5):598599.
  9. Gennari FJ.Disorders of potassium homeostasis. Hypokalemia and hyperkalemia.Crit Care Clin.2002;18(2):273288,vi.
  10. Stevens MS,Dunlay RW.Hyperkalemia in hospitalized patients.Int Urol Nephrol.2000;32(2):177180.
  11. Levraut J,Grimaud D.Treatment of metabolic acidosis.Curr Opin Crit Care.2003;9(4):260265.
  12. Orringer CE,Eustace JC,Wunsch CD,Gardner LB.Natural history of lactic acidosis after grand‐mal seizures. A model for the study of an anion‐gap acidosis not associated with hyperkalemia.N Engl J Med.1977;297(15):796799.
  13. Magner PO,Robinson L,Halperin RM,Zettle R,Halperin ML.The plasma potassium concentration in metabolic acidosis: a re‐evaluation.Am J Kidney Dis.1988;11(3):220224.
  14. Adrogue HJ,Lederer ED,Suki WN,Eknoyan G.Determinants of plasma potassium levels in diabetic ketoacidosis.Medicine (Baltimore).1986;65(3):163172.
  15. Adrogue HJ,Madias NE.Changes in plasma potassium concentration during acute acid‐base disturbances.Am J Med.1981;71(3):456467.
  16. Giebisch G,Hebert SC,Wang WH.New aspects of renal potassium transport.Pflugers Arch.2003;446(3):289297.
  17. Fraley DS,Adler S.Correction of hyperkalemia by bicarbonate despite constant blood pH.Kidney Int.1977;12(5):354360.
  18. Blumberg A,Weidmann P,Shaw S,Gnadinger M.Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.Am J Med.1988;85(4):507512.
  19. Allon M,Shanklin N.Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.Am J Kidney Dis.1996;28(4):508514.
  20. Gutierrez R,Schlessinger F,Oster JR,Rietberg B,Perez GO.Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end‐stage renal disease.Miner Electrolyte Metab.1991;17(5):297302.
  21. Kim HJ.Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end‐stage renal disease patients.Nephron.1996;72(3):476482.
  22. Blumberg A,Weidmann P,Ferrari P.Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.Kidney Int.1992;41(2):369374.
  23. Carlisle EJ,Donnelly SM,Ethier JH, et al.Modulation of the secretion of potassium by accompanying anions in humans.Kidney Int.1991;39(6):12061212.
  24. Kamel KS,Wei C.Controversial issues in the treatment of hyperkalaemia.Nephrol Dial Transplant.2003;18(11):22152218.
  25. Forsythe SM,Schmidt GA.Sodium bicarbonate for the treatment of lactic acidosis.Chest.2000;117(1):260267.
  26. Weisberg LS.Management of severe hyperkalemia.Crit Care Med.2008;36(12):32463251.
  27. Mizock BA,Mecher C.Pyroglutamic acid and high anion gap: looking through the keyhole?Crit Care Med.2000;28(6):21402141.
  28. Fenves AZ,Kirkpatrick HM,Patel VV,Sweetman L,Emmett M.Increased anion gap metabolic acidosis as a result of 5‐oxoproline (pyroglutamic acid): a role for acetaminophen.Clin J Am Soc Nephrol.2006;1(3):441447.
  29. Dempsey GA,Lyall HJ,Corke CF,Scheinkestel CD.Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis.Crit Care Med.2000;28(6):18031807.
  30. Humphreys BD,Forman JP,Zandi‐Nejad K,Bazari H,Seifter J,Magee CC.Acetaminophen‐induced anion gap metabolic acidosis and 5‐oxoprolinuria (pyroglutamic aciduria) acquired in hospital.Am J Kidney Dis.2005;46(1):143146.
  31. Yale SH,Mazza JJ.Anion gap acidosis associated with acetaminophen.Ann Intern Med.2000;133(9):752753.
  32. Foot CL,Fraser JF,Mullany DV.Pyroglutamic acidosis in a renal transplant patient.Nephrol Dial Transplant.2005;20(12):28362838.
  33. Altomare E,Vendemiale G,Albano O.Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases.Life Sci.1988;43(12):991998.
  34. Jewell SA,Di Monte D,Gentile A,Guglielmi A,Altomare E,Albano O.Decreased hepatic glutathione in chronic alcoholic patients.J Hepatol.1986;3(1):16.
  35. Jaeschke H,Bajt ML.Intracellular signaling mechanisms of acetaminophen‐induced liver cell death.Toxicol Sci.2006;89(1):3141.
  36. Persaud C,Forrester T,Jackson AA.Urinary excretion of 5‐L‐oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine.J Nutr.1996;126(11):28232830.
  37. Bonham JR,Rattenbury JM,Meeks A,Pollitt RJ.Pyroglutamicaciduria from vigabatrin.Lancet.1989;1(8652):14521453.
  38. Lyons J,Rauh‐Pfeiffer A,Ming‐Yu Y, et al.Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients.Crit Care Med.2001;29(4):870877.
  39. Pitt JJ,Hauser S.Transient 5‐oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects.Clin Chem.1998;44(7):14971503.
  40. Rolleman EJ,Hoorn EJ,Didden P,Zietse R.Guilty as charged: unmeasured urinary anions in a case of pyroglutamic acidosis.Neth J Med.2008;66(8):351353.
  41. Mizock BA,Belyaev S,Mecher C.Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid.Intensive Care Med.2004;30(3):502505.
  42. Martensson J,Gustafsson J,Larsson A.A therapeutic trial with N‐acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5‐oxoprolinuria).J Inherit Metab Dis.1989;12(2):120130.
  43. Gruchalla RS.Diagnosis of allergic reactions to sulfonamides.Allergy.1999;54Suppl 58:2832.
  44. Tilles SA.Practical issues in the management of hypersensitivity reactions: sulfonamides.South Med J.2001;94(8):817824.
  45. Knowles S,Shapiro L,Shear NH.Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of ‘sulfa’ allergy.Drug Saf.2001;24(4):239247.
  46. Bretza JA.Thrombocytopenia due to sulfonamide cross‐sensitivity.Wis Med J.1982;81(6):2123.
  47. Bukhalo M,Zeitouni NC,Cheney RT.Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross‐reaction of a sulfonamide and a sulfonylurea.Cutis.2003;71(3):235238.
  48. Ernst EJ,Egge JA.Celecoxib‐induced erythema multiforme with glyburide cross‐reactivity.Pharmacotherapy.2002;22(5):637640.
  49. Landor M,Rosenstreich DL.Vesiculobullous rash in a patient with systemic lupus erythematosus.Ann Allergy.1993;70(3):196203.
  50. Ahmad A,Ramakrishnan A,McLean MA, et al.Use of optical biosensor technology to study immunological cross‐reactivity between different sulfonamide drugs.Anal Biochem.2002;300(2):177184.
  51. Cribb AE,Lee BL,Trepanier LA,Spielberg SP.Adverse reactions to sulphonamide and sulphonamide‐trimethoprim antimicrobials: clinical syndromes and pathogenesis.Adverse Drug React Toxicol Rev.1996;15(1):950.
  52. Holtzer CD,Flaherty JF,Coleman RL.Cross‐reactivity in HIV‐infected patients switched from trimethoprim‐sulfamethoxazole to dapsone.Pharmacotherapy.1998;18(4):831835.
  53. Strom BL,Schinnar R,Apter AJ, et al.Absence of cross‐reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.N Engl J Med.2003;349(17):16281635.
  54. Earl G,Davenport J,Narula J.Furosemide challenge in patients with heart failure and adverse reactions to sulfa‐containing diuretics.Ann Intern Med.2003;138(4):358359.
References
  1. Waikar SS,Mount DB,Curhan GC.Mortality after hospitalization with mild, moderate, and severe hyponatremia.Am J Med.2009;122(9):857865.
  2. Kurtulmus N,Yarman S.Hyponatremia as the presenting manifestation of Sheehan's syndrome in elderly patients.Aging Clin Exp Res.2006;18(6):536539.
  3. Pham PC,Pham PA,Pham PT.Sodium and water disturbances in patients with Sheehan's syndrome.Am J Kidney Dis.2001;38(3):E14.
  4. Bai Y,Liu XM,Guo ZS,Dai WX,Shi YF,Zhou XY.Effect of acute water loading on plasma levels of antidiuretic hormone AVP aldosterone, ANP fractional excretion of sodium and plasma and urine osmolalities in myxedema.Chin Med J (Engl).1990;103(9):704708.
  5. Asami T,Uchiyama M.Sodium handling in congenitally hypothyroid neonates.Acta Paediatr.2004;93(1):2224.
  6. Baajafer FS,Hammami MM,Mohamed GE.Prevalence and severity of hyponatremia and hypercreatininemia in short‐term uncomplicated hypothyroidism.J Endocrinol Invest.1999;22(1):3539.
  7. Croal BL,Blake AM,Johnston J,Glen AC,O'Reilly DS.Absence of relation between hyponatraemia and hypothyroidism.Lancet.1997;350(9088):1402.
  8. Warner MH,Holding S,Kilpatrick ES.The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study.Clin Endocrinol (Oxf).2006;64(5):598599.
  9. Gennari FJ.Disorders of potassium homeostasis. Hypokalemia and hyperkalemia.Crit Care Clin.2002;18(2):273288,vi.
  10. Stevens MS,Dunlay RW.Hyperkalemia in hospitalized patients.Int Urol Nephrol.2000;32(2):177180.
  11. Levraut J,Grimaud D.Treatment of metabolic acidosis.Curr Opin Crit Care.2003;9(4):260265.
  12. Orringer CE,Eustace JC,Wunsch CD,Gardner LB.Natural history of lactic acidosis after grand‐mal seizures. A model for the study of an anion‐gap acidosis not associated with hyperkalemia.N Engl J Med.1977;297(15):796799.
  13. Magner PO,Robinson L,Halperin RM,Zettle R,Halperin ML.The plasma potassium concentration in metabolic acidosis: a re‐evaluation.Am J Kidney Dis.1988;11(3):220224.
  14. Adrogue HJ,Lederer ED,Suki WN,Eknoyan G.Determinants of plasma potassium levels in diabetic ketoacidosis.Medicine (Baltimore).1986;65(3):163172.
  15. Adrogue HJ,Madias NE.Changes in plasma potassium concentration during acute acid‐base disturbances.Am J Med.1981;71(3):456467.
  16. Giebisch G,Hebert SC,Wang WH.New aspects of renal potassium transport.Pflugers Arch.2003;446(3):289297.
  17. Fraley DS,Adler S.Correction of hyperkalemia by bicarbonate despite constant blood pH.Kidney Int.1977;12(5):354360.
  18. Blumberg A,Weidmann P,Shaw S,Gnadinger M.Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.Am J Med.1988;85(4):507512.
  19. Allon M,Shanklin N.Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.Am J Kidney Dis.1996;28(4):508514.
  20. Gutierrez R,Schlessinger F,Oster JR,Rietberg B,Perez GO.Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end‐stage renal disease.Miner Electrolyte Metab.1991;17(5):297302.
  21. Kim HJ.Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end‐stage renal disease patients.Nephron.1996;72(3):476482.
  22. Blumberg A,Weidmann P,Ferrari P.Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.Kidney Int.1992;41(2):369374.
  23. Carlisle EJ,Donnelly SM,Ethier JH, et al.Modulation of the secretion of potassium by accompanying anions in humans.Kidney Int.1991;39(6):12061212.
  24. Kamel KS,Wei C.Controversial issues in the treatment of hyperkalaemia.Nephrol Dial Transplant.2003;18(11):22152218.
  25. Forsythe SM,Schmidt GA.Sodium bicarbonate for the treatment of lactic acidosis.Chest.2000;117(1):260267.
  26. Weisberg LS.Management of severe hyperkalemia.Crit Care Med.2008;36(12):32463251.
  27. Mizock BA,Mecher C.Pyroglutamic acid and high anion gap: looking through the keyhole?Crit Care Med.2000;28(6):21402141.
  28. Fenves AZ,Kirkpatrick HM,Patel VV,Sweetman L,Emmett M.Increased anion gap metabolic acidosis as a result of 5‐oxoproline (pyroglutamic acid): a role for acetaminophen.Clin J Am Soc Nephrol.2006;1(3):441447.
  29. Dempsey GA,Lyall HJ,Corke CF,Scheinkestel CD.Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis.Crit Care Med.2000;28(6):18031807.
  30. Humphreys BD,Forman JP,Zandi‐Nejad K,Bazari H,Seifter J,Magee CC.Acetaminophen‐induced anion gap metabolic acidosis and 5‐oxoprolinuria (pyroglutamic aciduria) acquired in hospital.Am J Kidney Dis.2005;46(1):143146.
  31. Yale SH,Mazza JJ.Anion gap acidosis associated with acetaminophen.Ann Intern Med.2000;133(9):752753.
  32. Foot CL,Fraser JF,Mullany DV.Pyroglutamic acidosis in a renal transplant patient.Nephrol Dial Transplant.2005;20(12):28362838.
  33. Altomare E,Vendemiale G,Albano O.Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases.Life Sci.1988;43(12):991998.
  34. Jewell SA,Di Monte D,Gentile A,Guglielmi A,Altomare E,Albano O.Decreased hepatic glutathione in chronic alcoholic patients.J Hepatol.1986;3(1):16.
  35. Jaeschke H,Bajt ML.Intracellular signaling mechanisms of acetaminophen‐induced liver cell death.Toxicol Sci.2006;89(1):3141.
  36. Persaud C,Forrester T,Jackson AA.Urinary excretion of 5‐L‐oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine.J Nutr.1996;126(11):28232830.
  37. Bonham JR,Rattenbury JM,Meeks A,Pollitt RJ.Pyroglutamicaciduria from vigabatrin.Lancet.1989;1(8652):14521453.
  38. Lyons J,Rauh‐Pfeiffer A,Ming‐Yu Y, et al.Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients.Crit Care Med.2001;29(4):870877.
  39. Pitt JJ,Hauser S.Transient 5‐oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects.Clin Chem.1998;44(7):14971503.
  40. Rolleman EJ,Hoorn EJ,Didden P,Zietse R.Guilty as charged: unmeasured urinary anions in a case of pyroglutamic acidosis.Neth J Med.2008;66(8):351353.
  41. Mizock BA,Belyaev S,Mecher C.Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid.Intensive Care Med.2004;30(3):502505.
  42. Martensson J,Gustafsson J,Larsson A.A therapeutic trial with N‐acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5‐oxoprolinuria).J Inherit Metab Dis.1989;12(2):120130.
  43. Gruchalla RS.Diagnosis of allergic reactions to sulfonamides.Allergy.1999;54Suppl 58:2832.
  44. Tilles SA.Practical issues in the management of hypersensitivity reactions: sulfonamides.South Med J.2001;94(8):817824.
  45. Knowles S,Shapiro L,Shear NH.Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of ‘sulfa’ allergy.Drug Saf.2001;24(4):239247.
  46. Bretza JA.Thrombocytopenia due to sulfonamide cross‐sensitivity.Wis Med J.1982;81(6):2123.
  47. Bukhalo M,Zeitouni NC,Cheney RT.Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross‐reaction of a sulfonamide and a sulfonylurea.Cutis.2003;71(3):235238.
  48. Ernst EJ,Egge JA.Celecoxib‐induced erythema multiforme with glyburide cross‐reactivity.Pharmacotherapy.2002;22(5):637640.
  49. Landor M,Rosenstreich DL.Vesiculobullous rash in a patient with systemic lupus erythematosus.Ann Allergy.1993;70(3):196203.
  50. Ahmad A,Ramakrishnan A,McLean MA, et al.Use of optical biosensor technology to study immunological cross‐reactivity between different sulfonamide drugs.Anal Biochem.2002;300(2):177184.
  51. Cribb AE,Lee BL,Trepanier LA,Spielberg SP.Adverse reactions to sulphonamide and sulphonamide‐trimethoprim antimicrobials: clinical syndromes and pathogenesis.Adverse Drug React Toxicol Rev.1996;15(1):950.
  52. Holtzer CD,Flaherty JF,Coleman RL.Cross‐reactivity in HIV‐infected patients switched from trimethoprim‐sulfamethoxazole to dapsone.Pharmacotherapy.1998;18(4):831835.
  53. Strom BL,Schinnar R,Apter AJ, et al.Absence of cross‐reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.N Engl J Med.2003;349(17):16281635.
  54. Earl G,Davenport J,Narula J.Furosemide challenge in patients with heart failure and adverse reactions to sulfa‐containing diuretics.Ann Intern Med.2003;138(4):358359.
Issue
Journal of Hospital Medicine - 6(5)
Issue
Journal of Hospital Medicine - 6(5)
Page Number
E1-E5
Page Number
E1-E5
Article Type
Display Headline
Four nephrology myths debunked
Display Headline
Four nephrology myths debunked
Legacy Keywords
nephrology, myths, hospitalist
Legacy Keywords
nephrology, myths, hospitalist
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Education and Research building, second floor, Room #286, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Cooper University Hospital, Camden, NJ 08103
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Report Supports Telemedicine Use in ICU

Article Type
Changed
Fri, 09/14/2018 - 12:29
Display Headline
Report Supports Telemedicine Use in ICU

A new report that outlines the potential care delivery improvements and cost savings of telemedicine might also be a road map to increased efficiency for hospitalists, according to one of the study’s authors and a former SHM president.

Telemedicine "simplifies their life," says Mitchell Adams, AB, MBA, executive director of the Massachusetts Technology Collaborative (MTC) in Boston, which coauthored "Critical Care, Critical Choices: The Case for Tele-ICUs in Intensive Care" with the New England Healthcare Institute (NEHI) in Cambridge. "It means you have you less complications, you have less work. You have an intensivist looking over your shoulder, making sure you’re doing it right."

As the population ages and hospitalists become more entrenched in their institutions, they could end up spending more time on ICU cases. The use of telemedicine—where an intensivist at a remote “command center” oversees the delivery of care—could foster higher-quality and more efficient care, which would subsequently allow HM practitioners to focus on the rest of the census, according to Mary Jo Gorman, MD, MBA, FHM, former SHM president and CEO of St. Louis-based Advanced ICU Care, which provides intensivists to community hospitals using telemedicine.

The study, based on a demonstration project at the University of Massachusetts Memorial Medical Center and two associated community hospitals, reported a 20% drop in ICU mortality at the academic medical center (P=0.01). When adjusted for the severity of ICU illnesses, one community hospital reported a 36% drop in mortality (P=0.83); the other reported a 142% increase (P<0.001). All three centers also reported a reduction in length of stay (LOS) of at least 12 hours.

Dr. Gorman and Adams agree that it will take more evidence-based studies showing the efficacy of telemedicine before the practice becomes widespread, a phenomenon Adams attributes to the "inherent inertia and viscosity in the system to maintain the status quo."

"Everybody might know the right answer," Dr. Gorman adds. "It's still going to take a long time. That’s just the pace at which we move in healthcare."

Issue
The Hospitalist - 2010(12)
Publications
Topics
Sections

A new report that outlines the potential care delivery improvements and cost savings of telemedicine might also be a road map to increased efficiency for hospitalists, according to one of the study’s authors and a former SHM president.

Telemedicine "simplifies their life," says Mitchell Adams, AB, MBA, executive director of the Massachusetts Technology Collaborative (MTC) in Boston, which coauthored "Critical Care, Critical Choices: The Case for Tele-ICUs in Intensive Care" with the New England Healthcare Institute (NEHI) in Cambridge. "It means you have you less complications, you have less work. You have an intensivist looking over your shoulder, making sure you’re doing it right."

As the population ages and hospitalists become more entrenched in their institutions, they could end up spending more time on ICU cases. The use of telemedicine—where an intensivist at a remote “command center” oversees the delivery of care—could foster higher-quality and more efficient care, which would subsequently allow HM practitioners to focus on the rest of the census, according to Mary Jo Gorman, MD, MBA, FHM, former SHM president and CEO of St. Louis-based Advanced ICU Care, which provides intensivists to community hospitals using telemedicine.

The study, based on a demonstration project at the University of Massachusetts Memorial Medical Center and two associated community hospitals, reported a 20% drop in ICU mortality at the academic medical center (P=0.01). When adjusted for the severity of ICU illnesses, one community hospital reported a 36% drop in mortality (P=0.83); the other reported a 142% increase (P<0.001). All three centers also reported a reduction in length of stay (LOS) of at least 12 hours.

Dr. Gorman and Adams agree that it will take more evidence-based studies showing the efficacy of telemedicine before the practice becomes widespread, a phenomenon Adams attributes to the "inherent inertia and viscosity in the system to maintain the status quo."

"Everybody might know the right answer," Dr. Gorman adds. "It's still going to take a long time. That’s just the pace at which we move in healthcare."

A new report that outlines the potential care delivery improvements and cost savings of telemedicine might also be a road map to increased efficiency for hospitalists, according to one of the study’s authors and a former SHM president.

Telemedicine "simplifies their life," says Mitchell Adams, AB, MBA, executive director of the Massachusetts Technology Collaborative (MTC) in Boston, which coauthored "Critical Care, Critical Choices: The Case for Tele-ICUs in Intensive Care" with the New England Healthcare Institute (NEHI) in Cambridge. "It means you have you less complications, you have less work. You have an intensivist looking over your shoulder, making sure you’re doing it right."

As the population ages and hospitalists become more entrenched in their institutions, they could end up spending more time on ICU cases. The use of telemedicine—where an intensivist at a remote “command center” oversees the delivery of care—could foster higher-quality and more efficient care, which would subsequently allow HM practitioners to focus on the rest of the census, according to Mary Jo Gorman, MD, MBA, FHM, former SHM president and CEO of St. Louis-based Advanced ICU Care, which provides intensivists to community hospitals using telemedicine.

The study, based on a demonstration project at the University of Massachusetts Memorial Medical Center and two associated community hospitals, reported a 20% drop in ICU mortality at the academic medical center (P=0.01). When adjusted for the severity of ICU illnesses, one community hospital reported a 36% drop in mortality (P=0.83); the other reported a 142% increase (P<0.001). All three centers also reported a reduction in length of stay (LOS) of at least 12 hours.

Dr. Gorman and Adams agree that it will take more evidence-based studies showing the efficacy of telemedicine before the practice becomes widespread, a phenomenon Adams attributes to the "inherent inertia and viscosity in the system to maintain the status quo."

"Everybody might know the right answer," Dr. Gorman adds. "It's still going to take a long time. That’s just the pace at which we move in healthcare."

Issue
The Hospitalist - 2010(12)
Issue
The Hospitalist - 2010(12)
Publications
Publications
Topics
Article Type
Display Headline
Report Supports Telemedicine Use in ICU
Display Headline
Report Supports Telemedicine Use in ICU
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

CMS Announces Guidelines for $500M Care Transitions Program

Article Type
Changed
Fri, 09/14/2018 - 12:29
Display Headline
CMS Announces Guidelines for $500M Care Transitions Program

An eagerly awaited federal grant program that will allocate $500 million for improving care transitions and reducing rehospitalizations will soon release a solicitation and application instructions, possibly by the end of December.

The Community-Based Care Transitions Program (CCTP), funded for five years starting in January through the Affordable Care Act, is open to hospitals with higher-than-average rehospitalization rates and their community-based partners, and to coalitions of community-based organizations that include hospitals, CMS research analyst Juliana Tiongson explained during an all-day conference Dec. 3 in Baltimore.

Hospitalists and HM groups likely would not qualify directly for these grants, but they can start identifying and partnering with interested hospital leaders and relevant community-based providers. CCTP is designed to encourage communities to work together in ongoing learning collaboratives, drawing on evidence-based models for improving care transitions, Tiongson said. Examples of evidence-based strategies, such as Eric Coleman’s Community Care Transitions Program, Mary Naylor’s Transitional Care Model, and SHM’s Project BOOST, were described during the teleconference.

“We will require applicants to do their homework, including a thorough root cause analysis” of current care-transitions processes and their limitations, Tiongson said. Applications that include multiple stakeholders across the healthcare continuum, such as consumer representation, links to accountable-care organizations (ACOs), and medical homes, and those that are based in the communities they propose to serve, will be favored in the rolling application process. Applicants should demonstrate organizational readiness in terms of staffing, training, and preparation for better managing such transitions as hospital discharges.

Issue
The Hospitalist - 2010(12)
Publications
Sections

An eagerly awaited federal grant program that will allocate $500 million for improving care transitions and reducing rehospitalizations will soon release a solicitation and application instructions, possibly by the end of December.

The Community-Based Care Transitions Program (CCTP), funded for five years starting in January through the Affordable Care Act, is open to hospitals with higher-than-average rehospitalization rates and their community-based partners, and to coalitions of community-based organizations that include hospitals, CMS research analyst Juliana Tiongson explained during an all-day conference Dec. 3 in Baltimore.

Hospitalists and HM groups likely would not qualify directly for these grants, but they can start identifying and partnering with interested hospital leaders and relevant community-based providers. CCTP is designed to encourage communities to work together in ongoing learning collaboratives, drawing on evidence-based models for improving care transitions, Tiongson said. Examples of evidence-based strategies, such as Eric Coleman’s Community Care Transitions Program, Mary Naylor’s Transitional Care Model, and SHM’s Project BOOST, were described during the teleconference.

“We will require applicants to do their homework, including a thorough root cause analysis” of current care-transitions processes and their limitations, Tiongson said. Applications that include multiple stakeholders across the healthcare continuum, such as consumer representation, links to accountable-care organizations (ACOs), and medical homes, and those that are based in the communities they propose to serve, will be favored in the rolling application process. Applicants should demonstrate organizational readiness in terms of staffing, training, and preparation for better managing such transitions as hospital discharges.

An eagerly awaited federal grant program that will allocate $500 million for improving care transitions and reducing rehospitalizations will soon release a solicitation and application instructions, possibly by the end of December.

The Community-Based Care Transitions Program (CCTP), funded for five years starting in January through the Affordable Care Act, is open to hospitals with higher-than-average rehospitalization rates and their community-based partners, and to coalitions of community-based organizations that include hospitals, CMS research analyst Juliana Tiongson explained during an all-day conference Dec. 3 in Baltimore.

Hospitalists and HM groups likely would not qualify directly for these grants, but they can start identifying and partnering with interested hospital leaders and relevant community-based providers. CCTP is designed to encourage communities to work together in ongoing learning collaboratives, drawing on evidence-based models for improving care transitions, Tiongson said. Examples of evidence-based strategies, such as Eric Coleman’s Community Care Transitions Program, Mary Naylor’s Transitional Care Model, and SHM’s Project BOOST, were described during the teleconference.

“We will require applicants to do their homework, including a thorough root cause analysis” of current care-transitions processes and their limitations, Tiongson said. Applications that include multiple stakeholders across the healthcare continuum, such as consumer representation, links to accountable-care organizations (ACOs), and medical homes, and those that are based in the communities they propose to serve, will be favored in the rolling application process. Applicants should demonstrate organizational readiness in terms of staffing, training, and preparation for better managing such transitions as hospital discharges.

Issue
The Hospitalist - 2010(12)
Issue
The Hospitalist - 2010(12)
Publications
Publications
Article Type
Display Headline
CMS Announces Guidelines for $500M Care Transitions Program
Display Headline
CMS Announces Guidelines for $500M Care Transitions Program
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Patient Dissatisfaction

Article Type
Changed
Sun, 05/28/2017 - 20:06
Display Headline
What can we learn from patient dissatisfaction? An analysis of dissatisfying events at an academic medical center

The United States spends more money per capita on healthcare than any other industrialized nation,1 yet patients are the least satisfied with their care.2 Patient satisfaction is associated in both cross‐sectional3 and longitudinal studies4 with improved physical and mental health outcomes. Conversely, dissatisfaction with care hampers future medical interactions, prevents sharing of information, and impairs the building of trust.5 The increasing recognition that a patient's experience of care affects patient outcomes has furthered efforts to evaluate satisfaction with care.6, 7

However, patient satisfaction is challenging to define and understand. Even the definition of satisfaction is ambiguous, for to satisfy can mean both to make happy and the lesser, to be adequate. To dissatisfy is to displease or disappoint, but dissatisfaction is not the opposite of satisfaction: qualitative studies give little if any indication that patients evaluate satisfaction on a continuum ranging from dissatisfied at one end to very satisfied at the other.8 Instead, it appears that satisfaction and dissatisfaction are different constructs, such that patients may simultaneously be both satisfied and dissatisfied.9, 10 Patients often express overall satisfaction with a service or encounter while also reporting specific criticisms about its shortcomings.11, 12 Alternatively, consumers may be generally satisfied unless something unpleasant or improper happens.13 Thus, dissatisfaction and satisfaction may require different methods of measurement.

The most common model for measuring patient satisfaction is a quantitative survey of patients' experiences in specific predetermined domains. Of 54 hospital satisfaction surveys in common use, only 11 included patient input in their development,14 casting doubt on the relevance of these attributes to patients' priorities of care. Since it is well recognized that patient expectations influence satisfaction,8, 13, 15 it is important to identify patient expectations and priorities up front. However, these have not been clearly established. Furthermore, focusing purely on satisfaction with particular domains of care may miss the separate but illuminating construct of patient dissatisfaction.

In this study we therefore aim to understand patient dissatisfaction with hospitalization more fully as a means of elucidating implicit expectations for hospital care. Using qualitative techniques, we analyzed a large volume of patient responses to a single open‐ended study question to identify determinants and patterns of patient dissatisfaction.

Methods

Study Design

We conducted a qualitative analysis of telephone survey data obtained from adults recently discharged after an acute care hospitalization. Survey participants were asked five questions, including: If there was one thing we could have done to improve your experience in the hospital, what would it have been? Answers to this open‐ended question were included in this study.

Setting and Participants

The hospital is a 944‐bed, urban academic medical center. Patients or patient representatives were routinely surveyed in a telephone interview conducted by trained hospital staff 1‐5 days after hospital discharge. Calls were attempted to 90% of adult discharged patients, and approximately 50% of them were reached. For this study, we included patients who were age 18 or older, spoke English, and were discharged to home from a medical, surgical, gynecology‐oncology, neurology, neurosurgery, or intensive care unit. Of those patients, we randomly selected 10% of those surveyed between July 1, 2007 and June 30, 2008 for inclusion.

Primary Data Analysis

Qualitative data analysis was used to classify patient suggestions. The study team included internal medicine physicians (J.P.M., L.I.H.), a medical student (A.V.L.), and a recent college graduate (C.P.B.). Codes were generated using a mixed inductive and deductive approach by reading and rereading the primary data.16 A set of 100 interview responses were first read individually by three investigators (J.P.M., A.V.L., C.P.B.), after which investigators met to discuss themes and ideas. A preliminary list of coding categories was then generated. Each investigator then assigned these coding categories to additional survey responses in sets of 100. Subsequent meetings were held to refine codes using the constant comparative method.16 Disagreements were resolved by negotiated consensus. The full study group met periodically to review the code structure for logic and breadth. Once thematic saturation was achieved, the entire dataset was recoded by two investigators using the final coding structure. The final coding structure contained 42 unique codes organized into six broader themes. We used descriptive statistics to characterize the coding category results. The score for intercoder reliability was 0.91.

This study was approved by the Yale Human Investigation Committee, which granted a waiver of informed consent.

Results

A total of 976 surveys was randomly selected from 9,764 postdischarge phone interviews completed between July 1, 2007 and June 30, 2008. A total of 56.3% of patients was female. Nearly half the patients were discharged from medical units (Table 1). Of the 976 patients, 439 (45.0%) gave at least one suggestion for improvement, yielding a total of 579 suggestions. Patients also offered numerous positive comments about their care, but these comments were not included in the analysis.

Demographic Information (n = 976)
 No.% of Total Surveyed
Total surveys976 
Male42743.7
Female54956.3
Discharge Unit  
Medical43444.5
Surgical30331.0
Gynecology/Oncology10310.6
ICU/CCU/Step‐down717.3
Neurology/Neurosurgery656.6
No suggestions for improvement53755.0
At least one suggestion for improvement43945.0

Through qualitative analysis, we assigned suggestions for improvement to six major categories of dissatisfaction: 1) ineptitude, 2) disrespect, 3) prolonged waits, 4) ineffective communication, 5) lack of environmental control, and 6) substandard amenities. We considered the inverse of these problems to represent six implicit expectations of good hospital care: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities (Table 2). The number of patient suggestions related to each domain is detailed in Table 3.

Domains of Dissatisfaction and Corresponding Implicit Expectations
Domain of DissatisfactionImplicit ExpectationsExample
IneptitudeSafetyThe only thing was that when I was getting ready to get discharged, one of Dr. H*'s associates came in and said, We have to readmit you for a further procedure. I said, Well, that's strange because Dr. H* put in a stent yesterday, and I'm supposed to leave today. Well, he checked, and he had the wrong guy. I'm glad I said something or else they probably would have hauled me off.
DisrespectTreatment with respect and dignityTransport was rude due to me being a heavy person. They were saying they didn't want to move me and snickering.
Prolonged waitsPrompt and efficient careI called for someone because I had to use the bathroom really bad, but I had those things stuck to my legs and needed help walking to the bathroom but no one came. Well, I had to go so bad that I had a panic attack. Then all these people came rushing in to help. I felt so embarrassed.
Ineffective communicationSuccessful exchange of informationThere were a few days that [were] a little confusing to me. I didn't know if I was going to have surgery or go home. The communication wasn't that great.
Lack of environmental controlEnvironmental autonomy and controlI was put in a room with a man who had many issues. He was loud and yelling all night. It was a very disturbing experience.
Substandard amenitiesHigh‐quality amenitiesIn that ICU they should put a TV on the ceiling for when you're lying flat on your back looking at the ceiling tiles for 4 days.
Descriptive Statistics of Dissatisfaction Domains
Domain of DissatisfactionNo. (N = 579 suggestionsa)% of Total Surveyed% Within Domain
  • Some respondents gave more than one suggestion, resulting in a greater number of total suggestions than the number of respondents with at least one suggestion for improvement.

Perceived ineptitude757.7100
Adverse events181.824.0
Cleanliness363.748.0
Perceived lack of knowledge/skill121.216.0
Rushed out90.912.0
Disrespect596.0100
Unprofessional staff behavior555.693.2
Lack of privacy/confidentiality40.46.8
Prolonged waits15415.8100
Response to call bell   
Bathing/toileting/distress242.515.6
General414.226.6
Wait for physician121.27.8
Wait for admission bed293.018.8
Wait for transport161.610.4
Wait for food70.74.6
Wait for medication111.17.1
Wait for diagnostic test/procedures60.63.9
Wait for discharge80.85.2
Ineffective communication727.4100
Communication with patients333.445.8
Communication with family30.34.2
Translation20.22.8
Communication between providers131.318.1
Coordination of care (inpatient)111.115.3
Medication reconciliation50.56.9
Continuity inpatient to outpatient50.56.9
Lack of environmental control15215.6100
Physical environment   
Roommates383.925.0
Noise242.515.8
Temperature121.27.9
Smell10.10.7
Interruption by staff151.59.9
Lighting20.21.3
Chaos/hectic40.42.6
Shorter Stay80.85.3
General30.32.0
Facilities   
Pain control101.06.6
Painful procedures171.711.2
Facilities   
Bathrooms70.74.6
Maintenance response50.53.3
Traffic/parking60.63.9
Substandard amenities676.9100
Food quality262.738.8
Food variety50.57.5
Food service161.623.9
TV80.811.9
Beds80.811.9
Gowns40.46.0

Ineptitude

A total of 7.7% of interviewed patients reported experiencing a situation that made them feel unsafe. Dissatisfaction with safety included adverse events or near misses, uncleanliness, and a perceived lack of knowledge or skill. The implicit expectation that emerged from this domain was that the hospital would be safe, and that medical staff would be knowledgeable and skillful.

Adverse events or near misses were experienced in several areas, including diet, medication administration, patient identification, and equipment. Patients were particularly troubled when they or a family member caught the error:

There was one male nurse in training, C*, who was about to give my mother an injection. I asked what he was doing because she was about to go into surgery. He said he thought she was going home. He looked at the chart again and it turns out he was holding her roommate's chart. I don't know what would have happened if I wasn't there.

 

Dissatisfaction with the cleanliness of the hospital environment was also frequently expressed as a safety concern:

The rooms are dirtyThe floors are dirty. They don't sweep unless you ask them to. It took three different people to come and clean the bathroom right. I have to come back for surgery and I'm scared to death with all that bacteria and uncleanliness.

 

In this category, patients also described care by not too knowledgeable trainees or other staff as a safety hazard.

Disrespect

A total of 6.0% of surveyed patients suggested improvements that reflected disrespectful treatment, including poor work ethic, lack of warmth, rudeness, and a lack of attention to privacy and confidentiality. This type of dissatisfaction suggested an implicit expectation for treatment with respect and dignity that was clearly distinct from the expectation of technical quality:

[Hospital name] has always been like [this] since I started going there in 1982. They're very good technically but their bedside manner kind of sucks. You survive but you don't walk away with a warm fuzzy feeling.

 

Underprivileged patients were particularly sensitive to the need for respect:

I feel like the doctor that saw me that last night there was trying to get me out of there as fast as possible, saying not in so many words that it was because I don't have any insurance. I just feel like they treated me like an animal.

 

Violations of privacy and confidentiality were not only perceived as disrespectful, but also as a direct impediment to high‐quality care:

In the ER, I didn't like that I had no privacy especially talking with the doctor because I was in the hallway. I didn't have any privacy therefore I wasn't completely truthful with the doctor because everyone could hear.

 

Prolonged Waits

A total of 15.8% of patients noted dissatisfaction with wait times in the hospital. Waits for admission, transport, or discharge were frequently cited as anxiety‐provoking or frustrating:

The ER wait is too long. I was there from 8:00 AM to 2:00 AM the next day. I was there the whole day and night. When someone is in pain, they just want to be taken care of, not waiting around.

 

Waits related to receiving patient care, for example the inability to access nurses or physicians, more often caused feelings of fear and abandonment:

Every patient is different, I understand, but when you're there at night it can be a little scary. I was not only scared but in pain. The nurse tried to get a hold of the doctor that was on call, but the doctor took hours to respond. That was very scary.

 

It was also distressing to patients to watch roommates experience a delay in help for urgent needs:

The lady next to me was an elderly woman with a brace on her neck, and she couldn't speak very well. She had diarrhea at night and she would ask for a bedpan. The nurses would take forever bringing it to her. I just think when there are elderly people they should be more attentive to them because they tend to not be as vocal, you know?

 

Together, these comments represented an implicit expectation for prompt and efficient care.

Ineffective Communication

Communication during hospitalization was a source of dissatisfaction in 7.4% of surveyed patients. Communication failures occurred in several areas. Most common was the ineffective transfer of medical information to patients:

For days I thought I was having surgery on Friday. So all that day I ate and drank nothing and got prepped for surgery. Finally later that night I was told I was going to have it on Saturday. Saturday comes and still nothing. I never saw a surgeon or talked to anyone. Then later after that I was told I'm not having the surgery. That was the most frustrating thing.

 

Patients were also dissatisfied with their ability to communicate with their doctors:

I was sent home on a Friday and was sent right back on Friday night because my blood count was low and I ended up needing a blood transfusion. I tried to tell them this but they didn't listen. They need to listen to the patients.

 

Failed communication between care providers in the hospital was a third inadequacy noted by patients:

The only problem I had was all the different doctors coming in and out. There's so many that it confuses the patient, and a lot of them would contradict each other. One doctor said I could go home and another doctor said, No, you need to stay.

 

Finally, patients were dissatisfied when there was ineffective communication between inpatient and outpatient providers.

They said the VNA [Visiting Nurse Association] is supposed to come. The nurse hasn't come to see me and she hasn't called. My daughter and I have been waiting.

 

Thus, patients had an implicit expectation for effective communication between all parties in the hospital and were dissatisfied when any type of communication was inadequate.

Lack of Environmental Control

A total of 15.4% of surveyed patients reported dissatisfaction with the inability to control the physical environment. The inability to control noise levels, roommate behavior, temperature, smells, pain, lighting, staff interruptions, food service, smoking, and even humidity were all anxiety‐producing for different patients. The feeling of being imposed upon by an uncomfortable physical environment also extended to hospital facilities such as inaccessible bathrooms, traffic, and parking. Dissatisfaction with rooming arrangements was common:

I was in a triple room and one of my roommates had at least six visitors in the room at a time every day including two infant twins. Someone really should have said something about that. It became very disturbing, and I even left a day early because of that.

 

An expectation for quiet, especially during the night, was also repeatedly expressed:

The night shift could have been more considerate of people trying to rest. There was a lot of noise and bangs. I know people have to laugh and have fun but it could have been a little more quiet.

 

Related was the inability to control interruptions by staff members:

It's hard enough to get sleep, but then those blood suckers come in the middle of the night.

 

This category of dissatisfaction reflected an implicit expectation for autonomy and control over the environment so that it was conducive to rest and healing.

Substandard Amenities

A total of 6.9% of surveyed patients suggested improvements to amenities such as food, bedding, gowns, and television. Moving beyond the expectation of having peaceful surroundings, these comments reflected an expectation of a well‐appointed hospital environment with high‐quality amenities. A typical example was this comment about the food and service:

You never get what you order from the kitchen. Your tray either has something missing from it or it's the wrong tray or not the right diet. It's very frustrating and hard to get the orders the way you want.

 

Discussion

We analyzed 439 patient suggestions for improving hospital care and found that dissatisfaction resulted from six categories of negative experiences: 1) ineptitude, 2) disrespect, 3) prolonged wait times, 4) ineffective communication, 5) lack of environmental control, and 6) substandard amenities. These domains represented a corresponding set of implicit patient expectations for: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities. Each of these categories suggests avenues by which both the assessment and provision of hospital care can be made more patient‐centered.

The most widely used patient satisfaction survey in use in the United States today is the Hospital Consumer Assessment of Healthcare Providers & Systems (HCAHPS), which includes eight domains: communication with doctors, communication with nurses, responsiveness of hospital staff, pain management, communication about medicines, discharge information, cleanliness of the hospital environment, and quietness of the hospital environment.17 The dissatisfaction domains found in this study closely overlap the HCAHPS satisfaction domains, but with a few key differences.

First, dissatisfaction with ineptitude in our study encompassed concerns over adverse events and near misses, in addition to the cleanliness of the environment. Other research has shown that dissatisfaction with hospitalization can be predicted by the number of reported problems18 and the perception of receiving incorrect treatment.19 While elaborate methods have been devised to assess and compare the hospital quality and safety, patient satisfaction surveys including the HCAHPS survey often fail to ask patients directly about their perceptions of safety. In fact, this study and others20, 21 show that patients are able to recognize adverse events during hospitalization. Patient report may be a useful adjunct to other methods of adverse event case finding and outcomes reporting.

Second, while HCAHPS and others identify warmth, courtesy, concern, and respect as dimensions of patient‐centered care,14, 17, 22, 23 the ability of quantitative satisfaction surveys to capture the experience of disrespectful treatment may be limited, especially during hospitalization. Most respondents who commented on feeling disrespected identified only a single encounter, which can be masked by otherwise satisfying interactions with numerous care providers. Directly asking patients whether any experience during hospitalization caused them to feel disrespected, and allowing room for explanation, might more efficiently identify problem areas. This is particularly important because even one episode of disrespectful treatment, particularly when perceived to be racially motivated, increases the likelihood of not following a doctor's advice or putting off care.24

Third, HCAHPS emphasizes two aspects of communication: that between patients and doctors, and that between patients and nurses. Our patients confirmed that these are important, but they also noted a third dimension of communication contributing to dissatisfaction: provider‐provider communication. Communication and coordination failures among providers are key contributors to adverse events or near misses,2528 but their influence on patient satisfaction has not been widely assessed. Furthermore, patient input is rarely utilized to identify poor interprovider communication. Our study suggests that, just as patients can identify adverse events, they are also able to recognize poor provider‐provider communication.

Patients' reports of dissatisfying events also highlight areas in which small changes in hospital practice might greatly improve the patient experience. For instance, concerns over environment, food, sleep, hygiene, and pain appeared to be representative of a broader dissatisfaction with loss of autonomy and control. Hospitalized patients are often obliged to room with strangers, are subject to noise and interruptions, and cede control of their medication management at a time when they are feeling particularly vulnerable. The importance of this lack of autonomy to patients suggests a variety of small interventions that could improve satisfaction, such as individual control of noise and temperature, a visible commitment to a quiet hospital environment, and minimized interruptions and sleep disturbance.2932 Single‐occupancy hospital rooms have been associated with lower rates of nosocomial infection, medication errors, and patient stress, as well as increased privacy, rest, visitor involvement, and doctor‐patient communication.33, 34 The most sophisticated intervention, acuity‐adaptable private hospital rooms, allows hospitals to maintain patients in the same private hospital room during an entire admission, regardless of changes to level of acuity.35

In‐depth analysis of suggestions for improvement, as gathered by telephone surveys of recently discharged patients, was a particularly well‐suited approach to identifying explicit expectations for care that were violated by dissatisfying incidents. When allowed to express dissatisfaction in terms of suggestions for improvement, patients talked freely about specific dissatisfying experiences. Using telephone interviews allowed a large volume of patient responses to be included, unlike smaller focus groups. Our study was oral and did not rely on the literacy level of patients. Additionally, the open‐ended nature of questioning avoided some of the usual pitfalls of satisfaction surveys. We did not rely on predetermined satisfaction categories or presume the inherent value of particular attributes of care. Nonetheless, our study does have important limitations.

Patient perceptions were not compared with chart data or clinician report. Caregivers were allowed to participate in lieu of patients, which may have reduced identification of some dissatisfying events. Likewise, patients discharged to nursing homes or who were not English or Spanish speaking were excluded and may have had different dissatisfying experiences. Interviews were brief and dissatisfying events were not explored in detail. Although nearly half of respondents reported dissatisfying events, some patients may have been reluctant to criticize their care directly to a hospital representative. Finally, patients generally confined their comments to one or two dissatisfying events, even though there may have been others. We therefore cannot draw any conclusions about the relative frequency of dissatisfying events by domain.

Conclusions

All hospitalized patients bring expectations for their hospital experience. While specific expectations vary between patients, expectations for: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities were found in this study to encompass core expectations for hospitalization. It may be useful to ensure that postdischarge surveys explicitly address these expectations. Efforts to address and manage these core expectations of hospital care may help to reduce patient dissatisfaction with hospitalization and improve the delivery and quality of hospital care.

Files
References
  1. Cylus J,Anderson GF.Multinational Comparisons of Health Systems Data, 2006.Washington, DC:The Commonwealth Fund;2007.
  2. Schoen C,Osborn R,Doty MM,Bishop M,Peugh J,Murukutla N.Toward higher‐performance health systems: Adults' health care experiences in seven countries, 2007.Health Aff.2007;26:w717734.
  3. Glickman SW,Boulding W,Manary M, et al.Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction.Circ Cardiovasc Qual Outcomes.2010;3:188195.
  4. Wong WS,Fielding R.A longitudinal analysis of patient satisfaction and subsequent quality of life in Hong Kong Chinese breast and nasopharyngeal cancer patients.Med Care.2009;47:875881.
  5. Coyle J.Understanding dissatisfied users: developing a framework for comprehending criticisms of health care work.J Adv Nurs.1999;30:723731.
  6. Sitzia J,Wood N.Patient satisfaction: a review of issues and concepts.Soc Sci Med.1997;45:18291843.
  7. Institute of Medicine.Crossing the Quality Chasm: A New Health System for the 21st Century.Washington, DC:National Academy Press;2001.
  8. Williams B.Patient satisfaction: a valid concept?Soc Sci Med.1994;38:509516.
  9. Coyle J.Exploring the meaning of ‘dissatisfaction’ with health care: the importance of ‘personal identity threat’.Sociol Health Illn.1999;21:95123.
  10. Mulcahy L,Titter JQ.Pathways, pyramids and icebergs? Mapping the links between dissatisfaction and complaints.Sociol Health Illn.1998;20:825847.
  11. Williams SJ,Calnan M.Convergence and divergence: assessing criteria of consumer satisfaction across general practice, dental and hospital care settings.Soc Sci Med.1991;33:707716.
  12. Bruster S,Jarman B,Bosanquet N,Weston D,Erens R,Delbanco TL.National survey of hospital patients [see comment].BMJ.1994;309:15421546.
  13. Crow R,Gage H,Hampson S, et al.The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature.Health Technol Assess.2002;6:1244.
  14. Castle NG,Brown J,Hepner KA,Hays RD.Review of the literature on survey instruments used to collect data on hospital patients' perceptions of care.Health Serv Res.2005;40:19962017.
  15. Avis M,Bond M,Arthur A.Satisfying solutions? A review of some unresolved issues in the measurement of patient satisfaction.J Adv Nurs.1995;22:316322.
  16. Glaser BG,Strauss AL.The Discovery of Grounded Theory: Strategies for Qualitative Research.Chicago, IL:Aldine;1967.
  17. Hospital Consumer Assessment of Healthcare Providers 25:2536.
  18. Danielsen K,Garratt AM,Bjertnaes OA,Pettersen KI.Patient experiences in relation to respondent and health service delivery characteristics: a survey of 26,938 patients attending 62 hospitals throughout Norway.Scand J Public Health.2007;35:7077.
  19. Weingart SN,Pagovich O,Sands DZ, et al.What can hospitalized patients tell us about adverse events? Learning from patient‐reported incidents.J Gen Intern Med.2005;20:830836.
  20. Cleary PD.A hospitalization from hell: a patient's perspective on quality.Ann Intern Med.2003;138:3339.
  21. Gerteis M,Edgman‐Levitan S,Daley J,Delbanco TL.Through the Patient's Eyes: Understanding and Promoting Patient‐Centered Care.San Francisco, CA:Jossey‐Bass;1993.
  22. Sofaer S,Crofton C,Goldstein E,Hoy E,Crabb J.What do consumers want to know about the quality of care in hospitals?Health Serv Res.2005;40:20182036.
  23. Blanchard J,Lurie N.R‐e‐s‐p‐e‐c‐t: patient reports of disrespect in the health care setting and its impact on care.J Fam Pract.2004;53:721730.
  24. McKnight LK,Stetson PD,Bakken S,Curran C,Cimino JJ.Perceived information needs and communication difficulties of inpatient physicians and nurses.J Am Med Inform Assoc.2002;9(6 suppl 1):S64S69.
  25. Leonard M,Graham S,Bonacum D.The human factor: the critical importance of effective teamwork and communication in providing safe care.Qual Saf Health Care.2004;13:i85i90.
  26. Horwitz LI,Moin T,Krumholz HM,Wang L,Bradley EH.Consequences of inadequate sign‐out for patient care.Arch Intern Med.2008;168:17551760.
  27. Horwitz LI,Meredith T,Schuur JD,Shah NR,Kulkarni RG,Jenq GY.Dropping the baton: a qualitative analysis of failures during the transition from emergency department to inpatient care.Ann Emerg Med.2009;53:701710 e704.
  28. Topf M,Thompson S.Interactive relationships between hospital patients' noise‐induced stress and other stress with sleep.Heart Lung.2001;30:237243.
  29. Job RFS.The influence of subjective reactions to noise on health effects of the noise.Environ Int.1996;22:93104.
  30. Smykowski L.A novel PACU design for noise reduction.J Perianesth Nurs.2008;23:226229.
  31. Martin DP,Hunt JR,Conrad DA,Hughes‐Stone M.The Planetree Model Hospital Project: an example of the patient as partner. (Pacific Presbyterian Medical Center, San Francisco).Hosp Health Serv Admin.1990;35:591601.
  32. van de Glind I,van Dulmen S,Goossensen A.Physician‐patient communication in single‐bedded versus four‐bedded hospital rooms.Patient Educ Couns.2008;73:215219.
  33. Chaudhury H,Mahmood A,Valente M.Advantages and disadvantages of single‐versus multiple‐occupancy rooms in acute care environments: a review and analysis of the literature.Environ Behav.2005;37:760786.
  34. Brown KK,Gallant DB.Impacting patient outcomes through design: acuity adaptable care/universal room design.Crit Care Nurs Q.2006;29:326341.
Article PDF
Issue
Journal of Hospital Medicine - 5(9)
Page Number
514-520
Legacy Keywords
communication, patient satisfaction, professionalism, quality improvement, teamwork
Sections
Files
Files
Article PDF
Article PDF

The United States spends more money per capita on healthcare than any other industrialized nation,1 yet patients are the least satisfied with their care.2 Patient satisfaction is associated in both cross‐sectional3 and longitudinal studies4 with improved physical and mental health outcomes. Conversely, dissatisfaction with care hampers future medical interactions, prevents sharing of information, and impairs the building of trust.5 The increasing recognition that a patient's experience of care affects patient outcomes has furthered efforts to evaluate satisfaction with care.6, 7

However, patient satisfaction is challenging to define and understand. Even the definition of satisfaction is ambiguous, for to satisfy can mean both to make happy and the lesser, to be adequate. To dissatisfy is to displease or disappoint, but dissatisfaction is not the opposite of satisfaction: qualitative studies give little if any indication that patients evaluate satisfaction on a continuum ranging from dissatisfied at one end to very satisfied at the other.8 Instead, it appears that satisfaction and dissatisfaction are different constructs, such that patients may simultaneously be both satisfied and dissatisfied.9, 10 Patients often express overall satisfaction with a service or encounter while also reporting specific criticisms about its shortcomings.11, 12 Alternatively, consumers may be generally satisfied unless something unpleasant or improper happens.13 Thus, dissatisfaction and satisfaction may require different methods of measurement.

The most common model for measuring patient satisfaction is a quantitative survey of patients' experiences in specific predetermined domains. Of 54 hospital satisfaction surveys in common use, only 11 included patient input in their development,14 casting doubt on the relevance of these attributes to patients' priorities of care. Since it is well recognized that patient expectations influence satisfaction,8, 13, 15 it is important to identify patient expectations and priorities up front. However, these have not been clearly established. Furthermore, focusing purely on satisfaction with particular domains of care may miss the separate but illuminating construct of patient dissatisfaction.

In this study we therefore aim to understand patient dissatisfaction with hospitalization more fully as a means of elucidating implicit expectations for hospital care. Using qualitative techniques, we analyzed a large volume of patient responses to a single open‐ended study question to identify determinants and patterns of patient dissatisfaction.

Methods

Study Design

We conducted a qualitative analysis of telephone survey data obtained from adults recently discharged after an acute care hospitalization. Survey participants were asked five questions, including: If there was one thing we could have done to improve your experience in the hospital, what would it have been? Answers to this open‐ended question were included in this study.

Setting and Participants

The hospital is a 944‐bed, urban academic medical center. Patients or patient representatives were routinely surveyed in a telephone interview conducted by trained hospital staff 1‐5 days after hospital discharge. Calls were attempted to 90% of adult discharged patients, and approximately 50% of them were reached. For this study, we included patients who were age 18 or older, spoke English, and were discharged to home from a medical, surgical, gynecology‐oncology, neurology, neurosurgery, or intensive care unit. Of those patients, we randomly selected 10% of those surveyed between July 1, 2007 and June 30, 2008 for inclusion.

Primary Data Analysis

Qualitative data analysis was used to classify patient suggestions. The study team included internal medicine physicians (J.P.M., L.I.H.), a medical student (A.V.L.), and a recent college graduate (C.P.B.). Codes were generated using a mixed inductive and deductive approach by reading and rereading the primary data.16 A set of 100 interview responses were first read individually by three investigators (J.P.M., A.V.L., C.P.B.), after which investigators met to discuss themes and ideas. A preliminary list of coding categories was then generated. Each investigator then assigned these coding categories to additional survey responses in sets of 100. Subsequent meetings were held to refine codes using the constant comparative method.16 Disagreements were resolved by negotiated consensus. The full study group met periodically to review the code structure for logic and breadth. Once thematic saturation was achieved, the entire dataset was recoded by two investigators using the final coding structure. The final coding structure contained 42 unique codes organized into six broader themes. We used descriptive statistics to characterize the coding category results. The score for intercoder reliability was 0.91.

This study was approved by the Yale Human Investigation Committee, which granted a waiver of informed consent.

Results

A total of 976 surveys was randomly selected from 9,764 postdischarge phone interviews completed between July 1, 2007 and June 30, 2008. A total of 56.3% of patients was female. Nearly half the patients were discharged from medical units (Table 1). Of the 976 patients, 439 (45.0%) gave at least one suggestion for improvement, yielding a total of 579 suggestions. Patients also offered numerous positive comments about their care, but these comments were not included in the analysis.

Demographic Information (n = 976)
 No.% of Total Surveyed
Total surveys976 
Male42743.7
Female54956.3
Discharge Unit  
Medical43444.5
Surgical30331.0
Gynecology/Oncology10310.6
ICU/CCU/Step‐down717.3
Neurology/Neurosurgery656.6
No suggestions for improvement53755.0
At least one suggestion for improvement43945.0

Through qualitative analysis, we assigned suggestions for improvement to six major categories of dissatisfaction: 1) ineptitude, 2) disrespect, 3) prolonged waits, 4) ineffective communication, 5) lack of environmental control, and 6) substandard amenities. We considered the inverse of these problems to represent six implicit expectations of good hospital care: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities (Table 2). The number of patient suggestions related to each domain is detailed in Table 3.

Domains of Dissatisfaction and Corresponding Implicit Expectations
Domain of DissatisfactionImplicit ExpectationsExample
IneptitudeSafetyThe only thing was that when I was getting ready to get discharged, one of Dr. H*'s associates came in and said, We have to readmit you for a further procedure. I said, Well, that's strange because Dr. H* put in a stent yesterday, and I'm supposed to leave today. Well, he checked, and he had the wrong guy. I'm glad I said something or else they probably would have hauled me off.
DisrespectTreatment with respect and dignityTransport was rude due to me being a heavy person. They were saying they didn't want to move me and snickering.
Prolonged waitsPrompt and efficient careI called for someone because I had to use the bathroom really bad, but I had those things stuck to my legs and needed help walking to the bathroom but no one came. Well, I had to go so bad that I had a panic attack. Then all these people came rushing in to help. I felt so embarrassed.
Ineffective communicationSuccessful exchange of informationThere were a few days that [were] a little confusing to me. I didn't know if I was going to have surgery or go home. The communication wasn't that great.
Lack of environmental controlEnvironmental autonomy and controlI was put in a room with a man who had many issues. He was loud and yelling all night. It was a very disturbing experience.
Substandard amenitiesHigh‐quality amenitiesIn that ICU they should put a TV on the ceiling for when you're lying flat on your back looking at the ceiling tiles for 4 days.
Descriptive Statistics of Dissatisfaction Domains
Domain of DissatisfactionNo. (N = 579 suggestionsa)% of Total Surveyed% Within Domain
  • Some respondents gave more than one suggestion, resulting in a greater number of total suggestions than the number of respondents with at least one suggestion for improvement.

Perceived ineptitude757.7100
Adverse events181.824.0
Cleanliness363.748.0
Perceived lack of knowledge/skill121.216.0
Rushed out90.912.0
Disrespect596.0100
Unprofessional staff behavior555.693.2
Lack of privacy/confidentiality40.46.8
Prolonged waits15415.8100
Response to call bell   
Bathing/toileting/distress242.515.6
General414.226.6
Wait for physician121.27.8
Wait for admission bed293.018.8
Wait for transport161.610.4
Wait for food70.74.6
Wait for medication111.17.1
Wait for diagnostic test/procedures60.63.9
Wait for discharge80.85.2
Ineffective communication727.4100
Communication with patients333.445.8
Communication with family30.34.2
Translation20.22.8
Communication between providers131.318.1
Coordination of care (inpatient)111.115.3
Medication reconciliation50.56.9
Continuity inpatient to outpatient50.56.9
Lack of environmental control15215.6100
Physical environment   
Roommates383.925.0
Noise242.515.8
Temperature121.27.9
Smell10.10.7
Interruption by staff151.59.9
Lighting20.21.3
Chaos/hectic40.42.6
Shorter Stay80.85.3
General30.32.0
Facilities   
Pain control101.06.6
Painful procedures171.711.2
Facilities   
Bathrooms70.74.6
Maintenance response50.53.3
Traffic/parking60.63.9
Substandard amenities676.9100
Food quality262.738.8
Food variety50.57.5
Food service161.623.9
TV80.811.9
Beds80.811.9
Gowns40.46.0

Ineptitude

A total of 7.7% of interviewed patients reported experiencing a situation that made them feel unsafe. Dissatisfaction with safety included adverse events or near misses, uncleanliness, and a perceived lack of knowledge or skill. The implicit expectation that emerged from this domain was that the hospital would be safe, and that medical staff would be knowledgeable and skillful.

Adverse events or near misses were experienced in several areas, including diet, medication administration, patient identification, and equipment. Patients were particularly troubled when they or a family member caught the error:

There was one male nurse in training, C*, who was about to give my mother an injection. I asked what he was doing because she was about to go into surgery. He said he thought she was going home. He looked at the chart again and it turns out he was holding her roommate's chart. I don't know what would have happened if I wasn't there.

 

Dissatisfaction with the cleanliness of the hospital environment was also frequently expressed as a safety concern:

The rooms are dirtyThe floors are dirty. They don't sweep unless you ask them to. It took three different people to come and clean the bathroom right. I have to come back for surgery and I'm scared to death with all that bacteria and uncleanliness.

 

In this category, patients also described care by not too knowledgeable trainees or other staff as a safety hazard.

Disrespect

A total of 6.0% of surveyed patients suggested improvements that reflected disrespectful treatment, including poor work ethic, lack of warmth, rudeness, and a lack of attention to privacy and confidentiality. This type of dissatisfaction suggested an implicit expectation for treatment with respect and dignity that was clearly distinct from the expectation of technical quality:

[Hospital name] has always been like [this] since I started going there in 1982. They're very good technically but their bedside manner kind of sucks. You survive but you don't walk away with a warm fuzzy feeling.

 

Underprivileged patients were particularly sensitive to the need for respect:

I feel like the doctor that saw me that last night there was trying to get me out of there as fast as possible, saying not in so many words that it was because I don't have any insurance. I just feel like they treated me like an animal.

 

Violations of privacy and confidentiality were not only perceived as disrespectful, but also as a direct impediment to high‐quality care:

In the ER, I didn't like that I had no privacy especially talking with the doctor because I was in the hallway. I didn't have any privacy therefore I wasn't completely truthful with the doctor because everyone could hear.

 

Prolonged Waits

A total of 15.8% of patients noted dissatisfaction with wait times in the hospital. Waits for admission, transport, or discharge were frequently cited as anxiety‐provoking or frustrating:

The ER wait is too long. I was there from 8:00 AM to 2:00 AM the next day. I was there the whole day and night. When someone is in pain, they just want to be taken care of, not waiting around.

 

Waits related to receiving patient care, for example the inability to access nurses or physicians, more often caused feelings of fear and abandonment:

Every patient is different, I understand, but when you're there at night it can be a little scary. I was not only scared but in pain. The nurse tried to get a hold of the doctor that was on call, but the doctor took hours to respond. That was very scary.

 

It was also distressing to patients to watch roommates experience a delay in help for urgent needs:

The lady next to me was an elderly woman with a brace on her neck, and she couldn't speak very well. She had diarrhea at night and she would ask for a bedpan. The nurses would take forever bringing it to her. I just think when there are elderly people they should be more attentive to them because they tend to not be as vocal, you know?

 

Together, these comments represented an implicit expectation for prompt and efficient care.

Ineffective Communication

Communication during hospitalization was a source of dissatisfaction in 7.4% of surveyed patients. Communication failures occurred in several areas. Most common was the ineffective transfer of medical information to patients:

For days I thought I was having surgery on Friday. So all that day I ate and drank nothing and got prepped for surgery. Finally later that night I was told I was going to have it on Saturday. Saturday comes and still nothing. I never saw a surgeon or talked to anyone. Then later after that I was told I'm not having the surgery. That was the most frustrating thing.

 

Patients were also dissatisfied with their ability to communicate with their doctors:

I was sent home on a Friday and was sent right back on Friday night because my blood count was low and I ended up needing a blood transfusion. I tried to tell them this but they didn't listen. They need to listen to the patients.

 

Failed communication between care providers in the hospital was a third inadequacy noted by patients:

The only problem I had was all the different doctors coming in and out. There's so many that it confuses the patient, and a lot of them would contradict each other. One doctor said I could go home and another doctor said, No, you need to stay.

 

Finally, patients were dissatisfied when there was ineffective communication between inpatient and outpatient providers.

They said the VNA [Visiting Nurse Association] is supposed to come. The nurse hasn't come to see me and she hasn't called. My daughter and I have been waiting.

 

Thus, patients had an implicit expectation for effective communication between all parties in the hospital and were dissatisfied when any type of communication was inadequate.

Lack of Environmental Control

A total of 15.4% of surveyed patients reported dissatisfaction with the inability to control the physical environment. The inability to control noise levels, roommate behavior, temperature, smells, pain, lighting, staff interruptions, food service, smoking, and even humidity were all anxiety‐producing for different patients. The feeling of being imposed upon by an uncomfortable physical environment also extended to hospital facilities such as inaccessible bathrooms, traffic, and parking. Dissatisfaction with rooming arrangements was common:

I was in a triple room and one of my roommates had at least six visitors in the room at a time every day including two infant twins. Someone really should have said something about that. It became very disturbing, and I even left a day early because of that.

 

An expectation for quiet, especially during the night, was also repeatedly expressed:

The night shift could have been more considerate of people trying to rest. There was a lot of noise and bangs. I know people have to laugh and have fun but it could have been a little more quiet.

 

Related was the inability to control interruptions by staff members:

It's hard enough to get sleep, but then those blood suckers come in the middle of the night.

 

This category of dissatisfaction reflected an implicit expectation for autonomy and control over the environment so that it was conducive to rest and healing.

Substandard Amenities

A total of 6.9% of surveyed patients suggested improvements to amenities such as food, bedding, gowns, and television. Moving beyond the expectation of having peaceful surroundings, these comments reflected an expectation of a well‐appointed hospital environment with high‐quality amenities. A typical example was this comment about the food and service:

You never get what you order from the kitchen. Your tray either has something missing from it or it's the wrong tray or not the right diet. It's very frustrating and hard to get the orders the way you want.

 

Discussion

We analyzed 439 patient suggestions for improving hospital care and found that dissatisfaction resulted from six categories of negative experiences: 1) ineptitude, 2) disrespect, 3) prolonged wait times, 4) ineffective communication, 5) lack of environmental control, and 6) substandard amenities. These domains represented a corresponding set of implicit patient expectations for: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities. Each of these categories suggests avenues by which both the assessment and provision of hospital care can be made more patient‐centered.

The most widely used patient satisfaction survey in use in the United States today is the Hospital Consumer Assessment of Healthcare Providers & Systems (HCAHPS), which includes eight domains: communication with doctors, communication with nurses, responsiveness of hospital staff, pain management, communication about medicines, discharge information, cleanliness of the hospital environment, and quietness of the hospital environment.17 The dissatisfaction domains found in this study closely overlap the HCAHPS satisfaction domains, but with a few key differences.

First, dissatisfaction with ineptitude in our study encompassed concerns over adverse events and near misses, in addition to the cleanliness of the environment. Other research has shown that dissatisfaction with hospitalization can be predicted by the number of reported problems18 and the perception of receiving incorrect treatment.19 While elaborate methods have been devised to assess and compare the hospital quality and safety, patient satisfaction surveys including the HCAHPS survey often fail to ask patients directly about their perceptions of safety. In fact, this study and others20, 21 show that patients are able to recognize adverse events during hospitalization. Patient report may be a useful adjunct to other methods of adverse event case finding and outcomes reporting.

Second, while HCAHPS and others identify warmth, courtesy, concern, and respect as dimensions of patient‐centered care,14, 17, 22, 23 the ability of quantitative satisfaction surveys to capture the experience of disrespectful treatment may be limited, especially during hospitalization. Most respondents who commented on feeling disrespected identified only a single encounter, which can be masked by otherwise satisfying interactions with numerous care providers. Directly asking patients whether any experience during hospitalization caused them to feel disrespected, and allowing room for explanation, might more efficiently identify problem areas. This is particularly important because even one episode of disrespectful treatment, particularly when perceived to be racially motivated, increases the likelihood of not following a doctor's advice or putting off care.24

Third, HCAHPS emphasizes two aspects of communication: that between patients and doctors, and that between patients and nurses. Our patients confirmed that these are important, but they also noted a third dimension of communication contributing to dissatisfaction: provider‐provider communication. Communication and coordination failures among providers are key contributors to adverse events or near misses,2528 but their influence on patient satisfaction has not been widely assessed. Furthermore, patient input is rarely utilized to identify poor interprovider communication. Our study suggests that, just as patients can identify adverse events, they are also able to recognize poor provider‐provider communication.

Patients' reports of dissatisfying events also highlight areas in which small changes in hospital practice might greatly improve the patient experience. For instance, concerns over environment, food, sleep, hygiene, and pain appeared to be representative of a broader dissatisfaction with loss of autonomy and control. Hospitalized patients are often obliged to room with strangers, are subject to noise and interruptions, and cede control of their medication management at a time when they are feeling particularly vulnerable. The importance of this lack of autonomy to patients suggests a variety of small interventions that could improve satisfaction, such as individual control of noise and temperature, a visible commitment to a quiet hospital environment, and minimized interruptions and sleep disturbance.2932 Single‐occupancy hospital rooms have been associated with lower rates of nosocomial infection, medication errors, and patient stress, as well as increased privacy, rest, visitor involvement, and doctor‐patient communication.33, 34 The most sophisticated intervention, acuity‐adaptable private hospital rooms, allows hospitals to maintain patients in the same private hospital room during an entire admission, regardless of changes to level of acuity.35

In‐depth analysis of suggestions for improvement, as gathered by telephone surveys of recently discharged patients, was a particularly well‐suited approach to identifying explicit expectations for care that were violated by dissatisfying incidents. When allowed to express dissatisfaction in terms of suggestions for improvement, patients talked freely about specific dissatisfying experiences. Using telephone interviews allowed a large volume of patient responses to be included, unlike smaller focus groups. Our study was oral and did not rely on the literacy level of patients. Additionally, the open‐ended nature of questioning avoided some of the usual pitfalls of satisfaction surveys. We did not rely on predetermined satisfaction categories or presume the inherent value of particular attributes of care. Nonetheless, our study does have important limitations.

Patient perceptions were not compared with chart data or clinician report. Caregivers were allowed to participate in lieu of patients, which may have reduced identification of some dissatisfying events. Likewise, patients discharged to nursing homes or who were not English or Spanish speaking were excluded and may have had different dissatisfying experiences. Interviews were brief and dissatisfying events were not explored in detail. Although nearly half of respondents reported dissatisfying events, some patients may have been reluctant to criticize their care directly to a hospital representative. Finally, patients generally confined their comments to one or two dissatisfying events, even though there may have been others. We therefore cannot draw any conclusions about the relative frequency of dissatisfying events by domain.

Conclusions

All hospitalized patients bring expectations for their hospital experience. While specific expectations vary between patients, expectations for: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities were found in this study to encompass core expectations for hospitalization. It may be useful to ensure that postdischarge surveys explicitly address these expectations. Efforts to address and manage these core expectations of hospital care may help to reduce patient dissatisfaction with hospitalization and improve the delivery and quality of hospital care.

The United States spends more money per capita on healthcare than any other industrialized nation,1 yet patients are the least satisfied with their care.2 Patient satisfaction is associated in both cross‐sectional3 and longitudinal studies4 with improved physical and mental health outcomes. Conversely, dissatisfaction with care hampers future medical interactions, prevents sharing of information, and impairs the building of trust.5 The increasing recognition that a patient's experience of care affects patient outcomes has furthered efforts to evaluate satisfaction with care.6, 7

However, patient satisfaction is challenging to define and understand. Even the definition of satisfaction is ambiguous, for to satisfy can mean both to make happy and the lesser, to be adequate. To dissatisfy is to displease or disappoint, but dissatisfaction is not the opposite of satisfaction: qualitative studies give little if any indication that patients evaluate satisfaction on a continuum ranging from dissatisfied at one end to very satisfied at the other.8 Instead, it appears that satisfaction and dissatisfaction are different constructs, such that patients may simultaneously be both satisfied and dissatisfied.9, 10 Patients often express overall satisfaction with a service or encounter while also reporting specific criticisms about its shortcomings.11, 12 Alternatively, consumers may be generally satisfied unless something unpleasant or improper happens.13 Thus, dissatisfaction and satisfaction may require different methods of measurement.

The most common model for measuring patient satisfaction is a quantitative survey of patients' experiences in specific predetermined domains. Of 54 hospital satisfaction surveys in common use, only 11 included patient input in their development,14 casting doubt on the relevance of these attributes to patients' priorities of care. Since it is well recognized that patient expectations influence satisfaction,8, 13, 15 it is important to identify patient expectations and priorities up front. However, these have not been clearly established. Furthermore, focusing purely on satisfaction with particular domains of care may miss the separate but illuminating construct of patient dissatisfaction.

In this study we therefore aim to understand patient dissatisfaction with hospitalization more fully as a means of elucidating implicit expectations for hospital care. Using qualitative techniques, we analyzed a large volume of patient responses to a single open‐ended study question to identify determinants and patterns of patient dissatisfaction.

Methods

Study Design

We conducted a qualitative analysis of telephone survey data obtained from adults recently discharged after an acute care hospitalization. Survey participants were asked five questions, including: If there was one thing we could have done to improve your experience in the hospital, what would it have been? Answers to this open‐ended question were included in this study.

Setting and Participants

The hospital is a 944‐bed, urban academic medical center. Patients or patient representatives were routinely surveyed in a telephone interview conducted by trained hospital staff 1‐5 days after hospital discharge. Calls were attempted to 90% of adult discharged patients, and approximately 50% of them were reached. For this study, we included patients who were age 18 or older, spoke English, and were discharged to home from a medical, surgical, gynecology‐oncology, neurology, neurosurgery, or intensive care unit. Of those patients, we randomly selected 10% of those surveyed between July 1, 2007 and June 30, 2008 for inclusion.

Primary Data Analysis

Qualitative data analysis was used to classify patient suggestions. The study team included internal medicine physicians (J.P.M., L.I.H.), a medical student (A.V.L.), and a recent college graduate (C.P.B.). Codes were generated using a mixed inductive and deductive approach by reading and rereading the primary data.16 A set of 100 interview responses were first read individually by three investigators (J.P.M., A.V.L., C.P.B.), after which investigators met to discuss themes and ideas. A preliminary list of coding categories was then generated. Each investigator then assigned these coding categories to additional survey responses in sets of 100. Subsequent meetings were held to refine codes using the constant comparative method.16 Disagreements were resolved by negotiated consensus. The full study group met periodically to review the code structure for logic and breadth. Once thematic saturation was achieved, the entire dataset was recoded by two investigators using the final coding structure. The final coding structure contained 42 unique codes organized into six broader themes. We used descriptive statistics to characterize the coding category results. The score for intercoder reliability was 0.91.

This study was approved by the Yale Human Investigation Committee, which granted a waiver of informed consent.

Results

A total of 976 surveys was randomly selected from 9,764 postdischarge phone interviews completed between July 1, 2007 and June 30, 2008. A total of 56.3% of patients was female. Nearly half the patients were discharged from medical units (Table 1). Of the 976 patients, 439 (45.0%) gave at least one suggestion for improvement, yielding a total of 579 suggestions. Patients also offered numerous positive comments about their care, but these comments were not included in the analysis.

Demographic Information (n = 976)
 No.% of Total Surveyed
Total surveys976 
Male42743.7
Female54956.3
Discharge Unit  
Medical43444.5
Surgical30331.0
Gynecology/Oncology10310.6
ICU/CCU/Step‐down717.3
Neurology/Neurosurgery656.6
No suggestions for improvement53755.0
At least one suggestion for improvement43945.0

Through qualitative analysis, we assigned suggestions for improvement to six major categories of dissatisfaction: 1) ineptitude, 2) disrespect, 3) prolonged waits, 4) ineffective communication, 5) lack of environmental control, and 6) substandard amenities. We considered the inverse of these problems to represent six implicit expectations of good hospital care: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities (Table 2). The number of patient suggestions related to each domain is detailed in Table 3.

Domains of Dissatisfaction and Corresponding Implicit Expectations
Domain of DissatisfactionImplicit ExpectationsExample
IneptitudeSafetyThe only thing was that when I was getting ready to get discharged, one of Dr. H*'s associates came in and said, We have to readmit you for a further procedure. I said, Well, that's strange because Dr. H* put in a stent yesterday, and I'm supposed to leave today. Well, he checked, and he had the wrong guy. I'm glad I said something or else they probably would have hauled me off.
DisrespectTreatment with respect and dignityTransport was rude due to me being a heavy person. They were saying they didn't want to move me and snickering.
Prolonged waitsPrompt and efficient careI called for someone because I had to use the bathroom really bad, but I had those things stuck to my legs and needed help walking to the bathroom but no one came. Well, I had to go so bad that I had a panic attack. Then all these people came rushing in to help. I felt so embarrassed.
Ineffective communicationSuccessful exchange of informationThere were a few days that [were] a little confusing to me. I didn't know if I was going to have surgery or go home. The communication wasn't that great.
Lack of environmental controlEnvironmental autonomy and controlI was put in a room with a man who had many issues. He was loud and yelling all night. It was a very disturbing experience.
Substandard amenitiesHigh‐quality amenitiesIn that ICU they should put a TV on the ceiling for when you're lying flat on your back looking at the ceiling tiles for 4 days.
Descriptive Statistics of Dissatisfaction Domains
Domain of DissatisfactionNo. (N = 579 suggestionsa)% of Total Surveyed% Within Domain
  • Some respondents gave more than one suggestion, resulting in a greater number of total suggestions than the number of respondents with at least one suggestion for improvement.

Perceived ineptitude757.7100
Adverse events181.824.0
Cleanliness363.748.0
Perceived lack of knowledge/skill121.216.0
Rushed out90.912.0
Disrespect596.0100
Unprofessional staff behavior555.693.2
Lack of privacy/confidentiality40.46.8
Prolonged waits15415.8100
Response to call bell   
Bathing/toileting/distress242.515.6
General414.226.6
Wait for physician121.27.8
Wait for admission bed293.018.8
Wait for transport161.610.4
Wait for food70.74.6
Wait for medication111.17.1
Wait for diagnostic test/procedures60.63.9
Wait for discharge80.85.2
Ineffective communication727.4100
Communication with patients333.445.8
Communication with family30.34.2
Translation20.22.8
Communication between providers131.318.1
Coordination of care (inpatient)111.115.3
Medication reconciliation50.56.9
Continuity inpatient to outpatient50.56.9
Lack of environmental control15215.6100
Physical environment   
Roommates383.925.0
Noise242.515.8
Temperature121.27.9
Smell10.10.7
Interruption by staff151.59.9
Lighting20.21.3
Chaos/hectic40.42.6
Shorter Stay80.85.3
General30.32.0
Facilities   
Pain control101.06.6
Painful procedures171.711.2
Facilities   
Bathrooms70.74.6
Maintenance response50.53.3
Traffic/parking60.63.9
Substandard amenities676.9100
Food quality262.738.8
Food variety50.57.5
Food service161.623.9
TV80.811.9
Beds80.811.9
Gowns40.46.0

Ineptitude

A total of 7.7% of interviewed patients reported experiencing a situation that made them feel unsafe. Dissatisfaction with safety included adverse events or near misses, uncleanliness, and a perceived lack of knowledge or skill. The implicit expectation that emerged from this domain was that the hospital would be safe, and that medical staff would be knowledgeable and skillful.

Adverse events or near misses were experienced in several areas, including diet, medication administration, patient identification, and equipment. Patients were particularly troubled when they or a family member caught the error:

There was one male nurse in training, C*, who was about to give my mother an injection. I asked what he was doing because she was about to go into surgery. He said he thought she was going home. He looked at the chart again and it turns out he was holding her roommate's chart. I don't know what would have happened if I wasn't there.

 

Dissatisfaction with the cleanliness of the hospital environment was also frequently expressed as a safety concern:

The rooms are dirtyThe floors are dirty. They don't sweep unless you ask them to. It took three different people to come and clean the bathroom right. I have to come back for surgery and I'm scared to death with all that bacteria and uncleanliness.

 

In this category, patients also described care by not too knowledgeable trainees or other staff as a safety hazard.

Disrespect

A total of 6.0% of surveyed patients suggested improvements that reflected disrespectful treatment, including poor work ethic, lack of warmth, rudeness, and a lack of attention to privacy and confidentiality. This type of dissatisfaction suggested an implicit expectation for treatment with respect and dignity that was clearly distinct from the expectation of technical quality:

[Hospital name] has always been like [this] since I started going there in 1982. They're very good technically but their bedside manner kind of sucks. You survive but you don't walk away with a warm fuzzy feeling.

 

Underprivileged patients were particularly sensitive to the need for respect:

I feel like the doctor that saw me that last night there was trying to get me out of there as fast as possible, saying not in so many words that it was because I don't have any insurance. I just feel like they treated me like an animal.

 

Violations of privacy and confidentiality were not only perceived as disrespectful, but also as a direct impediment to high‐quality care:

In the ER, I didn't like that I had no privacy especially talking with the doctor because I was in the hallway. I didn't have any privacy therefore I wasn't completely truthful with the doctor because everyone could hear.

 

Prolonged Waits

A total of 15.8% of patients noted dissatisfaction with wait times in the hospital. Waits for admission, transport, or discharge were frequently cited as anxiety‐provoking or frustrating:

The ER wait is too long. I was there from 8:00 AM to 2:00 AM the next day. I was there the whole day and night. When someone is in pain, they just want to be taken care of, not waiting around.

 

Waits related to receiving patient care, for example the inability to access nurses or physicians, more often caused feelings of fear and abandonment:

Every patient is different, I understand, but when you're there at night it can be a little scary. I was not only scared but in pain. The nurse tried to get a hold of the doctor that was on call, but the doctor took hours to respond. That was very scary.

 

It was also distressing to patients to watch roommates experience a delay in help for urgent needs:

The lady next to me was an elderly woman with a brace on her neck, and she couldn't speak very well. She had diarrhea at night and she would ask for a bedpan. The nurses would take forever bringing it to her. I just think when there are elderly people they should be more attentive to them because they tend to not be as vocal, you know?

 

Together, these comments represented an implicit expectation for prompt and efficient care.

Ineffective Communication

Communication during hospitalization was a source of dissatisfaction in 7.4% of surveyed patients. Communication failures occurred in several areas. Most common was the ineffective transfer of medical information to patients:

For days I thought I was having surgery on Friday. So all that day I ate and drank nothing and got prepped for surgery. Finally later that night I was told I was going to have it on Saturday. Saturday comes and still nothing. I never saw a surgeon or talked to anyone. Then later after that I was told I'm not having the surgery. That was the most frustrating thing.

 

Patients were also dissatisfied with their ability to communicate with their doctors:

I was sent home on a Friday and was sent right back on Friday night because my blood count was low and I ended up needing a blood transfusion. I tried to tell them this but they didn't listen. They need to listen to the patients.

 

Failed communication between care providers in the hospital was a third inadequacy noted by patients:

The only problem I had was all the different doctors coming in and out. There's so many that it confuses the patient, and a lot of them would contradict each other. One doctor said I could go home and another doctor said, No, you need to stay.

 

Finally, patients were dissatisfied when there was ineffective communication between inpatient and outpatient providers.

They said the VNA [Visiting Nurse Association] is supposed to come. The nurse hasn't come to see me and she hasn't called. My daughter and I have been waiting.

 

Thus, patients had an implicit expectation for effective communication between all parties in the hospital and were dissatisfied when any type of communication was inadequate.

Lack of Environmental Control

A total of 15.4% of surveyed patients reported dissatisfaction with the inability to control the physical environment. The inability to control noise levels, roommate behavior, temperature, smells, pain, lighting, staff interruptions, food service, smoking, and even humidity were all anxiety‐producing for different patients. The feeling of being imposed upon by an uncomfortable physical environment also extended to hospital facilities such as inaccessible bathrooms, traffic, and parking. Dissatisfaction with rooming arrangements was common:

I was in a triple room and one of my roommates had at least six visitors in the room at a time every day including two infant twins. Someone really should have said something about that. It became very disturbing, and I even left a day early because of that.

 

An expectation for quiet, especially during the night, was also repeatedly expressed:

The night shift could have been more considerate of people trying to rest. There was a lot of noise and bangs. I know people have to laugh and have fun but it could have been a little more quiet.

 

Related was the inability to control interruptions by staff members:

It's hard enough to get sleep, but then those blood suckers come in the middle of the night.

 

This category of dissatisfaction reflected an implicit expectation for autonomy and control over the environment so that it was conducive to rest and healing.

Substandard Amenities

A total of 6.9% of surveyed patients suggested improvements to amenities such as food, bedding, gowns, and television. Moving beyond the expectation of having peaceful surroundings, these comments reflected an expectation of a well‐appointed hospital environment with high‐quality amenities. A typical example was this comment about the food and service:

You never get what you order from the kitchen. Your tray either has something missing from it or it's the wrong tray or not the right diet. It's very frustrating and hard to get the orders the way you want.

 

Discussion

We analyzed 439 patient suggestions for improving hospital care and found that dissatisfaction resulted from six categories of negative experiences: 1) ineptitude, 2) disrespect, 3) prolonged wait times, 4) ineffective communication, 5) lack of environmental control, and 6) substandard amenities. These domains represented a corresponding set of implicit patient expectations for: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities. Each of these categories suggests avenues by which both the assessment and provision of hospital care can be made more patient‐centered.

The most widely used patient satisfaction survey in use in the United States today is the Hospital Consumer Assessment of Healthcare Providers & Systems (HCAHPS), which includes eight domains: communication with doctors, communication with nurses, responsiveness of hospital staff, pain management, communication about medicines, discharge information, cleanliness of the hospital environment, and quietness of the hospital environment.17 The dissatisfaction domains found in this study closely overlap the HCAHPS satisfaction domains, but with a few key differences.

First, dissatisfaction with ineptitude in our study encompassed concerns over adverse events and near misses, in addition to the cleanliness of the environment. Other research has shown that dissatisfaction with hospitalization can be predicted by the number of reported problems18 and the perception of receiving incorrect treatment.19 While elaborate methods have been devised to assess and compare the hospital quality and safety, patient satisfaction surveys including the HCAHPS survey often fail to ask patients directly about their perceptions of safety. In fact, this study and others20, 21 show that patients are able to recognize adverse events during hospitalization. Patient report may be a useful adjunct to other methods of adverse event case finding and outcomes reporting.

Second, while HCAHPS and others identify warmth, courtesy, concern, and respect as dimensions of patient‐centered care,14, 17, 22, 23 the ability of quantitative satisfaction surveys to capture the experience of disrespectful treatment may be limited, especially during hospitalization. Most respondents who commented on feeling disrespected identified only a single encounter, which can be masked by otherwise satisfying interactions with numerous care providers. Directly asking patients whether any experience during hospitalization caused them to feel disrespected, and allowing room for explanation, might more efficiently identify problem areas. This is particularly important because even one episode of disrespectful treatment, particularly when perceived to be racially motivated, increases the likelihood of not following a doctor's advice or putting off care.24

Third, HCAHPS emphasizes two aspects of communication: that between patients and doctors, and that between patients and nurses. Our patients confirmed that these are important, but they also noted a third dimension of communication contributing to dissatisfaction: provider‐provider communication. Communication and coordination failures among providers are key contributors to adverse events or near misses,2528 but their influence on patient satisfaction has not been widely assessed. Furthermore, patient input is rarely utilized to identify poor interprovider communication. Our study suggests that, just as patients can identify adverse events, they are also able to recognize poor provider‐provider communication.

Patients' reports of dissatisfying events also highlight areas in which small changes in hospital practice might greatly improve the patient experience. For instance, concerns over environment, food, sleep, hygiene, and pain appeared to be representative of a broader dissatisfaction with loss of autonomy and control. Hospitalized patients are often obliged to room with strangers, are subject to noise and interruptions, and cede control of their medication management at a time when they are feeling particularly vulnerable. The importance of this lack of autonomy to patients suggests a variety of small interventions that could improve satisfaction, such as individual control of noise and temperature, a visible commitment to a quiet hospital environment, and minimized interruptions and sleep disturbance.2932 Single‐occupancy hospital rooms have been associated with lower rates of nosocomial infection, medication errors, and patient stress, as well as increased privacy, rest, visitor involvement, and doctor‐patient communication.33, 34 The most sophisticated intervention, acuity‐adaptable private hospital rooms, allows hospitals to maintain patients in the same private hospital room during an entire admission, regardless of changes to level of acuity.35

In‐depth analysis of suggestions for improvement, as gathered by telephone surveys of recently discharged patients, was a particularly well‐suited approach to identifying explicit expectations for care that were violated by dissatisfying incidents. When allowed to express dissatisfaction in terms of suggestions for improvement, patients talked freely about specific dissatisfying experiences. Using telephone interviews allowed a large volume of patient responses to be included, unlike smaller focus groups. Our study was oral and did not rely on the literacy level of patients. Additionally, the open‐ended nature of questioning avoided some of the usual pitfalls of satisfaction surveys. We did not rely on predetermined satisfaction categories or presume the inherent value of particular attributes of care. Nonetheless, our study does have important limitations.

Patient perceptions were not compared with chart data or clinician report. Caregivers were allowed to participate in lieu of patients, which may have reduced identification of some dissatisfying events. Likewise, patients discharged to nursing homes or who were not English or Spanish speaking were excluded and may have had different dissatisfying experiences. Interviews were brief and dissatisfying events were not explored in detail. Although nearly half of respondents reported dissatisfying events, some patients may have been reluctant to criticize their care directly to a hospital representative. Finally, patients generally confined their comments to one or two dissatisfying events, even though there may have been others. We therefore cannot draw any conclusions about the relative frequency of dissatisfying events by domain.

Conclusions

All hospitalized patients bring expectations for their hospital experience. While specific expectations vary between patients, expectations for: 1) safety, 2) treatment with respect and dignity, 3) prompt and efficient care, 4) successful exchange of information, 5) environmental autonomy and control, and 6) high‐quality amenities were found in this study to encompass core expectations for hospitalization. It may be useful to ensure that postdischarge surveys explicitly address these expectations. Efforts to address and manage these core expectations of hospital care may help to reduce patient dissatisfaction with hospitalization and improve the delivery and quality of hospital care.

References
  1. Cylus J,Anderson GF.Multinational Comparisons of Health Systems Data, 2006.Washington, DC:The Commonwealth Fund;2007.
  2. Schoen C,Osborn R,Doty MM,Bishop M,Peugh J,Murukutla N.Toward higher‐performance health systems: Adults' health care experiences in seven countries, 2007.Health Aff.2007;26:w717734.
  3. Glickman SW,Boulding W,Manary M, et al.Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction.Circ Cardiovasc Qual Outcomes.2010;3:188195.
  4. Wong WS,Fielding R.A longitudinal analysis of patient satisfaction and subsequent quality of life in Hong Kong Chinese breast and nasopharyngeal cancer patients.Med Care.2009;47:875881.
  5. Coyle J.Understanding dissatisfied users: developing a framework for comprehending criticisms of health care work.J Adv Nurs.1999;30:723731.
  6. Sitzia J,Wood N.Patient satisfaction: a review of issues and concepts.Soc Sci Med.1997;45:18291843.
  7. Institute of Medicine.Crossing the Quality Chasm: A New Health System for the 21st Century.Washington, DC:National Academy Press;2001.
  8. Williams B.Patient satisfaction: a valid concept?Soc Sci Med.1994;38:509516.
  9. Coyle J.Exploring the meaning of ‘dissatisfaction’ with health care: the importance of ‘personal identity threat’.Sociol Health Illn.1999;21:95123.
  10. Mulcahy L,Titter JQ.Pathways, pyramids and icebergs? Mapping the links between dissatisfaction and complaints.Sociol Health Illn.1998;20:825847.
  11. Williams SJ,Calnan M.Convergence and divergence: assessing criteria of consumer satisfaction across general practice, dental and hospital care settings.Soc Sci Med.1991;33:707716.
  12. Bruster S,Jarman B,Bosanquet N,Weston D,Erens R,Delbanco TL.National survey of hospital patients [see comment].BMJ.1994;309:15421546.
  13. Crow R,Gage H,Hampson S, et al.The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature.Health Technol Assess.2002;6:1244.
  14. Castle NG,Brown J,Hepner KA,Hays RD.Review of the literature on survey instruments used to collect data on hospital patients' perceptions of care.Health Serv Res.2005;40:19962017.
  15. Avis M,Bond M,Arthur A.Satisfying solutions? A review of some unresolved issues in the measurement of patient satisfaction.J Adv Nurs.1995;22:316322.
  16. Glaser BG,Strauss AL.The Discovery of Grounded Theory: Strategies for Qualitative Research.Chicago, IL:Aldine;1967.
  17. Hospital Consumer Assessment of Healthcare Providers 25:2536.
  18. Danielsen K,Garratt AM,Bjertnaes OA,Pettersen KI.Patient experiences in relation to respondent and health service delivery characteristics: a survey of 26,938 patients attending 62 hospitals throughout Norway.Scand J Public Health.2007;35:7077.
  19. Weingart SN,Pagovich O,Sands DZ, et al.What can hospitalized patients tell us about adverse events? Learning from patient‐reported incidents.J Gen Intern Med.2005;20:830836.
  20. Cleary PD.A hospitalization from hell: a patient's perspective on quality.Ann Intern Med.2003;138:3339.
  21. Gerteis M,Edgman‐Levitan S,Daley J,Delbanco TL.Through the Patient's Eyes: Understanding and Promoting Patient‐Centered Care.San Francisco, CA:Jossey‐Bass;1993.
  22. Sofaer S,Crofton C,Goldstein E,Hoy E,Crabb J.What do consumers want to know about the quality of care in hospitals?Health Serv Res.2005;40:20182036.
  23. Blanchard J,Lurie N.R‐e‐s‐p‐e‐c‐t: patient reports of disrespect in the health care setting and its impact on care.J Fam Pract.2004;53:721730.
  24. McKnight LK,Stetson PD,Bakken S,Curran C,Cimino JJ.Perceived information needs and communication difficulties of inpatient physicians and nurses.J Am Med Inform Assoc.2002;9(6 suppl 1):S64S69.
  25. Leonard M,Graham S,Bonacum D.The human factor: the critical importance of effective teamwork and communication in providing safe care.Qual Saf Health Care.2004;13:i85i90.
  26. Horwitz LI,Moin T,Krumholz HM,Wang L,Bradley EH.Consequences of inadequate sign‐out for patient care.Arch Intern Med.2008;168:17551760.
  27. Horwitz LI,Meredith T,Schuur JD,Shah NR,Kulkarni RG,Jenq GY.Dropping the baton: a qualitative analysis of failures during the transition from emergency department to inpatient care.Ann Emerg Med.2009;53:701710 e704.
  28. Topf M,Thompson S.Interactive relationships between hospital patients' noise‐induced stress and other stress with sleep.Heart Lung.2001;30:237243.
  29. Job RFS.The influence of subjective reactions to noise on health effects of the noise.Environ Int.1996;22:93104.
  30. Smykowski L.A novel PACU design for noise reduction.J Perianesth Nurs.2008;23:226229.
  31. Martin DP,Hunt JR,Conrad DA,Hughes‐Stone M.The Planetree Model Hospital Project: an example of the patient as partner. (Pacific Presbyterian Medical Center, San Francisco).Hosp Health Serv Admin.1990;35:591601.
  32. van de Glind I,van Dulmen S,Goossensen A.Physician‐patient communication in single‐bedded versus four‐bedded hospital rooms.Patient Educ Couns.2008;73:215219.
  33. Chaudhury H,Mahmood A,Valente M.Advantages and disadvantages of single‐versus multiple‐occupancy rooms in acute care environments: a review and analysis of the literature.Environ Behav.2005;37:760786.
  34. Brown KK,Gallant DB.Impacting patient outcomes through design: acuity adaptable care/universal room design.Crit Care Nurs Q.2006;29:326341.
References
  1. Cylus J,Anderson GF.Multinational Comparisons of Health Systems Data, 2006.Washington, DC:The Commonwealth Fund;2007.
  2. Schoen C,Osborn R,Doty MM,Bishop M,Peugh J,Murukutla N.Toward higher‐performance health systems: Adults' health care experiences in seven countries, 2007.Health Aff.2007;26:w717734.
  3. Glickman SW,Boulding W,Manary M, et al.Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction.Circ Cardiovasc Qual Outcomes.2010;3:188195.
  4. Wong WS,Fielding R.A longitudinal analysis of patient satisfaction and subsequent quality of life in Hong Kong Chinese breast and nasopharyngeal cancer patients.Med Care.2009;47:875881.
  5. Coyle J.Understanding dissatisfied users: developing a framework for comprehending criticisms of health care work.J Adv Nurs.1999;30:723731.
  6. Sitzia J,Wood N.Patient satisfaction: a review of issues and concepts.Soc Sci Med.1997;45:18291843.
  7. Institute of Medicine.Crossing the Quality Chasm: A New Health System for the 21st Century.Washington, DC:National Academy Press;2001.
  8. Williams B.Patient satisfaction: a valid concept?Soc Sci Med.1994;38:509516.
  9. Coyle J.Exploring the meaning of ‘dissatisfaction’ with health care: the importance of ‘personal identity threat’.Sociol Health Illn.1999;21:95123.
  10. Mulcahy L,Titter JQ.Pathways, pyramids and icebergs? Mapping the links between dissatisfaction and complaints.Sociol Health Illn.1998;20:825847.
  11. Williams SJ,Calnan M.Convergence and divergence: assessing criteria of consumer satisfaction across general practice, dental and hospital care settings.Soc Sci Med.1991;33:707716.
  12. Bruster S,Jarman B,Bosanquet N,Weston D,Erens R,Delbanco TL.National survey of hospital patients [see comment].BMJ.1994;309:15421546.
  13. Crow R,Gage H,Hampson S, et al.The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature.Health Technol Assess.2002;6:1244.
  14. Castle NG,Brown J,Hepner KA,Hays RD.Review of the literature on survey instruments used to collect data on hospital patients' perceptions of care.Health Serv Res.2005;40:19962017.
  15. Avis M,Bond M,Arthur A.Satisfying solutions? A review of some unresolved issues in the measurement of patient satisfaction.J Adv Nurs.1995;22:316322.
  16. Glaser BG,Strauss AL.The Discovery of Grounded Theory: Strategies for Qualitative Research.Chicago, IL:Aldine;1967.
  17. Hospital Consumer Assessment of Healthcare Providers 25:2536.
  18. Danielsen K,Garratt AM,Bjertnaes OA,Pettersen KI.Patient experiences in relation to respondent and health service delivery characteristics: a survey of 26,938 patients attending 62 hospitals throughout Norway.Scand J Public Health.2007;35:7077.
  19. Weingart SN,Pagovich O,Sands DZ, et al.What can hospitalized patients tell us about adverse events? Learning from patient‐reported incidents.J Gen Intern Med.2005;20:830836.
  20. Cleary PD.A hospitalization from hell: a patient's perspective on quality.Ann Intern Med.2003;138:3339.
  21. Gerteis M,Edgman‐Levitan S,Daley J,Delbanco TL.Through the Patient's Eyes: Understanding and Promoting Patient‐Centered Care.San Francisco, CA:Jossey‐Bass;1993.
  22. Sofaer S,Crofton C,Goldstein E,Hoy E,Crabb J.What do consumers want to know about the quality of care in hospitals?Health Serv Res.2005;40:20182036.
  23. Blanchard J,Lurie N.R‐e‐s‐p‐e‐c‐t: patient reports of disrespect in the health care setting and its impact on care.J Fam Pract.2004;53:721730.
  24. McKnight LK,Stetson PD,Bakken S,Curran C,Cimino JJ.Perceived information needs and communication difficulties of inpatient physicians and nurses.J Am Med Inform Assoc.2002;9(6 suppl 1):S64S69.
  25. Leonard M,Graham S,Bonacum D.The human factor: the critical importance of effective teamwork and communication in providing safe care.Qual Saf Health Care.2004;13:i85i90.
  26. Horwitz LI,Moin T,Krumholz HM,Wang L,Bradley EH.Consequences of inadequate sign‐out for patient care.Arch Intern Med.2008;168:17551760.
  27. Horwitz LI,Meredith T,Schuur JD,Shah NR,Kulkarni RG,Jenq GY.Dropping the baton: a qualitative analysis of failures during the transition from emergency department to inpatient care.Ann Emerg Med.2009;53:701710 e704.
  28. Topf M,Thompson S.Interactive relationships between hospital patients' noise‐induced stress and other stress with sleep.Heart Lung.2001;30:237243.
  29. Job RFS.The influence of subjective reactions to noise on health effects of the noise.Environ Int.1996;22:93104.
  30. Smykowski L.A novel PACU design for noise reduction.J Perianesth Nurs.2008;23:226229.
  31. Martin DP,Hunt JR,Conrad DA,Hughes‐Stone M.The Planetree Model Hospital Project: an example of the patient as partner. (Pacific Presbyterian Medical Center, San Francisco).Hosp Health Serv Admin.1990;35:591601.
  32. van de Glind I,van Dulmen S,Goossensen A.Physician‐patient communication in single‐bedded versus four‐bedded hospital rooms.Patient Educ Couns.2008;73:215219.
  33. Chaudhury H,Mahmood A,Valente M.Advantages and disadvantages of single‐versus multiple‐occupancy rooms in acute care environments: a review and analysis of the literature.Environ Behav.2005;37:760786.
  34. Brown KK,Gallant DB.Impacting patient outcomes through design: acuity adaptable care/universal room design.Crit Care Nurs Q.2006;29:326341.
Issue
Journal of Hospital Medicine - 5(9)
Issue
Journal of Hospital Medicine - 5(9)
Page Number
514-520
Page Number
514-520
Article Type
Display Headline
What can we learn from patient dissatisfaction? An analysis of dissatisfying events at an academic medical center
Display Headline
What can we learn from patient dissatisfaction? An analysis of dissatisfying events at an academic medical center
Legacy Keywords
communication, patient satisfaction, professionalism, quality improvement, teamwork
Legacy Keywords
communication, patient satisfaction, professionalism, quality improvement, teamwork
Sections
Article Source

Copyright © 2010 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
General Internal Medicine, P.O. Box 208093, New Haven, CT 06520‐8093
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media
Media Files

Assessing Hospitalist Communication

Article Type
Changed
Sun, 05/28/2017 - 20:04
Display Headline
Assessing patient perceptions of hospitalist communication skills using the Communication Assessment Tool (CAT)

Effective communication between patients and physicians improves a number of important outcomes including patient adherence to treatment,1‐3 quality of the medical history4 and clinical outcomes.1, 5, 6 Recognizing the importance of physician communication skills, the American Board of Medical Specialties, American Council for Graduate Medical Education and The Joint Commission all identify communication as a core competency for physicians.7‐9 For hospitalists and their patients, building a therapeutic partnership is challenged by the lack of a preexisting relationship and potential lack of patient history information, particularly psychosocial history.10 Other factors that complicate the relationships between hospitalists and their patients include acuity of illness, limited time course, and absence of or lack of input from patients' primary physicians.11

As a rapidly increasing percentage of hospitalized patients are cared for by hospitalists,12, 13 communication skills need to be directly assessed and addressed. As of 2006, at least 37% of all Medicare claims for inpatient evaluation and management services by general internists were attributed to hospitalists, and more than half of hospitalized Medicare patients are seen by hospitalists.14 Yet, a search of the MEDLINE database for articles published between 1965 and September 2009, querying hospitalist AND patient AND communication within the article title and abstract, yielded only 2 studies assessing hospitalist‐patient communication. A 1998 study15 compared patient‐reported communication problems with hospitalists versus continuity physicians involved with hospital care, and found that patients whose continuity physicians remained involved with care during the hospitalization were less likely to report communication problems than those patients who were cared for by a hospitalist alone. A 2004 study16 utilized chart documentation to compare the end‐of‐life care and communication provided by continuity physicians and hospitalists. Hospitalists were found to document end‐of‐life care discussions more often than continuity physicians, and were more likely to be present for these meetings, which may suggest improved end‐of‐life care. Neither of these hospitalist‐patient communication studies directly assessed patient perceptions of communication with hospitalists.

We undertook this study to explore patient perceptions of communication with hospitalists using the Communication Assessment Tool (CAT), a psychometrically validated instrument for patient assessment of physician communication skills.17 The CAT was initially field tested in outpatient offices, omitting the inpatient experience. A 2008 study18 successfully adapted the CAT tool for use in assessing emergency department (ED) teams. Given the importance of physician‐patient communication when patients are sickest and most vulnerable in the hospital setting, we sought to establish a baseline assessment of patient perceptions of communication with hospitalists in our group. Second, we compared results of our CAT implementation with published results examining communication in other physician groups.

Methods

Between September 2008 and August 2009 we performed a cross‐sectional study of patients admitted to the hospital medicine service at an urban, academic medical center with 873 beds. This busy service was responsible for 10,225 admissions in 2008. Patients of age 18 years or older and cared for by a hospitalist or teaching team led by a hospitalist were eligible to participate. Exclusion criteria included patient confusion, physiological instability, non‐English speaking, patient unable to communicate, or patient in isolation status. Interviews were conducted in the patient's private room with no other staff present.

Patient perception of communication with hospitalists was measured with the CAT.17 This 15‐item survey is written at a fourth grade reading level, and measures responses along a 5‐point scale (1 = poor, 2 = fair, 3 = good, 4 = very good, 5 = excellent). The CAT was originally field tested with a convenience sample of 38 physicians from various regions within the US, across 6 specialties (Dermatology, Family Medicine, Neurosurgery, Ophthalmology, Orthopedic Surgery, and Physical Medicine & Rehabilitation). Each physician's office recruited 25 patients to complete the CAT through a phone or Internet‐based system.

The 14 core items of the CAT, which focus on communication with the individual physician, were used in this study. The 15th item, The doctor's staff treated me with respect, was dropped as it does not reflect the inpatient setting. Results for each physician are reported as the percentage of excellent responses. This dichotomized scoring is consistent with the development study, where analysis with Andrich's rating scale model19, 20 indicated that excellent scores correspond to a yes response while poor through very good scores correspond to a no response. This method of reporting scores as a percentage of excellent responses was found to be more useful for summarizing physician scores than reporting mean scores, which are highly skewed towards positive performance.17

Interviews were conducted by trained research assistants during hospitalists' weekday shifts. Hospitalists were not told which patients would be recruited, but were aware that patients on the service were being interviewed to assess communication. A list of patient names, room numbers, dates of admission, and assigned hospitalists was obtained daily from the electronic medical record system. Patients were approached on the second or third day of the hospital admission, and only if they had been assigned to the same hospitalist for at least 2 consecutive days. After explaining the study to patients and receiving verbal consent, researchers verified that the patient recognized the hospitalist, providing a photo if necessary. Patients who were not confident of their hospitalist's identity were excluded.

The 14 core items of the CAT survey were read aloud to the patient, who was provided with a copy of the instrument's scale and asked to respond with a number or word description (1 = poor to 5 = excellent). Patients were allowed to skip any questions they did not wish to answer. At the conclusion of the survey, patients were asked if they had any further comments to add. Patient demographics as well as hospitalist service (general or teaching) and unit were recorded. Most interviews were completed in less than 5 minutes. Based on the recommendations of the original development and validation of the CAT,17 we collected 20 patient surveys for each hospitalist. For CAT items that the patients skipped, we did not impute values; rather the percentage of excellent responses was calculated based on the number of questions the patient answered. To examine basic psychometric characteristics, we assessed scale reliability and performed a factor analysis using the principal components method of extraction with Varimax rotation.

This project was determined exempt by the Northwestern University Institutional Review Board.

Results

We identified 1,137 patients as potentially eligible for the study. Figure 1 shows a flowchart of patient exclusion. Of note, 107 patients consenting to participate (13% overall) were unable to identify their hospitalist by name or photo. More specifically, 70 teaching service patients (25% of 275 eligible patients) were unable to identify their hospitalist, compared to 37 patients on general service (7% of 553 eligible patients); (z = 7.58, P < 0.001). Another 21 (3%) declined to participate because they had not talked enough with their doctor to render an assessment.

Figure 1
Eligible patient inclusion/exclusion flowchart.

We analyzed 700 patient surveys (20 patients for each of 35 hospitalists; 62% of patients identified). Patient and hospitalist characteristics are presented in Table 1. The proportion of excellent ratings for each hospitalist ranged from 38.5% to 73.5% with an average of 59.1% excellent (standard deviation [SD] = 9.5). See Figure 2 for the distribution of hospitalist scores. For the group as a whole, highest ratings on individual CAT items were for treating the patient with respect (66% excellent), letting the patient talk without interruptions (66%), and talking in terms the patient can understand (64%). Lowest ratings were for involving the patient in decisions as much as he or she wanted (53%), encouraging the patient to ask questions (53%), and greeting the patient in a way that made him or her feel comfortable (55%). Table 2 contains a full ranking of individual item scores.

Figure 2
Overall Communication Assessment Tool (CAT) scores.
Characteristics of Participating Patients and the Hospitalists Rated
Characteristics 
 Patients (n =700), n (%)
Sex, female378 (54)
Age, years 
44 and younger189 (27)
45‐64266 (38)
65 and older245 (35)
Race 
Caucasian357 (51)
African American266 (38)
Hispanic49 (7)
Other28 (4)
 Hospitalists (n = 35), n (%)
Sex, female18 (51)
Age, years 
Range3039
Mean (SD)33 (2.4)
Race 
Caucasian14 (40)
South Asian11 (31)
Asian7 (20)
African American3 (9)
Non‐native English speaker5 (14)
Foreign medical graduate3 (9)
Communication Assessment Tool (CAT) Scores by Item for Group of Hospitalists
Communication Assessment Tool ItemPercent Excellent Scores
1. Greeted me in a way that made me feel comfortable54.9
2. Treated me with respect66.3
3. Showed interest in my ideas about my health58.2
4. Understood my main health concerns57.4
5. Paid attention to me (looked at me, listened carefully)64.1
6. Let me talk without interruptions66.3
7. Gave me as much information as I wanted56.0
8. Talked in terms I could understand64.2
9. Checked to be sure I understood everything57.1
10. Encouraged me to ask questions53.2
11. Involved me in decisions as much as I wanted52.9
12. Discussed next steps including any follow‐up plans58.2
13. Showed care and concern63.8
14. Spent the right amount of time with me57.0

Overall scale reliability proved to be high (Cronbach's alpha = 0.97) in this sample. The factor analysis showed that scores for each of the 14 items load onto 1 factor. These results are consistent with the high reliability and single‐factor loading found in Makoul's original scale reliability and validity testing.17

The ad hoc comments made by patients at the conclusion of the CAT survey were categorized as positive or negative. Although many positive comments were made, they tended to be general in nature (eg, She is a great doctor). Negative comments were more explicit. A total of 110 patients (16%) made specific negative comments, which fell into 7 general domains: lack of information (35 comments), not enough time spent with the patient (27 comments), poor listening to the patient (24 comments), ineffective care delivery (7 comments), issues of care, concern, and respect (6 comments), ineffective communication with other staff (5 comments), and unclear role of physician (3 comments). Three patient comments were not related to these domains.

Patient age, race or gender did not correlate with CAT results. Hospitalist factors of age, race, gender, years of experience also were not associated with differences in ratings. However, race concordance between the patient and hospitalist was associated with improved CAT ratings. Patients of the same race as their hospitalist rated the hospitalist's communication significantly higher (M = 64.9%, SD = 39.1) than did patients who were of a different race than their hospitalist (M = 57.3%, SD = 40.3), P < 0.05. Gender concordance was not associated with improved CAT ratings. No score differences were found between patients cared for by a hospitalist on teaching service and direct care, and there were no differences between nursing units.

Discussion

To the best of our knowledge, this is the first study to explicitly measure patient perceptions of communication with hospitalists. The results yielded a wide distribution of scores for physicians within a single, large hospital medicine group. Comparing their own scores to those of peers may allow low‐scoring hospitalists to grasp the potential for improving their communication with patients. Our reliability testing matched the results of the original development study,17 indicating very high overall scale reliability. This suggests that the CAT could be streamlined by dropping some of the survey items. However we agree with Makoul et al.17 that it is best to keep the full set as it provides specific information for physicians without placing undue burden on patients (ie, the CAT takes only 1‐2 min to complete). Individual item scores for each of the 14 CAT items highlight specific communication tasks where intervention may be targeted for individual hospitalists and the group as a whole. It may be feasible to utilize CAT results as an individual report card for physicians. While program leaders should be aware that implementation of the CAT requires standardized data collection, it may be possible to build this into existing structures such as the discharge process.

Interestingly, many patients could not recognize the hospitalist caring for them by name or photo. More than 1 in 10 patients (107 of 828; 13%) were unable to identify their hospitalist. This was more than 3 times as common on the teaching service, where the hospitalist is accompanied by house staff and the intern or resident is the primary physician for patient contact, compared to the service on which hospitalists directly take care of patients without residents. It is also troubling that another 3% of patients (21 of 828) stated they hadn't talked enough with their hospitalist to answer basic communication questions, when approached 2 or 3 days into the relationship. It may be telling that Greeted me in a way that made me feel comfortable was one of the lowest‐rated survey items. Hospitalists should recognize that patients, in addition to facing their own physical and emotional stressors, see many hospital staff members throughout the day; all of whom may be strangers to them. Thus it becomes vital for hospitalists to not only establish an initial rapport with the patient, but to reintroduce themselves each time they enter the room.

An examination of the ad hoc negative comments made by survey respondents reinforces and extends findings related to the CAT items, particularly about those areas of communication valued by patients. The majority of comments fell into categories of failing to give enough information (eg, Sometimes I was left confused when the doctor was ready to leave), not spending enough time with the patient (eg, He was just in and out), and not listening to the patient's own ideas (eg, When giving my history, she cut me off at some points when I had more to say). The information and time categories may directly relate to scores on the CAT items Gave me as much information as I wanted and Spent the right amount of time with me, which are among the lowest‐scoring items. Listening to the patient may reflect broader issues of considering the patient's own experience, questions, concerns and goals.

In this study, patient‐physician race concordance was associated with CAT ratings. Patients who were of the same race as their hospitalist rated the hospitalist higher compared to patients who were of a different race than their hospitalist. This effect is consistent with previous research describing higher patient ratings of communication and care when the patient and physician are of the same race or ethnicity.21

A number of factors limit interpretation of the results of this study. The data were collected at a single site, thus limiting generalizability to other hospitalist practice environments. We used a retrospective, patient assessment of hospitalist communication which may have inherent biases different from a study using direct researcher observation or recording of patient‐hospitalist interactions to assess communication. This methodology allowed us to examine the patient's own perceptions and expectations of communication, but certainly leaves room for selection bias in recruitment and recall bias. Patients were interviewed on the second or third day of their admission. This controlled the length of exposure to the hospitalist, but the course of treatment might vary considerably; at the time of interview, some patients may not yet have had a clear diagnosis and plan while others may have been ready for discharge. Future work should examine how stage of evaluation and management might affect patients' perception of communication with hospitalists. Severity of condition is another factor that may affect patients' ratings, and was not examined in this study.

When compared to physicians from the CAT development study's field test, this study sample of hospitalists scored much lower, 59.1% excellent vs. 76.3% (P < 0.001). A number of factors may account for some of these differences. The majority of patients in the original field test had multiple interactions with their physician, and rated their health status as good or very good. In contrast, hospitalized patients usually lack previous exposure to the hospitalist, and likely have poorer health status. Also, physicians in the original field test volunteered to participate, and patients completed the CAT survey through the Internet or phone response system, rather than through a face‐to‐face interview by trained research assistants. Another key difference is that field‐test patients answered the CAT within 1 day of their outpatient visit, while in this study patients were interviewed in the midst of their hospital admission and prior to completion of their hospital course. Finally, patients commonly choose their outpatient physician and can select someone else if dissatisfied with their communication skills, while hospitalized patients are assigned hospitalists based on availability. Thus, given this potential selection bias, outpatients could be expected to rate their personal physician higher.

Another possibility is that hospitalists are on average less skilled in patient communication than outpatient physicians. Given the transient nature of the inpatient relationship, hospitalists may not value developing rapport with patients, and may not make this a goal of patient care or seek extensive training in communication skills. In future research, evaluating hospitalists' training in and attitudes towards patient communication could be paired with communication assessment results.

Although it is beyond the scope of this study to assess precisely how these environmental and survey implementation factors may affect CAT summary scores, their importance is evident. Another hospital‐based implementation of the CAT tool, an evaluation of ED teams,18 utilized face‐to‐face interviews with trained research assistants. The study yielded results similar to our findings: the average percent excellent score for ED teams was 62.3%, vs. 58.2% percent excellent for our hospitalist group. Taken together, these study comparisons between the original field‐test, our hospitalist implementation, and the ED team implementation support the argument that factors of setting (inpatient vs. outpatient), mode of survey administration (face‐to‐face interview vs. self‐administration through phone or Internet), and shorter duration or course of patient‐physician interaction may be important considerations when implementing the CAT tool to assess physician communication skills, or attempting to set standards of minimally acceptable or desired scoring.

More work must be done to establish norms and/or minimally acceptable scores for hospitalists. Numerous factors of specialty, practice setting, survey implementation, patient variables, and even the expertise of who is setting the communication standards22 may strongly influence comparisons between physician groups, even within a single institution. Organizations seeking to establish norms or minimally acceptable scores for physician‐patient communication should be aware of these factors. As the original development study points out, standard‐setting studies could establish specialty‐specific and country‐specific norms as well as norms or standards for level‐of‐training (eg, medical students versus attending physicians).17

Conclusion

The previously validated CAT instrument appears to have reliable test characteristics and can be used to gauge patient perceptions of hospitalist communication skills. Comparative scores between physicians of different specialties and settings should be interpreted cautiously as there may be confounding variables. Within our single institution, comparative scores between hospitalists, along with an examination of the hospitalist's individual item scores, may offer useful feedback for efforts aimed at enhancing communication. Many hospitalists in this study may benefit from targeted training to improve patient communication skills, particularly in the areas of encouraging questions and involving patients in decision making. Future qualitative research in the context of hospital medicine could identify specific communication techniques used by highly‐rated physicians, with the goal of developing tools for targeted improvement and determining impact on outcomes.

Acknowledgements

The authors thank Christie Edwards, Rachel Grayer and Caitlin Lawes for assistance with data collection, and Jie Peng for help with the analysis.

References
  1. Beach MC,Keruly J,Moore RD.Is the quality of the patient‐provider relationship associated with better adherence and health outcomes for patients with HIV?J Gen Intern Med.2006;21(6):661665.
  2. Heisler M,Cole I,Weir D,Kerr EA,Hayward RA.Does physician communication influence older patients' diabetes self‐management and glycemic control? Results from the Health and Retirement Study (HRS).J Gerontol A Biol Sci Med Sci.2007;62(12):14351442.
  3. Zolnierek KB,Dimatteo MR.Physician communication and patient adherence to treatment: a meta‐analysis.Med Care.2009;47(8):826834.
  4. Beckman HB,Frankel RM.The effect of physician behavior on the collection of data.Ann Intern Med.1984;101(5):692696.
  5. Trummer UF,Mueller UO,Nowak P,Stidl T,Pelikan JM.Does physician‐patient communication that aims at empowering patients improve clinical outcome? A case study.Patient Educ Couns.2006;61(2):299306.
  6. Stewart MA.Effective physician‐patient communication and health outcomes: a review.CMAJ.1995;152(9):14231433.
  7. Horowitz SD.Evaluation of clinical competencies: basic certification, subspecialty certification, and recertification.Am J Phys Med Rehabil.2000;79(5):478480.
  8. Batalden P,Leach D,Swing S,Dreyfus H,Dreyfus S.General competencies and accreditation in graduate medical education.Health Aff (Millwood).2002;21(5):103111.
  9. Joint Commission on Accreditation of Healthcare Organizations. The Joint Commission Standards supporting effective communication, cultural competence, and patient‐centered care.2009:44.
  10. Barnett PB.Rapport and the hospitalist.Am J Med.2001;111(9B):31S35S.
  11. Wachter RM,Goldman L.The emerging role of “hospitalists” in the American health care system.N Engl J Med.1996;335(7):514517.
  12. Lindenauer PK,Pantilat SZ,Katz PP,Wachter RM.Hospitalists and the practice of inpatient medicine: results of a survey of the National Association of Inpatient Physicians.Ann Intern Med.1999;130(4 Pt 2):343349.
  13. Kralovec PD,Miller JA,Wellikson L,Huddleston JM.The status of hospital medicine groups in the United States.J Hosp Med.2006;1:7580.
  14. Kuo YF,Sharma G,Freeman JL,Goodwin JS.Growth in the care of older patients by hospitalists in the United States.N Engl J Med.2009;360(11):11021112.
  15. Simon SR,Lee TH,Goldman L,McDonough AL,Pearson SD.Communication problems for patients hospitalized with chest pain.J Gen Intern Med.1998;13(12):836838.
  16. Auerbach AD,Pantilat SZ.End‐of‐life care in a voluntary hospitalist model: effects on communication, processes of care, and patient symptoms.Am J Med.2004;116(10):669675.
  17. Makoul G,Krupat E,Chang CH.Measuring patient views of physician communication skills: development and testing of the Communication Assessment Tool.Patient Educ Couns.2007;67(3):333342.
  18. Mercer LM,Tanabe P,Pang PS, et al.Patient perspectives on communication with the medical team: pilot study using the Communication Assessment Tool‐Team (CAT‐T).Patient Educ Couns.2008;73(2):220223.
  19. Andrich D.Understanding resistance to the data‐model relationship in Rasch's paradigm: a reflection for the next generation.J Appl Meas.2002;3(3):325359.
  20. Andrich D,Luo G.Conditional pairwise estimation in the Rasch model for ordered response categories using principal components.J Appl Meas.2003;4(3):205221.
  21. Cooper LA,Roter DL,Johnson RL,Ford DE,Steinwachs DM,Powe NR.Patient‐centered communication, ratings of care, and concordance of patient and physician race.Ann Intern Med.2003;139(11):907915.
  22. Wayne DB,Cohen E,Makoul G,McGaghie WC.The impact of judge selection on standard setting for a patient survey of physician communication skills.Acad Med.2008;83(10 Suppl):S17S20.
Article PDF
Issue
Journal of Hospital Medicine - 5(9)
Page Number
522-527
Legacy Keywords
communication, professionalism, quality improvement
Sections
Article PDF
Article PDF

Effective communication between patients and physicians improves a number of important outcomes including patient adherence to treatment,1‐3 quality of the medical history4 and clinical outcomes.1, 5, 6 Recognizing the importance of physician communication skills, the American Board of Medical Specialties, American Council for Graduate Medical Education and The Joint Commission all identify communication as a core competency for physicians.7‐9 For hospitalists and their patients, building a therapeutic partnership is challenged by the lack of a preexisting relationship and potential lack of patient history information, particularly psychosocial history.10 Other factors that complicate the relationships between hospitalists and their patients include acuity of illness, limited time course, and absence of or lack of input from patients' primary physicians.11

As a rapidly increasing percentage of hospitalized patients are cared for by hospitalists,12, 13 communication skills need to be directly assessed and addressed. As of 2006, at least 37% of all Medicare claims for inpatient evaluation and management services by general internists were attributed to hospitalists, and more than half of hospitalized Medicare patients are seen by hospitalists.14 Yet, a search of the MEDLINE database for articles published between 1965 and September 2009, querying hospitalist AND patient AND communication within the article title and abstract, yielded only 2 studies assessing hospitalist‐patient communication. A 1998 study15 compared patient‐reported communication problems with hospitalists versus continuity physicians involved with hospital care, and found that patients whose continuity physicians remained involved with care during the hospitalization were less likely to report communication problems than those patients who were cared for by a hospitalist alone. A 2004 study16 utilized chart documentation to compare the end‐of‐life care and communication provided by continuity physicians and hospitalists. Hospitalists were found to document end‐of‐life care discussions more often than continuity physicians, and were more likely to be present for these meetings, which may suggest improved end‐of‐life care. Neither of these hospitalist‐patient communication studies directly assessed patient perceptions of communication with hospitalists.

We undertook this study to explore patient perceptions of communication with hospitalists using the Communication Assessment Tool (CAT), a psychometrically validated instrument for patient assessment of physician communication skills.17 The CAT was initially field tested in outpatient offices, omitting the inpatient experience. A 2008 study18 successfully adapted the CAT tool for use in assessing emergency department (ED) teams. Given the importance of physician‐patient communication when patients are sickest and most vulnerable in the hospital setting, we sought to establish a baseline assessment of patient perceptions of communication with hospitalists in our group. Second, we compared results of our CAT implementation with published results examining communication in other physician groups.

Methods

Between September 2008 and August 2009 we performed a cross‐sectional study of patients admitted to the hospital medicine service at an urban, academic medical center with 873 beds. This busy service was responsible for 10,225 admissions in 2008. Patients of age 18 years or older and cared for by a hospitalist or teaching team led by a hospitalist were eligible to participate. Exclusion criteria included patient confusion, physiological instability, non‐English speaking, patient unable to communicate, or patient in isolation status. Interviews were conducted in the patient's private room with no other staff present.

Patient perception of communication with hospitalists was measured with the CAT.17 This 15‐item survey is written at a fourth grade reading level, and measures responses along a 5‐point scale (1 = poor, 2 = fair, 3 = good, 4 = very good, 5 = excellent). The CAT was originally field tested with a convenience sample of 38 physicians from various regions within the US, across 6 specialties (Dermatology, Family Medicine, Neurosurgery, Ophthalmology, Orthopedic Surgery, and Physical Medicine & Rehabilitation). Each physician's office recruited 25 patients to complete the CAT through a phone or Internet‐based system.

The 14 core items of the CAT, which focus on communication with the individual physician, were used in this study. The 15th item, The doctor's staff treated me with respect, was dropped as it does not reflect the inpatient setting. Results for each physician are reported as the percentage of excellent responses. This dichotomized scoring is consistent with the development study, where analysis with Andrich's rating scale model19, 20 indicated that excellent scores correspond to a yes response while poor through very good scores correspond to a no response. This method of reporting scores as a percentage of excellent responses was found to be more useful for summarizing physician scores than reporting mean scores, which are highly skewed towards positive performance.17

Interviews were conducted by trained research assistants during hospitalists' weekday shifts. Hospitalists were not told which patients would be recruited, but were aware that patients on the service were being interviewed to assess communication. A list of patient names, room numbers, dates of admission, and assigned hospitalists was obtained daily from the electronic medical record system. Patients were approached on the second or third day of the hospital admission, and only if they had been assigned to the same hospitalist for at least 2 consecutive days. After explaining the study to patients and receiving verbal consent, researchers verified that the patient recognized the hospitalist, providing a photo if necessary. Patients who were not confident of their hospitalist's identity were excluded.

The 14 core items of the CAT survey were read aloud to the patient, who was provided with a copy of the instrument's scale and asked to respond with a number or word description (1 = poor to 5 = excellent). Patients were allowed to skip any questions they did not wish to answer. At the conclusion of the survey, patients were asked if they had any further comments to add. Patient demographics as well as hospitalist service (general or teaching) and unit were recorded. Most interviews were completed in less than 5 minutes. Based on the recommendations of the original development and validation of the CAT,17 we collected 20 patient surveys for each hospitalist. For CAT items that the patients skipped, we did not impute values; rather the percentage of excellent responses was calculated based on the number of questions the patient answered. To examine basic psychometric characteristics, we assessed scale reliability and performed a factor analysis using the principal components method of extraction with Varimax rotation.

This project was determined exempt by the Northwestern University Institutional Review Board.

Results

We identified 1,137 patients as potentially eligible for the study. Figure 1 shows a flowchart of patient exclusion. Of note, 107 patients consenting to participate (13% overall) were unable to identify their hospitalist by name or photo. More specifically, 70 teaching service patients (25% of 275 eligible patients) were unable to identify their hospitalist, compared to 37 patients on general service (7% of 553 eligible patients); (z = 7.58, P < 0.001). Another 21 (3%) declined to participate because they had not talked enough with their doctor to render an assessment.

Figure 1
Eligible patient inclusion/exclusion flowchart.

We analyzed 700 patient surveys (20 patients for each of 35 hospitalists; 62% of patients identified). Patient and hospitalist characteristics are presented in Table 1. The proportion of excellent ratings for each hospitalist ranged from 38.5% to 73.5% with an average of 59.1% excellent (standard deviation [SD] = 9.5). See Figure 2 for the distribution of hospitalist scores. For the group as a whole, highest ratings on individual CAT items were for treating the patient with respect (66% excellent), letting the patient talk without interruptions (66%), and talking in terms the patient can understand (64%). Lowest ratings were for involving the patient in decisions as much as he or she wanted (53%), encouraging the patient to ask questions (53%), and greeting the patient in a way that made him or her feel comfortable (55%). Table 2 contains a full ranking of individual item scores.

Figure 2
Overall Communication Assessment Tool (CAT) scores.
Characteristics of Participating Patients and the Hospitalists Rated
Characteristics 
 Patients (n =700), n (%)
Sex, female378 (54)
Age, years 
44 and younger189 (27)
45‐64266 (38)
65 and older245 (35)
Race 
Caucasian357 (51)
African American266 (38)
Hispanic49 (7)
Other28 (4)
 Hospitalists (n = 35), n (%)
Sex, female18 (51)
Age, years 
Range3039
Mean (SD)33 (2.4)
Race 
Caucasian14 (40)
South Asian11 (31)
Asian7 (20)
African American3 (9)
Non‐native English speaker5 (14)
Foreign medical graduate3 (9)
Communication Assessment Tool (CAT) Scores by Item for Group of Hospitalists
Communication Assessment Tool ItemPercent Excellent Scores
1. Greeted me in a way that made me feel comfortable54.9
2. Treated me with respect66.3
3. Showed interest in my ideas about my health58.2
4. Understood my main health concerns57.4
5. Paid attention to me (looked at me, listened carefully)64.1
6. Let me talk without interruptions66.3
7. Gave me as much information as I wanted56.0
8. Talked in terms I could understand64.2
9. Checked to be sure I understood everything57.1
10. Encouraged me to ask questions53.2
11. Involved me in decisions as much as I wanted52.9
12. Discussed next steps including any follow‐up plans58.2
13. Showed care and concern63.8
14. Spent the right amount of time with me57.0

Overall scale reliability proved to be high (Cronbach's alpha = 0.97) in this sample. The factor analysis showed that scores for each of the 14 items load onto 1 factor. These results are consistent with the high reliability and single‐factor loading found in Makoul's original scale reliability and validity testing.17

The ad hoc comments made by patients at the conclusion of the CAT survey were categorized as positive or negative. Although many positive comments were made, they tended to be general in nature (eg, She is a great doctor). Negative comments were more explicit. A total of 110 patients (16%) made specific negative comments, which fell into 7 general domains: lack of information (35 comments), not enough time spent with the patient (27 comments), poor listening to the patient (24 comments), ineffective care delivery (7 comments), issues of care, concern, and respect (6 comments), ineffective communication with other staff (5 comments), and unclear role of physician (3 comments). Three patient comments were not related to these domains.

Patient age, race or gender did not correlate with CAT results. Hospitalist factors of age, race, gender, years of experience also were not associated with differences in ratings. However, race concordance between the patient and hospitalist was associated with improved CAT ratings. Patients of the same race as their hospitalist rated the hospitalist's communication significantly higher (M = 64.9%, SD = 39.1) than did patients who were of a different race than their hospitalist (M = 57.3%, SD = 40.3), P < 0.05. Gender concordance was not associated with improved CAT ratings. No score differences were found between patients cared for by a hospitalist on teaching service and direct care, and there were no differences between nursing units.

Discussion

To the best of our knowledge, this is the first study to explicitly measure patient perceptions of communication with hospitalists. The results yielded a wide distribution of scores for physicians within a single, large hospital medicine group. Comparing their own scores to those of peers may allow low‐scoring hospitalists to grasp the potential for improving their communication with patients. Our reliability testing matched the results of the original development study,17 indicating very high overall scale reliability. This suggests that the CAT could be streamlined by dropping some of the survey items. However we agree with Makoul et al.17 that it is best to keep the full set as it provides specific information for physicians without placing undue burden on patients (ie, the CAT takes only 1‐2 min to complete). Individual item scores for each of the 14 CAT items highlight specific communication tasks where intervention may be targeted for individual hospitalists and the group as a whole. It may be feasible to utilize CAT results as an individual report card for physicians. While program leaders should be aware that implementation of the CAT requires standardized data collection, it may be possible to build this into existing structures such as the discharge process.

Interestingly, many patients could not recognize the hospitalist caring for them by name or photo. More than 1 in 10 patients (107 of 828; 13%) were unable to identify their hospitalist. This was more than 3 times as common on the teaching service, where the hospitalist is accompanied by house staff and the intern or resident is the primary physician for patient contact, compared to the service on which hospitalists directly take care of patients without residents. It is also troubling that another 3% of patients (21 of 828) stated they hadn't talked enough with their hospitalist to answer basic communication questions, when approached 2 or 3 days into the relationship. It may be telling that Greeted me in a way that made me feel comfortable was one of the lowest‐rated survey items. Hospitalists should recognize that patients, in addition to facing their own physical and emotional stressors, see many hospital staff members throughout the day; all of whom may be strangers to them. Thus it becomes vital for hospitalists to not only establish an initial rapport with the patient, but to reintroduce themselves each time they enter the room.

An examination of the ad hoc negative comments made by survey respondents reinforces and extends findings related to the CAT items, particularly about those areas of communication valued by patients. The majority of comments fell into categories of failing to give enough information (eg, Sometimes I was left confused when the doctor was ready to leave), not spending enough time with the patient (eg, He was just in and out), and not listening to the patient's own ideas (eg, When giving my history, she cut me off at some points when I had more to say). The information and time categories may directly relate to scores on the CAT items Gave me as much information as I wanted and Spent the right amount of time with me, which are among the lowest‐scoring items. Listening to the patient may reflect broader issues of considering the patient's own experience, questions, concerns and goals.

In this study, patient‐physician race concordance was associated with CAT ratings. Patients who were of the same race as their hospitalist rated the hospitalist higher compared to patients who were of a different race than their hospitalist. This effect is consistent with previous research describing higher patient ratings of communication and care when the patient and physician are of the same race or ethnicity.21

A number of factors limit interpretation of the results of this study. The data were collected at a single site, thus limiting generalizability to other hospitalist practice environments. We used a retrospective, patient assessment of hospitalist communication which may have inherent biases different from a study using direct researcher observation or recording of patient‐hospitalist interactions to assess communication. This methodology allowed us to examine the patient's own perceptions and expectations of communication, but certainly leaves room for selection bias in recruitment and recall bias. Patients were interviewed on the second or third day of their admission. This controlled the length of exposure to the hospitalist, but the course of treatment might vary considerably; at the time of interview, some patients may not yet have had a clear diagnosis and plan while others may have been ready for discharge. Future work should examine how stage of evaluation and management might affect patients' perception of communication with hospitalists. Severity of condition is another factor that may affect patients' ratings, and was not examined in this study.

When compared to physicians from the CAT development study's field test, this study sample of hospitalists scored much lower, 59.1% excellent vs. 76.3% (P < 0.001). A number of factors may account for some of these differences. The majority of patients in the original field test had multiple interactions with their physician, and rated their health status as good or very good. In contrast, hospitalized patients usually lack previous exposure to the hospitalist, and likely have poorer health status. Also, physicians in the original field test volunteered to participate, and patients completed the CAT survey through the Internet or phone response system, rather than through a face‐to‐face interview by trained research assistants. Another key difference is that field‐test patients answered the CAT within 1 day of their outpatient visit, while in this study patients were interviewed in the midst of their hospital admission and prior to completion of their hospital course. Finally, patients commonly choose their outpatient physician and can select someone else if dissatisfied with their communication skills, while hospitalized patients are assigned hospitalists based on availability. Thus, given this potential selection bias, outpatients could be expected to rate their personal physician higher.

Another possibility is that hospitalists are on average less skilled in patient communication than outpatient physicians. Given the transient nature of the inpatient relationship, hospitalists may not value developing rapport with patients, and may not make this a goal of patient care or seek extensive training in communication skills. In future research, evaluating hospitalists' training in and attitudes towards patient communication could be paired with communication assessment results.

Although it is beyond the scope of this study to assess precisely how these environmental and survey implementation factors may affect CAT summary scores, their importance is evident. Another hospital‐based implementation of the CAT tool, an evaluation of ED teams,18 utilized face‐to‐face interviews with trained research assistants. The study yielded results similar to our findings: the average percent excellent score for ED teams was 62.3%, vs. 58.2% percent excellent for our hospitalist group. Taken together, these study comparisons between the original field‐test, our hospitalist implementation, and the ED team implementation support the argument that factors of setting (inpatient vs. outpatient), mode of survey administration (face‐to‐face interview vs. self‐administration through phone or Internet), and shorter duration or course of patient‐physician interaction may be important considerations when implementing the CAT tool to assess physician communication skills, or attempting to set standards of minimally acceptable or desired scoring.

More work must be done to establish norms and/or minimally acceptable scores for hospitalists. Numerous factors of specialty, practice setting, survey implementation, patient variables, and even the expertise of who is setting the communication standards22 may strongly influence comparisons between physician groups, even within a single institution. Organizations seeking to establish norms or minimally acceptable scores for physician‐patient communication should be aware of these factors. As the original development study points out, standard‐setting studies could establish specialty‐specific and country‐specific norms as well as norms or standards for level‐of‐training (eg, medical students versus attending physicians).17

Conclusion

The previously validated CAT instrument appears to have reliable test characteristics and can be used to gauge patient perceptions of hospitalist communication skills. Comparative scores between physicians of different specialties and settings should be interpreted cautiously as there may be confounding variables. Within our single institution, comparative scores between hospitalists, along with an examination of the hospitalist's individual item scores, may offer useful feedback for efforts aimed at enhancing communication. Many hospitalists in this study may benefit from targeted training to improve patient communication skills, particularly in the areas of encouraging questions and involving patients in decision making. Future qualitative research in the context of hospital medicine could identify specific communication techniques used by highly‐rated physicians, with the goal of developing tools for targeted improvement and determining impact on outcomes.

Acknowledgements

The authors thank Christie Edwards, Rachel Grayer and Caitlin Lawes for assistance with data collection, and Jie Peng for help with the analysis.

Effective communication between patients and physicians improves a number of important outcomes including patient adherence to treatment,1‐3 quality of the medical history4 and clinical outcomes.1, 5, 6 Recognizing the importance of physician communication skills, the American Board of Medical Specialties, American Council for Graduate Medical Education and The Joint Commission all identify communication as a core competency for physicians.7‐9 For hospitalists and their patients, building a therapeutic partnership is challenged by the lack of a preexisting relationship and potential lack of patient history information, particularly psychosocial history.10 Other factors that complicate the relationships between hospitalists and their patients include acuity of illness, limited time course, and absence of or lack of input from patients' primary physicians.11

As a rapidly increasing percentage of hospitalized patients are cared for by hospitalists,12, 13 communication skills need to be directly assessed and addressed. As of 2006, at least 37% of all Medicare claims for inpatient evaluation and management services by general internists were attributed to hospitalists, and more than half of hospitalized Medicare patients are seen by hospitalists.14 Yet, a search of the MEDLINE database for articles published between 1965 and September 2009, querying hospitalist AND patient AND communication within the article title and abstract, yielded only 2 studies assessing hospitalist‐patient communication. A 1998 study15 compared patient‐reported communication problems with hospitalists versus continuity physicians involved with hospital care, and found that patients whose continuity physicians remained involved with care during the hospitalization were less likely to report communication problems than those patients who were cared for by a hospitalist alone. A 2004 study16 utilized chart documentation to compare the end‐of‐life care and communication provided by continuity physicians and hospitalists. Hospitalists were found to document end‐of‐life care discussions more often than continuity physicians, and were more likely to be present for these meetings, which may suggest improved end‐of‐life care. Neither of these hospitalist‐patient communication studies directly assessed patient perceptions of communication with hospitalists.

We undertook this study to explore patient perceptions of communication with hospitalists using the Communication Assessment Tool (CAT), a psychometrically validated instrument for patient assessment of physician communication skills.17 The CAT was initially field tested in outpatient offices, omitting the inpatient experience. A 2008 study18 successfully adapted the CAT tool for use in assessing emergency department (ED) teams. Given the importance of physician‐patient communication when patients are sickest and most vulnerable in the hospital setting, we sought to establish a baseline assessment of patient perceptions of communication with hospitalists in our group. Second, we compared results of our CAT implementation with published results examining communication in other physician groups.

Methods

Between September 2008 and August 2009 we performed a cross‐sectional study of patients admitted to the hospital medicine service at an urban, academic medical center with 873 beds. This busy service was responsible for 10,225 admissions in 2008. Patients of age 18 years or older and cared for by a hospitalist or teaching team led by a hospitalist were eligible to participate. Exclusion criteria included patient confusion, physiological instability, non‐English speaking, patient unable to communicate, or patient in isolation status. Interviews were conducted in the patient's private room with no other staff present.

Patient perception of communication with hospitalists was measured with the CAT.17 This 15‐item survey is written at a fourth grade reading level, and measures responses along a 5‐point scale (1 = poor, 2 = fair, 3 = good, 4 = very good, 5 = excellent). The CAT was originally field tested with a convenience sample of 38 physicians from various regions within the US, across 6 specialties (Dermatology, Family Medicine, Neurosurgery, Ophthalmology, Orthopedic Surgery, and Physical Medicine & Rehabilitation). Each physician's office recruited 25 patients to complete the CAT through a phone or Internet‐based system.

The 14 core items of the CAT, which focus on communication with the individual physician, were used in this study. The 15th item, The doctor's staff treated me with respect, was dropped as it does not reflect the inpatient setting. Results for each physician are reported as the percentage of excellent responses. This dichotomized scoring is consistent with the development study, where analysis with Andrich's rating scale model19, 20 indicated that excellent scores correspond to a yes response while poor through very good scores correspond to a no response. This method of reporting scores as a percentage of excellent responses was found to be more useful for summarizing physician scores than reporting mean scores, which are highly skewed towards positive performance.17

Interviews were conducted by trained research assistants during hospitalists' weekday shifts. Hospitalists were not told which patients would be recruited, but were aware that patients on the service were being interviewed to assess communication. A list of patient names, room numbers, dates of admission, and assigned hospitalists was obtained daily from the electronic medical record system. Patients were approached on the second or third day of the hospital admission, and only if they had been assigned to the same hospitalist for at least 2 consecutive days. After explaining the study to patients and receiving verbal consent, researchers verified that the patient recognized the hospitalist, providing a photo if necessary. Patients who were not confident of their hospitalist's identity were excluded.

The 14 core items of the CAT survey were read aloud to the patient, who was provided with a copy of the instrument's scale and asked to respond with a number or word description (1 = poor to 5 = excellent). Patients were allowed to skip any questions they did not wish to answer. At the conclusion of the survey, patients were asked if they had any further comments to add. Patient demographics as well as hospitalist service (general or teaching) and unit were recorded. Most interviews were completed in less than 5 minutes. Based on the recommendations of the original development and validation of the CAT,17 we collected 20 patient surveys for each hospitalist. For CAT items that the patients skipped, we did not impute values; rather the percentage of excellent responses was calculated based on the number of questions the patient answered. To examine basic psychometric characteristics, we assessed scale reliability and performed a factor analysis using the principal components method of extraction with Varimax rotation.

This project was determined exempt by the Northwestern University Institutional Review Board.

Results

We identified 1,137 patients as potentially eligible for the study. Figure 1 shows a flowchart of patient exclusion. Of note, 107 patients consenting to participate (13% overall) were unable to identify their hospitalist by name or photo. More specifically, 70 teaching service patients (25% of 275 eligible patients) were unable to identify their hospitalist, compared to 37 patients on general service (7% of 553 eligible patients); (z = 7.58, P < 0.001). Another 21 (3%) declined to participate because they had not talked enough with their doctor to render an assessment.

Figure 1
Eligible patient inclusion/exclusion flowchart.

We analyzed 700 patient surveys (20 patients for each of 35 hospitalists; 62% of patients identified). Patient and hospitalist characteristics are presented in Table 1. The proportion of excellent ratings for each hospitalist ranged from 38.5% to 73.5% with an average of 59.1% excellent (standard deviation [SD] = 9.5). See Figure 2 for the distribution of hospitalist scores. For the group as a whole, highest ratings on individual CAT items were for treating the patient with respect (66% excellent), letting the patient talk without interruptions (66%), and talking in terms the patient can understand (64%). Lowest ratings were for involving the patient in decisions as much as he or she wanted (53%), encouraging the patient to ask questions (53%), and greeting the patient in a way that made him or her feel comfortable (55%). Table 2 contains a full ranking of individual item scores.

Figure 2
Overall Communication Assessment Tool (CAT) scores.
Characteristics of Participating Patients and the Hospitalists Rated
Characteristics 
 Patients (n =700), n (%)
Sex, female378 (54)
Age, years 
44 and younger189 (27)
45‐64266 (38)
65 and older245 (35)
Race 
Caucasian357 (51)
African American266 (38)
Hispanic49 (7)
Other28 (4)
 Hospitalists (n = 35), n (%)
Sex, female18 (51)
Age, years 
Range3039
Mean (SD)33 (2.4)
Race 
Caucasian14 (40)
South Asian11 (31)
Asian7 (20)
African American3 (9)
Non‐native English speaker5 (14)
Foreign medical graduate3 (9)
Communication Assessment Tool (CAT) Scores by Item for Group of Hospitalists
Communication Assessment Tool ItemPercent Excellent Scores
1. Greeted me in a way that made me feel comfortable54.9
2. Treated me with respect66.3
3. Showed interest in my ideas about my health58.2
4. Understood my main health concerns57.4
5. Paid attention to me (looked at me, listened carefully)64.1
6. Let me talk without interruptions66.3
7. Gave me as much information as I wanted56.0
8. Talked in terms I could understand64.2
9. Checked to be sure I understood everything57.1
10. Encouraged me to ask questions53.2
11. Involved me in decisions as much as I wanted52.9
12. Discussed next steps including any follow‐up plans58.2
13. Showed care and concern63.8
14. Spent the right amount of time with me57.0

Overall scale reliability proved to be high (Cronbach's alpha = 0.97) in this sample. The factor analysis showed that scores for each of the 14 items load onto 1 factor. These results are consistent with the high reliability and single‐factor loading found in Makoul's original scale reliability and validity testing.17

The ad hoc comments made by patients at the conclusion of the CAT survey were categorized as positive or negative. Although many positive comments were made, they tended to be general in nature (eg, She is a great doctor). Negative comments were more explicit. A total of 110 patients (16%) made specific negative comments, which fell into 7 general domains: lack of information (35 comments), not enough time spent with the patient (27 comments), poor listening to the patient (24 comments), ineffective care delivery (7 comments), issues of care, concern, and respect (6 comments), ineffective communication with other staff (5 comments), and unclear role of physician (3 comments). Three patient comments were not related to these domains.

Patient age, race or gender did not correlate with CAT results. Hospitalist factors of age, race, gender, years of experience also were not associated with differences in ratings. However, race concordance between the patient and hospitalist was associated with improved CAT ratings. Patients of the same race as their hospitalist rated the hospitalist's communication significantly higher (M = 64.9%, SD = 39.1) than did patients who were of a different race than their hospitalist (M = 57.3%, SD = 40.3), P < 0.05. Gender concordance was not associated with improved CAT ratings. No score differences were found between patients cared for by a hospitalist on teaching service and direct care, and there were no differences between nursing units.

Discussion

To the best of our knowledge, this is the first study to explicitly measure patient perceptions of communication with hospitalists. The results yielded a wide distribution of scores for physicians within a single, large hospital medicine group. Comparing their own scores to those of peers may allow low‐scoring hospitalists to grasp the potential for improving their communication with patients. Our reliability testing matched the results of the original development study,17 indicating very high overall scale reliability. This suggests that the CAT could be streamlined by dropping some of the survey items. However we agree with Makoul et al.17 that it is best to keep the full set as it provides specific information for physicians without placing undue burden on patients (ie, the CAT takes only 1‐2 min to complete). Individual item scores for each of the 14 CAT items highlight specific communication tasks where intervention may be targeted for individual hospitalists and the group as a whole. It may be feasible to utilize CAT results as an individual report card for physicians. While program leaders should be aware that implementation of the CAT requires standardized data collection, it may be possible to build this into existing structures such as the discharge process.

Interestingly, many patients could not recognize the hospitalist caring for them by name or photo. More than 1 in 10 patients (107 of 828; 13%) were unable to identify their hospitalist. This was more than 3 times as common on the teaching service, where the hospitalist is accompanied by house staff and the intern or resident is the primary physician for patient contact, compared to the service on which hospitalists directly take care of patients without residents. It is also troubling that another 3% of patients (21 of 828) stated they hadn't talked enough with their hospitalist to answer basic communication questions, when approached 2 or 3 days into the relationship. It may be telling that Greeted me in a way that made me feel comfortable was one of the lowest‐rated survey items. Hospitalists should recognize that patients, in addition to facing their own physical and emotional stressors, see many hospital staff members throughout the day; all of whom may be strangers to them. Thus it becomes vital for hospitalists to not only establish an initial rapport with the patient, but to reintroduce themselves each time they enter the room.

An examination of the ad hoc negative comments made by survey respondents reinforces and extends findings related to the CAT items, particularly about those areas of communication valued by patients. The majority of comments fell into categories of failing to give enough information (eg, Sometimes I was left confused when the doctor was ready to leave), not spending enough time with the patient (eg, He was just in and out), and not listening to the patient's own ideas (eg, When giving my history, she cut me off at some points when I had more to say). The information and time categories may directly relate to scores on the CAT items Gave me as much information as I wanted and Spent the right amount of time with me, which are among the lowest‐scoring items. Listening to the patient may reflect broader issues of considering the patient's own experience, questions, concerns and goals.

In this study, patient‐physician race concordance was associated with CAT ratings. Patients who were of the same race as their hospitalist rated the hospitalist higher compared to patients who were of a different race than their hospitalist. This effect is consistent with previous research describing higher patient ratings of communication and care when the patient and physician are of the same race or ethnicity.21

A number of factors limit interpretation of the results of this study. The data were collected at a single site, thus limiting generalizability to other hospitalist practice environments. We used a retrospective, patient assessment of hospitalist communication which may have inherent biases different from a study using direct researcher observation or recording of patient‐hospitalist interactions to assess communication. This methodology allowed us to examine the patient's own perceptions and expectations of communication, but certainly leaves room for selection bias in recruitment and recall bias. Patients were interviewed on the second or third day of their admission. This controlled the length of exposure to the hospitalist, but the course of treatment might vary considerably; at the time of interview, some patients may not yet have had a clear diagnosis and plan while others may have been ready for discharge. Future work should examine how stage of evaluation and management might affect patients' perception of communication with hospitalists. Severity of condition is another factor that may affect patients' ratings, and was not examined in this study.

When compared to physicians from the CAT development study's field test, this study sample of hospitalists scored much lower, 59.1% excellent vs. 76.3% (P < 0.001). A number of factors may account for some of these differences. The majority of patients in the original field test had multiple interactions with their physician, and rated their health status as good or very good. In contrast, hospitalized patients usually lack previous exposure to the hospitalist, and likely have poorer health status. Also, physicians in the original field test volunteered to participate, and patients completed the CAT survey through the Internet or phone response system, rather than through a face‐to‐face interview by trained research assistants. Another key difference is that field‐test patients answered the CAT within 1 day of their outpatient visit, while in this study patients were interviewed in the midst of their hospital admission and prior to completion of their hospital course. Finally, patients commonly choose their outpatient physician and can select someone else if dissatisfied with their communication skills, while hospitalized patients are assigned hospitalists based on availability. Thus, given this potential selection bias, outpatients could be expected to rate their personal physician higher.

Another possibility is that hospitalists are on average less skilled in patient communication than outpatient physicians. Given the transient nature of the inpatient relationship, hospitalists may not value developing rapport with patients, and may not make this a goal of patient care or seek extensive training in communication skills. In future research, evaluating hospitalists' training in and attitudes towards patient communication could be paired with communication assessment results.

Although it is beyond the scope of this study to assess precisely how these environmental and survey implementation factors may affect CAT summary scores, their importance is evident. Another hospital‐based implementation of the CAT tool, an evaluation of ED teams,18 utilized face‐to‐face interviews with trained research assistants. The study yielded results similar to our findings: the average percent excellent score for ED teams was 62.3%, vs. 58.2% percent excellent for our hospitalist group. Taken together, these study comparisons between the original field‐test, our hospitalist implementation, and the ED team implementation support the argument that factors of setting (inpatient vs. outpatient), mode of survey administration (face‐to‐face interview vs. self‐administration through phone or Internet), and shorter duration or course of patient‐physician interaction may be important considerations when implementing the CAT tool to assess physician communication skills, or attempting to set standards of minimally acceptable or desired scoring.

More work must be done to establish norms and/or minimally acceptable scores for hospitalists. Numerous factors of specialty, practice setting, survey implementation, patient variables, and even the expertise of who is setting the communication standards22 may strongly influence comparisons between physician groups, even within a single institution. Organizations seeking to establish norms or minimally acceptable scores for physician‐patient communication should be aware of these factors. As the original development study points out, standard‐setting studies could establish specialty‐specific and country‐specific norms as well as norms or standards for level‐of‐training (eg, medical students versus attending physicians).17

Conclusion

The previously validated CAT instrument appears to have reliable test characteristics and can be used to gauge patient perceptions of hospitalist communication skills. Comparative scores between physicians of different specialties and settings should be interpreted cautiously as there may be confounding variables. Within our single institution, comparative scores between hospitalists, along with an examination of the hospitalist's individual item scores, may offer useful feedback for efforts aimed at enhancing communication. Many hospitalists in this study may benefit from targeted training to improve patient communication skills, particularly in the areas of encouraging questions and involving patients in decision making. Future qualitative research in the context of hospital medicine could identify specific communication techniques used by highly‐rated physicians, with the goal of developing tools for targeted improvement and determining impact on outcomes.

Acknowledgements

The authors thank Christie Edwards, Rachel Grayer and Caitlin Lawes for assistance with data collection, and Jie Peng for help with the analysis.

References
  1. Beach MC,Keruly J,Moore RD.Is the quality of the patient‐provider relationship associated with better adherence and health outcomes for patients with HIV?J Gen Intern Med.2006;21(6):661665.
  2. Heisler M,Cole I,Weir D,Kerr EA,Hayward RA.Does physician communication influence older patients' diabetes self‐management and glycemic control? Results from the Health and Retirement Study (HRS).J Gerontol A Biol Sci Med Sci.2007;62(12):14351442.
  3. Zolnierek KB,Dimatteo MR.Physician communication and patient adherence to treatment: a meta‐analysis.Med Care.2009;47(8):826834.
  4. Beckman HB,Frankel RM.The effect of physician behavior on the collection of data.Ann Intern Med.1984;101(5):692696.
  5. Trummer UF,Mueller UO,Nowak P,Stidl T,Pelikan JM.Does physician‐patient communication that aims at empowering patients improve clinical outcome? A case study.Patient Educ Couns.2006;61(2):299306.
  6. Stewart MA.Effective physician‐patient communication and health outcomes: a review.CMAJ.1995;152(9):14231433.
  7. Horowitz SD.Evaluation of clinical competencies: basic certification, subspecialty certification, and recertification.Am J Phys Med Rehabil.2000;79(5):478480.
  8. Batalden P,Leach D,Swing S,Dreyfus H,Dreyfus S.General competencies and accreditation in graduate medical education.Health Aff (Millwood).2002;21(5):103111.
  9. Joint Commission on Accreditation of Healthcare Organizations. The Joint Commission Standards supporting effective communication, cultural competence, and patient‐centered care.2009:44.
  10. Barnett PB.Rapport and the hospitalist.Am J Med.2001;111(9B):31S35S.
  11. Wachter RM,Goldman L.The emerging role of “hospitalists” in the American health care system.N Engl J Med.1996;335(7):514517.
  12. Lindenauer PK,Pantilat SZ,Katz PP,Wachter RM.Hospitalists and the practice of inpatient medicine: results of a survey of the National Association of Inpatient Physicians.Ann Intern Med.1999;130(4 Pt 2):343349.
  13. Kralovec PD,Miller JA,Wellikson L,Huddleston JM.The status of hospital medicine groups in the United States.J Hosp Med.2006;1:7580.
  14. Kuo YF,Sharma G,Freeman JL,Goodwin JS.Growth in the care of older patients by hospitalists in the United States.N Engl J Med.2009;360(11):11021112.
  15. Simon SR,Lee TH,Goldman L,McDonough AL,Pearson SD.Communication problems for patients hospitalized with chest pain.J Gen Intern Med.1998;13(12):836838.
  16. Auerbach AD,Pantilat SZ.End‐of‐life care in a voluntary hospitalist model: effects on communication, processes of care, and patient symptoms.Am J Med.2004;116(10):669675.
  17. Makoul G,Krupat E,Chang CH.Measuring patient views of physician communication skills: development and testing of the Communication Assessment Tool.Patient Educ Couns.2007;67(3):333342.
  18. Mercer LM,Tanabe P,Pang PS, et al.Patient perspectives on communication with the medical team: pilot study using the Communication Assessment Tool‐Team (CAT‐T).Patient Educ Couns.2008;73(2):220223.
  19. Andrich D.Understanding resistance to the data‐model relationship in Rasch's paradigm: a reflection for the next generation.J Appl Meas.2002;3(3):325359.
  20. Andrich D,Luo G.Conditional pairwise estimation in the Rasch model for ordered response categories using principal components.J Appl Meas.2003;4(3):205221.
  21. Cooper LA,Roter DL,Johnson RL,Ford DE,Steinwachs DM,Powe NR.Patient‐centered communication, ratings of care, and concordance of patient and physician race.Ann Intern Med.2003;139(11):907915.
  22. Wayne DB,Cohen E,Makoul G,McGaghie WC.The impact of judge selection on standard setting for a patient survey of physician communication skills.Acad Med.2008;83(10 Suppl):S17S20.
References
  1. Beach MC,Keruly J,Moore RD.Is the quality of the patient‐provider relationship associated with better adherence and health outcomes for patients with HIV?J Gen Intern Med.2006;21(6):661665.
  2. Heisler M,Cole I,Weir D,Kerr EA,Hayward RA.Does physician communication influence older patients' diabetes self‐management and glycemic control? Results from the Health and Retirement Study (HRS).J Gerontol A Biol Sci Med Sci.2007;62(12):14351442.
  3. Zolnierek KB,Dimatteo MR.Physician communication and patient adherence to treatment: a meta‐analysis.Med Care.2009;47(8):826834.
  4. Beckman HB,Frankel RM.The effect of physician behavior on the collection of data.Ann Intern Med.1984;101(5):692696.
  5. Trummer UF,Mueller UO,Nowak P,Stidl T,Pelikan JM.Does physician‐patient communication that aims at empowering patients improve clinical outcome? A case study.Patient Educ Couns.2006;61(2):299306.
  6. Stewart MA.Effective physician‐patient communication and health outcomes: a review.CMAJ.1995;152(9):14231433.
  7. Horowitz SD.Evaluation of clinical competencies: basic certification, subspecialty certification, and recertification.Am J Phys Med Rehabil.2000;79(5):478480.
  8. Batalden P,Leach D,Swing S,Dreyfus H,Dreyfus S.General competencies and accreditation in graduate medical education.Health Aff (Millwood).2002;21(5):103111.
  9. Joint Commission on Accreditation of Healthcare Organizations. The Joint Commission Standards supporting effective communication, cultural competence, and patient‐centered care.2009:44.
  10. Barnett PB.Rapport and the hospitalist.Am J Med.2001;111(9B):31S35S.
  11. Wachter RM,Goldman L.The emerging role of “hospitalists” in the American health care system.N Engl J Med.1996;335(7):514517.
  12. Lindenauer PK,Pantilat SZ,Katz PP,Wachter RM.Hospitalists and the practice of inpatient medicine: results of a survey of the National Association of Inpatient Physicians.Ann Intern Med.1999;130(4 Pt 2):343349.
  13. Kralovec PD,Miller JA,Wellikson L,Huddleston JM.The status of hospital medicine groups in the United States.J Hosp Med.2006;1:7580.
  14. Kuo YF,Sharma G,Freeman JL,Goodwin JS.Growth in the care of older patients by hospitalists in the United States.N Engl J Med.2009;360(11):11021112.
  15. Simon SR,Lee TH,Goldman L,McDonough AL,Pearson SD.Communication problems for patients hospitalized with chest pain.J Gen Intern Med.1998;13(12):836838.
  16. Auerbach AD,Pantilat SZ.End‐of‐life care in a voluntary hospitalist model: effects on communication, processes of care, and patient symptoms.Am J Med.2004;116(10):669675.
  17. Makoul G,Krupat E,Chang CH.Measuring patient views of physician communication skills: development and testing of the Communication Assessment Tool.Patient Educ Couns.2007;67(3):333342.
  18. Mercer LM,Tanabe P,Pang PS, et al.Patient perspectives on communication with the medical team: pilot study using the Communication Assessment Tool‐Team (CAT‐T).Patient Educ Couns.2008;73(2):220223.
  19. Andrich D.Understanding resistance to the data‐model relationship in Rasch's paradigm: a reflection for the next generation.J Appl Meas.2002;3(3):325359.
  20. Andrich D,Luo G.Conditional pairwise estimation in the Rasch model for ordered response categories using principal components.J Appl Meas.2003;4(3):205221.
  21. Cooper LA,Roter DL,Johnson RL,Ford DE,Steinwachs DM,Powe NR.Patient‐centered communication, ratings of care, and concordance of patient and physician race.Ann Intern Med.2003;139(11):907915.
  22. Wayne DB,Cohen E,Makoul G,McGaghie WC.The impact of judge selection on standard setting for a patient survey of physician communication skills.Acad Med.2008;83(10 Suppl):S17S20.
Issue
Journal of Hospital Medicine - 5(9)
Issue
Journal of Hospital Medicine - 5(9)
Page Number
522-527
Page Number
522-527
Article Type
Display Headline
Assessing patient perceptions of hospitalist communication skills using the Communication Assessment Tool (CAT)
Display Headline
Assessing patient perceptions of hospitalist communication skills using the Communication Assessment Tool (CAT)
Legacy Keywords
communication, professionalism, quality improvement
Legacy Keywords
communication, professionalism, quality improvement
Sections
Article Source

Copyright © 2010 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Division of Hospital Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 750 N. Lakeshore Drive, 11th floor — Ste. 187, Chicago, IL 60611
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Article PDF Media

Elements of Confusion

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Elements of confusion

A 23‐year‐old man presented to his family physician's office with a 2‐week history of fever, chills, night sweats, anorexia, and fatigue. This was associated with a 4‐month history of a nonproductive cough and a 20‐pound involuntary weight loss. He denied shortness of breath, chest pain, headaches, abdominal pain, vomiting, diarrhea, dysuria, and rash. There was no recent travel, sick contacts, or animal exposures.

This patient's symptoms could represent an underlying infectious, neoplastic, or inflammatory process. I would ascertain any relevant personal or family history and explore whether the patient has risk factors for human immunodeficiency virus (HIV) infection or tuberculosis (TB). On physical examination, I would listen for a heart murmur and look for lymphadenopathy, hepatosplenomegaly, and arthritis. Investigations including cultures, urinalysis, and a chest radiograph would be indicated at this time.

During the 2 weeks after his initial presentation, he experienced persistent fever, and further weight loss. He was admitted to the hospital to determine the etiology of his symptoms. The patient had no previous medical problems. On initial examination, his temperature was 102 degrees Fahrenheit, blood pressure was 100/65 mmHg, heart rate was 105 per minute, respiratory rate was 22 breaths per minute and oxygen saturation was normal on ambient air. He appeared cachectic. He was oriented to person, place, and time. Head and neck examination revealed no intraoral pathology, lymphadenopathy or scleral icterus, but did reveal conjunctival pallor. The chest was clear to auscultation, and the cardiovascular examination revealed a normal apical impulse and heart sounds with no murmurs. There was peripheral edema to the level of the mid‐shins bilaterally. The abdomen was soft and non‐tender with no appreciable hepatosplenomegaly. There were no stigmata of chronic liver disease. There was no axillary or inguinal lymphadenopathy. The remainder of the examination was normal. A complete blood count showed a hemoglobin concentration of 5.2 g/dL with a mean corpuscular volume (MCV) of 89fL, white blood cells were 1,400 cells/mm3 with an absolute neutrophil count (ANC) of 800 cells/mm3 and a platelet count of 90,000 cells/mm3 The serum sodium was 124 mmol/L, potassium 3.0 mmol/L, chloride 91 mmol/L, bicarbonate 26 mmol/L, and the creatinine 1.36 mg/dL His liver enzyme profile showed aspartate aminotransferase (AST) 68 U/L (normal <35), alanine aminotransferase (ALT) 25 U/L (normal <40), alkaline phosphatase (ALP) 210 U/L (normal <110) and a total bilirubin of 1.64 mg/dL.

The patient is clearly very unwell and requires admission to the hospital for treatment and further investigation. Emergent management includes administration of intravenous fluids to correct his electrolyte abnormalities, empiric broad spectrum antibiotics (given his relative neutropenia and fever), and a transfusion for his profound anemia. I would be very concerned that he has an underlying malignancy such as lymphoma or leukemia. Pancytopenia related to decreased cell production may be secondary to infiltration (malignant or granulomatous), infection (HIV, TB, fungal, viral), or aplasia (primary or drug‐related). Less likely etiologies include B12 or folate deficiency (unlikely given the normal MCV), systemic lupus erythematosus, paroxysmal nocturnal hemoglobinuria or cell sequestration due to hypersplenism. A history of recent exposure to drugs or toxins should be elicited. The patient's pulmonary symptoms may relate to the primary disorder or may represent an infection secondary to myelosuppression. I would want an immediate review of the peripheral blood smear, a hemolysis work‐up (drawn prior to transfusion including lactate dehydrogenase [LDH], haptoglobin, fractionated bilirubin, reticulocyte count and direct antiglobulin testing), antinuclear antibody (ANA), B12 and folate levels, imaging of the chest and blood cultures.

With evidence of fever and pancytopenia, acute leukemia was suspected and the patient was admitted to a hematology service. Over the next two weeks an extensive investigation including blood and urine cultures, and computed tomograms (CT) of the chest and abdomen were performed. A bone marrow aspirate and biopsy were also were done and were submitted for histopathologic examination and culture. The CT scan of the chest revealed left axillary and supraclavicular lymphadenopathy (Figure 1), and the abdominal imaging revealed splenomegaly. The blood, urine and bone marrow cultures were all negative. A peripheral blood smear showed pancytopenia with a hematologist interpretation suggesting that an intrinsic bone marrow process may be resulting in impaired cell production. The corresponding bone marrow biopsy and aspirate showed no evidence of malignancy, but there were numerous granulomata, and the periodic acid‐Schiff (PAS) and silver staining showed cells that resembled fungal elements (Figure 2).

Figure 1
CT axial image of the chest revealing left axillary lymph node enlargement (arrow).
Figure 2
Periodic acid‐Schiff stain of the bone marrow revealing particles (arrows) felt to be compatible with fungal elements (63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

The absence of malignant cells in the bone marrow leaves us to consider infectious and inflammatory causes of this patient's presentation. Infectious etiologies associated with bone marrow granulomata include fungal, mycobacterial, bacterial (brucellosis, typhoid and Q fever) and viral pathogens including HIV, Epstein‐Barr virus (EBV), and cytomegalovirus (CMV). Noninfectious causes include sarcoidosis, drug effects, and autoimmune conditions. The PAS and silver staining suggests this patient has a disseminated fungal infection. Disseminated Histoplasma capsulatum is the most likely organism but blastomycosis and coccidioidomycosis should be considered. HIV and occult lymphoma are considerations as is a primary immune disorder such as common variable immunodeficiency (CVID) which can present in this age group. While there is no recent travel history, it will be critical to determine where the patient currently lives and previously resided, review the medical record for prior infections and HIV risk factors, and take a thorough occupational history.

At this point, the following investigations should be undertaken: blood, sputum, and bone marrow culture; fungal and acid‐fast bacilli (AFB) stains on sputum and bone marrow; Histoplasma urine antigen; tuberculin skin test; serology for HIV and histoplasmosis; and serum protein electrophoresis with immunofixation and quantitation of immunoglobulins.

Acid fast staining of the bone marrow as well as mycobacterial and fungal cultures were negative. He lived in eastern Ontario and worked in construction. He reported helping tear down an old cabin in a wooded area, but denied any insect bites. This project coincided with the onset of his cough. He had no history of high risk sexual activity, intravenous drug use, tattoos or blood transfusions previous to his presentation. The HIV test was negative. His clinicians at this point considered a disseminated fungal infection as a cause for his symptoms and started him empirically on itraconazole He was discharged from the hospital with a plan for close outpatient followup. Within three days of discharge on the itraconazole, the patient's fever began to diminish, but did not completely resolve.

The clinical picture including cough, geography, and recent occupational exposure is entirely consistent with disseminated histoplasmosis. However, we are still lacking microbiologic confirmation of the diagnosis. Sarcoidosis and occult malignancy must still be considered. In the absence of a definitive diagnosis, I would consider bronchoscopy with bronchoalveolar lavage (BAL) and obtaining a lymph node or liver biopsy for microbiologic and pathologic examination. With the patient now receiving antifungal therapy, a diagnosis of histoplasmosis would be supported by a response to therapy, declining Histoplasma antigen levels and clinical improvement including recovery of his bone marrow.

The urine specimen was negative for Histoplasma antigen. Seven days after initiating itraconazole, he developed jaundice and confusion and was taken back to the hospital. On presentation, he was disoriented but awake. His temperature was 103.1 degrees Fahrenheit, blood pressure was 90/60 mm Hg, heart rate was 115 per minute, and oxygen saturation was normal on room air. He was obviously jaundiced, and more cachectic than previous. The neurologic examination demonstrated disorientation with no localizing findings. The chest and cardiovascular examinations were normal. His abdomen was soft and non‐tender with no evidence of hepatomegaly, but the spleen tip was palpable. There was no ascites or any other signs of portal hypertension, but his peripheral edema was worse than before and asterixis was present. The remainder of the examination was unchanged from previous. His laboratory investigations at this point showed a bilirubin of 18.5 mg/dL, AST 269 U/L, ALT 76 U/L, ALP 165 U/L, albumin 18 g/L, fibrinogen 1.53 g/L (normal 1.5‐3.5), triglycerides 2.4 mmol/L (normal <2), ferritin 59415 ug/L (normal 22‐275) an international normalized ratio (INR) of 2.65. His complete blood count still showed pancytopenia.

The patient has now developed fulminant hepatic failure. He requires volume resuscitation, drawing of repeat cultures, initiation of empiric broad spectrum antibiotics, urgent hepatology consultation and intensive care unit (ICU) support. The most common causes of acute liver failure are drug toxicity (including acetaminophen), viral hepatitis, Wilson's disease, Budd‐Chiari syndrome, cryptogenic liver disease and fatty infiltration. The critical diagnostic issue at this point is to determine if the liver failure is a secondary process (in which case drug toxicity due to itraconazole would be the most likely cause) or if this represents evolution of his primary disease with extensive hepatic involvement. Liver failure due to itraconazole has been reported and given the lack of microbiologic confirmation of a fungal infection, this agent should clearly be discontinued. Returning to our initial differential diagnosis of this man's granulomatous bone marrow infiltration and pancytopenia, etiologies which may progress to hepatic failure include viral infections (EBV or CMV) and malignancy. This patient's presentation could be an unusual manifestation of a common illness such as EBV or a rapidly progressive lymphoma. An abdominal Doppler ultrasound is required to rule out Budd‐Chiari syndrome. Given his abrupt change in clinical status, I would repeat a CT scan of his chest and abdomen to evaluate for evidence of infection, infiltration, or malignancy. Owing to the uncertainty regarding this patient's diagnosis and the rapidly progressive nature of his disease, serious consideration must be given to a transjugular liver biopsy.

Soon after admission, he developed hematemesis. He was given multiple blood transfusions, and then intravenous fluids, broad spectrum antibiotics and lactulose. Upper gastrointestinal endoscopy showed no varices, but did reveal multiple esophageal and gastric ulcerations. He was then transferred to a liver transplant center where repeat bone marrow biopsy and a liver biopsy were done. Both revealed extensive granulomatosis and the bone marrow biopsy showed evidence of hemophagocytosis (Figure 3).

Figure 3
Pathology specimens of the bone marrow and liver (Panels A, B, C, D). In Panel A the arrows surround a granuloma infiltrating the liver (Masson‐trichrome, 50× original magnification). The arrows in Panel B encompass granuloma formation in the bone marrow (63× original magnification). Panels C‐D are bone marrow aspirates revealing hemophagocytosis. An arrow points to a macrophage engulfing a nucleated red blood cell in Panel C (hematoxylin and eosin, 63× original magnification). Neutrophils engulfed by a macrophage are seen in Panel D (hematoxylin and eosin, 63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

The finding of hemophagocytosis in the setting of fever, hepatosplenomegaly, and pancytopenia is consistent with a diagnosis of hemophagocytic lymphohistiocytosis (HLH). The cornerstone of therapy for patients with HLH is suppression of the severe inflammatory response with corticosteroids, etoposide and cyclosporin. Patients who respond to this are candidates for allogeneic stem cell transplant with curative intent. This patient's hepatic dysfunction precludes the use of etoposide and initial therapy should therefore include dexamethasone and cyclosporin.

All bacterial, fungal, and mycobacterial cultures again demonstrated no growth. Broad spectrum antibiotics were continued, and empiric intravenous amphotericin B was added. He became hemodynamically unstable, was intubated, put on mechanical ventilation and required vasoactive medications to maintain his blood pressure. An empiric course of pulse corticosteroids was given for the possibility of sarcoidosis. His blood pressure stabilized, though he continued to require vasopressors.

While HLH has been very rarely reported in association with sarcoidosis, the underlying pathogenesis of his clinical presentation (infectious, neoplastic, or inflammatory) has not yet been confirmed. In the meantime, I would continue with supportive care and intravenous corticosteroids.

Immunohistochemical studies of the liver biopsy returned showing CD15/30+ cells with weak‐to‐negative CD45 expression cells typical of Hodgkin lymphoma (HL) (Figure 4). He was started on chemotherapy, but over 48 hours became progressively more hypotensive. The patient died of Klebsiella and Pseudomonas sepsis on the 7th hospital day. Post‐mortem immunohistochemical examination revealed evidence of Hodgkin disease in the axillary lymph nodes, bone marrow and liver. The bone marrow showed evidence of hemophagocytosis and was also positive for Epstein‐Barr encoded RNA (EBER). Serologic studies were subsequently available and revealed positive EBV IgM against the viral capsid antigen (VCA) as well as EBV IgG VCA, which in conjunction with the marrow findings, was highly suggestive of reactivation EBV disease.

Figure 4
Pathology specimens of the liver and bone marrow (A, B, C). Panel A shows infiltration of the liver with Hodgkin disease with an atypical binucleated cell (arrow) (hematoxylin and eosin, 400× magnification). Panels B and C are immunohistochemical stains showing CD30 Reed‐Sternberg cells in the liver (B) (400× original magnification) and the bone marrow aspirate (Panel C) (63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Discussion

This patient's diagnostic course led both the clinical team and discussant down a winding path, which ultimately ended in the finding of Hodgkin lymphoma, a relatively common diagnosis that had been clouded by seemingly contradictory clinical and laboratory data. The provisional diagnosis of disseminated histoplasmosis was reasonable given that H. capsulatum is endemic in Ontario and that the patient's occupation placed him at risk of infection. Given the acuity of his illness, empiric antifungal therapy based on the report of fungal elements on bone marrow examination seemed reasonable. However, Histoplasma urinary antigen testing has been shown in the literature to be 98% sensitive in immunosuppressed populations, and the negative result prompted a re‐examination of the marrow specimen. The previously described fungal elements were felt to be most likely artifact, and the underlying diagnosis was reconsidered.1 This is when the repeat bone marrow examination pointed towards the diagnosis of HLH.

Hemophagocytic lymphohistiocytosis (HLH) is a severe, systemic hyperinflammatory disorder characterized by histiocytic proliferation that may be primary or can be triggered by infection, connective tissue diseases or malignancy.25 The central pathogenesis involves dysregulated Th1 cytokine secretion. This results in an uncontrolled accumulation of activated T‐lymphocytes and histiocytes in various organs including the liver, spleen and bone marrow. The infiltration of histiocytes into major organs can lead to disruption of function and multiorgan failure.6 Viruses are the most common infectious triggers of HLH, particularly EBV, and lymphoma is the most common associated malignancy.25 It is hypothesized that EBV can interfere with normal lymphocyte signaling pathways leading to the aforementioned over‐expression of Th1 cytokines, which can then trigger HLH.7 The diagnosis of HLH is based on a combination of clinical and laboratory parameters as outlined in Table 1.8 Our patient met all five of the major criteria.

Major and Minor Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis
  • Diagnosis made if all 5 major criteria are present. Alternatively, one of the major criteria can be substituted with either A or the combination of B and C.

Major criteria 1. Fever
2. Splenomegaly
3. Cytopenia in two or more cell lines
4. Hypertriglyceridemia or hypofibrinogenemia
5. Hemophagocytosis on histopathologic examination
Alternative criteria A. Low or absent natural killer cell activity
B. Serum ferritin level >500 ug/L
C. Soluble CD‐25 level >2400 U/mL

The recommended treatment of HLH involves the administration of the HLH‐94 protocol consisting of corticosteroids, cyclosporine and etoposide.9, 10 Those who survive this initial phase are recommended for hematopoetic stem cell transplantation producing an overall 3‐year survival rate of 64%. However, those who do not receive early etoposide therapy fare much worse, with a mortality rate of 92%.10 This patient was not able to receive etoposide because of his decompensated liver disease.

In this case, the development of Hodgkin lymphoma involving the bone marrow and liver may have resulted in a state of immune suppression. The loss of immune function likely allowed the reactivation of Epstein‐Barr virus which triggered HLH and his fulminant presentation.35,9 Indeed, both the liver and bone marrow samples showed evidence of EBV reactivation as evidenced by the presence of EBER. The diagnosis of Hodgkin lymphoma was made from a liver biopsy specimen rather than bone marrow examination. The diagnosis of Hodgkin lymphoma is based on the presence of Reed‐Sternberg cells surrounded by an inflammatory milieu of cells including variable numbers of small lymphocytes, neutrophils eosinophils and fibroblasts. The HLH‐induced pancytopenia depleted the aforementioned inflammatory milieu in the bone marrow, which obscured the diagnosis of Hodgkin lymphoma. Unfortunately, lymphoma‐associated HLH has a very poor prognosis with a mortality rate of up to 60%.4 At the outset of this case, the reported fungal elements proved to be a source of confusion which delayed the diagnosis of Hodgkin lymphoma. Given the poor prognosis of lymphoma‐associated HLH, it is unlikely this would have had any effect on the ultimate outcome.

Teaching Points

  • HLH is a rare and complex hyperinflammatory disorder which may present as pancytopenia.

  • Triggers of HLH can include infections (particularly EBV), malignancy (particularly lymphoma) and connective tissue diseases.

  • The diagnosis of HLH is based on clinical and laboratory criteria, including cytopenias that may make the evaluation for triggering conditions such as HL more difficult.

  • Lymphoma should be included in the differential diagnosis of granulomatous inflammation.

Acknowledgements

The authors acknowledge Ralph Meyer, MD (Queen's University, Kingston, Ontario) for his comments on a draft of this paper and Drs. David Barth and Maha Guindi (Department of Laboratory Medicine, University Health Network) for their reviews of the pathology specimens.

References
  1. Wheat LJ,Antigen detection for diagnosis of the endemic mycoses.Curr Fung Infect Rep.2008;4:189193.
  2. Han AR,Lee HR,Park BB, et al.Lymphoma‐associated hemophagocytic syndrome: Clinical features and treatment outcome.Ann Hematol.2007;86:493498.
  3. Menard F,Besson C,Rince P, et al.Hodgkin lymphoma‐associated hemophagocytic syndrome: A disorder strongly correlated with Epstein‐Barr virus.Clin Inf Dis.2008;47:531534.
  4. Machaczka M,Vaktnas J.Hemophagocytic syndrome associated with Hodgkin lymphoma and pneumocystis jiroveci pneumonitis.Br J Hematol.2007;138:672.
  5. Rouphael NG,Talati NJ,Vaughan C, et al.Infections associated with haemophagocytic syndrome.Lancet Infect Dis.2007;12:814822.
  6. Nahum E,Ben‐Ari J,Stain J,Schonfeld T.Hemophagocytic lymphohistiocytic syndrome: Unrecognized cause of multiple organ failure.Pediatr Crit Care Med.2000;1:5154.
  7. Chuang HC,Lay JD,Hsieh WC, et al.Epstein‐Barr virus LMP1 Inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.Blood.2005;106:30903096.
  8. Henter JI,Elinder G,Ost A.Diagnostic guidelines for hemophagocytic lymphohistiocytosis.Semin Oncol.1991;18:2933
  9. Imashuku S,Kuriyama K,Sakai R, et al.Treatment of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH) in young adults: A report from the HLH Study Center.Med Pediatr Oncol.2003;41:103109.
  10. Horne AC,Janka G,Maarten Egeler R, et al.Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.Br J Haematol.2005;129:622630.
Article PDF
Issue
Journal of Hospital Medicine - 5(9)
Page Number
560-564
Sections
Article PDF
Article PDF

A 23‐year‐old man presented to his family physician's office with a 2‐week history of fever, chills, night sweats, anorexia, and fatigue. This was associated with a 4‐month history of a nonproductive cough and a 20‐pound involuntary weight loss. He denied shortness of breath, chest pain, headaches, abdominal pain, vomiting, diarrhea, dysuria, and rash. There was no recent travel, sick contacts, or animal exposures.

This patient's symptoms could represent an underlying infectious, neoplastic, or inflammatory process. I would ascertain any relevant personal or family history and explore whether the patient has risk factors for human immunodeficiency virus (HIV) infection or tuberculosis (TB). On physical examination, I would listen for a heart murmur and look for lymphadenopathy, hepatosplenomegaly, and arthritis. Investigations including cultures, urinalysis, and a chest radiograph would be indicated at this time.

During the 2 weeks after his initial presentation, he experienced persistent fever, and further weight loss. He was admitted to the hospital to determine the etiology of his symptoms. The patient had no previous medical problems. On initial examination, his temperature was 102 degrees Fahrenheit, blood pressure was 100/65 mmHg, heart rate was 105 per minute, respiratory rate was 22 breaths per minute and oxygen saturation was normal on ambient air. He appeared cachectic. He was oriented to person, place, and time. Head and neck examination revealed no intraoral pathology, lymphadenopathy or scleral icterus, but did reveal conjunctival pallor. The chest was clear to auscultation, and the cardiovascular examination revealed a normal apical impulse and heart sounds with no murmurs. There was peripheral edema to the level of the mid‐shins bilaterally. The abdomen was soft and non‐tender with no appreciable hepatosplenomegaly. There were no stigmata of chronic liver disease. There was no axillary or inguinal lymphadenopathy. The remainder of the examination was normal. A complete blood count showed a hemoglobin concentration of 5.2 g/dL with a mean corpuscular volume (MCV) of 89fL, white blood cells were 1,400 cells/mm3 with an absolute neutrophil count (ANC) of 800 cells/mm3 and a platelet count of 90,000 cells/mm3 The serum sodium was 124 mmol/L, potassium 3.0 mmol/L, chloride 91 mmol/L, bicarbonate 26 mmol/L, and the creatinine 1.36 mg/dL His liver enzyme profile showed aspartate aminotransferase (AST) 68 U/L (normal <35), alanine aminotransferase (ALT) 25 U/L (normal <40), alkaline phosphatase (ALP) 210 U/L (normal <110) and a total bilirubin of 1.64 mg/dL.

The patient is clearly very unwell and requires admission to the hospital for treatment and further investigation. Emergent management includes administration of intravenous fluids to correct his electrolyte abnormalities, empiric broad spectrum antibiotics (given his relative neutropenia and fever), and a transfusion for his profound anemia. I would be very concerned that he has an underlying malignancy such as lymphoma or leukemia. Pancytopenia related to decreased cell production may be secondary to infiltration (malignant or granulomatous), infection (HIV, TB, fungal, viral), or aplasia (primary or drug‐related). Less likely etiologies include B12 or folate deficiency (unlikely given the normal MCV), systemic lupus erythematosus, paroxysmal nocturnal hemoglobinuria or cell sequestration due to hypersplenism. A history of recent exposure to drugs or toxins should be elicited. The patient's pulmonary symptoms may relate to the primary disorder or may represent an infection secondary to myelosuppression. I would want an immediate review of the peripheral blood smear, a hemolysis work‐up (drawn prior to transfusion including lactate dehydrogenase [LDH], haptoglobin, fractionated bilirubin, reticulocyte count and direct antiglobulin testing), antinuclear antibody (ANA), B12 and folate levels, imaging of the chest and blood cultures.

With evidence of fever and pancytopenia, acute leukemia was suspected and the patient was admitted to a hematology service. Over the next two weeks an extensive investigation including blood and urine cultures, and computed tomograms (CT) of the chest and abdomen were performed. A bone marrow aspirate and biopsy were also were done and were submitted for histopathologic examination and culture. The CT scan of the chest revealed left axillary and supraclavicular lymphadenopathy (Figure 1), and the abdominal imaging revealed splenomegaly. The blood, urine and bone marrow cultures were all negative. A peripheral blood smear showed pancytopenia with a hematologist interpretation suggesting that an intrinsic bone marrow process may be resulting in impaired cell production. The corresponding bone marrow biopsy and aspirate showed no evidence of malignancy, but there were numerous granulomata, and the periodic acid‐Schiff (PAS) and silver staining showed cells that resembled fungal elements (Figure 2).

Figure 1
CT axial image of the chest revealing left axillary lymph node enlargement (arrow).
Figure 2
Periodic acid‐Schiff stain of the bone marrow revealing particles (arrows) felt to be compatible with fungal elements (63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

The absence of malignant cells in the bone marrow leaves us to consider infectious and inflammatory causes of this patient's presentation. Infectious etiologies associated with bone marrow granulomata include fungal, mycobacterial, bacterial (brucellosis, typhoid and Q fever) and viral pathogens including HIV, Epstein‐Barr virus (EBV), and cytomegalovirus (CMV). Noninfectious causes include sarcoidosis, drug effects, and autoimmune conditions. The PAS and silver staining suggests this patient has a disseminated fungal infection. Disseminated Histoplasma capsulatum is the most likely organism but blastomycosis and coccidioidomycosis should be considered. HIV and occult lymphoma are considerations as is a primary immune disorder such as common variable immunodeficiency (CVID) which can present in this age group. While there is no recent travel history, it will be critical to determine where the patient currently lives and previously resided, review the medical record for prior infections and HIV risk factors, and take a thorough occupational history.

At this point, the following investigations should be undertaken: blood, sputum, and bone marrow culture; fungal and acid‐fast bacilli (AFB) stains on sputum and bone marrow; Histoplasma urine antigen; tuberculin skin test; serology for HIV and histoplasmosis; and serum protein electrophoresis with immunofixation and quantitation of immunoglobulins.

Acid fast staining of the bone marrow as well as mycobacterial and fungal cultures were negative. He lived in eastern Ontario and worked in construction. He reported helping tear down an old cabin in a wooded area, but denied any insect bites. This project coincided with the onset of his cough. He had no history of high risk sexual activity, intravenous drug use, tattoos or blood transfusions previous to his presentation. The HIV test was negative. His clinicians at this point considered a disseminated fungal infection as a cause for his symptoms and started him empirically on itraconazole He was discharged from the hospital with a plan for close outpatient followup. Within three days of discharge on the itraconazole, the patient's fever began to diminish, but did not completely resolve.

The clinical picture including cough, geography, and recent occupational exposure is entirely consistent with disseminated histoplasmosis. However, we are still lacking microbiologic confirmation of the diagnosis. Sarcoidosis and occult malignancy must still be considered. In the absence of a definitive diagnosis, I would consider bronchoscopy with bronchoalveolar lavage (BAL) and obtaining a lymph node or liver biopsy for microbiologic and pathologic examination. With the patient now receiving antifungal therapy, a diagnosis of histoplasmosis would be supported by a response to therapy, declining Histoplasma antigen levels and clinical improvement including recovery of his bone marrow.

The urine specimen was negative for Histoplasma antigen. Seven days after initiating itraconazole, he developed jaundice and confusion and was taken back to the hospital. On presentation, he was disoriented but awake. His temperature was 103.1 degrees Fahrenheit, blood pressure was 90/60 mm Hg, heart rate was 115 per minute, and oxygen saturation was normal on room air. He was obviously jaundiced, and more cachectic than previous. The neurologic examination demonstrated disorientation with no localizing findings. The chest and cardiovascular examinations were normal. His abdomen was soft and non‐tender with no evidence of hepatomegaly, but the spleen tip was palpable. There was no ascites or any other signs of portal hypertension, but his peripheral edema was worse than before and asterixis was present. The remainder of the examination was unchanged from previous. His laboratory investigations at this point showed a bilirubin of 18.5 mg/dL, AST 269 U/L, ALT 76 U/L, ALP 165 U/L, albumin 18 g/L, fibrinogen 1.53 g/L (normal 1.5‐3.5), triglycerides 2.4 mmol/L (normal <2), ferritin 59415 ug/L (normal 22‐275) an international normalized ratio (INR) of 2.65. His complete blood count still showed pancytopenia.

The patient has now developed fulminant hepatic failure. He requires volume resuscitation, drawing of repeat cultures, initiation of empiric broad spectrum antibiotics, urgent hepatology consultation and intensive care unit (ICU) support. The most common causes of acute liver failure are drug toxicity (including acetaminophen), viral hepatitis, Wilson's disease, Budd‐Chiari syndrome, cryptogenic liver disease and fatty infiltration. The critical diagnostic issue at this point is to determine if the liver failure is a secondary process (in which case drug toxicity due to itraconazole would be the most likely cause) or if this represents evolution of his primary disease with extensive hepatic involvement. Liver failure due to itraconazole has been reported and given the lack of microbiologic confirmation of a fungal infection, this agent should clearly be discontinued. Returning to our initial differential diagnosis of this man's granulomatous bone marrow infiltration and pancytopenia, etiologies which may progress to hepatic failure include viral infections (EBV or CMV) and malignancy. This patient's presentation could be an unusual manifestation of a common illness such as EBV or a rapidly progressive lymphoma. An abdominal Doppler ultrasound is required to rule out Budd‐Chiari syndrome. Given his abrupt change in clinical status, I would repeat a CT scan of his chest and abdomen to evaluate for evidence of infection, infiltration, or malignancy. Owing to the uncertainty regarding this patient's diagnosis and the rapidly progressive nature of his disease, serious consideration must be given to a transjugular liver biopsy.

Soon after admission, he developed hematemesis. He was given multiple blood transfusions, and then intravenous fluids, broad spectrum antibiotics and lactulose. Upper gastrointestinal endoscopy showed no varices, but did reveal multiple esophageal and gastric ulcerations. He was then transferred to a liver transplant center where repeat bone marrow biopsy and a liver biopsy were done. Both revealed extensive granulomatosis and the bone marrow biopsy showed evidence of hemophagocytosis (Figure 3).

Figure 3
Pathology specimens of the bone marrow and liver (Panels A, B, C, D). In Panel A the arrows surround a granuloma infiltrating the liver (Masson‐trichrome, 50× original magnification). The arrows in Panel B encompass granuloma formation in the bone marrow (63× original magnification). Panels C‐D are bone marrow aspirates revealing hemophagocytosis. An arrow points to a macrophage engulfing a nucleated red blood cell in Panel C (hematoxylin and eosin, 63× original magnification). Neutrophils engulfed by a macrophage are seen in Panel D (hematoxylin and eosin, 63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

The finding of hemophagocytosis in the setting of fever, hepatosplenomegaly, and pancytopenia is consistent with a diagnosis of hemophagocytic lymphohistiocytosis (HLH). The cornerstone of therapy for patients with HLH is suppression of the severe inflammatory response with corticosteroids, etoposide and cyclosporin. Patients who respond to this are candidates for allogeneic stem cell transplant with curative intent. This patient's hepatic dysfunction precludes the use of etoposide and initial therapy should therefore include dexamethasone and cyclosporin.

All bacterial, fungal, and mycobacterial cultures again demonstrated no growth. Broad spectrum antibiotics were continued, and empiric intravenous amphotericin B was added. He became hemodynamically unstable, was intubated, put on mechanical ventilation and required vasoactive medications to maintain his blood pressure. An empiric course of pulse corticosteroids was given for the possibility of sarcoidosis. His blood pressure stabilized, though he continued to require vasopressors.

While HLH has been very rarely reported in association with sarcoidosis, the underlying pathogenesis of his clinical presentation (infectious, neoplastic, or inflammatory) has not yet been confirmed. In the meantime, I would continue with supportive care and intravenous corticosteroids.

Immunohistochemical studies of the liver biopsy returned showing CD15/30+ cells with weak‐to‐negative CD45 expression cells typical of Hodgkin lymphoma (HL) (Figure 4). He was started on chemotherapy, but over 48 hours became progressively more hypotensive. The patient died of Klebsiella and Pseudomonas sepsis on the 7th hospital day. Post‐mortem immunohistochemical examination revealed evidence of Hodgkin disease in the axillary lymph nodes, bone marrow and liver. The bone marrow showed evidence of hemophagocytosis and was also positive for Epstein‐Barr encoded RNA (EBER). Serologic studies were subsequently available and revealed positive EBV IgM against the viral capsid antigen (VCA) as well as EBV IgG VCA, which in conjunction with the marrow findings, was highly suggestive of reactivation EBV disease.

Figure 4
Pathology specimens of the liver and bone marrow (A, B, C). Panel A shows infiltration of the liver with Hodgkin disease with an atypical binucleated cell (arrow) (hematoxylin and eosin, 400× magnification). Panels B and C are immunohistochemical stains showing CD30 Reed‐Sternberg cells in the liver (B) (400× original magnification) and the bone marrow aspirate (Panel C) (63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Discussion

This patient's diagnostic course led both the clinical team and discussant down a winding path, which ultimately ended in the finding of Hodgkin lymphoma, a relatively common diagnosis that had been clouded by seemingly contradictory clinical and laboratory data. The provisional diagnosis of disseminated histoplasmosis was reasonable given that H. capsulatum is endemic in Ontario and that the patient's occupation placed him at risk of infection. Given the acuity of his illness, empiric antifungal therapy based on the report of fungal elements on bone marrow examination seemed reasonable. However, Histoplasma urinary antigen testing has been shown in the literature to be 98% sensitive in immunosuppressed populations, and the negative result prompted a re‐examination of the marrow specimen. The previously described fungal elements were felt to be most likely artifact, and the underlying diagnosis was reconsidered.1 This is when the repeat bone marrow examination pointed towards the diagnosis of HLH.

Hemophagocytic lymphohistiocytosis (HLH) is a severe, systemic hyperinflammatory disorder characterized by histiocytic proliferation that may be primary or can be triggered by infection, connective tissue diseases or malignancy.25 The central pathogenesis involves dysregulated Th1 cytokine secretion. This results in an uncontrolled accumulation of activated T‐lymphocytes and histiocytes in various organs including the liver, spleen and bone marrow. The infiltration of histiocytes into major organs can lead to disruption of function and multiorgan failure.6 Viruses are the most common infectious triggers of HLH, particularly EBV, and lymphoma is the most common associated malignancy.25 It is hypothesized that EBV can interfere with normal lymphocyte signaling pathways leading to the aforementioned over‐expression of Th1 cytokines, which can then trigger HLH.7 The diagnosis of HLH is based on a combination of clinical and laboratory parameters as outlined in Table 1.8 Our patient met all five of the major criteria.

Major and Minor Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis
  • Diagnosis made if all 5 major criteria are present. Alternatively, one of the major criteria can be substituted with either A or the combination of B and C.

Major criteria 1. Fever
2. Splenomegaly
3. Cytopenia in two or more cell lines
4. Hypertriglyceridemia or hypofibrinogenemia
5. Hemophagocytosis on histopathologic examination
Alternative criteria A. Low or absent natural killer cell activity
B. Serum ferritin level >500 ug/L
C. Soluble CD‐25 level >2400 U/mL

The recommended treatment of HLH involves the administration of the HLH‐94 protocol consisting of corticosteroids, cyclosporine and etoposide.9, 10 Those who survive this initial phase are recommended for hematopoetic stem cell transplantation producing an overall 3‐year survival rate of 64%. However, those who do not receive early etoposide therapy fare much worse, with a mortality rate of 92%.10 This patient was not able to receive etoposide because of his decompensated liver disease.

In this case, the development of Hodgkin lymphoma involving the bone marrow and liver may have resulted in a state of immune suppression. The loss of immune function likely allowed the reactivation of Epstein‐Barr virus which triggered HLH and his fulminant presentation.35,9 Indeed, both the liver and bone marrow samples showed evidence of EBV reactivation as evidenced by the presence of EBER. The diagnosis of Hodgkin lymphoma was made from a liver biopsy specimen rather than bone marrow examination. The diagnosis of Hodgkin lymphoma is based on the presence of Reed‐Sternberg cells surrounded by an inflammatory milieu of cells including variable numbers of small lymphocytes, neutrophils eosinophils and fibroblasts. The HLH‐induced pancytopenia depleted the aforementioned inflammatory milieu in the bone marrow, which obscured the diagnosis of Hodgkin lymphoma. Unfortunately, lymphoma‐associated HLH has a very poor prognosis with a mortality rate of up to 60%.4 At the outset of this case, the reported fungal elements proved to be a source of confusion which delayed the diagnosis of Hodgkin lymphoma. Given the poor prognosis of lymphoma‐associated HLH, it is unlikely this would have had any effect on the ultimate outcome.

Teaching Points

  • HLH is a rare and complex hyperinflammatory disorder which may present as pancytopenia.

  • Triggers of HLH can include infections (particularly EBV), malignancy (particularly lymphoma) and connective tissue diseases.

  • The diagnosis of HLH is based on clinical and laboratory criteria, including cytopenias that may make the evaluation for triggering conditions such as HL more difficult.

  • Lymphoma should be included in the differential diagnosis of granulomatous inflammation.

Acknowledgements

The authors acknowledge Ralph Meyer, MD (Queen's University, Kingston, Ontario) for his comments on a draft of this paper and Drs. David Barth and Maha Guindi (Department of Laboratory Medicine, University Health Network) for their reviews of the pathology specimens.

A 23‐year‐old man presented to his family physician's office with a 2‐week history of fever, chills, night sweats, anorexia, and fatigue. This was associated with a 4‐month history of a nonproductive cough and a 20‐pound involuntary weight loss. He denied shortness of breath, chest pain, headaches, abdominal pain, vomiting, diarrhea, dysuria, and rash. There was no recent travel, sick contacts, or animal exposures.

This patient's symptoms could represent an underlying infectious, neoplastic, or inflammatory process. I would ascertain any relevant personal or family history and explore whether the patient has risk factors for human immunodeficiency virus (HIV) infection or tuberculosis (TB). On physical examination, I would listen for a heart murmur and look for lymphadenopathy, hepatosplenomegaly, and arthritis. Investigations including cultures, urinalysis, and a chest radiograph would be indicated at this time.

During the 2 weeks after his initial presentation, he experienced persistent fever, and further weight loss. He was admitted to the hospital to determine the etiology of his symptoms. The patient had no previous medical problems. On initial examination, his temperature was 102 degrees Fahrenheit, blood pressure was 100/65 mmHg, heart rate was 105 per minute, respiratory rate was 22 breaths per minute and oxygen saturation was normal on ambient air. He appeared cachectic. He was oriented to person, place, and time. Head and neck examination revealed no intraoral pathology, lymphadenopathy or scleral icterus, but did reveal conjunctival pallor. The chest was clear to auscultation, and the cardiovascular examination revealed a normal apical impulse and heart sounds with no murmurs. There was peripheral edema to the level of the mid‐shins bilaterally. The abdomen was soft and non‐tender with no appreciable hepatosplenomegaly. There were no stigmata of chronic liver disease. There was no axillary or inguinal lymphadenopathy. The remainder of the examination was normal. A complete blood count showed a hemoglobin concentration of 5.2 g/dL with a mean corpuscular volume (MCV) of 89fL, white blood cells were 1,400 cells/mm3 with an absolute neutrophil count (ANC) of 800 cells/mm3 and a platelet count of 90,000 cells/mm3 The serum sodium was 124 mmol/L, potassium 3.0 mmol/L, chloride 91 mmol/L, bicarbonate 26 mmol/L, and the creatinine 1.36 mg/dL His liver enzyme profile showed aspartate aminotransferase (AST) 68 U/L (normal <35), alanine aminotransferase (ALT) 25 U/L (normal <40), alkaline phosphatase (ALP) 210 U/L (normal <110) and a total bilirubin of 1.64 mg/dL.

The patient is clearly very unwell and requires admission to the hospital for treatment and further investigation. Emergent management includes administration of intravenous fluids to correct his electrolyte abnormalities, empiric broad spectrum antibiotics (given his relative neutropenia and fever), and a transfusion for his profound anemia. I would be very concerned that he has an underlying malignancy such as lymphoma or leukemia. Pancytopenia related to decreased cell production may be secondary to infiltration (malignant or granulomatous), infection (HIV, TB, fungal, viral), or aplasia (primary or drug‐related). Less likely etiologies include B12 or folate deficiency (unlikely given the normal MCV), systemic lupus erythematosus, paroxysmal nocturnal hemoglobinuria or cell sequestration due to hypersplenism. A history of recent exposure to drugs or toxins should be elicited. The patient's pulmonary symptoms may relate to the primary disorder or may represent an infection secondary to myelosuppression. I would want an immediate review of the peripheral blood smear, a hemolysis work‐up (drawn prior to transfusion including lactate dehydrogenase [LDH], haptoglobin, fractionated bilirubin, reticulocyte count and direct antiglobulin testing), antinuclear antibody (ANA), B12 and folate levels, imaging of the chest and blood cultures.

With evidence of fever and pancytopenia, acute leukemia was suspected and the patient was admitted to a hematology service. Over the next two weeks an extensive investigation including blood and urine cultures, and computed tomograms (CT) of the chest and abdomen were performed. A bone marrow aspirate and biopsy were also were done and were submitted for histopathologic examination and culture. The CT scan of the chest revealed left axillary and supraclavicular lymphadenopathy (Figure 1), and the abdominal imaging revealed splenomegaly. The blood, urine and bone marrow cultures were all negative. A peripheral blood smear showed pancytopenia with a hematologist interpretation suggesting that an intrinsic bone marrow process may be resulting in impaired cell production. The corresponding bone marrow biopsy and aspirate showed no evidence of malignancy, but there were numerous granulomata, and the periodic acid‐Schiff (PAS) and silver staining showed cells that resembled fungal elements (Figure 2).

Figure 1
CT axial image of the chest revealing left axillary lymph node enlargement (arrow).
Figure 2
Periodic acid‐Schiff stain of the bone marrow revealing particles (arrows) felt to be compatible with fungal elements (63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

The absence of malignant cells in the bone marrow leaves us to consider infectious and inflammatory causes of this patient's presentation. Infectious etiologies associated with bone marrow granulomata include fungal, mycobacterial, bacterial (brucellosis, typhoid and Q fever) and viral pathogens including HIV, Epstein‐Barr virus (EBV), and cytomegalovirus (CMV). Noninfectious causes include sarcoidosis, drug effects, and autoimmune conditions. The PAS and silver staining suggests this patient has a disseminated fungal infection. Disseminated Histoplasma capsulatum is the most likely organism but blastomycosis and coccidioidomycosis should be considered. HIV and occult lymphoma are considerations as is a primary immune disorder such as common variable immunodeficiency (CVID) which can present in this age group. While there is no recent travel history, it will be critical to determine where the patient currently lives and previously resided, review the medical record for prior infections and HIV risk factors, and take a thorough occupational history.

At this point, the following investigations should be undertaken: blood, sputum, and bone marrow culture; fungal and acid‐fast bacilli (AFB) stains on sputum and bone marrow; Histoplasma urine antigen; tuberculin skin test; serology for HIV and histoplasmosis; and serum protein electrophoresis with immunofixation and quantitation of immunoglobulins.

Acid fast staining of the bone marrow as well as mycobacterial and fungal cultures were negative. He lived in eastern Ontario and worked in construction. He reported helping tear down an old cabin in a wooded area, but denied any insect bites. This project coincided with the onset of his cough. He had no history of high risk sexual activity, intravenous drug use, tattoos or blood transfusions previous to his presentation. The HIV test was negative. His clinicians at this point considered a disseminated fungal infection as a cause for his symptoms and started him empirically on itraconazole He was discharged from the hospital with a plan for close outpatient followup. Within three days of discharge on the itraconazole, the patient's fever began to diminish, but did not completely resolve.

The clinical picture including cough, geography, and recent occupational exposure is entirely consistent with disseminated histoplasmosis. However, we are still lacking microbiologic confirmation of the diagnosis. Sarcoidosis and occult malignancy must still be considered. In the absence of a definitive diagnosis, I would consider bronchoscopy with bronchoalveolar lavage (BAL) and obtaining a lymph node or liver biopsy for microbiologic and pathologic examination. With the patient now receiving antifungal therapy, a diagnosis of histoplasmosis would be supported by a response to therapy, declining Histoplasma antigen levels and clinical improvement including recovery of his bone marrow.

The urine specimen was negative for Histoplasma antigen. Seven days after initiating itraconazole, he developed jaundice and confusion and was taken back to the hospital. On presentation, he was disoriented but awake. His temperature was 103.1 degrees Fahrenheit, blood pressure was 90/60 mm Hg, heart rate was 115 per minute, and oxygen saturation was normal on room air. He was obviously jaundiced, and more cachectic than previous. The neurologic examination demonstrated disorientation with no localizing findings. The chest and cardiovascular examinations were normal. His abdomen was soft and non‐tender with no evidence of hepatomegaly, but the spleen tip was palpable. There was no ascites or any other signs of portal hypertension, but his peripheral edema was worse than before and asterixis was present. The remainder of the examination was unchanged from previous. His laboratory investigations at this point showed a bilirubin of 18.5 mg/dL, AST 269 U/L, ALT 76 U/L, ALP 165 U/L, albumin 18 g/L, fibrinogen 1.53 g/L (normal 1.5‐3.5), triglycerides 2.4 mmol/L (normal <2), ferritin 59415 ug/L (normal 22‐275) an international normalized ratio (INR) of 2.65. His complete blood count still showed pancytopenia.

The patient has now developed fulminant hepatic failure. He requires volume resuscitation, drawing of repeat cultures, initiation of empiric broad spectrum antibiotics, urgent hepatology consultation and intensive care unit (ICU) support. The most common causes of acute liver failure are drug toxicity (including acetaminophen), viral hepatitis, Wilson's disease, Budd‐Chiari syndrome, cryptogenic liver disease and fatty infiltration. The critical diagnostic issue at this point is to determine if the liver failure is a secondary process (in which case drug toxicity due to itraconazole would be the most likely cause) or if this represents evolution of his primary disease with extensive hepatic involvement. Liver failure due to itraconazole has been reported and given the lack of microbiologic confirmation of a fungal infection, this agent should clearly be discontinued. Returning to our initial differential diagnosis of this man's granulomatous bone marrow infiltration and pancytopenia, etiologies which may progress to hepatic failure include viral infections (EBV or CMV) and malignancy. This patient's presentation could be an unusual manifestation of a common illness such as EBV or a rapidly progressive lymphoma. An abdominal Doppler ultrasound is required to rule out Budd‐Chiari syndrome. Given his abrupt change in clinical status, I would repeat a CT scan of his chest and abdomen to evaluate for evidence of infection, infiltration, or malignancy. Owing to the uncertainty regarding this patient's diagnosis and the rapidly progressive nature of his disease, serious consideration must be given to a transjugular liver biopsy.

Soon after admission, he developed hematemesis. He was given multiple blood transfusions, and then intravenous fluids, broad spectrum antibiotics and lactulose. Upper gastrointestinal endoscopy showed no varices, but did reveal multiple esophageal and gastric ulcerations. He was then transferred to a liver transplant center where repeat bone marrow biopsy and a liver biopsy were done. Both revealed extensive granulomatosis and the bone marrow biopsy showed evidence of hemophagocytosis (Figure 3).

Figure 3
Pathology specimens of the bone marrow and liver (Panels A, B, C, D). In Panel A the arrows surround a granuloma infiltrating the liver (Masson‐trichrome, 50× original magnification). The arrows in Panel B encompass granuloma formation in the bone marrow (63× original magnification). Panels C‐D are bone marrow aspirates revealing hemophagocytosis. An arrow points to a macrophage engulfing a nucleated red blood cell in Panel C (hematoxylin and eosin, 63× original magnification). Neutrophils engulfed by a macrophage are seen in Panel D (hematoxylin and eosin, 63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

The finding of hemophagocytosis in the setting of fever, hepatosplenomegaly, and pancytopenia is consistent with a diagnosis of hemophagocytic lymphohistiocytosis (HLH). The cornerstone of therapy for patients with HLH is suppression of the severe inflammatory response with corticosteroids, etoposide and cyclosporin. Patients who respond to this are candidates for allogeneic stem cell transplant with curative intent. This patient's hepatic dysfunction precludes the use of etoposide and initial therapy should therefore include dexamethasone and cyclosporin.

All bacterial, fungal, and mycobacterial cultures again demonstrated no growth. Broad spectrum antibiotics were continued, and empiric intravenous amphotericin B was added. He became hemodynamically unstable, was intubated, put on mechanical ventilation and required vasoactive medications to maintain his blood pressure. An empiric course of pulse corticosteroids was given for the possibility of sarcoidosis. His blood pressure stabilized, though he continued to require vasopressors.

While HLH has been very rarely reported in association with sarcoidosis, the underlying pathogenesis of his clinical presentation (infectious, neoplastic, or inflammatory) has not yet been confirmed. In the meantime, I would continue with supportive care and intravenous corticosteroids.

Immunohistochemical studies of the liver biopsy returned showing CD15/30+ cells with weak‐to‐negative CD45 expression cells typical of Hodgkin lymphoma (HL) (Figure 4). He was started on chemotherapy, but over 48 hours became progressively more hypotensive. The patient died of Klebsiella and Pseudomonas sepsis on the 7th hospital day. Post‐mortem immunohistochemical examination revealed evidence of Hodgkin disease in the axillary lymph nodes, bone marrow and liver. The bone marrow showed evidence of hemophagocytosis and was also positive for Epstein‐Barr encoded RNA (EBER). Serologic studies were subsequently available and revealed positive EBV IgM against the viral capsid antigen (VCA) as well as EBV IgG VCA, which in conjunction with the marrow findings, was highly suggestive of reactivation EBV disease.

Figure 4
Pathology specimens of the liver and bone marrow (A, B, C). Panel A shows infiltration of the liver with Hodgkin disease with an atypical binucleated cell (arrow) (hematoxylin and eosin, 400× magnification). Panels B and C are immunohistochemical stains showing CD30 Reed‐Sternberg cells in the liver (B) (400× original magnification) and the bone marrow aspirate (Panel C) (63× original magnification). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

Discussion

This patient's diagnostic course led both the clinical team and discussant down a winding path, which ultimately ended in the finding of Hodgkin lymphoma, a relatively common diagnosis that had been clouded by seemingly contradictory clinical and laboratory data. The provisional diagnosis of disseminated histoplasmosis was reasonable given that H. capsulatum is endemic in Ontario and that the patient's occupation placed him at risk of infection. Given the acuity of his illness, empiric antifungal therapy based on the report of fungal elements on bone marrow examination seemed reasonable. However, Histoplasma urinary antigen testing has been shown in the literature to be 98% sensitive in immunosuppressed populations, and the negative result prompted a re‐examination of the marrow specimen. The previously described fungal elements were felt to be most likely artifact, and the underlying diagnosis was reconsidered.1 This is when the repeat bone marrow examination pointed towards the diagnosis of HLH.

Hemophagocytic lymphohistiocytosis (HLH) is a severe, systemic hyperinflammatory disorder characterized by histiocytic proliferation that may be primary or can be triggered by infection, connective tissue diseases or malignancy.25 The central pathogenesis involves dysregulated Th1 cytokine secretion. This results in an uncontrolled accumulation of activated T‐lymphocytes and histiocytes in various organs including the liver, spleen and bone marrow. The infiltration of histiocytes into major organs can lead to disruption of function and multiorgan failure.6 Viruses are the most common infectious triggers of HLH, particularly EBV, and lymphoma is the most common associated malignancy.25 It is hypothesized that EBV can interfere with normal lymphocyte signaling pathways leading to the aforementioned over‐expression of Th1 cytokines, which can then trigger HLH.7 The diagnosis of HLH is based on a combination of clinical and laboratory parameters as outlined in Table 1.8 Our patient met all five of the major criteria.

Major and Minor Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis
  • Diagnosis made if all 5 major criteria are present. Alternatively, one of the major criteria can be substituted with either A or the combination of B and C.

Major criteria 1. Fever
2. Splenomegaly
3. Cytopenia in two or more cell lines
4. Hypertriglyceridemia or hypofibrinogenemia
5. Hemophagocytosis on histopathologic examination
Alternative criteria A. Low or absent natural killer cell activity
B. Serum ferritin level >500 ug/L
C. Soluble CD‐25 level >2400 U/mL

The recommended treatment of HLH involves the administration of the HLH‐94 protocol consisting of corticosteroids, cyclosporine and etoposide.9, 10 Those who survive this initial phase are recommended for hematopoetic stem cell transplantation producing an overall 3‐year survival rate of 64%. However, those who do not receive early etoposide therapy fare much worse, with a mortality rate of 92%.10 This patient was not able to receive etoposide because of his decompensated liver disease.

In this case, the development of Hodgkin lymphoma involving the bone marrow and liver may have resulted in a state of immune suppression. The loss of immune function likely allowed the reactivation of Epstein‐Barr virus which triggered HLH and his fulminant presentation.35,9 Indeed, both the liver and bone marrow samples showed evidence of EBV reactivation as evidenced by the presence of EBER. The diagnosis of Hodgkin lymphoma was made from a liver biopsy specimen rather than bone marrow examination. The diagnosis of Hodgkin lymphoma is based on the presence of Reed‐Sternberg cells surrounded by an inflammatory milieu of cells including variable numbers of small lymphocytes, neutrophils eosinophils and fibroblasts. The HLH‐induced pancytopenia depleted the aforementioned inflammatory milieu in the bone marrow, which obscured the diagnosis of Hodgkin lymphoma. Unfortunately, lymphoma‐associated HLH has a very poor prognosis with a mortality rate of up to 60%.4 At the outset of this case, the reported fungal elements proved to be a source of confusion which delayed the diagnosis of Hodgkin lymphoma. Given the poor prognosis of lymphoma‐associated HLH, it is unlikely this would have had any effect on the ultimate outcome.

Teaching Points

  • HLH is a rare and complex hyperinflammatory disorder which may present as pancytopenia.

  • Triggers of HLH can include infections (particularly EBV), malignancy (particularly lymphoma) and connective tissue diseases.

  • The diagnosis of HLH is based on clinical and laboratory criteria, including cytopenias that may make the evaluation for triggering conditions such as HL more difficult.

  • Lymphoma should be included in the differential diagnosis of granulomatous inflammation.

Acknowledgements

The authors acknowledge Ralph Meyer, MD (Queen's University, Kingston, Ontario) for his comments on a draft of this paper and Drs. David Barth and Maha Guindi (Department of Laboratory Medicine, University Health Network) for their reviews of the pathology specimens.

References
  1. Wheat LJ,Antigen detection for diagnosis of the endemic mycoses.Curr Fung Infect Rep.2008;4:189193.
  2. Han AR,Lee HR,Park BB, et al.Lymphoma‐associated hemophagocytic syndrome: Clinical features and treatment outcome.Ann Hematol.2007;86:493498.
  3. Menard F,Besson C,Rince P, et al.Hodgkin lymphoma‐associated hemophagocytic syndrome: A disorder strongly correlated with Epstein‐Barr virus.Clin Inf Dis.2008;47:531534.
  4. Machaczka M,Vaktnas J.Hemophagocytic syndrome associated with Hodgkin lymphoma and pneumocystis jiroveci pneumonitis.Br J Hematol.2007;138:672.
  5. Rouphael NG,Talati NJ,Vaughan C, et al.Infections associated with haemophagocytic syndrome.Lancet Infect Dis.2007;12:814822.
  6. Nahum E,Ben‐Ari J,Stain J,Schonfeld T.Hemophagocytic lymphohistiocytic syndrome: Unrecognized cause of multiple organ failure.Pediatr Crit Care Med.2000;1:5154.
  7. Chuang HC,Lay JD,Hsieh WC, et al.Epstein‐Barr virus LMP1 Inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.Blood.2005;106:30903096.
  8. Henter JI,Elinder G,Ost A.Diagnostic guidelines for hemophagocytic lymphohistiocytosis.Semin Oncol.1991;18:2933
  9. Imashuku S,Kuriyama K,Sakai R, et al.Treatment of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH) in young adults: A report from the HLH Study Center.Med Pediatr Oncol.2003;41:103109.
  10. Horne AC,Janka G,Maarten Egeler R, et al.Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.Br J Haematol.2005;129:622630.
References
  1. Wheat LJ,Antigen detection for diagnosis of the endemic mycoses.Curr Fung Infect Rep.2008;4:189193.
  2. Han AR,Lee HR,Park BB, et al.Lymphoma‐associated hemophagocytic syndrome: Clinical features and treatment outcome.Ann Hematol.2007;86:493498.
  3. Menard F,Besson C,Rince P, et al.Hodgkin lymphoma‐associated hemophagocytic syndrome: A disorder strongly correlated with Epstein‐Barr virus.Clin Inf Dis.2008;47:531534.
  4. Machaczka M,Vaktnas J.Hemophagocytic syndrome associated with Hodgkin lymphoma and pneumocystis jiroveci pneumonitis.Br J Hematol.2007;138:672.
  5. Rouphael NG,Talati NJ,Vaughan C, et al.Infections associated with haemophagocytic syndrome.Lancet Infect Dis.2007;12:814822.
  6. Nahum E,Ben‐Ari J,Stain J,Schonfeld T.Hemophagocytic lymphohistiocytic syndrome: Unrecognized cause of multiple organ failure.Pediatr Crit Care Med.2000;1:5154.
  7. Chuang HC,Lay JD,Hsieh WC, et al.Epstein‐Barr virus LMP1 Inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.Blood.2005;106:30903096.
  8. Henter JI,Elinder G,Ost A.Diagnostic guidelines for hemophagocytic lymphohistiocytosis.Semin Oncol.1991;18:2933
  9. Imashuku S,Kuriyama K,Sakai R, et al.Treatment of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH) in young adults: A report from the HLH Study Center.Med Pediatr Oncol.2003;41:103109.
  10. Horne AC,Janka G,Maarten Egeler R, et al.Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.Br J Haematol.2005;129:622630.
Issue
Journal of Hospital Medicine - 5(9)
Issue
Journal of Hospital Medicine - 5(9)
Page Number
560-564
Page Number
560-564
Article Type
Display Headline
Elements of confusion
Display Headline
Elements of confusion
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Mount Sinai Hospital, 600 University Avenue, Suite 429, Toronto, Ontario, Canada M5G 1X5
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Continuing Medical Education Program in

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Continuing Medical Education Program in the Journal of Hospital Medicine

If you wish to receive credit for this activity, which begins on the next page, please refer to the website: www. blackwellpublishing.com/cme.

Accreditation and Designation Statement

Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Educational Objectives

Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:

  • Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.

  • Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.

  • Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.

  • Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.

  • Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.

  • Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.

Instructions on Receiving Credit

For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.

Follow these steps to earn credit:

  • Log on to www.blackwellpublishing.com/cme.

  • Read the target audience, learning objectives, and author disclosures.

  • Read the article in print or online format.

  • Reflect on the article.

  • Access the CME Exam, and choose the best answer to each question.

  • Complete the required evaluation component of the activity.

Article PDF
Issue
Journal of Hospital Medicine - 5(9)
Page Number
521-521
Sections
Article PDF
Article PDF

If you wish to receive credit for this activity, which begins on the next page, please refer to the website: www. blackwellpublishing.com/cme.

Accreditation and Designation Statement

Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Educational Objectives

Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:

  • Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.

  • Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.

  • Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.

  • Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.

  • Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.

  • Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.

Instructions on Receiving Credit

For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.

Follow these steps to earn credit:

  • Log on to www.blackwellpublishing.com/cme.

  • Read the target audience, learning objectives, and author disclosures.

  • Read the article in print or online format.

  • Reflect on the article.

  • Access the CME Exam, and choose the best answer to each question.

  • Complete the required evaluation component of the activity.

If you wish to receive credit for this activity, which begins on the next page, please refer to the website: www. blackwellpublishing.com/cme.

Accreditation and Designation Statement

Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Educational Objectives

Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:

  • Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.

  • Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.

  • Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.

  • Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.

  • Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.

  • Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.

Instructions on Receiving Credit

For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.

Follow these steps to earn credit:

  • Log on to www.blackwellpublishing.com/cme.

  • Read the target audience, learning objectives, and author disclosures.

  • Read the article in print or online format.

  • Reflect on the article.

  • Access the CME Exam, and choose the best answer to each question.

  • Complete the required evaluation component of the activity.

Issue
Journal of Hospital Medicine - 5(9)
Issue
Journal of Hospital Medicine - 5(9)
Page Number
521-521
Page Number
521-521
Article Type
Display Headline
Continuing Medical Education Program in the Journal of Hospital Medicine
Display Headline
Continuing Medical Education Program in the Journal of Hospital Medicine
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Antiplatelet Therapy: Role of Effient® (prasugrel)

Article Type
Changed
Thu, 12/06/2018 - 20:27
Display Headline
Antiplatelet Therapy: Role of Effient® (prasugrel)

A Best Practices supplement to Internal Medicine News. This promotional supplement was supported by Daiichi-Sankyo, Inc. and Eli Lilly and Company.

Antiplatelet Therapy: Role of Effient® (prasugrel)

Topics
Faculty/Faculty Disclosures


To view the supplement, click the image above.

TOPIC HIGHLIGHTS

 

 

 

 

 

 

 

  • Introduction
  • Clinical Pharmacology
  • TRITON-TIMI 38
  • Bleeding
  • Application of TRITON-TIMI 38 to Clinical Practice
  • Conclusion
  • Effient Important Safety Information

 

FACULTY/FACULTY DISCLOSURE

Roxana Mehran, MD
Director of Interventional Cardiovascular Research and Clinical Trials
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Chief Scientific Officer
Clinical Trials Center
Cardiovascular Research Foundation
New York, NY

Dr Mehran receives grant support from sanofi-aventis/Bristol-Myers Squibb and is a consultant for Abbott Vascular, Accumetrics, Cardiva, and The Medicines Company and is a paid consultant to Daiichi Sankyo, Inc. and Lilly USA, LLC.

Benjamin Z. Galper, MD, MPH
Medical Resident
Department of Medicine
New York Presbyterian Hospital/Columbia University Medical Center
New York, NY

Dr Galper is a paid consultant of Daiichi Sankyo, Inc. and Lilly USA, LLC.

George D. Dangas, MD, PhD
Director of Cardiovascular Innovation
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Director, Academic Affairs
Cardiovascular Research Foundation
New York, NY

Dr Dangas is a consultant for AstraZeneca and Cordis Corp. (a Johnson & Johnson Company) and a paid consultant to
Daiichi Sankyo, Inc. and Lilly USA, LLC.

Copyright © 2010 Elsevier Inc.

Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

A Best Practices supplement to Internal Medicine News. This promotional supplement was supported by Daiichi-Sankyo, Inc. and Eli Lilly and Company.

Antiplatelet Therapy: Role of Effient® (prasugrel)

Topics
Faculty/Faculty Disclosures


To view the supplement, click the image above.

TOPIC HIGHLIGHTS

 

 

 

 

 

 

 

  • Introduction
  • Clinical Pharmacology
  • TRITON-TIMI 38
  • Bleeding
  • Application of TRITON-TIMI 38 to Clinical Practice
  • Conclusion
  • Effient Important Safety Information

 

FACULTY/FACULTY DISCLOSURE

Roxana Mehran, MD
Director of Interventional Cardiovascular Research and Clinical Trials
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Chief Scientific Officer
Clinical Trials Center
Cardiovascular Research Foundation
New York, NY

Dr Mehran receives grant support from sanofi-aventis/Bristol-Myers Squibb and is a consultant for Abbott Vascular, Accumetrics, Cardiva, and The Medicines Company and is a paid consultant to Daiichi Sankyo, Inc. and Lilly USA, LLC.

Benjamin Z. Galper, MD, MPH
Medical Resident
Department of Medicine
New York Presbyterian Hospital/Columbia University Medical Center
New York, NY

Dr Galper is a paid consultant of Daiichi Sankyo, Inc. and Lilly USA, LLC.

George D. Dangas, MD, PhD
Director of Cardiovascular Innovation
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Director, Academic Affairs
Cardiovascular Research Foundation
New York, NY

Dr Dangas is a consultant for AstraZeneca and Cordis Corp. (a Johnson & Johnson Company) and a paid consultant to
Daiichi Sankyo, Inc. and Lilly USA, LLC.

Copyright © 2010 Elsevier Inc.

A Best Practices supplement to Internal Medicine News. This promotional supplement was supported by Daiichi-Sankyo, Inc. and Eli Lilly and Company.

Antiplatelet Therapy: Role of Effient® (prasugrel)

Topics
Faculty/Faculty Disclosures


To view the supplement, click the image above.

TOPIC HIGHLIGHTS

 

 

 

 

 

 

 

  • Introduction
  • Clinical Pharmacology
  • TRITON-TIMI 38
  • Bleeding
  • Application of TRITON-TIMI 38 to Clinical Practice
  • Conclusion
  • Effient Important Safety Information

 

FACULTY/FACULTY DISCLOSURE

Roxana Mehran, MD
Director of Interventional Cardiovascular Research and Clinical Trials
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Chief Scientific Officer
Clinical Trials Center
Cardiovascular Research Foundation
New York, NY

Dr Mehran receives grant support from sanofi-aventis/Bristol-Myers Squibb and is a consultant for Abbott Vascular, Accumetrics, Cardiva, and The Medicines Company and is a paid consultant to Daiichi Sankyo, Inc. and Lilly USA, LLC.

Benjamin Z. Galper, MD, MPH
Medical Resident
Department of Medicine
New York Presbyterian Hospital/Columbia University Medical Center
New York, NY

Dr Galper is a paid consultant of Daiichi Sankyo, Inc. and Lilly USA, LLC.

George D. Dangas, MD, PhD
Director of Cardiovascular Innovation
Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai School of Medicine
Professor of Medicine
Mount Sinai School of Medicine
Director, Academic Affairs
Cardiovascular Research Foundation
New York, NY

Dr Dangas is a consultant for AstraZeneca and Cordis Corp. (a Johnson & Johnson Company) and a paid consultant to
Daiichi Sankyo, Inc. and Lilly USA, LLC.

Copyright © 2010 Elsevier Inc.

Publications
Publications
Article Type
Display Headline
Antiplatelet Therapy: Role of Effient® (prasugrel)
Display Headline
Antiplatelet Therapy: Role of Effient® (prasugrel)
Sections
Disallow All Ads
Alternative CME

Acute Coronary Syndrome Update

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Acute coronary syndrome update for hospitalists

Acute coronary syndrome (ACS) remains a major healthcare challenge. Currently, the majority of patients with ACS have nonST‐segment (ST, part of an electrocardiogram between the QRS complex and the T wave) elevation myocardial infarction (MI) and unstable angina.1 Nevertheless, ST‐segment elevation MI is also an important cause of morbidity and mortality. In recent years, our understanding of ACS has improved as a result of several major advances based on results from multiple randomized clinical trials and registry analyses. The results of these analyses have influenced guidelines issued by professional societies and in some cases have become performance metrics. Therefore, it is particularly important for physicians involved in the care of patients with ACS to be aware of evolving treatment patterns (Table 1).

Hospitalist Core Competencies for Management of ACS
  • Related data were reported by the Society of Hospital Medicine.27

  • Abbreviations: ACS, Acute coronary syndrome; CABG, coronary artery bypass graft; CAD, coronary artery disease; ECG, electrocardiogram; MI, myocardial infarction; STEMI, ST‐segment elevation myocardial infarction.

Hospitalists should demonstrate a knowledge of:
ACS without enzyme leak, NSTEMI, and STEMI
Variable presentations of unstable angina, acute MI
Conditions that mimic ACS
Cardiac biomarkers
Role of noninvasive cardiac testing
Risks; indications for cardiac catheterization
Risk factors for CAD
Validated risk stratification tools
Indications for hospitalization of patients with chest pain
Indications, contraindications for thrombolytic therapy
Indications, contraindications, and pharmacology of drugs for ACS
Indications for early invasive interventions
Angiography, stenting and/or CABG
Laboratory studies or imaging indicative of disease severity
Safe hospital discharge
Hospitalists should demonstrate skill in:
History and physical exam relative to cardiac disease
Recognizing signs and severity of ACS
Diagnosing ACS through appropriate testing
History and physical, ECG, x‐rays, biomarkers
Risk stratification using validated tools
Formulating an evidence‐based treatment plan
Identifying patients for thrombolytics and/or early revascularization
Recognizing and treating patient discomfort
Recognizing decompensation, initiating immediate therapy
Managing complicating factors
Bleeding, inadequate response, cardiopulmonary compromise
Timely patient assessment, co‐management with other providers
Hospitalists should demonstrate attitudes that facilitate:
Communication with patients and families relative to cardiac disease and all aspects of care plan
Obtain informed consent
Early specialty consultation
Initiation of secondary prevention measures before discharge
Multidisciplinary care throughout the hospital stay
Safe discharge and transition back into primary care

Case Study

A 64‐year‐old man presents to the emergency department with the chief complaint of chest pressure for the past 2 hours. His chest pressure began after he moved furniture in his home. He initially believed that a pulled muscle was the cause of the pain, but when the discomfort did not improve with rest and continued to worsen, he thought it best that his wife drive him to the emergency department, where he continues to have chest pressure. He has never had this symptom before. His past medical history is notable only for mild hypertension for which he takes hydrochlorothiazide 25 mg daily. Otherwise, he has been healthy.

Clinical Presentation and Risk Assessment

The clinical presentation of ACS is not always straightforward. Although physicians frequently inquire about chest pain, the pain often manifests as chest heaviness or chest pressure. Additionally, some patients have a more atypical presentation, where the predominant symptom of acute coronary ischemia is dyspnea or extreme fatigue. These atypical presentations are believed to be somewhat more common in women and in the elderly, but it is important to realize that they can occur in any patient. Nausea, vomiting, or diaphoresis may accompany these symptoms or occur in isolation. Chest discomfort radiating to the jaw, neck, or left arm may be present, but is not necessary to the diagnosis. Thus, we see a variety of symptoms presenting in a patient with ACS.

This varied presentation makes objective assessment of ACS particularly important. To inform assessment, biomarkers have emerged as a quick and effective tool to help with the diagnosis of ACS. In particular, troponin measurement is important and serial troponin measurement is useful to exclude myonecrosis. It should be noted that the initial troponin level may be normal during the early stages of ACS. A bedside troponin measurement can be useful for rapid identification of myocardial damage. Quantitative troponin measurement also adds value, as higher levels of troponin are associated with progressively worse outcomes, including mortality (Figure 1). Although a number of biomarkers are available, the most important commonly used at present is troponin.0, 0, 0, 0

Figure 1
Cardiac troponin predicts the risk of mortality in UA/NSTEMI (unstable angina/non–ST‐segment elevation myocardial infarction). Cardiac troponin levels measured at baseline. P < 0.001 for increase in mortality rate with increasing cardiac troponin I at enrollment. Source: Antman et al. N Engl J Med. 1996;335:1342‐1349. Reprinted with permission from the New England Journal of Medicine. Copyright 1996 Massachusetts Medical Society. All rights reserved.
Figure 2
Mortality rates by early catheterization vs. no early catheterization in high‐risk ACS patients. P < 0.001 for comparisons within each risk group. Source: Bhatt et al. JAMA. 2004;292:2096‐2104. Reprinted with permission from the Journal of the American Medical Association. Copyright 2004 American Medical Association. All rights reserved.
Figure 3
Relative risk of all‐cause mortality at a mean follow‐up 2 years for invasive vs. conservative strategy in high‐risk ACS patients. FRISC‐II, Fragmin and Fast Revascularization During Instability in Coronary Disease; ICTUS, Invasive vs. Conservative Treatment in Unstable Coronary Syndromes Investigators; ISAR‐COOL, Intracoronary Stenting With Antithrombotic Regimen Cooling Off; RITA‐3, Randomized Intervention Trial of Unstable Angina; TIMI‐18, Thrombolysis in Myocardial Infarction‐18; TRUCS, Treatment of Refractory Unstable Angina in Geographically Isolated Areas Without Cardiac Surgery; VINO, Value of First Day Coronary Angiography/Angioplasty in Evolving Non–ST‐Segment Elevation Myocardial Infarction. Source: Bavry et al. J Am Coll Cardiol. 2006;48:1319‐1325. Reprinted with permission from the Journal of the American College of Cardiology (Elsevier).
Figure 4
Mortality rates by the number of acute recommended therapies from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) National Quality Improvement Initiative. Acute therapies defined as aspirin, beta blockers, heparin, GP IIb/IIIa inhibitors, or cardiac catheterization < 48 hours. Risk group based upon CRUSADE risk score. Source: Peterson et al. J Am Med Assoc. 2006;295:1912‐1920. Copyright 2006. Reprinted with permission of the American Medical Association. All rights reserved.
Figure 5
All‐cause mortality for patients receiving a drug‐eluting stent vs. a bare metal stent. PES, paclitaxel‐eluting stent; SES, sirolimus‐eluting stent; DES, drug‐eluting stent; BMS, bare metal stent. Source: Bavry and Bhatt. Lancet. 2008;371:2134‐2143. Reprinted with permission from The Lancet (Elsevier).

In addition to biomarkers, the electrocardiogram (ECG) remains extremely important in diagnosis and risk stratification. In a moderate‐level emergency department, the triage nurse should obtain a 12‐lead ECG for a patient with a history that is suspicious for coronary ischemia, and ask the attending physician to review the ECG immediately. If there is ST‐segment elevation or any new or presumed new left bundle‐branch block, the patient should be triaged to the ST‐segment elevation MI pathway of care. If there is ST‐segment depression or marked T‐wave inversion, this greatly raises the suspicion for nonST‐segment elevation MI or unstable angina. The presence of any of these features on the ECG places the patient at markedly elevated risk of short‐term ischemic complications.

A protocol should be in place for rapid treatment of patients with ST‐segment elevation MI.2 If the hospital has 24/7 percutaneous coronary intervention (PCI) capability, the catheterization lab should be immediately activated and the patient should proceed to primary PCI. The goal door‐to‐balloon time is 90 minutes or less. A patient who presents to a hospital without primary PCI capability should receive either fibrinolysis or be transferred to a center that can perform primary PCI. If fibrinolytic therapy is planned, it is essential that the patient not have any absolute contraindications to fibrinolytic therapy. Fibrinolysis should be administered within 30 minutes of patient contact. If transfer for primary PCI is planned, it is important that systems to support the transfer are in place so that the time from first medical contact to PCI does not exceed 90 minutes. As a practical point, it can be difficult to achieve these short transfer times in many geographic regions of the United States. However, with organized systems of care, it is certainly possible to have effective transfer systems and to achieve a short door‐to‐balloon time.3

If the patient does not have ST‐segment elevation MI, the next step depends on the patient's level of risk, where risk stratification is particularly important. As mentioned above, troponin measurement and the ECG are both essential aspects of risk stratification, but they alone are not sufficient to establish risk. It is recommended that an objective risk tool also be used. This is especially important because the patient can be initially troponin‐negative and have a normal ECG but still be at high risk for ischemic complications. The TIMI risk score (Table 2) is 1 of a number of resources that can help determine whether patients are at high risk for short‐term ischemic complications using means more objective than the eyeball test (Table 3).

Components of TIMI Risk Score for UA/NSTEMI
  • Related data were reported by Antman et al.28

  • Abbreviations: ASA, acetylsalicylic acid; CAD, coronary artery disease; ST, part of an electrocardiogram between the QRS complex and the T wave; TIMI, Thrombolysis in Myocardial Infarction; UA/NSTEMI, unstable angina/nonST‐segment elevation myocardial infarction.

Historical
Age 65 year
3 CAD risk factors
Family history, hypertension, hypercholesterolemia, diabetes, active smoker
Known CAD (stenosis 50%)
ASA use in past 7 days
At presentation
Recent (24 hours) severe angina
Elevated cardiac markers
ST deviation 0.5 mm
Risk score = total points, range: 07
Risk of Cardiac Events by 14 Days in TIMI 11B
Risk Score Death or MI (%) Death, MI, or Urgent Revascularization (%)
  • NOTE: Entry criteria: MI or NSTEMI defined as ischemic pain at rest within past 24 hours, with evidence of CAD (ST‐segment deviation or positive marker).

  • Related data were reported by Antman et al.28

  • Abbreviations: CAD, coronary artery disease; MI, myocardial infarction; NSTEMI, nonST‐segment elevation myocardial infarction; ST, part of an electrocardiogram between the QRS complex and the T wave; TIMI, Thrombolysis in Myocardial Infarction.

0/1 3 5
2 3 8
3 5 13
4 7 20
5 12 26
6/7 19 41

Delineation of the coronary anatomy in the catheterization lab is warranted for patients judged to be at high risk on the basis of the TIMI risk score, which would include most patients with elevated troponin or ST‐segment deviation. Many patients will undergo PCI on the basis of those test results and a smaller percentage might undergo coronary artery bypass grafting (CABG). Additionally, a sizeable minority of patients will be managed medically. This latter group is challenging because it consists of patients who have either trivial coronary artery disease or extensive coronary artery disease not amenable to revascularization and who have either a very low or very high risk of ischemic complications.

Even though catheterization may not be necessary, further evaluation is warranted in patients with ACS deemed to be at low risk. Typically, some form of functional assessment is indicated. In patients who are able to exercise, this would consist of exercise stress testing, often with an imaging modality. If the stress test is abnormal, cardiac catheterization is often the next step.

Case Study (cont)

An ECG is rapidly obtained on this patient and there is ST‐segment depression in leads II, III, and aVF. A bedside troponin is positive. The patient is at high risk of ischemic complications. He is diagnosed with nonST‐segment elevation MI. The next step is to initiate medical therapy. Presumably, the patient would have already (or at least should have already) received aspirin. Chewing or swallowing a dose of 325 mg nonenteric coated aspirin should provide a prompt aspirin effect. It would be reasonable to initiate anticoagulation as well, and the guidelines support a number of choices such as unfractionated heparin or low molecular weight heparin. Consideration should also be given to starting additional antiplatelet therapy, such as a loading dose of clopidogrel. Although aspirin provides some degree of antiplatelet effect, in a patient with activated platelets who presents with an ACS, additional antiplatelet therapy is necessary, although the exact timing of it is a matter of debate. Finally, consideration needs to be given to the need for catheterization. This patient, on the basis of his high ischemic risk and lack of obvious contraindications, should go to the catheterization laboratory, and the timing of catheterization requires further thought.

Guideline Update

The American College of Cardiology/American Heart Association 2009 Focused Guideline Update provides new information and recommendations pertinent to the care of patients with ACS2 and incorporates new data relevant to the initial emergency care and subsequent inpatient care of patients with ACS. Guideline highlights are presented in Table 4.

New Recommendations From the 2009 Joint STEMI/PCI Focused Update
Intervention Recommendation
  • NOTE: Classification of recommendations: Class I. Benefit ⋙ risk. Procedure or treatment should be performed or administered. Class IIa. Benefit ≫ risk. Additional studies with focused objectives are needed. It is reasonable to perform procedure or administer treatment. Class IIb. Benefit risk. Additional studies with broad objectives are needed; additional registry data would be helpful. Procedure or treatment may be considered. Class III. Risk benefit. Procedure or treatment should not be performed or administered since it is not helpful and may be harmful.

  • Related data were reported by Bavry et al.4

  • Abbreviations: ASA, aspirin; BMS, bare metal stent; CABG, coronary artery bypass graft; CAD, coronary artery disease; CKD, chronic kidney disease; d, days; DES, drug‐eluting stent; FFR, fractional flow reserve, PCI, percutaneous coronary intervention; STEMI, ST‐segment elevation myocardial infarction; TIA, transient ischemic attack; UA/NSTEMI, unstable angina/nonST‐segment elevation myocardial infarction.

GP IIb/IIIa receptor antagonists
Class IIa Start abciximab, tirofiban, or eptifibatide at primary PCI (with/without stenting) in selected patients with STEMI.
Class IIb Uncertain value in STEMI when given before arrival at catheterization lab.
Thienopyridines
Class I Use loading dose for planned PCI in STEMI. Regimens for primary and nonprimary PCI are detailed within the guideline.
Duration of therapy after stent placement of at least 12 months. Stop early if bleeding risk outweighs benefit.
Discontinue before planned, delayed CABG (5 d clopidogrel; 7 d prasugrel) unless the need for CABG outweighs bleeding risk.
Class IIb After DES placement, consider continuing clopidogrel or prasugrel beyond the first 15 months of therapy.
Class III Prasugrel is not recommended for primary PCI in patients with STEMI who have a history of stroke or TIA.
Parenteral anticoagulants
Class I In primary PCI, supportive anticoagulants include unfractionated heparin, enoxaparin, fondaparinux, or bivalirudin, following ASA and a thienopyridine.
Class IIa Bivalirudin is reasonable in patients at high risk of bleeding undergoing PCI for STEMI.
Triage and transfer for PCI
Class I STEMI system of care is supported by dedicated teams and protocols required for all communities.
Class IIa Transfer patients who received fibrinolytic therapy at a nonPCI‐capable facility to a PCI‐capable facility. Consider preparatory antithrombotic regimen before or during transfer.
Class IIb Consider expeditious transfer of nonhigh‐risk patients from a nonPCI‐capable facility to a PCI‐capable facility after administration of fibrinolytic. Consider preparatory antithrombotic regimen before or during transfer.
Intensive glucose control in STEMI
Class IIa Insulin is reasonable to maintain glucose <180 mg/dL (avoid hypoglycemia) for any patient with STEMI.
Thrombus aspiration during PCI of STEMI
Class IIa Aspiration thombectomy is reasonable.
Use of stents in STEMI
Class IIa DES is a reasonable alternative to BMS for primary PCI in STEMI.
Class IIb Consider DES when clinical or anatomical factors suggest favorable safety and efficacy for DES.
Angiography in CKD
Class I Isomolar contrast or low molecular weight contrast (not ioxaglate or iohexol) is indicated for CKD patients not on dialysis.
Fractional flow reserve
Class IIa FFR is useful to assess a specific coronary lesion or as an alternative to noninvasive functional testing to justify PCI. Reasonable for intermediate coronary stenosis in patients with angina.
Class III Routine use of FFR is not recommended to assess severity of CAD in patients with angina who have had a positive, unequivocal, noninvasive functional study.
PCI for unprotected left main CAD
Class IIb PCI of left main coronary artery with stents is an alternative to CABG for anatomy associated with low risk of PCI complications and a clinical scenario with higher risk of adverse surgical outcomes.
Timing of angiography and antiplatelet therapy in UA/NSTEMI
Class I Initiate dual‐antiplatelet therapy for UA/NSTEMI and an invasive approach. Start ASA on presentation. Clopidogrel (before or at PCI) or prasugrel (at PCI) as a second antiplatelet agent.
Class IIa Early invasive strategy within 12 to 24 hours of admission is reasonable for stabilized high‐risk UA/NSTEMI; an early approach is also reasonable for UA/STEMI not at high‐risk.

Several studies support an invasive strategy to assess high‐risk ACS patients. Randomized clinical trials and meta‐analyses of these trials have confirmed a significant reduction in subsequent ischemic events, including mortality, in patients who undergo an invasive vs. a more conservative strategy.4 Registry data have confirmed that these randomized clinical trial data reflect patients in the real‐world setting of clinical practice.5

The timing of angiography has recently been examined in detail.6, 7 It appears that for patients with nonST‐segment elevation ACS, unlike those with ST‐segment elevation MI, there is no need for emergent transfer to the catheterization laboratory, assuming patients are electrically and hemodynamically stable. Emergency transfer is warranted for unstable patients and those with ongoing chest discomfort. Otherwise, it appears sufficient to send the patient with nonST‐segment elevation ACS for catheterization within the subsequent 48 hours, or, alternatively, to adopt a more expectant approach in which catheterization is deferred until either recurrent symptoms develop or risk stratification suggests that there is substantial myocardium in jeopardy.

PCI is performed in the catheterization laboratory most often in the setting of ACS.5 When PCI is performed, an important consideration is whether to use a bare metal stent or a drug‐eluting stent.8 Drug‐eluting stents have been shown to have a significant benefit in reducing restenosis and the need for repeat revascularization. However, in aggregate, they have not been shown to either increase or decrease mortality.9 A key issue for the referring physician is to ascertain whether patients who go to the catheterization laboratory are likely to tolerate and be compliant with prolonged dual antiplatelet therapy. If it appears that the patient can or will not be compliant, a bare metal stent is preferable to a drug‐eluting stent; a bare metal stent requires dual antiplatelet therapy of shorter duration.

Additional considerations when sending patients to the catheterization laboratory are related to renal function. In patients with renal dysfunction, the most important way to prevent contrast nephropathy is adequate hydration prior to the procedure. In patients with left ventricular dysfunction, hydration must be done judiciously. Other strategies for preventing contrast nephropathy are being studied, although it is not entirely clear which strategies beyond hydration are truly effective.

Use of upstream glycoprotein IIb/IIIa inhibitors has become more common in patients with nonST‐segment elevation ACS. However, the most recent trial to examine this issue, the Early Glycoprotein IIb/IIIa Inhibition in NonST‐Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial, did not find a clear benefit for routine administration of upstream glycoprotein IIb/IIIa inhibitors when studying all patients with ACS.10 There did appear to be a signal of benefit in troponin‐positive patients, but as an overall strategy no significant benefit and even some detriment associated with an increase in bleeding were shown. Similarly, the results of the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial did not support the benefit of upstream glycoprotein IIb/IIIa inhibitors in patients with ACS.11

New data have also been released with respect to the thienopyridines. The Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with PrasugrelThrombolysis in Myocardial Infarction (TRITONTIMI) 38 study found that the more potent thienopyridine prasugrel significantly reduced ischemic events when compared with clopidogrel in patients with ACS undergoing PCI.1214 A significant reduction in stent thrombosis was reported regardless of the type of stent.15 However, the study reported a significant increase in major bleeding and a small, but statistically significant, excess of fatal bleeding. A subgroup analysis of patients with diabetes or with ST‐segment elevation MI from the TRITON‐TIMI 38 study showed a particularly large benefit associated with the use of prasugrel vs. clopidogrel and, interestingly, bleeding hazards were attenuated in these subgroups.16, 17 In the small subgroup of patients with prior stroke or transient ischemic attack (TIA), there was an excessive rate of intracranial hemorrhage with prasugrel vs. clopidogrel, indicating that prasugrel should not be used in these patients. Patients age 75 years or older or who weighed less than 60 kg also appeared to have a higher bleeding risk with prasugrel compared to clopidogrel. Careful thought is needed before using prasugrel in those patients identified as having a higher risk of bleeding.

Recently, a higher clopidogrel loading dose of 600 mg vs. the standard 300 mg dose was tested in patients who presented with ACS in the Clopidogrel optimal loading dose Usage to Reduce Recurrent EveNTs‐Organization to Assess Strategies in Ischemic Syndromes (CURRENT‐OASIS) 7 trial.18 Patients also received 150 mg of clopidogrel daily for the ensuing 6 days vs. the standard 75 mg daily dose. All patients then received 75 mg clopidogrel for 1 month of follow‐up. In the overall population, there was no benefit to using the higher clopidogrel loading dose. In contrast, there was a significant reduction in stent thrombosis in patients who received stents. The higher loading dose of clopidogrel was associated with a higher rate of bleeding.

Ticagrelor is a novel adenosine diphosphate receptor antagonist that was compared with clopidogrel in patients with ACS.19, 20 Compared to clopidogrel, ticagrelor significantly reduced ischemic events and there was also a significant reduction in cardiovascular mortality and in all‐cause mortality. Surprisingly, overall major bleeding did not increase with ticagrelor, but nonCABG‐related major bleeding increased.

The use of proton pump inhibitors (PPIs) in patients receiving dual antiplatelet therapy has also been a matter of vigorous recent debate.21 Evidence to date suggests there is no significant clinical interaction between PPIs and prasugrel. The data with clopidogrel and PPIs are mixed, although data are limited because much were derived from observational studies. Randomized clinical trial data are needed to assess whether there is an interaction between clopidogrel and PPIs that warrants clinical action, although preliminary data suggest there is no adverse cardiovascular interaction.22

New data regarding the intravenous anticoagulant bivalirudin have become available and have been incorporated into the Focused Guideline Update. Although bivalirudin is to be used primarily in the catheterization laboratory during PCI, it does appear to be associated with significantly less bleeding than heparin plus glycoprotein IIb/IIIa inhibitors.11, 2326

Case Study (cont)

The patient undergoes cardiac catheterization. An occluded dominant left circumflex artery is noted and is opened up with balloon angioplasty after aspiration thrombectomy. The patient receives 60 mg of prasugrel as a loading dose and bivalirudin as the anticoagulant during the procedure. A drug‐eluting stent is implanted with excellent results. The patient is transferred to the cardiac care unit for further care. It appears that this is a patient who functionally has an ST‐segment elevation MI with an occluded artery, although it manifested on the ECG as ST depression. Because of the patient's ongoing chest discomfort, it was fortunate that prompt angiography was performed.

Discussion

Patients with ACS present several challenges in management. Risk stratification is particularly important for nonST‐segment elevation ACS and requires thoughtful evaluation by the physician. Additionally, the large amount of new data and guideline updates create a rapidly evolving field, making it difficult to keep abreast of new developments. Physicians of patients with ACS need to be aware of these key developments so that they can provide optimal care to their patients with potentially life‐threatening ACS.

Acknowledgements

Denise M. Erkkila, RPh of DIME, provided editorial assistance consisting of help with tables, figures, and reference formatting for this manuscript.

References
  1. Lloyd‐Jones D,Adams RJ,Brown TM, et al.Heart disease and stroke statistics‐‐2010 update: a report from the American Heart Association.Circulation.2010;121:e46e215.
  2. Kushner FG,Hand M,Smith SC, et al.2009 focused updates: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol.2009;54:22052241.
  3. Kumbhani DJ,Cannon CP,Fonarow GC, et al.Association of hospital primary angioplasty volume in ST‐segment elevation myocardial infarction with quality and outcomes.JAMA.2009;302:22072213.
  4. Bavry AA,Kumbhani DJ,Rassi AN,Bhatt DL,Askari AT.Benefit of early invasive therapy in acute coronary syndromes: a meta‐analysis of contemporary randomized clinical trials.J Am Coll Cardiol.2006;48:13191325.
  5. Bhatt DL,Roe MT,Peterson ED, et al.Utilization of early invasive management strategies for high‐risk patients with non‐ST‐segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.JAMA.2004;292:20962104.
  6. Mehta SR,Granger CB,Boden WE, et al.Early versus delayed invasive intervention in acute coronary syndromes.N Engl J Med.2009;360:21652175.
  7. Montalescot G,Cayla G,Collet JP, et al.Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.JAMA.2009;302:947954.
  8. Bavry AA,Bhatt DL.Drug‐eluting stents: dual antiplatelet therapy for every survivor?Circulation.2007;116:696699.
  9. Bavry AA,Bhatt DL.Appropriate use of drug‐eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.Lancet.2008;371:21342143.
  10. Giugliano RP,White JA,Bode C, et al.Early versus delayed, provisional eptifibatide in acute coronary syndromes.N Engl J Med.2009;360:21762190.
  11. Stone GW,Ware JH,Bertrand ME, et al.Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one‐year results from the ACUITY trial.JAMA.2007;298:24972506.
  12. Bhatt DL.Intensifying platelet inhibition‐‐navigating between Scylla and Charybdis.N Engl J Med.2007;357:20782081.
  13. Bhatt DL.Prasugrel in clinical practice.N Engl J Med.2009;361:940942.
  14. Wiviott SD,Braunwald E,McCabe CH, et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes.N Engl J Med.2007;357:20012015.
  15. Wiviott SD,Braunwald E,McCabe CH, et al.Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON‐TIMI 38 trial: a subanalysis of a randomised trial.Lancet.2008;371:13531363.
  16. Montalescot G,Wiviott SD,Braunwald E, et al.Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST‐elevation myocardial infarction (TRITON‐TIMI 38): double‐blind, randomised controlled trial.Lancet.2009;373:723731.
  17. Wiviott SD,Braunwald E,Angiolillo DJ, et al.Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel—Thrombolysis in Myocardial Infarction 38.Circulation.2008;118:16261636.
  18. Mehta SR, CURRENT Investigators. A randomized comparison of a clopidogrel high loading and maintenance dose regimen versus standard dose and high versus low dose aspirin in 25,000 patients with acute coronary syndromes: results of the CURRENT OASIS 7 trial. Available at: http://www.escardio.org/congresses/esc‐2009/congress‐reports/Pages/706003‐706004‐mehta‐vandewerf.aspx#discussant.2009. Accessed July 2010.
  19. Bhatt DL.Antiplatelet therapy: ticagrelor in ACS‐what does PLATO teach us?Nat Rev Cardiol.2009;6:737738.
  20. Wallentin L,Becker RC,Budaj A, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes.N Engl J Med.2009;361:10451057.
  21. Depta JP,Bhatt DL.Omeprazole and clopidogrel: Should clinicians be worried?Cleve Clin J Med.2010;77:113116.
  22. Bhatt DL.COGENT: a prospective, randomized, placebo‐controlled trial of omeprazole in patients receiving aspirin and clopidogrel. Transcatheter Cardiovascular Therapeutics (TCT) 2009; September 24,2009;San Francisco, CA.
  23. Mehran R,Brodie B,Cox DA, et al.The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) Trial: study design and rationale.Am Heart J.2008;156:4456.
  24. Mehran R,Lansky AJ,Witzenbichler B, et al.Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS‐AMI): 1‐year results of a randomised controlled trial.Lancet.2009;374:11491159.
  25. Stone GW,Bertrand M,Colombo A, et al.Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.Am Heart J.2004;148:764775.
  26. Stone GW,White HD,Ohman EM, et al.Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.Lancet.2007;369:907919.
  27. Society of Hospital Medicine.Acute coronary syndrome.J Hosp Med.2006;1 (suppl 1):23.
  28. Antman EM,Cohen M,Bernink PJ, et al.The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making.JAMA.2000;284:835842.
Article PDF
Issue
Journal of Hospital Medicine - 5(4)
Page Number
S15-S21
Legacy Keywords
acute coronary syndrome, non–ST‐segment elevation myocardial infarction, ST‐segment elevation myocardial infarction
Sections
Article PDF
Article PDF

Acute coronary syndrome (ACS) remains a major healthcare challenge. Currently, the majority of patients with ACS have nonST‐segment (ST, part of an electrocardiogram between the QRS complex and the T wave) elevation myocardial infarction (MI) and unstable angina.1 Nevertheless, ST‐segment elevation MI is also an important cause of morbidity and mortality. In recent years, our understanding of ACS has improved as a result of several major advances based on results from multiple randomized clinical trials and registry analyses. The results of these analyses have influenced guidelines issued by professional societies and in some cases have become performance metrics. Therefore, it is particularly important for physicians involved in the care of patients with ACS to be aware of evolving treatment patterns (Table 1).

Hospitalist Core Competencies for Management of ACS
  • Related data were reported by the Society of Hospital Medicine.27

  • Abbreviations: ACS, Acute coronary syndrome; CABG, coronary artery bypass graft; CAD, coronary artery disease; ECG, electrocardiogram; MI, myocardial infarction; STEMI, ST‐segment elevation myocardial infarction.

Hospitalists should demonstrate a knowledge of:
ACS without enzyme leak, NSTEMI, and STEMI
Variable presentations of unstable angina, acute MI
Conditions that mimic ACS
Cardiac biomarkers
Role of noninvasive cardiac testing
Risks; indications for cardiac catheterization
Risk factors for CAD
Validated risk stratification tools
Indications for hospitalization of patients with chest pain
Indications, contraindications for thrombolytic therapy
Indications, contraindications, and pharmacology of drugs for ACS
Indications for early invasive interventions
Angiography, stenting and/or CABG
Laboratory studies or imaging indicative of disease severity
Safe hospital discharge
Hospitalists should demonstrate skill in:
History and physical exam relative to cardiac disease
Recognizing signs and severity of ACS
Diagnosing ACS through appropriate testing
History and physical, ECG, x‐rays, biomarkers
Risk stratification using validated tools
Formulating an evidence‐based treatment plan
Identifying patients for thrombolytics and/or early revascularization
Recognizing and treating patient discomfort
Recognizing decompensation, initiating immediate therapy
Managing complicating factors
Bleeding, inadequate response, cardiopulmonary compromise
Timely patient assessment, co‐management with other providers
Hospitalists should demonstrate attitudes that facilitate:
Communication with patients and families relative to cardiac disease and all aspects of care plan
Obtain informed consent
Early specialty consultation
Initiation of secondary prevention measures before discharge
Multidisciplinary care throughout the hospital stay
Safe discharge and transition back into primary care

Case Study

A 64‐year‐old man presents to the emergency department with the chief complaint of chest pressure for the past 2 hours. His chest pressure began after he moved furniture in his home. He initially believed that a pulled muscle was the cause of the pain, but when the discomfort did not improve with rest and continued to worsen, he thought it best that his wife drive him to the emergency department, where he continues to have chest pressure. He has never had this symptom before. His past medical history is notable only for mild hypertension for which he takes hydrochlorothiazide 25 mg daily. Otherwise, he has been healthy.

Clinical Presentation and Risk Assessment

The clinical presentation of ACS is not always straightforward. Although physicians frequently inquire about chest pain, the pain often manifests as chest heaviness or chest pressure. Additionally, some patients have a more atypical presentation, where the predominant symptom of acute coronary ischemia is dyspnea or extreme fatigue. These atypical presentations are believed to be somewhat more common in women and in the elderly, but it is important to realize that they can occur in any patient. Nausea, vomiting, or diaphoresis may accompany these symptoms or occur in isolation. Chest discomfort radiating to the jaw, neck, or left arm may be present, but is not necessary to the diagnosis. Thus, we see a variety of symptoms presenting in a patient with ACS.

This varied presentation makes objective assessment of ACS particularly important. To inform assessment, biomarkers have emerged as a quick and effective tool to help with the diagnosis of ACS. In particular, troponin measurement is important and serial troponin measurement is useful to exclude myonecrosis. It should be noted that the initial troponin level may be normal during the early stages of ACS. A bedside troponin measurement can be useful for rapid identification of myocardial damage. Quantitative troponin measurement also adds value, as higher levels of troponin are associated with progressively worse outcomes, including mortality (Figure 1). Although a number of biomarkers are available, the most important commonly used at present is troponin.0, 0, 0, 0

Figure 1
Cardiac troponin predicts the risk of mortality in UA/NSTEMI (unstable angina/non–ST‐segment elevation myocardial infarction). Cardiac troponin levels measured at baseline. P < 0.001 for increase in mortality rate with increasing cardiac troponin I at enrollment. Source: Antman et al. N Engl J Med. 1996;335:1342‐1349. Reprinted with permission from the New England Journal of Medicine. Copyright 1996 Massachusetts Medical Society. All rights reserved.
Figure 2
Mortality rates by early catheterization vs. no early catheterization in high‐risk ACS patients. P < 0.001 for comparisons within each risk group. Source: Bhatt et al. JAMA. 2004;292:2096‐2104. Reprinted with permission from the Journal of the American Medical Association. Copyright 2004 American Medical Association. All rights reserved.
Figure 3
Relative risk of all‐cause mortality at a mean follow‐up 2 years for invasive vs. conservative strategy in high‐risk ACS patients. FRISC‐II, Fragmin and Fast Revascularization During Instability in Coronary Disease; ICTUS, Invasive vs. Conservative Treatment in Unstable Coronary Syndromes Investigators; ISAR‐COOL, Intracoronary Stenting With Antithrombotic Regimen Cooling Off; RITA‐3, Randomized Intervention Trial of Unstable Angina; TIMI‐18, Thrombolysis in Myocardial Infarction‐18; TRUCS, Treatment of Refractory Unstable Angina in Geographically Isolated Areas Without Cardiac Surgery; VINO, Value of First Day Coronary Angiography/Angioplasty in Evolving Non–ST‐Segment Elevation Myocardial Infarction. Source: Bavry et al. J Am Coll Cardiol. 2006;48:1319‐1325. Reprinted with permission from the Journal of the American College of Cardiology (Elsevier).
Figure 4
Mortality rates by the number of acute recommended therapies from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) National Quality Improvement Initiative. Acute therapies defined as aspirin, beta blockers, heparin, GP IIb/IIIa inhibitors, or cardiac catheterization < 48 hours. Risk group based upon CRUSADE risk score. Source: Peterson et al. J Am Med Assoc. 2006;295:1912‐1920. Copyright 2006. Reprinted with permission of the American Medical Association. All rights reserved.
Figure 5
All‐cause mortality for patients receiving a drug‐eluting stent vs. a bare metal stent. PES, paclitaxel‐eluting stent; SES, sirolimus‐eluting stent; DES, drug‐eluting stent; BMS, bare metal stent. Source: Bavry and Bhatt. Lancet. 2008;371:2134‐2143. Reprinted with permission from The Lancet (Elsevier).

In addition to biomarkers, the electrocardiogram (ECG) remains extremely important in diagnosis and risk stratification. In a moderate‐level emergency department, the triage nurse should obtain a 12‐lead ECG for a patient with a history that is suspicious for coronary ischemia, and ask the attending physician to review the ECG immediately. If there is ST‐segment elevation or any new or presumed new left bundle‐branch block, the patient should be triaged to the ST‐segment elevation MI pathway of care. If there is ST‐segment depression or marked T‐wave inversion, this greatly raises the suspicion for nonST‐segment elevation MI or unstable angina. The presence of any of these features on the ECG places the patient at markedly elevated risk of short‐term ischemic complications.

A protocol should be in place for rapid treatment of patients with ST‐segment elevation MI.2 If the hospital has 24/7 percutaneous coronary intervention (PCI) capability, the catheterization lab should be immediately activated and the patient should proceed to primary PCI. The goal door‐to‐balloon time is 90 minutes or less. A patient who presents to a hospital without primary PCI capability should receive either fibrinolysis or be transferred to a center that can perform primary PCI. If fibrinolytic therapy is planned, it is essential that the patient not have any absolute contraindications to fibrinolytic therapy. Fibrinolysis should be administered within 30 minutes of patient contact. If transfer for primary PCI is planned, it is important that systems to support the transfer are in place so that the time from first medical contact to PCI does not exceed 90 minutes. As a practical point, it can be difficult to achieve these short transfer times in many geographic regions of the United States. However, with organized systems of care, it is certainly possible to have effective transfer systems and to achieve a short door‐to‐balloon time.3

If the patient does not have ST‐segment elevation MI, the next step depends on the patient's level of risk, where risk stratification is particularly important. As mentioned above, troponin measurement and the ECG are both essential aspects of risk stratification, but they alone are not sufficient to establish risk. It is recommended that an objective risk tool also be used. This is especially important because the patient can be initially troponin‐negative and have a normal ECG but still be at high risk for ischemic complications. The TIMI risk score (Table 2) is 1 of a number of resources that can help determine whether patients are at high risk for short‐term ischemic complications using means more objective than the eyeball test (Table 3).

Components of TIMI Risk Score for UA/NSTEMI
  • Related data were reported by Antman et al.28

  • Abbreviations: ASA, acetylsalicylic acid; CAD, coronary artery disease; ST, part of an electrocardiogram between the QRS complex and the T wave; TIMI, Thrombolysis in Myocardial Infarction; UA/NSTEMI, unstable angina/nonST‐segment elevation myocardial infarction.

Historical
Age 65 year
3 CAD risk factors
Family history, hypertension, hypercholesterolemia, diabetes, active smoker
Known CAD (stenosis 50%)
ASA use in past 7 days
At presentation
Recent (24 hours) severe angina
Elevated cardiac markers
ST deviation 0.5 mm
Risk score = total points, range: 07
Risk of Cardiac Events by 14 Days in TIMI 11B
Risk Score Death or MI (%) Death, MI, or Urgent Revascularization (%)
  • NOTE: Entry criteria: MI or NSTEMI defined as ischemic pain at rest within past 24 hours, with evidence of CAD (ST‐segment deviation or positive marker).

  • Related data were reported by Antman et al.28

  • Abbreviations: CAD, coronary artery disease; MI, myocardial infarction; NSTEMI, nonST‐segment elevation myocardial infarction; ST, part of an electrocardiogram between the QRS complex and the T wave; TIMI, Thrombolysis in Myocardial Infarction.

0/1 3 5
2 3 8
3 5 13
4 7 20
5 12 26
6/7 19 41

Delineation of the coronary anatomy in the catheterization lab is warranted for patients judged to be at high risk on the basis of the TIMI risk score, which would include most patients with elevated troponin or ST‐segment deviation. Many patients will undergo PCI on the basis of those test results and a smaller percentage might undergo coronary artery bypass grafting (CABG). Additionally, a sizeable minority of patients will be managed medically. This latter group is challenging because it consists of patients who have either trivial coronary artery disease or extensive coronary artery disease not amenable to revascularization and who have either a very low or very high risk of ischemic complications.

Even though catheterization may not be necessary, further evaluation is warranted in patients with ACS deemed to be at low risk. Typically, some form of functional assessment is indicated. In patients who are able to exercise, this would consist of exercise stress testing, often with an imaging modality. If the stress test is abnormal, cardiac catheterization is often the next step.

Case Study (cont)

An ECG is rapidly obtained on this patient and there is ST‐segment depression in leads II, III, and aVF. A bedside troponin is positive. The patient is at high risk of ischemic complications. He is diagnosed with nonST‐segment elevation MI. The next step is to initiate medical therapy. Presumably, the patient would have already (or at least should have already) received aspirin. Chewing or swallowing a dose of 325 mg nonenteric coated aspirin should provide a prompt aspirin effect. It would be reasonable to initiate anticoagulation as well, and the guidelines support a number of choices such as unfractionated heparin or low molecular weight heparin. Consideration should also be given to starting additional antiplatelet therapy, such as a loading dose of clopidogrel. Although aspirin provides some degree of antiplatelet effect, in a patient with activated platelets who presents with an ACS, additional antiplatelet therapy is necessary, although the exact timing of it is a matter of debate. Finally, consideration needs to be given to the need for catheterization. This patient, on the basis of his high ischemic risk and lack of obvious contraindications, should go to the catheterization laboratory, and the timing of catheterization requires further thought.

Guideline Update

The American College of Cardiology/American Heart Association 2009 Focused Guideline Update provides new information and recommendations pertinent to the care of patients with ACS2 and incorporates new data relevant to the initial emergency care and subsequent inpatient care of patients with ACS. Guideline highlights are presented in Table 4.

New Recommendations From the 2009 Joint STEMI/PCI Focused Update
Intervention Recommendation
  • NOTE: Classification of recommendations: Class I. Benefit ⋙ risk. Procedure or treatment should be performed or administered. Class IIa. Benefit ≫ risk. Additional studies with focused objectives are needed. It is reasonable to perform procedure or administer treatment. Class IIb. Benefit risk. Additional studies with broad objectives are needed; additional registry data would be helpful. Procedure or treatment may be considered. Class III. Risk benefit. Procedure or treatment should not be performed or administered since it is not helpful and may be harmful.

  • Related data were reported by Bavry et al.4

  • Abbreviations: ASA, aspirin; BMS, bare metal stent; CABG, coronary artery bypass graft; CAD, coronary artery disease; CKD, chronic kidney disease; d, days; DES, drug‐eluting stent; FFR, fractional flow reserve, PCI, percutaneous coronary intervention; STEMI, ST‐segment elevation myocardial infarction; TIA, transient ischemic attack; UA/NSTEMI, unstable angina/nonST‐segment elevation myocardial infarction.

GP IIb/IIIa receptor antagonists
Class IIa Start abciximab, tirofiban, or eptifibatide at primary PCI (with/without stenting) in selected patients with STEMI.
Class IIb Uncertain value in STEMI when given before arrival at catheterization lab.
Thienopyridines
Class I Use loading dose for planned PCI in STEMI. Regimens for primary and nonprimary PCI are detailed within the guideline.
Duration of therapy after stent placement of at least 12 months. Stop early if bleeding risk outweighs benefit.
Discontinue before planned, delayed CABG (5 d clopidogrel; 7 d prasugrel) unless the need for CABG outweighs bleeding risk.
Class IIb After DES placement, consider continuing clopidogrel or prasugrel beyond the first 15 months of therapy.
Class III Prasugrel is not recommended for primary PCI in patients with STEMI who have a history of stroke or TIA.
Parenteral anticoagulants
Class I In primary PCI, supportive anticoagulants include unfractionated heparin, enoxaparin, fondaparinux, or bivalirudin, following ASA and a thienopyridine.
Class IIa Bivalirudin is reasonable in patients at high risk of bleeding undergoing PCI for STEMI.
Triage and transfer for PCI
Class I STEMI system of care is supported by dedicated teams and protocols required for all communities.
Class IIa Transfer patients who received fibrinolytic therapy at a nonPCI‐capable facility to a PCI‐capable facility. Consider preparatory antithrombotic regimen before or during transfer.
Class IIb Consider expeditious transfer of nonhigh‐risk patients from a nonPCI‐capable facility to a PCI‐capable facility after administration of fibrinolytic. Consider preparatory antithrombotic regimen before or during transfer.
Intensive glucose control in STEMI
Class IIa Insulin is reasonable to maintain glucose <180 mg/dL (avoid hypoglycemia) for any patient with STEMI.
Thrombus aspiration during PCI of STEMI
Class IIa Aspiration thombectomy is reasonable.
Use of stents in STEMI
Class IIa DES is a reasonable alternative to BMS for primary PCI in STEMI.
Class IIb Consider DES when clinical or anatomical factors suggest favorable safety and efficacy for DES.
Angiography in CKD
Class I Isomolar contrast or low molecular weight contrast (not ioxaglate or iohexol) is indicated for CKD patients not on dialysis.
Fractional flow reserve
Class IIa FFR is useful to assess a specific coronary lesion or as an alternative to noninvasive functional testing to justify PCI. Reasonable for intermediate coronary stenosis in patients with angina.
Class III Routine use of FFR is not recommended to assess severity of CAD in patients with angina who have had a positive, unequivocal, noninvasive functional study.
PCI for unprotected left main CAD
Class IIb PCI of left main coronary artery with stents is an alternative to CABG for anatomy associated with low risk of PCI complications and a clinical scenario with higher risk of adverse surgical outcomes.
Timing of angiography and antiplatelet therapy in UA/NSTEMI
Class I Initiate dual‐antiplatelet therapy for UA/NSTEMI and an invasive approach. Start ASA on presentation. Clopidogrel (before or at PCI) or prasugrel (at PCI) as a second antiplatelet agent.
Class IIa Early invasive strategy within 12 to 24 hours of admission is reasonable for stabilized high‐risk UA/NSTEMI; an early approach is also reasonable for UA/STEMI not at high‐risk.

Several studies support an invasive strategy to assess high‐risk ACS patients. Randomized clinical trials and meta‐analyses of these trials have confirmed a significant reduction in subsequent ischemic events, including mortality, in patients who undergo an invasive vs. a more conservative strategy.4 Registry data have confirmed that these randomized clinical trial data reflect patients in the real‐world setting of clinical practice.5

The timing of angiography has recently been examined in detail.6, 7 It appears that for patients with nonST‐segment elevation ACS, unlike those with ST‐segment elevation MI, there is no need for emergent transfer to the catheterization laboratory, assuming patients are electrically and hemodynamically stable. Emergency transfer is warranted for unstable patients and those with ongoing chest discomfort. Otherwise, it appears sufficient to send the patient with nonST‐segment elevation ACS for catheterization within the subsequent 48 hours, or, alternatively, to adopt a more expectant approach in which catheterization is deferred until either recurrent symptoms develop or risk stratification suggests that there is substantial myocardium in jeopardy.

PCI is performed in the catheterization laboratory most often in the setting of ACS.5 When PCI is performed, an important consideration is whether to use a bare metal stent or a drug‐eluting stent.8 Drug‐eluting stents have been shown to have a significant benefit in reducing restenosis and the need for repeat revascularization. However, in aggregate, they have not been shown to either increase or decrease mortality.9 A key issue for the referring physician is to ascertain whether patients who go to the catheterization laboratory are likely to tolerate and be compliant with prolonged dual antiplatelet therapy. If it appears that the patient can or will not be compliant, a bare metal stent is preferable to a drug‐eluting stent; a bare metal stent requires dual antiplatelet therapy of shorter duration.

Additional considerations when sending patients to the catheterization laboratory are related to renal function. In patients with renal dysfunction, the most important way to prevent contrast nephropathy is adequate hydration prior to the procedure. In patients with left ventricular dysfunction, hydration must be done judiciously. Other strategies for preventing contrast nephropathy are being studied, although it is not entirely clear which strategies beyond hydration are truly effective.

Use of upstream glycoprotein IIb/IIIa inhibitors has become more common in patients with nonST‐segment elevation ACS. However, the most recent trial to examine this issue, the Early Glycoprotein IIb/IIIa Inhibition in NonST‐Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial, did not find a clear benefit for routine administration of upstream glycoprotein IIb/IIIa inhibitors when studying all patients with ACS.10 There did appear to be a signal of benefit in troponin‐positive patients, but as an overall strategy no significant benefit and even some detriment associated with an increase in bleeding were shown. Similarly, the results of the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial did not support the benefit of upstream glycoprotein IIb/IIIa inhibitors in patients with ACS.11

New data have also been released with respect to the thienopyridines. The Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with PrasugrelThrombolysis in Myocardial Infarction (TRITONTIMI) 38 study found that the more potent thienopyridine prasugrel significantly reduced ischemic events when compared with clopidogrel in patients with ACS undergoing PCI.1214 A significant reduction in stent thrombosis was reported regardless of the type of stent.15 However, the study reported a significant increase in major bleeding and a small, but statistically significant, excess of fatal bleeding. A subgroup analysis of patients with diabetes or with ST‐segment elevation MI from the TRITON‐TIMI 38 study showed a particularly large benefit associated with the use of prasugrel vs. clopidogrel and, interestingly, bleeding hazards were attenuated in these subgroups.16, 17 In the small subgroup of patients with prior stroke or transient ischemic attack (TIA), there was an excessive rate of intracranial hemorrhage with prasugrel vs. clopidogrel, indicating that prasugrel should not be used in these patients. Patients age 75 years or older or who weighed less than 60 kg also appeared to have a higher bleeding risk with prasugrel compared to clopidogrel. Careful thought is needed before using prasugrel in those patients identified as having a higher risk of bleeding.

Recently, a higher clopidogrel loading dose of 600 mg vs. the standard 300 mg dose was tested in patients who presented with ACS in the Clopidogrel optimal loading dose Usage to Reduce Recurrent EveNTs‐Organization to Assess Strategies in Ischemic Syndromes (CURRENT‐OASIS) 7 trial.18 Patients also received 150 mg of clopidogrel daily for the ensuing 6 days vs. the standard 75 mg daily dose. All patients then received 75 mg clopidogrel for 1 month of follow‐up. In the overall population, there was no benefit to using the higher clopidogrel loading dose. In contrast, there was a significant reduction in stent thrombosis in patients who received stents. The higher loading dose of clopidogrel was associated with a higher rate of bleeding.

Ticagrelor is a novel adenosine diphosphate receptor antagonist that was compared with clopidogrel in patients with ACS.19, 20 Compared to clopidogrel, ticagrelor significantly reduced ischemic events and there was also a significant reduction in cardiovascular mortality and in all‐cause mortality. Surprisingly, overall major bleeding did not increase with ticagrelor, but nonCABG‐related major bleeding increased.

The use of proton pump inhibitors (PPIs) in patients receiving dual antiplatelet therapy has also been a matter of vigorous recent debate.21 Evidence to date suggests there is no significant clinical interaction between PPIs and prasugrel. The data with clopidogrel and PPIs are mixed, although data are limited because much were derived from observational studies. Randomized clinical trial data are needed to assess whether there is an interaction between clopidogrel and PPIs that warrants clinical action, although preliminary data suggest there is no adverse cardiovascular interaction.22

New data regarding the intravenous anticoagulant bivalirudin have become available and have been incorporated into the Focused Guideline Update. Although bivalirudin is to be used primarily in the catheterization laboratory during PCI, it does appear to be associated with significantly less bleeding than heparin plus glycoprotein IIb/IIIa inhibitors.11, 2326

Case Study (cont)

The patient undergoes cardiac catheterization. An occluded dominant left circumflex artery is noted and is opened up with balloon angioplasty after aspiration thrombectomy. The patient receives 60 mg of prasugrel as a loading dose and bivalirudin as the anticoagulant during the procedure. A drug‐eluting stent is implanted with excellent results. The patient is transferred to the cardiac care unit for further care. It appears that this is a patient who functionally has an ST‐segment elevation MI with an occluded artery, although it manifested on the ECG as ST depression. Because of the patient's ongoing chest discomfort, it was fortunate that prompt angiography was performed.

Discussion

Patients with ACS present several challenges in management. Risk stratification is particularly important for nonST‐segment elevation ACS and requires thoughtful evaluation by the physician. Additionally, the large amount of new data and guideline updates create a rapidly evolving field, making it difficult to keep abreast of new developments. Physicians of patients with ACS need to be aware of these key developments so that they can provide optimal care to their patients with potentially life‐threatening ACS.

Acknowledgements

Denise M. Erkkila, RPh of DIME, provided editorial assistance consisting of help with tables, figures, and reference formatting for this manuscript.

Acute coronary syndrome (ACS) remains a major healthcare challenge. Currently, the majority of patients with ACS have nonST‐segment (ST, part of an electrocardiogram between the QRS complex and the T wave) elevation myocardial infarction (MI) and unstable angina.1 Nevertheless, ST‐segment elevation MI is also an important cause of morbidity and mortality. In recent years, our understanding of ACS has improved as a result of several major advances based on results from multiple randomized clinical trials and registry analyses. The results of these analyses have influenced guidelines issued by professional societies and in some cases have become performance metrics. Therefore, it is particularly important for physicians involved in the care of patients with ACS to be aware of evolving treatment patterns (Table 1).

Hospitalist Core Competencies for Management of ACS
  • Related data were reported by the Society of Hospital Medicine.27

  • Abbreviations: ACS, Acute coronary syndrome; CABG, coronary artery bypass graft; CAD, coronary artery disease; ECG, electrocardiogram; MI, myocardial infarction; STEMI, ST‐segment elevation myocardial infarction.

Hospitalists should demonstrate a knowledge of:
ACS without enzyme leak, NSTEMI, and STEMI
Variable presentations of unstable angina, acute MI
Conditions that mimic ACS
Cardiac biomarkers
Role of noninvasive cardiac testing
Risks; indications for cardiac catheterization
Risk factors for CAD
Validated risk stratification tools
Indications for hospitalization of patients with chest pain
Indications, contraindications for thrombolytic therapy
Indications, contraindications, and pharmacology of drugs for ACS
Indications for early invasive interventions
Angiography, stenting and/or CABG
Laboratory studies or imaging indicative of disease severity
Safe hospital discharge
Hospitalists should demonstrate skill in:
History and physical exam relative to cardiac disease
Recognizing signs and severity of ACS
Diagnosing ACS through appropriate testing
History and physical, ECG, x‐rays, biomarkers
Risk stratification using validated tools
Formulating an evidence‐based treatment plan
Identifying patients for thrombolytics and/or early revascularization
Recognizing and treating patient discomfort
Recognizing decompensation, initiating immediate therapy
Managing complicating factors
Bleeding, inadequate response, cardiopulmonary compromise
Timely patient assessment, co‐management with other providers
Hospitalists should demonstrate attitudes that facilitate:
Communication with patients and families relative to cardiac disease and all aspects of care plan
Obtain informed consent
Early specialty consultation
Initiation of secondary prevention measures before discharge
Multidisciplinary care throughout the hospital stay
Safe discharge and transition back into primary care

Case Study

A 64‐year‐old man presents to the emergency department with the chief complaint of chest pressure for the past 2 hours. His chest pressure began after he moved furniture in his home. He initially believed that a pulled muscle was the cause of the pain, but when the discomfort did not improve with rest and continued to worsen, he thought it best that his wife drive him to the emergency department, where he continues to have chest pressure. He has never had this symptom before. His past medical history is notable only for mild hypertension for which he takes hydrochlorothiazide 25 mg daily. Otherwise, he has been healthy.

Clinical Presentation and Risk Assessment

The clinical presentation of ACS is not always straightforward. Although physicians frequently inquire about chest pain, the pain often manifests as chest heaviness or chest pressure. Additionally, some patients have a more atypical presentation, where the predominant symptom of acute coronary ischemia is dyspnea or extreme fatigue. These atypical presentations are believed to be somewhat more common in women and in the elderly, but it is important to realize that they can occur in any patient. Nausea, vomiting, or diaphoresis may accompany these symptoms or occur in isolation. Chest discomfort radiating to the jaw, neck, or left arm may be present, but is not necessary to the diagnosis. Thus, we see a variety of symptoms presenting in a patient with ACS.

This varied presentation makes objective assessment of ACS particularly important. To inform assessment, biomarkers have emerged as a quick and effective tool to help with the diagnosis of ACS. In particular, troponin measurement is important and serial troponin measurement is useful to exclude myonecrosis. It should be noted that the initial troponin level may be normal during the early stages of ACS. A bedside troponin measurement can be useful for rapid identification of myocardial damage. Quantitative troponin measurement also adds value, as higher levels of troponin are associated with progressively worse outcomes, including mortality (Figure 1). Although a number of biomarkers are available, the most important commonly used at present is troponin.0, 0, 0, 0

Figure 1
Cardiac troponin predicts the risk of mortality in UA/NSTEMI (unstable angina/non–ST‐segment elevation myocardial infarction). Cardiac troponin levels measured at baseline. P < 0.001 for increase in mortality rate with increasing cardiac troponin I at enrollment. Source: Antman et al. N Engl J Med. 1996;335:1342‐1349. Reprinted with permission from the New England Journal of Medicine. Copyright 1996 Massachusetts Medical Society. All rights reserved.
Figure 2
Mortality rates by early catheterization vs. no early catheterization in high‐risk ACS patients. P < 0.001 for comparisons within each risk group. Source: Bhatt et al. JAMA. 2004;292:2096‐2104. Reprinted with permission from the Journal of the American Medical Association. Copyright 2004 American Medical Association. All rights reserved.
Figure 3
Relative risk of all‐cause mortality at a mean follow‐up 2 years for invasive vs. conservative strategy in high‐risk ACS patients. FRISC‐II, Fragmin and Fast Revascularization During Instability in Coronary Disease; ICTUS, Invasive vs. Conservative Treatment in Unstable Coronary Syndromes Investigators; ISAR‐COOL, Intracoronary Stenting With Antithrombotic Regimen Cooling Off; RITA‐3, Randomized Intervention Trial of Unstable Angina; TIMI‐18, Thrombolysis in Myocardial Infarction‐18; TRUCS, Treatment of Refractory Unstable Angina in Geographically Isolated Areas Without Cardiac Surgery; VINO, Value of First Day Coronary Angiography/Angioplasty in Evolving Non–ST‐Segment Elevation Myocardial Infarction. Source: Bavry et al. J Am Coll Cardiol. 2006;48:1319‐1325. Reprinted with permission from the Journal of the American College of Cardiology (Elsevier).
Figure 4
Mortality rates by the number of acute recommended therapies from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) National Quality Improvement Initiative. Acute therapies defined as aspirin, beta blockers, heparin, GP IIb/IIIa inhibitors, or cardiac catheterization < 48 hours. Risk group based upon CRUSADE risk score. Source: Peterson et al. J Am Med Assoc. 2006;295:1912‐1920. Copyright 2006. Reprinted with permission of the American Medical Association. All rights reserved.
Figure 5
All‐cause mortality for patients receiving a drug‐eluting stent vs. a bare metal stent. PES, paclitaxel‐eluting stent; SES, sirolimus‐eluting stent; DES, drug‐eluting stent; BMS, bare metal stent. Source: Bavry and Bhatt. Lancet. 2008;371:2134‐2143. Reprinted with permission from The Lancet (Elsevier).

In addition to biomarkers, the electrocardiogram (ECG) remains extremely important in diagnosis and risk stratification. In a moderate‐level emergency department, the triage nurse should obtain a 12‐lead ECG for a patient with a history that is suspicious for coronary ischemia, and ask the attending physician to review the ECG immediately. If there is ST‐segment elevation or any new or presumed new left bundle‐branch block, the patient should be triaged to the ST‐segment elevation MI pathway of care. If there is ST‐segment depression or marked T‐wave inversion, this greatly raises the suspicion for nonST‐segment elevation MI or unstable angina. The presence of any of these features on the ECG places the patient at markedly elevated risk of short‐term ischemic complications.

A protocol should be in place for rapid treatment of patients with ST‐segment elevation MI.2 If the hospital has 24/7 percutaneous coronary intervention (PCI) capability, the catheterization lab should be immediately activated and the patient should proceed to primary PCI. The goal door‐to‐balloon time is 90 minutes or less. A patient who presents to a hospital without primary PCI capability should receive either fibrinolysis or be transferred to a center that can perform primary PCI. If fibrinolytic therapy is planned, it is essential that the patient not have any absolute contraindications to fibrinolytic therapy. Fibrinolysis should be administered within 30 minutes of patient contact. If transfer for primary PCI is planned, it is important that systems to support the transfer are in place so that the time from first medical contact to PCI does not exceed 90 minutes. As a practical point, it can be difficult to achieve these short transfer times in many geographic regions of the United States. However, with organized systems of care, it is certainly possible to have effective transfer systems and to achieve a short door‐to‐balloon time.3

If the patient does not have ST‐segment elevation MI, the next step depends on the patient's level of risk, where risk stratification is particularly important. As mentioned above, troponin measurement and the ECG are both essential aspects of risk stratification, but they alone are not sufficient to establish risk. It is recommended that an objective risk tool also be used. This is especially important because the patient can be initially troponin‐negative and have a normal ECG but still be at high risk for ischemic complications. The TIMI risk score (Table 2) is 1 of a number of resources that can help determine whether patients are at high risk for short‐term ischemic complications using means more objective than the eyeball test (Table 3).

Components of TIMI Risk Score for UA/NSTEMI
  • Related data were reported by Antman et al.28

  • Abbreviations: ASA, acetylsalicylic acid; CAD, coronary artery disease; ST, part of an electrocardiogram between the QRS complex and the T wave; TIMI, Thrombolysis in Myocardial Infarction; UA/NSTEMI, unstable angina/nonST‐segment elevation myocardial infarction.

Historical
Age 65 year
3 CAD risk factors
Family history, hypertension, hypercholesterolemia, diabetes, active smoker
Known CAD (stenosis 50%)
ASA use in past 7 days
At presentation
Recent (24 hours) severe angina
Elevated cardiac markers
ST deviation 0.5 mm
Risk score = total points, range: 07
Risk of Cardiac Events by 14 Days in TIMI 11B
Risk Score Death or MI (%) Death, MI, or Urgent Revascularization (%)
  • NOTE: Entry criteria: MI or NSTEMI defined as ischemic pain at rest within past 24 hours, with evidence of CAD (ST‐segment deviation or positive marker).

  • Related data were reported by Antman et al.28

  • Abbreviations: CAD, coronary artery disease; MI, myocardial infarction; NSTEMI, nonST‐segment elevation myocardial infarction; ST, part of an electrocardiogram between the QRS complex and the T wave; TIMI, Thrombolysis in Myocardial Infarction.

0/1 3 5
2 3 8
3 5 13
4 7 20
5 12 26
6/7 19 41

Delineation of the coronary anatomy in the catheterization lab is warranted for patients judged to be at high risk on the basis of the TIMI risk score, which would include most patients with elevated troponin or ST‐segment deviation. Many patients will undergo PCI on the basis of those test results and a smaller percentage might undergo coronary artery bypass grafting (CABG). Additionally, a sizeable minority of patients will be managed medically. This latter group is challenging because it consists of patients who have either trivial coronary artery disease or extensive coronary artery disease not amenable to revascularization and who have either a very low or very high risk of ischemic complications.

Even though catheterization may not be necessary, further evaluation is warranted in patients with ACS deemed to be at low risk. Typically, some form of functional assessment is indicated. In patients who are able to exercise, this would consist of exercise stress testing, often with an imaging modality. If the stress test is abnormal, cardiac catheterization is often the next step.

Case Study (cont)

An ECG is rapidly obtained on this patient and there is ST‐segment depression in leads II, III, and aVF. A bedside troponin is positive. The patient is at high risk of ischemic complications. He is diagnosed with nonST‐segment elevation MI. The next step is to initiate medical therapy. Presumably, the patient would have already (or at least should have already) received aspirin. Chewing or swallowing a dose of 325 mg nonenteric coated aspirin should provide a prompt aspirin effect. It would be reasonable to initiate anticoagulation as well, and the guidelines support a number of choices such as unfractionated heparin or low molecular weight heparin. Consideration should also be given to starting additional antiplatelet therapy, such as a loading dose of clopidogrel. Although aspirin provides some degree of antiplatelet effect, in a patient with activated platelets who presents with an ACS, additional antiplatelet therapy is necessary, although the exact timing of it is a matter of debate. Finally, consideration needs to be given to the need for catheterization. This patient, on the basis of his high ischemic risk and lack of obvious contraindications, should go to the catheterization laboratory, and the timing of catheterization requires further thought.

Guideline Update

The American College of Cardiology/American Heart Association 2009 Focused Guideline Update provides new information and recommendations pertinent to the care of patients with ACS2 and incorporates new data relevant to the initial emergency care and subsequent inpatient care of patients with ACS. Guideline highlights are presented in Table 4.

New Recommendations From the 2009 Joint STEMI/PCI Focused Update
Intervention Recommendation
  • NOTE: Classification of recommendations: Class I. Benefit ⋙ risk. Procedure or treatment should be performed or administered. Class IIa. Benefit ≫ risk. Additional studies with focused objectives are needed. It is reasonable to perform procedure or administer treatment. Class IIb. Benefit risk. Additional studies with broad objectives are needed; additional registry data would be helpful. Procedure or treatment may be considered. Class III. Risk benefit. Procedure or treatment should not be performed or administered since it is not helpful and may be harmful.

  • Related data were reported by Bavry et al.4

  • Abbreviations: ASA, aspirin; BMS, bare metal stent; CABG, coronary artery bypass graft; CAD, coronary artery disease; CKD, chronic kidney disease; d, days; DES, drug‐eluting stent; FFR, fractional flow reserve, PCI, percutaneous coronary intervention; STEMI, ST‐segment elevation myocardial infarction; TIA, transient ischemic attack; UA/NSTEMI, unstable angina/nonST‐segment elevation myocardial infarction.

GP IIb/IIIa receptor antagonists
Class IIa Start abciximab, tirofiban, or eptifibatide at primary PCI (with/without stenting) in selected patients with STEMI.
Class IIb Uncertain value in STEMI when given before arrival at catheterization lab.
Thienopyridines
Class I Use loading dose for planned PCI in STEMI. Regimens for primary and nonprimary PCI are detailed within the guideline.
Duration of therapy after stent placement of at least 12 months. Stop early if bleeding risk outweighs benefit.
Discontinue before planned, delayed CABG (5 d clopidogrel; 7 d prasugrel) unless the need for CABG outweighs bleeding risk.
Class IIb After DES placement, consider continuing clopidogrel or prasugrel beyond the first 15 months of therapy.
Class III Prasugrel is not recommended for primary PCI in patients with STEMI who have a history of stroke or TIA.
Parenteral anticoagulants
Class I In primary PCI, supportive anticoagulants include unfractionated heparin, enoxaparin, fondaparinux, or bivalirudin, following ASA and a thienopyridine.
Class IIa Bivalirudin is reasonable in patients at high risk of bleeding undergoing PCI for STEMI.
Triage and transfer for PCI
Class I STEMI system of care is supported by dedicated teams and protocols required for all communities.
Class IIa Transfer patients who received fibrinolytic therapy at a nonPCI‐capable facility to a PCI‐capable facility. Consider preparatory antithrombotic regimen before or during transfer.
Class IIb Consider expeditious transfer of nonhigh‐risk patients from a nonPCI‐capable facility to a PCI‐capable facility after administration of fibrinolytic. Consider preparatory antithrombotic regimen before or during transfer.
Intensive glucose control in STEMI
Class IIa Insulin is reasonable to maintain glucose <180 mg/dL (avoid hypoglycemia) for any patient with STEMI.
Thrombus aspiration during PCI of STEMI
Class IIa Aspiration thombectomy is reasonable.
Use of stents in STEMI
Class IIa DES is a reasonable alternative to BMS for primary PCI in STEMI.
Class IIb Consider DES when clinical or anatomical factors suggest favorable safety and efficacy for DES.
Angiography in CKD
Class I Isomolar contrast or low molecular weight contrast (not ioxaglate or iohexol) is indicated for CKD patients not on dialysis.
Fractional flow reserve
Class IIa FFR is useful to assess a specific coronary lesion or as an alternative to noninvasive functional testing to justify PCI. Reasonable for intermediate coronary stenosis in patients with angina.
Class III Routine use of FFR is not recommended to assess severity of CAD in patients with angina who have had a positive, unequivocal, noninvasive functional study.
PCI for unprotected left main CAD
Class IIb PCI of left main coronary artery with stents is an alternative to CABG for anatomy associated with low risk of PCI complications and a clinical scenario with higher risk of adverse surgical outcomes.
Timing of angiography and antiplatelet therapy in UA/NSTEMI
Class I Initiate dual‐antiplatelet therapy for UA/NSTEMI and an invasive approach. Start ASA on presentation. Clopidogrel (before or at PCI) or prasugrel (at PCI) as a second antiplatelet agent.
Class IIa Early invasive strategy within 12 to 24 hours of admission is reasonable for stabilized high‐risk UA/NSTEMI; an early approach is also reasonable for UA/STEMI not at high‐risk.

Several studies support an invasive strategy to assess high‐risk ACS patients. Randomized clinical trials and meta‐analyses of these trials have confirmed a significant reduction in subsequent ischemic events, including mortality, in patients who undergo an invasive vs. a more conservative strategy.4 Registry data have confirmed that these randomized clinical trial data reflect patients in the real‐world setting of clinical practice.5

The timing of angiography has recently been examined in detail.6, 7 It appears that for patients with nonST‐segment elevation ACS, unlike those with ST‐segment elevation MI, there is no need for emergent transfer to the catheterization laboratory, assuming patients are electrically and hemodynamically stable. Emergency transfer is warranted for unstable patients and those with ongoing chest discomfort. Otherwise, it appears sufficient to send the patient with nonST‐segment elevation ACS for catheterization within the subsequent 48 hours, or, alternatively, to adopt a more expectant approach in which catheterization is deferred until either recurrent symptoms develop or risk stratification suggests that there is substantial myocardium in jeopardy.

PCI is performed in the catheterization laboratory most often in the setting of ACS.5 When PCI is performed, an important consideration is whether to use a bare metal stent or a drug‐eluting stent.8 Drug‐eluting stents have been shown to have a significant benefit in reducing restenosis and the need for repeat revascularization. However, in aggregate, they have not been shown to either increase or decrease mortality.9 A key issue for the referring physician is to ascertain whether patients who go to the catheterization laboratory are likely to tolerate and be compliant with prolonged dual antiplatelet therapy. If it appears that the patient can or will not be compliant, a bare metal stent is preferable to a drug‐eluting stent; a bare metal stent requires dual antiplatelet therapy of shorter duration.

Additional considerations when sending patients to the catheterization laboratory are related to renal function. In patients with renal dysfunction, the most important way to prevent contrast nephropathy is adequate hydration prior to the procedure. In patients with left ventricular dysfunction, hydration must be done judiciously. Other strategies for preventing contrast nephropathy are being studied, although it is not entirely clear which strategies beyond hydration are truly effective.

Use of upstream glycoprotein IIb/IIIa inhibitors has become more common in patients with nonST‐segment elevation ACS. However, the most recent trial to examine this issue, the Early Glycoprotein IIb/IIIa Inhibition in NonST‐Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial, did not find a clear benefit for routine administration of upstream glycoprotein IIb/IIIa inhibitors when studying all patients with ACS.10 There did appear to be a signal of benefit in troponin‐positive patients, but as an overall strategy no significant benefit and even some detriment associated with an increase in bleeding were shown. Similarly, the results of the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial did not support the benefit of upstream glycoprotein IIb/IIIa inhibitors in patients with ACS.11

New data have also been released with respect to the thienopyridines. The Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with PrasugrelThrombolysis in Myocardial Infarction (TRITONTIMI) 38 study found that the more potent thienopyridine prasugrel significantly reduced ischemic events when compared with clopidogrel in patients with ACS undergoing PCI.1214 A significant reduction in stent thrombosis was reported regardless of the type of stent.15 However, the study reported a significant increase in major bleeding and a small, but statistically significant, excess of fatal bleeding. A subgroup analysis of patients with diabetes or with ST‐segment elevation MI from the TRITON‐TIMI 38 study showed a particularly large benefit associated with the use of prasugrel vs. clopidogrel and, interestingly, bleeding hazards were attenuated in these subgroups.16, 17 In the small subgroup of patients with prior stroke or transient ischemic attack (TIA), there was an excessive rate of intracranial hemorrhage with prasugrel vs. clopidogrel, indicating that prasugrel should not be used in these patients. Patients age 75 years or older or who weighed less than 60 kg also appeared to have a higher bleeding risk with prasugrel compared to clopidogrel. Careful thought is needed before using prasugrel in those patients identified as having a higher risk of bleeding.

Recently, a higher clopidogrel loading dose of 600 mg vs. the standard 300 mg dose was tested in patients who presented with ACS in the Clopidogrel optimal loading dose Usage to Reduce Recurrent EveNTs‐Organization to Assess Strategies in Ischemic Syndromes (CURRENT‐OASIS) 7 trial.18 Patients also received 150 mg of clopidogrel daily for the ensuing 6 days vs. the standard 75 mg daily dose. All patients then received 75 mg clopidogrel for 1 month of follow‐up. In the overall population, there was no benefit to using the higher clopidogrel loading dose. In contrast, there was a significant reduction in stent thrombosis in patients who received stents. The higher loading dose of clopidogrel was associated with a higher rate of bleeding.

Ticagrelor is a novel adenosine diphosphate receptor antagonist that was compared with clopidogrel in patients with ACS.19, 20 Compared to clopidogrel, ticagrelor significantly reduced ischemic events and there was also a significant reduction in cardiovascular mortality and in all‐cause mortality. Surprisingly, overall major bleeding did not increase with ticagrelor, but nonCABG‐related major bleeding increased.

The use of proton pump inhibitors (PPIs) in patients receiving dual antiplatelet therapy has also been a matter of vigorous recent debate.21 Evidence to date suggests there is no significant clinical interaction between PPIs and prasugrel. The data with clopidogrel and PPIs are mixed, although data are limited because much were derived from observational studies. Randomized clinical trial data are needed to assess whether there is an interaction between clopidogrel and PPIs that warrants clinical action, although preliminary data suggest there is no adverse cardiovascular interaction.22

New data regarding the intravenous anticoagulant bivalirudin have become available and have been incorporated into the Focused Guideline Update. Although bivalirudin is to be used primarily in the catheterization laboratory during PCI, it does appear to be associated with significantly less bleeding than heparin plus glycoprotein IIb/IIIa inhibitors.11, 2326

Case Study (cont)

The patient undergoes cardiac catheterization. An occluded dominant left circumflex artery is noted and is opened up with balloon angioplasty after aspiration thrombectomy. The patient receives 60 mg of prasugrel as a loading dose and bivalirudin as the anticoagulant during the procedure. A drug‐eluting stent is implanted with excellent results. The patient is transferred to the cardiac care unit for further care. It appears that this is a patient who functionally has an ST‐segment elevation MI with an occluded artery, although it manifested on the ECG as ST depression. Because of the patient's ongoing chest discomfort, it was fortunate that prompt angiography was performed.

Discussion

Patients with ACS present several challenges in management. Risk stratification is particularly important for nonST‐segment elevation ACS and requires thoughtful evaluation by the physician. Additionally, the large amount of new data and guideline updates create a rapidly evolving field, making it difficult to keep abreast of new developments. Physicians of patients with ACS need to be aware of these key developments so that they can provide optimal care to their patients with potentially life‐threatening ACS.

Acknowledgements

Denise M. Erkkila, RPh of DIME, provided editorial assistance consisting of help with tables, figures, and reference formatting for this manuscript.

References
  1. Lloyd‐Jones D,Adams RJ,Brown TM, et al.Heart disease and stroke statistics‐‐2010 update: a report from the American Heart Association.Circulation.2010;121:e46e215.
  2. Kushner FG,Hand M,Smith SC, et al.2009 focused updates: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol.2009;54:22052241.
  3. Kumbhani DJ,Cannon CP,Fonarow GC, et al.Association of hospital primary angioplasty volume in ST‐segment elevation myocardial infarction with quality and outcomes.JAMA.2009;302:22072213.
  4. Bavry AA,Kumbhani DJ,Rassi AN,Bhatt DL,Askari AT.Benefit of early invasive therapy in acute coronary syndromes: a meta‐analysis of contemporary randomized clinical trials.J Am Coll Cardiol.2006;48:13191325.
  5. Bhatt DL,Roe MT,Peterson ED, et al.Utilization of early invasive management strategies for high‐risk patients with non‐ST‐segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.JAMA.2004;292:20962104.
  6. Mehta SR,Granger CB,Boden WE, et al.Early versus delayed invasive intervention in acute coronary syndromes.N Engl J Med.2009;360:21652175.
  7. Montalescot G,Cayla G,Collet JP, et al.Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.JAMA.2009;302:947954.
  8. Bavry AA,Bhatt DL.Drug‐eluting stents: dual antiplatelet therapy for every survivor?Circulation.2007;116:696699.
  9. Bavry AA,Bhatt DL.Appropriate use of drug‐eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.Lancet.2008;371:21342143.
  10. Giugliano RP,White JA,Bode C, et al.Early versus delayed, provisional eptifibatide in acute coronary syndromes.N Engl J Med.2009;360:21762190.
  11. Stone GW,Ware JH,Bertrand ME, et al.Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one‐year results from the ACUITY trial.JAMA.2007;298:24972506.
  12. Bhatt DL.Intensifying platelet inhibition‐‐navigating between Scylla and Charybdis.N Engl J Med.2007;357:20782081.
  13. Bhatt DL.Prasugrel in clinical practice.N Engl J Med.2009;361:940942.
  14. Wiviott SD,Braunwald E,McCabe CH, et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes.N Engl J Med.2007;357:20012015.
  15. Wiviott SD,Braunwald E,McCabe CH, et al.Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON‐TIMI 38 trial: a subanalysis of a randomised trial.Lancet.2008;371:13531363.
  16. Montalescot G,Wiviott SD,Braunwald E, et al.Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST‐elevation myocardial infarction (TRITON‐TIMI 38): double‐blind, randomised controlled trial.Lancet.2009;373:723731.
  17. Wiviott SD,Braunwald E,Angiolillo DJ, et al.Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel—Thrombolysis in Myocardial Infarction 38.Circulation.2008;118:16261636.
  18. Mehta SR, CURRENT Investigators. A randomized comparison of a clopidogrel high loading and maintenance dose regimen versus standard dose and high versus low dose aspirin in 25,000 patients with acute coronary syndromes: results of the CURRENT OASIS 7 trial. Available at: http://www.escardio.org/congresses/esc‐2009/congress‐reports/Pages/706003‐706004‐mehta‐vandewerf.aspx#discussant.2009. Accessed July 2010.
  19. Bhatt DL.Antiplatelet therapy: ticagrelor in ACS‐what does PLATO teach us?Nat Rev Cardiol.2009;6:737738.
  20. Wallentin L,Becker RC,Budaj A, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes.N Engl J Med.2009;361:10451057.
  21. Depta JP,Bhatt DL.Omeprazole and clopidogrel: Should clinicians be worried?Cleve Clin J Med.2010;77:113116.
  22. Bhatt DL.COGENT: a prospective, randomized, placebo‐controlled trial of omeprazole in patients receiving aspirin and clopidogrel. Transcatheter Cardiovascular Therapeutics (TCT) 2009; September 24,2009;San Francisco, CA.
  23. Mehran R,Brodie B,Cox DA, et al.The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) Trial: study design and rationale.Am Heart J.2008;156:4456.
  24. Mehran R,Lansky AJ,Witzenbichler B, et al.Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS‐AMI): 1‐year results of a randomised controlled trial.Lancet.2009;374:11491159.
  25. Stone GW,Bertrand M,Colombo A, et al.Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.Am Heart J.2004;148:764775.
  26. Stone GW,White HD,Ohman EM, et al.Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.Lancet.2007;369:907919.
  27. Society of Hospital Medicine.Acute coronary syndrome.J Hosp Med.2006;1 (suppl 1):23.
  28. Antman EM,Cohen M,Bernink PJ, et al.The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making.JAMA.2000;284:835842.
References
  1. Lloyd‐Jones D,Adams RJ,Brown TM, et al.Heart disease and stroke statistics‐‐2010 update: a report from the American Heart Association.Circulation.2010;121:e46e215.
  2. Kushner FG,Hand M,Smith SC, et al.2009 focused updates: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol.2009;54:22052241.
  3. Kumbhani DJ,Cannon CP,Fonarow GC, et al.Association of hospital primary angioplasty volume in ST‐segment elevation myocardial infarction with quality and outcomes.JAMA.2009;302:22072213.
  4. Bavry AA,Kumbhani DJ,Rassi AN,Bhatt DL,Askari AT.Benefit of early invasive therapy in acute coronary syndromes: a meta‐analysis of contemporary randomized clinical trials.J Am Coll Cardiol.2006;48:13191325.
  5. Bhatt DL,Roe MT,Peterson ED, et al.Utilization of early invasive management strategies for high‐risk patients with non‐ST‐segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.JAMA.2004;292:20962104.
  6. Mehta SR,Granger CB,Boden WE, et al.Early versus delayed invasive intervention in acute coronary syndromes.N Engl J Med.2009;360:21652175.
  7. Montalescot G,Cayla G,Collet JP, et al.Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.JAMA.2009;302:947954.
  8. Bavry AA,Bhatt DL.Drug‐eluting stents: dual antiplatelet therapy for every survivor?Circulation.2007;116:696699.
  9. Bavry AA,Bhatt DL.Appropriate use of drug‐eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.Lancet.2008;371:21342143.
  10. Giugliano RP,White JA,Bode C, et al.Early versus delayed, provisional eptifibatide in acute coronary syndromes.N Engl J Med.2009;360:21762190.
  11. Stone GW,Ware JH,Bertrand ME, et al.Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one‐year results from the ACUITY trial.JAMA.2007;298:24972506.
  12. Bhatt DL.Intensifying platelet inhibition‐‐navigating between Scylla and Charybdis.N Engl J Med.2007;357:20782081.
  13. Bhatt DL.Prasugrel in clinical practice.N Engl J Med.2009;361:940942.
  14. Wiviott SD,Braunwald E,McCabe CH, et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes.N Engl J Med.2007;357:20012015.
  15. Wiviott SD,Braunwald E,McCabe CH, et al.Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON‐TIMI 38 trial: a subanalysis of a randomised trial.Lancet.2008;371:13531363.
  16. Montalescot G,Wiviott SD,Braunwald E, et al.Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST‐elevation myocardial infarction (TRITON‐TIMI 38): double‐blind, randomised controlled trial.Lancet.2009;373:723731.
  17. Wiviott SD,Braunwald E,Angiolillo DJ, et al.Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel—Thrombolysis in Myocardial Infarction 38.Circulation.2008;118:16261636.
  18. Mehta SR, CURRENT Investigators. A randomized comparison of a clopidogrel high loading and maintenance dose regimen versus standard dose and high versus low dose aspirin in 25,000 patients with acute coronary syndromes: results of the CURRENT OASIS 7 trial. Available at: http://www.escardio.org/congresses/esc‐2009/congress‐reports/Pages/706003‐706004‐mehta‐vandewerf.aspx#discussant.2009. Accessed July 2010.
  19. Bhatt DL.Antiplatelet therapy: ticagrelor in ACS‐what does PLATO teach us?Nat Rev Cardiol.2009;6:737738.
  20. Wallentin L,Becker RC,Budaj A, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes.N Engl J Med.2009;361:10451057.
  21. Depta JP,Bhatt DL.Omeprazole and clopidogrel: Should clinicians be worried?Cleve Clin J Med.2010;77:113116.
  22. Bhatt DL.COGENT: a prospective, randomized, placebo‐controlled trial of omeprazole in patients receiving aspirin and clopidogrel. Transcatheter Cardiovascular Therapeutics (TCT) 2009; September 24,2009;San Francisco, CA.
  23. Mehran R,Brodie B,Cox DA, et al.The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) Trial: study design and rationale.Am Heart J.2008;156:4456.
  24. Mehran R,Lansky AJ,Witzenbichler B, et al.Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS‐AMI): 1‐year results of a randomised controlled trial.Lancet.2009;374:11491159.
  25. Stone GW,Bertrand M,Colombo A, et al.Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.Am Heart J.2004;148:764775.
  26. Stone GW,White HD,Ohman EM, et al.Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.Lancet.2007;369:907919.
  27. Society of Hospital Medicine.Acute coronary syndrome.J Hosp Med.2006;1 (suppl 1):23.
  28. Antman EM,Cohen M,Bernink PJ, et al.The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making.JAMA.2000;284:835842.
Issue
Journal of Hospital Medicine - 5(4)
Issue
Journal of Hospital Medicine - 5(4)
Page Number
S15-S21
Page Number
S15-S21
Article Type
Display Headline
Acute coronary syndrome update for hospitalists
Display Headline
Acute coronary syndrome update for hospitalists
Legacy Keywords
acute coronary syndrome, non–ST‐segment elevation myocardial infarction, ST‐segment elevation myocardial infarction
Legacy Keywords
acute coronary syndrome, non–ST‐segment elevation myocardial infarction, ST‐segment elevation myocardial infarction
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

QI Systems for Managing ACS

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
The role of the hospitalist in quality improvement: Systems for improving the care of patients with acute coronary syndrome

Addressing quality improvement (QI) for the management of acute coronary syndrome (ACS) at the institutional level is essential for supporting hospitalists and other clinicians as they manage patients with ACS and achieve desired institutional outcomes. This systems approach may identify institution‐specific barriers to quality care, including those that affect the complex management of ACS. Having a firsthand view of patient care puts the hospitalist in a good position to assess the viability of existing processes and protocols that support care. Indeed, the hospitalist has a vested interest in improving systems of care as these systems directly affect the hospitalist's practice. This unique perspective gives the hospitalist an opportunity to facilitate systems change within the institution and to become an integral participant or leader in QI initiatives.

An increasing number of hospitalists are providing critical care at secondary and tertiary care facilities, driven by a shortage of intensivists in the United States. In a 20052006 survey about 75% of hospitalists reported they provide critical care services as part of their practice,1 and this would include care of patients with ACS. The Society of Hospital Medicine (SHM) has developed core competencies that recognize the important role of hospitalists in leading or participating in QI teams for ACS.2 Hospitalists must also be able to apply evidenced‐based outcomes data to support these initiatives.3 Hospitalist competencies for ACS include protocol development that supports the timely diagnosis and treatment of ACS, evaluation of resource utilization, staff education of secondary prevention measures, and implementation of measures to ensure institutional compliance with national quality standards (Table 1).2 Most hospital medicine groups will be expected to contribute to systems improvement, an area where hospitalists have already shown leadership for QI protocols related to glycemic control and venous thromboembolism prophylaxis. Hospitalists were prominent in targeting QI in these areas even though these QI initiatives could easily have been spearheaded by specialists.46

Core Hospitalist Competencies for System Organization and Improvement Relative to ACS
  • Related data were reported by the Society of Hospital Medicine.2

  • Abbreviation:ACS, acute coronary syndrome.

Lead, coordinate, or participate in:
Protocol development to rapidly identify ACS, minimizing time to intervention
Protocol development for rapid identification and transfer of patients with ACS to a facility with an appropriate level of care
Multidisciplinary initiatives, including order sets for ACS and chest pain, that promote patient safety and optimize the use of resources
Staff education initiatives on the value of smoking cessation counseling and other prevention measures
Implement or integrate:
Systems to ensure hospitalwide adherence to national standards, documenting adherence as required by certifying organizations
Outcomes research, institution‐specific laboratory policies, and hospital formulary to create indicated and cost‐effective diagnostic and management strategies for patients with ACS

QI Basics

QI at the institutional level addresses systems of care rather than individual performance, targeting both institutional performance and use of resources.3 QI is a continuous process in which practices and procedures related to patient management are regularly assessed to ascertain whether a quality gap exists. This in turn may lead to new processes, protocols, and algorithms that help the institution and clinicians meet benchmarks of quality care.

QI starts when an existing gap is recognizedthe gap between the scientific understanding of optimal care and actual patient care. The goal is to narrow or close this gap so that each patient receives optimal care. Underlying any QI initiative are 2 essential concepts. First, improvement requires systems changeany system will produce exactly what it is designed to produce. For example, if procedures are not in place to educate patients about smoking cessation while they are hospitalized, it is unlikely that the majority will routinely receive this counseling before they are discharged. Second, less is moreproductivity is not destroyed but often is enhanced by initiating simple and practical change. If a patient arrives in the emergency department (ED) with chest pain, instituting an order set that reminds clinicians to start antiplatelet therapy or a beta blocker can lessen the chance that these medications will be overlooked, especially when the patient transitions between providers or services within the hospital.

SHM has identified 7 essential elements of any QI initiative, and these are applicable to the care of the ACS patient (Table 2).7 These elements highlight the need for institutional support and teamwork that support standardized measures and tools specific to issues in ACS management. These issues include: (1) rapidly identifying a patient with ACS and initiating a care plan when the patient is admitted; (2) encouraging good communication between providers; (3) symptom management; (4) medication safety, polypharmacy, and medication reconciliation; (5) patient and caregiver education; (6) safe discharge and transitions in care; and (7) meeting Centers for Medicare and Medicaid Services (CMS) core measures.

Essential Elements of a Quality Initiative for ACS
  • Related data were reported by the Society of Hospital Medicine Acute Coronary Syndrome Advisory Board.7

  • Abbreviations: ACS, acute coronary syndrome; CMS, Centers for Medicare and Medicaid Services; PQRI, Physician Quality Reporting Initiative.

Institutional support Commitment of time, personnel, and tools to support the initiative
Multidisciplinary team Team that focuses on quality of care for patients with ACS
Reliable metrics Reflect CMS core and applicable PQRI measures; also reportable to inform team decision making
Identify the goal Establish a measurable, achievable goal with an established timeline
Standard order sets Defined clinical pathways that support evidence‐based treatment strategies, risk stratification, and safe transitions in care
Policies that support algorithms and protocols Institution‐specific to support order sets
Education programs Targeted to clinicians and patients; should cover items addressed in order sets, algorithms, and protocols

Tools such as process flow mapping and run charts can reveal quality gaps and indicate if process improvements are leading to stated objectives. Process flow mapping makes it possible to identify and visualize quality gaps that might otherwise be hidden and to identify their source or cause. Process mapping documents discrete steps within the flow and usually requires input from multiple disciplines; this information can guide a multidisciplinary QI team when formulating interventions for process improvement.7 Figure 1 shows process flow mapping for the early identification of ST‐segment elevation myocardial infarction (STEMI) when hospitalists have open access to activate the catheterization laboratory (cath lab). The time from door‐to‐balloon is a critical factor in reducing STEMI‐related morbidity8; processes that overcome delays to percutaneous coronary intervention (PCI) and improve communication can have a direct benefit on patient outcomes.

Figure 1
Simplified process flow mapping for identifying STEMI and reducing door‐to‐balloon time. STEMI, ST‐segment elevation myocardial infarction; ECG, electrocardiogram; ED, emergency department; PCI, percutaneous coronary intervention.

A run chart is a commonly used tool which graphically depicts progress in attaining a goal over time, before and after an intervention. Figure 2a is a run chart that shows the average time to PCI following implementation of an order set designed to support the use of a risk stratification tool for the early diagnosis of STEMI. In this case, the average time to PCI is observed to decrease over time, but still lags behind the desired goal of less than 90 minutes. This run chart indicates that further work is needed to improve the process of identifying patients with STEMI. Figure 2b shows the number of eligible STEMI patients who received aspirin at discharge following implementation of a discharge order set; here, the hospital has clearly made progress toward meeting this CMS core measure.

Figure 2
A: Sample run chart documenting number of patients with STEMI having time to PCI >90 minutes. B: Sample process control chart for project monitoring successful acetylsalicylic acid (ASA) at hospital discharge. UCL, upper confidence level; LCL, lower confidence level. ASA, aspirin; PCI, percutaneous coronary intervention; STEMI, ST‐segment elevation myocardial infarction.

The following is a case study that illustrates how the implementation of standardized measures and tools can help hospitalists and other clinicians achieve quality measures in the care of a patient with ACS.

Case Study

Mary, a 68‐year‐old woman, presents to the ED with fatigue and some heartburn. She has a history of hypertension and may have had a mini stroke a few years ago. Her symptoms, which she has had on and off for the past few days, worsened considerably right before her arrival. She has been taking chewable antacids but is unsure if they have helped. Her physical exam is unremarkable. A stat electrocardiogram (ECG) shows inferior ST (part of an electrocardiogram between the QRS complex and the T wave) elevation in leads II and III, and augmented vector foot (aVF). Troponins are positive. This case can be approached from 2 perspectives.

Scenario 1

Mary arrives at a hospital that has few standardized systems or protocols for triage and transitions in care. The triage nurse recognizes the need for and obtains an ECG, but fails to alert the ED physician. When the ED physician eventually sees the patient and reviews the ECG, she immediately administers nitroglycerin and pages the cardiologist on call and the hospitalist. The hospitalist arrives first and recognizes the STEMI, but hesitates to start unfractionated or low molecular weight heparin until the cardiologist determines whether the patient will undergo PCI. The cardiologist orders PCI, the cath lab is alerted, and the patient is started on the appropriate medications; the patient does not start an aspirin until after PCI. In this scenario, several short delays amount to a significant delay of about 2 hours before the patient reaches the cath lab. In addition, although aspirin is given on day 1, it is not done on arrival. Following PCI, the patient is transferred to the coronary care unit (CCU).

Scenario 2

Mary arrives at an institution with well‐defined, institution‐specific protocols for triage and transitions in care. The triage nurse recognizes the need for and obtains an ECG; the results are immediately reviewed with the ED physician. STEMI is diagnosed and the cath lab protocol is activated; the patient receives aspirin as part of a standing order. The hospitalist meets the patient in the ED within 5 minutes and begins the protocol for unfractionated heparin and preparation for immediate PCI, allowing the ED physician to return to ED care. Simultaneously, the interventional cardiologist and cath lab are mobilized and the patient is transferred within 15 minutes. Additional appropriate medications are begun. The door‐to‐balloon time is 60 minutes, well within recommended timeframes. Following PCI, the patient is transferred to the CCU.

Measuring Performance Relative to ACS

Two agencies promulgating quality measures for hospital inpatient care are The Joint Commission (TJC) and the CMS. TJC and CMS jointly established core measures for patients with acute myocardial infarction (AMI) and these are considered key indicators of quality, evidence‐based care. As outlined in Table 3, the TJC/CMS recommendations promote, unless contraindicated, a minimum standard of care for patients with AMI.9, 10 Public reporting of institutional core measure performance has led to an intense focus on improving these metrics.

TJC/CMS Core Measures and Metrics for Acute MI
Core Measure Sample Metric
  • NOTE: All medications given unless contraindicated.

  • Related data were reported by The Joint Commission and Centers for Medicare and Medicare Services.9, 10

  • Abbreviations: ACE, angiotensin converting enzyme; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVSD, left ventricular systolic dysfunction; PCI, percutaneous coronary intervention.

Aspirin at arrival Percentage of patients receiving aspirin within 24 hours before or after hospital arrival
Aspirin at discharge Percentage of patients prescribed aspirin at hospital discharge
ACE inhibitor or ARB for LVSD Percentage of patients with LVSD prescribed an ACEI or ARB at hospital discharge
Beta blocker Percentage of patients prescribed a beta blocker at hospital discharge
Fibrinolytic medication given within 30 minutes of hospital arrival Median time to fibrinolysis
Percentage of patients given fibrinolytic medication within 30 minutes of hospital arrival
PCI received within 90 minutes of hospital arrival Median time to PCI
Percentage of patients receiving primary PCI within 90 minutes of hospital arrival
Smoking cessation counseling Percentage of patients with a history of smoking cigarettes who are counseled about smoking cessation during hospitalization

On a national level, TJC documented performance improvement from 2002 to 2008 for each of the core measures. Compliance with smoking cessation counseling improved the most, rising from 67% to almost 99%. In 2008, a combined measure of all individual core measures indicated that, overall, care of heart attack patients is of high quality. Hospitals delivered evidenced‐based care in 96.7% of the opportunities they had to provide this care. Compliance related to oral medications was also good (95%); however, a closer look at other individual measures shows that improvement is needed to reduce the time to fibrinolysis (52.4% compliance rate for 30 minutes or less) and time to primary PCI (81.6% compliance rate for 90 minutes or less).11

Financial incentives are tied to QI measures including those from CMS. At present, this system is in the pay‐for‐reporting phase, in which institutions are penalized for not reporting quality metrics for the CMS core measures. It is likely that, to further incentivize institutions to meet quality benchmarks, this will be expanded to a pay‐for‐performance system (eg, differential payments for readmissions or different payment scales based on prior performance). Public disclosure of institutional performance relative to ACS and other medical conditions is available through the HHS.gov website (www.hospitalcompare.hhs.gov), which compares performance between hospitals and provides a clear business motivation for institutions to improve and provide high quality care.

Two other reporting systems should be noted. The CMS Physician Quality Reporting Initiative (PQRI) includes physician‐related quality measures specific to ACS12 that overlap with institution‐level CMS core measures with regard to prescribing ACS medications. Payments associated with the PQRI are currently a small financial factor for hospitalists, but will likely grow as quality initiatives develop overall. The Hospital Care Quality Information From the Consumer Perspective (HCAHPS) initiative, also from CMS, strives to capture patients' perspectives on hospital care through a standardized survey. The goals are to collect data that can be used to compare hospital performance, create an incentive for QI through public disclosure of results, and increase transparency regarding the quality of hospital care.13 However, the focus is not ACS‐specific. Patients are queried about communication with hospital staff, communication about medications, and information about discharge, all areas of concern for the hospitalist in general that have been identified as areas for improvement relative to ACS.

Case Study (cont)

Scenario 1 (cont)

Mary recuperates in the CCU and is transferred to the medical floor. The hospitalist and cardiologist see her separately on rounds and each assumes the other has a reason for not starting a beta blocker; therefore, a beta blocker is not prescribed. The nurse cannot tell who is in charge and does not anticipate the day of dischargeshe is just implementing the orders as they are written. The day of discharge arrives; the nurse learns from Mary that the hospitalist will discharge her that day. The hospitalist reviews the list of ACS medications and realizes that Mary still has not started a beta blocker. He cannot reach the cardiologist before Mary's ride home arrives, so he writes a note in the discharge summary alerting the primary care physician (PCP) to consider a beta blocker at follow‐up. Because of this lack of communication and systems for tracking the implementation of guideline‐recommended therapies, Mary is discharged without a CMS core measure medication, with no assurance that this will be addressed by the PCP.

Scenario 2 (cont)

Mary recuperates in the CCU and is transferred to the medical floor. Standard post‐PCI/STEMI orders are in place according to institutional protocol. The hospitalist is able to confirm that all interventions required at admission (aspirin, beta blocker, assessment of smoking status) have occurred by reviewing a well‐structured checklist that includes easy‐to‐read visual cues. The checklist indicates that Mary was counseled about smoking cessation on day 1 of her stay in the CCU. Mary and her physicians and nurses are all aware of the target discharge date and the milestones that must be met prior to discharge (eg, echocardiogram, medication review, education, assessment of mobility, etc). Mary is instructed about each new medication and given educational materials.14 Follow‐up appointments postdischarge are made, and the discharge summary is sent electronically to the PCP. These institution‐specific protocols enhance communication overall and help the hospital meet high standards of patient care.

Special QI Issues in ACS Management for the Hospitalist

Coordination is especially important for patients with ACS because their care is so complex. Seamless transitions promote safe care as the patient moves from the ED, cath lab, recovery unit, medical floor, and discharge through the transition to primary care. Poor communication between clinicians during these transitions may result in delayed or overlooked treatment and other medical errors. Implementing an institutional system of care may overcome communication barriers and help ensure the institution meets its quality benchmarks, such as the CMS core measures. Standard order sets and protocols identify the steps and components needed to manage ACS. At admission, these measures promote early assessment of patient risk, triage to early intervention, medication reconciliation, and communication between stakeholders such as the hospitalist, cardiologist, and the cath lab.15, 16 During hospitalization, they help assure ongoing risk assessment and early consideration of discharge planning, culminating in discharge and the transition back to primary care.

A recent guideline update8 focused attention on the coordination of care between institutions and the critical importance of rapid triage for patients who need primary PCI and transfer from a non‐PCI to a PCI‐capable institution. The decision to transfer rests on multiple factors and requires rapid decision making on the part of clinicians. Time to reperfusion is shown to have a direct effect on patient outcomes. Established protocols within a non‐PCI facility can support timely transfer to a PCI‐capable facility if indicated. Factors such as the patient's mortality risk, the risk of bleeding from fibrinolytic therapy, duration of symptoms, and the time for transport to a PCI facility all must be considered. It is recognized that a regional system of STEMI care best supports collaborative efforts between institutions and community resources that support QI efforts.

Transitions in care, and particularly discharge, are areas with identified gaps in quality care17, 18 for which improvement has been pursued on an institutional level. Project BOOST (Better Outcomes for Older Adults Through Safe Transitions) seeks to improve the care of patients during the transition from inpatient to outpatient care, and focuses on elderly patients identified to be at high‐risk for adverse events during this transition.19 The goal is to improve outcomes related to 30‐day readmission rates, patient satisfaction, communication between inpatient and outpatient providers, identification of high‐risk patients who need intervention to reduce risk, and patient education about their risk for an adverse event. BOOST addresses these outcomes at an institutional level by offering resources related to project management, data collection, tools for clinicians and patients, and participating mentor institutions. These resources help an institution assess its readiness for change, identify quality gaps, promote teamwork, and guide the implementation and subsequent evaluation of process improvements. Specific tools for clinicians also support institutional goals for teamwork and communication, creating an environment for safe transitions. Both BOOST19 and the adaptable Transitions Tool from the SHM20 provide a framework for understanding processes that involve multiple departments and stakeholders, breaking complex processes into discrete parts for which quality gaps can be identified and change instituted to improve care. A checklist can also be a useful tool for ensuring specific issues are addressed during transitions in care. SHM developed a checklist for hospitalist use that lists elements of a discharge summary for patients with ACS (Table 4).21

Discharge Summary Checklist
  • Related data were reported by Halasyamani et al.17

  • Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; ECG, electrocardiogram; ECHO, echocardiogram; ETT, exercise tolerance test; INR, international normalized ratio; LDL, low‐density lipoprotein; LFTs, liver function tests; MI, myocardial infarction; NTG, nitroglycerin.

Diagnoses Elaborate on details of MI such as location, complications
Comorbidities List, including diabetes, lipids, hypertension, renal disease
Medications Note medication reconciliation, reason for not prescribing core measure medications, titration of any medications
Specific medications to address include ACE/ARB inhibitors, aspirin, beta blockers, statin, sublingual NTG, clopidogrel (include duration of therapy)
Procedures Type of stent (bare‐metal stent, drug‐eluting stent) and stent location
Complications (hematoma, transfusion)
If ECHO, note type, ejection fraction; provide copy of ECG
Follow‐up appointment(s) Primary care, cardiology, others such as cardiac rehabilitation
Follow‐up testing ETT (type, timeframe); ECHO if indicated; laboratory assessments
Code status
Activity
Diet
Wound care (eg, groin)
Treatment course Address cognitive level, discharge LDL, discharge creatinine, INR if on warfarin, LFTs if on statin
Copy all providers

Staff and patient education is also an area that can benefit from evaluation. Clinicians from multiple disciplines are stakeholders in QI and they should receive education about its purpose and goals. Usually institutions will have a QI methodology in place, and this should be conveyed to the members of the ACS team. Staff education about ACS should be tailored to each specialty, be institution‐specific, current, and comprehensive, and include methods for assessing the learner. Education should be easily available (eg, on the Internet or via an electronic format), interactive, case‐based, and mandatory. For patients, education should be available in languages other than English and identify community resources and opportunities for additional outpatient education. The value of any educational program should be assessed to measure learner participation, satisfaction, and comprehension.

Gathering metrics and generating objective evidence of change is critical to QI; quantifying improvement (or lack thereof) must be done to determine whether the changes implemented improve care and ultimately whether desired outcomes are met. Metrics should be meaningful, associated with standards of care (eg, CMS core measures), and carefully chosen to reflect current practice. CMS core measures are a good target for collecting metrics to assess an institution's performance relative to ACS (Table 3). The Specifications Manual for National and Hospital Inpatient Quality Measures10 from TJC and CMS identifies the data elements needed for reporting. Other metrics not specified as core measures are worthy of measurement because they are considered the standard of care for patients with ACS (Table 5). The metrics shown in Tables 3 and 5 assume that all patients are eligible for core‐measure or standard‐of‐care medications and procedures. Because some measures are contraindicated in some patients, it is more meaningful to measure the percentage of patients without a contraindication who receive the measure. If a measure is contraindicated, the patient's medical record must include supporting documentation indicating why a core measure was not met. To be objective and reduce bias regarding the effectiveness of QI measures, data collection is best done prospectively. If necessary, periodic assessments against performance measures (institutional, government, professional association) should be made to support timely intervention. Run charts can be particularly useful here, measuring change over time to identify trends or an intervention that supported, did not affect, or was a barrier to the desired change.

Case Study (cont)

Scenario 1 (cont)

Mary tells the hospitalist she felt the discharge process was rushed and confusing and that she was dissatisfied with her care overall. Recalling a recent review article on the process for public disclosure of patient ratings related to hospital stay, the hospitalist locates HospitalCompare.com on the Internet. He reviews results from patient satisfaction surveys that compare his institution with others in the geographic area and is surprised to discover that patients generally give his institution a poor rating as well as low marks for the quality of nursing and physicianpatient communication. He is interested in this information but is not aware of resources for further exploration.

Scenario 2 (cont)

At discharge, the hospitalist confirms with Mary that she has received smoking cessation counseling during her hospital stay; he documents this in her chart and discharge summary. The hospitalist was aware of this particular quality measure because the recent weekly score card of hospital performance, posted in the unit, reported that the hospital was not meeting its goal of 100% compliance for this CMS core measure. Among heart attack patients who were identified as smokers, only 80% of charts documented that the patient had been counseled about smoking cessation during the hospital stay. Mary says that she understands the importance of not smoking and says she will make an effort to stop.

Standard of Care Measures and Metrics for ACS
Standard of Care Measure Sample Metric
  • Abbreviations: ACS, acute coronary syndrome; LDL, low‐density lipoprotein; LVEF, left ventricular ejection fraction; PCP, primary care provider.

LDL‐cholesterol assessment Percentage of patients who have LDL cholesterol measured during hospitalization
Lipid‐lowering therapy at discharge Percentage of patients prescribed a statin at hospital discharge
Dietary consultation Percentage of patients who receive a dietary consult during hospitalization
Time to receipt of high‐risk abnormal laboratory assessments Median time to receipt of high‐risk laboratory results, eg, troponins
Cardiac risk assessment Percentage of patients who receive a cardiac risk assessment during admission
Measurement of LVEF Percentage of patients who receive a cardiac echocardiogram to measure of LVEF before discharge
Document communication with PCP Percentage of patients whose communication with the PCP was documented at discharge
Completed medication reconciliation Percentage of patients for whom medication reconciliation was documented by the time of discharge
Make 1‐week follow‐up appointment with PCP Percentage of patients for whom a 1‐week follow‐up appointment with the PCP was documented at the time of discharge
Additional Measure
Inpatient mortality

Conclusion

Each hospitalist can have an impact on ACS care systemwide. Hospitalists are on the front line of care and have a unique perspective on patients as they are transitioned through the hospital stay and on how an institution handles patient care overall. They experience firsthand the challenges presented by poor communication between providers, patients, and their families. They can offer breadth of experience and perspective when assessing processes linked to patient care and can be instrumental in ensuring each patient experiences safe transitions during the hospital stay. Hospitalists should participate in QI initiatives for ACS and should consider opportunities to take the lead on these initiatives within their institutions.

Acknowledgements

The author thanks Denise Erkkila, RPh for her editorial assistance in the preparation of this manuscript.

References
  1. Heisler M.Hospitalists and intensivists: partners in caring for the critically ill—the time has come.J Hosp Med.2010;5:13.
  2. Society of Hospital Medicine. Acute coronary syndrome.J Hosp Med.2006;1(suppl 1):23.
  3. Society of Hospital Medicine. Quality improvement.J Hosp Med.2006;1 (suppl):92.
  4. McKean S,Stein J,Maynard G, et al.Curriculum development: the venous thromboembolism quality improvement resource room.J Hosp Med.2006;1:124132.
  5. Schnipper JL,Magee M,Larsen K,Inzucchi SE,Maynard G.Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts.J Hosp Med.2008;3:6675.
  6. Schnipper JL,Ndumele CD,Liang CL,Pendergrass ML.Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial.J Hosp Med.2009;4:1627.
  7. SHM Acute Coronary Syndrome Advisory Board. A guide for effective quality improvement: improving acute coronary syndrome care for hospitalized patients. Available at: http://www.hospitalmedicine.org. 2010. Accessed July 2010.
  8. Kushner FG,Hand M,Smith SC, et al.2009focused updates: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol.year="2009"2009;54:22052241.
  9. The Joint Commission. Performance measure intiatives. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Acute+Myocardial+Infarction+Core+Measure+Set.htm. 2010. Accessed July 2010.
  10. The Joint Commission, Centers for Medicare and Medicare Services. Specifications manual for national hospital inpatient quality measures, version 2.5. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Current+NHQM+Manual.htm. 2009 November 6. Accessed July 2010.
  11. The Joint Commission. Improving America's hospitals: The Joint Commission's annual report on quality and safety 2009. Available at: http://www.jointcommission.org/Library/annual_report.2009. Accessed July 2010.
  12. Centers for Medicare and Medicare Services. Physician quality reporting initiative (PQRI). Available at: http://www.cms.hhs.gov/pqri. 2010. Accessed July 2010.
  13. Hospital Care Quality Information from the Consumer Perspective. CAHPS hospital survey. Available at: http://www.hcahpsonline.org. 2010. Accessed July 2010.
  14. Koelling TM,Johnson ML,Cody RJ,Aronson KD.Discharge education improves clinical outcomes in patients with chronic heart failure.Circulation.2005;111:179185.
  15. Bradley EH,Nallamothu BK,Herrin J, et al.National efforts to improve door‐to‐balloon time results from the Door‐to‐Balloon Alliance.J Am Coll Cardiol.2009;54:24232429.
  16. Nestler DM,Noheria A,Haro LH, et al.Sustaining improvement in door‐to‐balloon time over 4 years: the Mayo clinic ST‐elevation myocardial infarction protocol.Circ Cardiovasc Qual Outcomes.2009;2:508513.
  17. Kripalani S,Jackson AT,Schnipper JL,Coleman EA.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2:314323.
  18. Coleman EA,Berenson RA.Lost in transition: challenges and opportunities for improving the quality of transitional care.Ann Intern Med.2004;141:533536.
  19. Society of Hospital Medicine. Boosting Care Transitions Resource Room. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/RR_CareTransitions/CT_Home.cfm. 2010. Accessed July 2010.
  20. SHM ACS Transitions Workgroup. SHM ACS Transitions Tool. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/RR_ACS/html_ACS/12ClinicalTools/05_Transitions.cfm. 2010. Accessed July 2010.
  21. Halasyamani L,Kripalani S,Coleman E, et al.Transition of care for hospitalized elderly patients‐‐development of a discharge checklist for hospitalists.J Hosp Med.2006;1:354360.
Article PDF
Issue
Journal of Hospital Medicine - 5(4)
Page Number
S1-S7
Legacy Keywords
ACS, acute coronary syndrome, quality improvement
Sections
Article PDF
Article PDF

Addressing quality improvement (QI) for the management of acute coronary syndrome (ACS) at the institutional level is essential for supporting hospitalists and other clinicians as they manage patients with ACS and achieve desired institutional outcomes. This systems approach may identify institution‐specific barriers to quality care, including those that affect the complex management of ACS. Having a firsthand view of patient care puts the hospitalist in a good position to assess the viability of existing processes and protocols that support care. Indeed, the hospitalist has a vested interest in improving systems of care as these systems directly affect the hospitalist's practice. This unique perspective gives the hospitalist an opportunity to facilitate systems change within the institution and to become an integral participant or leader in QI initiatives.

An increasing number of hospitalists are providing critical care at secondary and tertiary care facilities, driven by a shortage of intensivists in the United States. In a 20052006 survey about 75% of hospitalists reported they provide critical care services as part of their practice,1 and this would include care of patients with ACS. The Society of Hospital Medicine (SHM) has developed core competencies that recognize the important role of hospitalists in leading or participating in QI teams for ACS.2 Hospitalists must also be able to apply evidenced‐based outcomes data to support these initiatives.3 Hospitalist competencies for ACS include protocol development that supports the timely diagnosis and treatment of ACS, evaluation of resource utilization, staff education of secondary prevention measures, and implementation of measures to ensure institutional compliance with national quality standards (Table 1).2 Most hospital medicine groups will be expected to contribute to systems improvement, an area where hospitalists have already shown leadership for QI protocols related to glycemic control and venous thromboembolism prophylaxis. Hospitalists were prominent in targeting QI in these areas even though these QI initiatives could easily have been spearheaded by specialists.46

Core Hospitalist Competencies for System Organization and Improvement Relative to ACS
  • Related data were reported by the Society of Hospital Medicine.2

  • Abbreviation:ACS, acute coronary syndrome.

Lead, coordinate, or participate in:
Protocol development to rapidly identify ACS, minimizing time to intervention
Protocol development for rapid identification and transfer of patients with ACS to a facility with an appropriate level of care
Multidisciplinary initiatives, including order sets for ACS and chest pain, that promote patient safety and optimize the use of resources
Staff education initiatives on the value of smoking cessation counseling and other prevention measures
Implement or integrate:
Systems to ensure hospitalwide adherence to national standards, documenting adherence as required by certifying organizations
Outcomes research, institution‐specific laboratory policies, and hospital formulary to create indicated and cost‐effective diagnostic and management strategies for patients with ACS

QI Basics

QI at the institutional level addresses systems of care rather than individual performance, targeting both institutional performance and use of resources.3 QI is a continuous process in which practices and procedures related to patient management are regularly assessed to ascertain whether a quality gap exists. This in turn may lead to new processes, protocols, and algorithms that help the institution and clinicians meet benchmarks of quality care.

QI starts when an existing gap is recognizedthe gap between the scientific understanding of optimal care and actual patient care. The goal is to narrow or close this gap so that each patient receives optimal care. Underlying any QI initiative are 2 essential concepts. First, improvement requires systems changeany system will produce exactly what it is designed to produce. For example, if procedures are not in place to educate patients about smoking cessation while they are hospitalized, it is unlikely that the majority will routinely receive this counseling before they are discharged. Second, less is moreproductivity is not destroyed but often is enhanced by initiating simple and practical change. If a patient arrives in the emergency department (ED) with chest pain, instituting an order set that reminds clinicians to start antiplatelet therapy or a beta blocker can lessen the chance that these medications will be overlooked, especially when the patient transitions between providers or services within the hospital.

SHM has identified 7 essential elements of any QI initiative, and these are applicable to the care of the ACS patient (Table 2).7 These elements highlight the need for institutional support and teamwork that support standardized measures and tools specific to issues in ACS management. These issues include: (1) rapidly identifying a patient with ACS and initiating a care plan when the patient is admitted; (2) encouraging good communication between providers; (3) symptom management; (4) medication safety, polypharmacy, and medication reconciliation; (5) patient and caregiver education; (6) safe discharge and transitions in care; and (7) meeting Centers for Medicare and Medicaid Services (CMS) core measures.

Essential Elements of a Quality Initiative for ACS
  • Related data were reported by the Society of Hospital Medicine Acute Coronary Syndrome Advisory Board.7

  • Abbreviations: ACS, acute coronary syndrome; CMS, Centers for Medicare and Medicaid Services; PQRI, Physician Quality Reporting Initiative.

Institutional support Commitment of time, personnel, and tools to support the initiative
Multidisciplinary team Team that focuses on quality of care for patients with ACS
Reliable metrics Reflect CMS core and applicable PQRI measures; also reportable to inform team decision making
Identify the goal Establish a measurable, achievable goal with an established timeline
Standard order sets Defined clinical pathways that support evidence‐based treatment strategies, risk stratification, and safe transitions in care
Policies that support algorithms and protocols Institution‐specific to support order sets
Education programs Targeted to clinicians and patients; should cover items addressed in order sets, algorithms, and protocols

Tools such as process flow mapping and run charts can reveal quality gaps and indicate if process improvements are leading to stated objectives. Process flow mapping makes it possible to identify and visualize quality gaps that might otherwise be hidden and to identify their source or cause. Process mapping documents discrete steps within the flow and usually requires input from multiple disciplines; this information can guide a multidisciplinary QI team when formulating interventions for process improvement.7 Figure 1 shows process flow mapping for the early identification of ST‐segment elevation myocardial infarction (STEMI) when hospitalists have open access to activate the catheterization laboratory (cath lab). The time from door‐to‐balloon is a critical factor in reducing STEMI‐related morbidity8; processes that overcome delays to percutaneous coronary intervention (PCI) and improve communication can have a direct benefit on patient outcomes.

Figure 1
Simplified process flow mapping for identifying STEMI and reducing door‐to‐balloon time. STEMI, ST‐segment elevation myocardial infarction; ECG, electrocardiogram; ED, emergency department; PCI, percutaneous coronary intervention.

A run chart is a commonly used tool which graphically depicts progress in attaining a goal over time, before and after an intervention. Figure 2a is a run chart that shows the average time to PCI following implementation of an order set designed to support the use of a risk stratification tool for the early diagnosis of STEMI. In this case, the average time to PCI is observed to decrease over time, but still lags behind the desired goal of less than 90 minutes. This run chart indicates that further work is needed to improve the process of identifying patients with STEMI. Figure 2b shows the number of eligible STEMI patients who received aspirin at discharge following implementation of a discharge order set; here, the hospital has clearly made progress toward meeting this CMS core measure.

Figure 2
A: Sample run chart documenting number of patients with STEMI having time to PCI >90 minutes. B: Sample process control chart for project monitoring successful acetylsalicylic acid (ASA) at hospital discharge. UCL, upper confidence level; LCL, lower confidence level. ASA, aspirin; PCI, percutaneous coronary intervention; STEMI, ST‐segment elevation myocardial infarction.

The following is a case study that illustrates how the implementation of standardized measures and tools can help hospitalists and other clinicians achieve quality measures in the care of a patient with ACS.

Case Study

Mary, a 68‐year‐old woman, presents to the ED with fatigue and some heartburn. She has a history of hypertension and may have had a mini stroke a few years ago. Her symptoms, which she has had on and off for the past few days, worsened considerably right before her arrival. She has been taking chewable antacids but is unsure if they have helped. Her physical exam is unremarkable. A stat electrocardiogram (ECG) shows inferior ST (part of an electrocardiogram between the QRS complex and the T wave) elevation in leads II and III, and augmented vector foot (aVF). Troponins are positive. This case can be approached from 2 perspectives.

Scenario 1

Mary arrives at a hospital that has few standardized systems or protocols for triage and transitions in care. The triage nurse recognizes the need for and obtains an ECG, but fails to alert the ED physician. When the ED physician eventually sees the patient and reviews the ECG, she immediately administers nitroglycerin and pages the cardiologist on call and the hospitalist. The hospitalist arrives first and recognizes the STEMI, but hesitates to start unfractionated or low molecular weight heparin until the cardiologist determines whether the patient will undergo PCI. The cardiologist orders PCI, the cath lab is alerted, and the patient is started on the appropriate medications; the patient does not start an aspirin until after PCI. In this scenario, several short delays amount to a significant delay of about 2 hours before the patient reaches the cath lab. In addition, although aspirin is given on day 1, it is not done on arrival. Following PCI, the patient is transferred to the coronary care unit (CCU).

Scenario 2

Mary arrives at an institution with well‐defined, institution‐specific protocols for triage and transitions in care. The triage nurse recognizes the need for and obtains an ECG; the results are immediately reviewed with the ED physician. STEMI is diagnosed and the cath lab protocol is activated; the patient receives aspirin as part of a standing order. The hospitalist meets the patient in the ED within 5 minutes and begins the protocol for unfractionated heparin and preparation for immediate PCI, allowing the ED physician to return to ED care. Simultaneously, the interventional cardiologist and cath lab are mobilized and the patient is transferred within 15 minutes. Additional appropriate medications are begun. The door‐to‐balloon time is 60 minutes, well within recommended timeframes. Following PCI, the patient is transferred to the CCU.

Measuring Performance Relative to ACS

Two agencies promulgating quality measures for hospital inpatient care are The Joint Commission (TJC) and the CMS. TJC and CMS jointly established core measures for patients with acute myocardial infarction (AMI) and these are considered key indicators of quality, evidence‐based care. As outlined in Table 3, the TJC/CMS recommendations promote, unless contraindicated, a minimum standard of care for patients with AMI.9, 10 Public reporting of institutional core measure performance has led to an intense focus on improving these metrics.

TJC/CMS Core Measures and Metrics for Acute MI
Core Measure Sample Metric
  • NOTE: All medications given unless contraindicated.

  • Related data were reported by The Joint Commission and Centers for Medicare and Medicare Services.9, 10

  • Abbreviations: ACE, angiotensin converting enzyme; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVSD, left ventricular systolic dysfunction; PCI, percutaneous coronary intervention.

Aspirin at arrival Percentage of patients receiving aspirin within 24 hours before or after hospital arrival
Aspirin at discharge Percentage of patients prescribed aspirin at hospital discharge
ACE inhibitor or ARB for LVSD Percentage of patients with LVSD prescribed an ACEI or ARB at hospital discharge
Beta blocker Percentage of patients prescribed a beta blocker at hospital discharge
Fibrinolytic medication given within 30 minutes of hospital arrival Median time to fibrinolysis
Percentage of patients given fibrinolytic medication within 30 minutes of hospital arrival
PCI received within 90 minutes of hospital arrival Median time to PCI
Percentage of patients receiving primary PCI within 90 minutes of hospital arrival
Smoking cessation counseling Percentage of patients with a history of smoking cigarettes who are counseled about smoking cessation during hospitalization

On a national level, TJC documented performance improvement from 2002 to 2008 for each of the core measures. Compliance with smoking cessation counseling improved the most, rising from 67% to almost 99%. In 2008, a combined measure of all individual core measures indicated that, overall, care of heart attack patients is of high quality. Hospitals delivered evidenced‐based care in 96.7% of the opportunities they had to provide this care. Compliance related to oral medications was also good (95%); however, a closer look at other individual measures shows that improvement is needed to reduce the time to fibrinolysis (52.4% compliance rate for 30 minutes or less) and time to primary PCI (81.6% compliance rate for 90 minutes or less).11

Financial incentives are tied to QI measures including those from CMS. At present, this system is in the pay‐for‐reporting phase, in which institutions are penalized for not reporting quality metrics for the CMS core measures. It is likely that, to further incentivize institutions to meet quality benchmarks, this will be expanded to a pay‐for‐performance system (eg, differential payments for readmissions or different payment scales based on prior performance). Public disclosure of institutional performance relative to ACS and other medical conditions is available through the HHS.gov website (www.hospitalcompare.hhs.gov), which compares performance between hospitals and provides a clear business motivation for institutions to improve and provide high quality care.

Two other reporting systems should be noted. The CMS Physician Quality Reporting Initiative (PQRI) includes physician‐related quality measures specific to ACS12 that overlap with institution‐level CMS core measures with regard to prescribing ACS medications. Payments associated with the PQRI are currently a small financial factor for hospitalists, but will likely grow as quality initiatives develop overall. The Hospital Care Quality Information From the Consumer Perspective (HCAHPS) initiative, also from CMS, strives to capture patients' perspectives on hospital care through a standardized survey. The goals are to collect data that can be used to compare hospital performance, create an incentive for QI through public disclosure of results, and increase transparency regarding the quality of hospital care.13 However, the focus is not ACS‐specific. Patients are queried about communication with hospital staff, communication about medications, and information about discharge, all areas of concern for the hospitalist in general that have been identified as areas for improvement relative to ACS.

Case Study (cont)

Scenario 1 (cont)

Mary recuperates in the CCU and is transferred to the medical floor. The hospitalist and cardiologist see her separately on rounds and each assumes the other has a reason for not starting a beta blocker; therefore, a beta blocker is not prescribed. The nurse cannot tell who is in charge and does not anticipate the day of dischargeshe is just implementing the orders as they are written. The day of discharge arrives; the nurse learns from Mary that the hospitalist will discharge her that day. The hospitalist reviews the list of ACS medications and realizes that Mary still has not started a beta blocker. He cannot reach the cardiologist before Mary's ride home arrives, so he writes a note in the discharge summary alerting the primary care physician (PCP) to consider a beta blocker at follow‐up. Because of this lack of communication and systems for tracking the implementation of guideline‐recommended therapies, Mary is discharged without a CMS core measure medication, with no assurance that this will be addressed by the PCP.

Scenario 2 (cont)

Mary recuperates in the CCU and is transferred to the medical floor. Standard post‐PCI/STEMI orders are in place according to institutional protocol. The hospitalist is able to confirm that all interventions required at admission (aspirin, beta blocker, assessment of smoking status) have occurred by reviewing a well‐structured checklist that includes easy‐to‐read visual cues. The checklist indicates that Mary was counseled about smoking cessation on day 1 of her stay in the CCU. Mary and her physicians and nurses are all aware of the target discharge date and the milestones that must be met prior to discharge (eg, echocardiogram, medication review, education, assessment of mobility, etc). Mary is instructed about each new medication and given educational materials.14 Follow‐up appointments postdischarge are made, and the discharge summary is sent electronically to the PCP. These institution‐specific protocols enhance communication overall and help the hospital meet high standards of patient care.

Special QI Issues in ACS Management for the Hospitalist

Coordination is especially important for patients with ACS because their care is so complex. Seamless transitions promote safe care as the patient moves from the ED, cath lab, recovery unit, medical floor, and discharge through the transition to primary care. Poor communication between clinicians during these transitions may result in delayed or overlooked treatment and other medical errors. Implementing an institutional system of care may overcome communication barriers and help ensure the institution meets its quality benchmarks, such as the CMS core measures. Standard order sets and protocols identify the steps and components needed to manage ACS. At admission, these measures promote early assessment of patient risk, triage to early intervention, medication reconciliation, and communication between stakeholders such as the hospitalist, cardiologist, and the cath lab.15, 16 During hospitalization, they help assure ongoing risk assessment and early consideration of discharge planning, culminating in discharge and the transition back to primary care.

A recent guideline update8 focused attention on the coordination of care between institutions and the critical importance of rapid triage for patients who need primary PCI and transfer from a non‐PCI to a PCI‐capable institution. The decision to transfer rests on multiple factors and requires rapid decision making on the part of clinicians. Time to reperfusion is shown to have a direct effect on patient outcomes. Established protocols within a non‐PCI facility can support timely transfer to a PCI‐capable facility if indicated. Factors such as the patient's mortality risk, the risk of bleeding from fibrinolytic therapy, duration of symptoms, and the time for transport to a PCI facility all must be considered. It is recognized that a regional system of STEMI care best supports collaborative efforts between institutions and community resources that support QI efforts.

Transitions in care, and particularly discharge, are areas with identified gaps in quality care17, 18 for which improvement has been pursued on an institutional level. Project BOOST (Better Outcomes for Older Adults Through Safe Transitions) seeks to improve the care of patients during the transition from inpatient to outpatient care, and focuses on elderly patients identified to be at high‐risk for adverse events during this transition.19 The goal is to improve outcomes related to 30‐day readmission rates, patient satisfaction, communication between inpatient and outpatient providers, identification of high‐risk patients who need intervention to reduce risk, and patient education about their risk for an adverse event. BOOST addresses these outcomes at an institutional level by offering resources related to project management, data collection, tools for clinicians and patients, and participating mentor institutions. These resources help an institution assess its readiness for change, identify quality gaps, promote teamwork, and guide the implementation and subsequent evaluation of process improvements. Specific tools for clinicians also support institutional goals for teamwork and communication, creating an environment for safe transitions. Both BOOST19 and the adaptable Transitions Tool from the SHM20 provide a framework for understanding processes that involve multiple departments and stakeholders, breaking complex processes into discrete parts for which quality gaps can be identified and change instituted to improve care. A checklist can also be a useful tool for ensuring specific issues are addressed during transitions in care. SHM developed a checklist for hospitalist use that lists elements of a discharge summary for patients with ACS (Table 4).21

Discharge Summary Checklist
  • Related data were reported by Halasyamani et al.17

  • Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; ECG, electrocardiogram; ECHO, echocardiogram; ETT, exercise tolerance test; INR, international normalized ratio; LDL, low‐density lipoprotein; LFTs, liver function tests; MI, myocardial infarction; NTG, nitroglycerin.

Diagnoses Elaborate on details of MI such as location, complications
Comorbidities List, including diabetes, lipids, hypertension, renal disease
Medications Note medication reconciliation, reason for not prescribing core measure medications, titration of any medications
Specific medications to address include ACE/ARB inhibitors, aspirin, beta blockers, statin, sublingual NTG, clopidogrel (include duration of therapy)
Procedures Type of stent (bare‐metal stent, drug‐eluting stent) and stent location
Complications (hematoma, transfusion)
If ECHO, note type, ejection fraction; provide copy of ECG
Follow‐up appointment(s) Primary care, cardiology, others such as cardiac rehabilitation
Follow‐up testing ETT (type, timeframe); ECHO if indicated; laboratory assessments
Code status
Activity
Diet
Wound care (eg, groin)
Treatment course Address cognitive level, discharge LDL, discharge creatinine, INR if on warfarin, LFTs if on statin
Copy all providers

Staff and patient education is also an area that can benefit from evaluation. Clinicians from multiple disciplines are stakeholders in QI and they should receive education about its purpose and goals. Usually institutions will have a QI methodology in place, and this should be conveyed to the members of the ACS team. Staff education about ACS should be tailored to each specialty, be institution‐specific, current, and comprehensive, and include methods for assessing the learner. Education should be easily available (eg, on the Internet or via an electronic format), interactive, case‐based, and mandatory. For patients, education should be available in languages other than English and identify community resources and opportunities for additional outpatient education. The value of any educational program should be assessed to measure learner participation, satisfaction, and comprehension.

Gathering metrics and generating objective evidence of change is critical to QI; quantifying improvement (or lack thereof) must be done to determine whether the changes implemented improve care and ultimately whether desired outcomes are met. Metrics should be meaningful, associated with standards of care (eg, CMS core measures), and carefully chosen to reflect current practice. CMS core measures are a good target for collecting metrics to assess an institution's performance relative to ACS (Table 3). The Specifications Manual for National and Hospital Inpatient Quality Measures10 from TJC and CMS identifies the data elements needed for reporting. Other metrics not specified as core measures are worthy of measurement because they are considered the standard of care for patients with ACS (Table 5). The metrics shown in Tables 3 and 5 assume that all patients are eligible for core‐measure or standard‐of‐care medications and procedures. Because some measures are contraindicated in some patients, it is more meaningful to measure the percentage of patients without a contraindication who receive the measure. If a measure is contraindicated, the patient's medical record must include supporting documentation indicating why a core measure was not met. To be objective and reduce bias regarding the effectiveness of QI measures, data collection is best done prospectively. If necessary, periodic assessments against performance measures (institutional, government, professional association) should be made to support timely intervention. Run charts can be particularly useful here, measuring change over time to identify trends or an intervention that supported, did not affect, or was a barrier to the desired change.

Case Study (cont)

Scenario 1 (cont)

Mary tells the hospitalist she felt the discharge process was rushed and confusing and that she was dissatisfied with her care overall. Recalling a recent review article on the process for public disclosure of patient ratings related to hospital stay, the hospitalist locates HospitalCompare.com on the Internet. He reviews results from patient satisfaction surveys that compare his institution with others in the geographic area and is surprised to discover that patients generally give his institution a poor rating as well as low marks for the quality of nursing and physicianpatient communication. He is interested in this information but is not aware of resources for further exploration.

Scenario 2 (cont)

At discharge, the hospitalist confirms with Mary that she has received smoking cessation counseling during her hospital stay; he documents this in her chart and discharge summary. The hospitalist was aware of this particular quality measure because the recent weekly score card of hospital performance, posted in the unit, reported that the hospital was not meeting its goal of 100% compliance for this CMS core measure. Among heart attack patients who were identified as smokers, only 80% of charts documented that the patient had been counseled about smoking cessation during the hospital stay. Mary says that she understands the importance of not smoking and says she will make an effort to stop.

Standard of Care Measures and Metrics for ACS
Standard of Care Measure Sample Metric
  • Abbreviations: ACS, acute coronary syndrome; LDL, low‐density lipoprotein; LVEF, left ventricular ejection fraction; PCP, primary care provider.

LDL‐cholesterol assessment Percentage of patients who have LDL cholesterol measured during hospitalization
Lipid‐lowering therapy at discharge Percentage of patients prescribed a statin at hospital discharge
Dietary consultation Percentage of patients who receive a dietary consult during hospitalization
Time to receipt of high‐risk abnormal laboratory assessments Median time to receipt of high‐risk laboratory results, eg, troponins
Cardiac risk assessment Percentage of patients who receive a cardiac risk assessment during admission
Measurement of LVEF Percentage of patients who receive a cardiac echocardiogram to measure of LVEF before discharge
Document communication with PCP Percentage of patients whose communication with the PCP was documented at discharge
Completed medication reconciliation Percentage of patients for whom medication reconciliation was documented by the time of discharge
Make 1‐week follow‐up appointment with PCP Percentage of patients for whom a 1‐week follow‐up appointment with the PCP was documented at the time of discharge
Additional Measure
Inpatient mortality

Conclusion

Each hospitalist can have an impact on ACS care systemwide. Hospitalists are on the front line of care and have a unique perspective on patients as they are transitioned through the hospital stay and on how an institution handles patient care overall. They experience firsthand the challenges presented by poor communication between providers, patients, and their families. They can offer breadth of experience and perspective when assessing processes linked to patient care and can be instrumental in ensuring each patient experiences safe transitions during the hospital stay. Hospitalists should participate in QI initiatives for ACS and should consider opportunities to take the lead on these initiatives within their institutions.

Acknowledgements

The author thanks Denise Erkkila, RPh for her editorial assistance in the preparation of this manuscript.

Addressing quality improvement (QI) for the management of acute coronary syndrome (ACS) at the institutional level is essential for supporting hospitalists and other clinicians as they manage patients with ACS and achieve desired institutional outcomes. This systems approach may identify institution‐specific barriers to quality care, including those that affect the complex management of ACS. Having a firsthand view of patient care puts the hospitalist in a good position to assess the viability of existing processes and protocols that support care. Indeed, the hospitalist has a vested interest in improving systems of care as these systems directly affect the hospitalist's practice. This unique perspective gives the hospitalist an opportunity to facilitate systems change within the institution and to become an integral participant or leader in QI initiatives.

An increasing number of hospitalists are providing critical care at secondary and tertiary care facilities, driven by a shortage of intensivists in the United States. In a 20052006 survey about 75% of hospitalists reported they provide critical care services as part of their practice,1 and this would include care of patients with ACS. The Society of Hospital Medicine (SHM) has developed core competencies that recognize the important role of hospitalists in leading or participating in QI teams for ACS.2 Hospitalists must also be able to apply evidenced‐based outcomes data to support these initiatives.3 Hospitalist competencies for ACS include protocol development that supports the timely diagnosis and treatment of ACS, evaluation of resource utilization, staff education of secondary prevention measures, and implementation of measures to ensure institutional compliance with national quality standards (Table 1).2 Most hospital medicine groups will be expected to contribute to systems improvement, an area where hospitalists have already shown leadership for QI protocols related to glycemic control and venous thromboembolism prophylaxis. Hospitalists were prominent in targeting QI in these areas even though these QI initiatives could easily have been spearheaded by specialists.46

Core Hospitalist Competencies for System Organization and Improvement Relative to ACS
  • Related data were reported by the Society of Hospital Medicine.2

  • Abbreviation:ACS, acute coronary syndrome.

Lead, coordinate, or participate in:
Protocol development to rapidly identify ACS, minimizing time to intervention
Protocol development for rapid identification and transfer of patients with ACS to a facility with an appropriate level of care
Multidisciplinary initiatives, including order sets for ACS and chest pain, that promote patient safety and optimize the use of resources
Staff education initiatives on the value of smoking cessation counseling and other prevention measures
Implement or integrate:
Systems to ensure hospitalwide adherence to national standards, documenting adherence as required by certifying organizations
Outcomes research, institution‐specific laboratory policies, and hospital formulary to create indicated and cost‐effective diagnostic and management strategies for patients with ACS

QI Basics

QI at the institutional level addresses systems of care rather than individual performance, targeting both institutional performance and use of resources.3 QI is a continuous process in which practices and procedures related to patient management are regularly assessed to ascertain whether a quality gap exists. This in turn may lead to new processes, protocols, and algorithms that help the institution and clinicians meet benchmarks of quality care.

QI starts when an existing gap is recognizedthe gap between the scientific understanding of optimal care and actual patient care. The goal is to narrow or close this gap so that each patient receives optimal care. Underlying any QI initiative are 2 essential concepts. First, improvement requires systems changeany system will produce exactly what it is designed to produce. For example, if procedures are not in place to educate patients about smoking cessation while they are hospitalized, it is unlikely that the majority will routinely receive this counseling before they are discharged. Second, less is moreproductivity is not destroyed but often is enhanced by initiating simple and practical change. If a patient arrives in the emergency department (ED) with chest pain, instituting an order set that reminds clinicians to start antiplatelet therapy or a beta blocker can lessen the chance that these medications will be overlooked, especially when the patient transitions between providers or services within the hospital.

SHM has identified 7 essential elements of any QI initiative, and these are applicable to the care of the ACS patient (Table 2).7 These elements highlight the need for institutional support and teamwork that support standardized measures and tools specific to issues in ACS management. These issues include: (1) rapidly identifying a patient with ACS and initiating a care plan when the patient is admitted; (2) encouraging good communication between providers; (3) symptom management; (4) medication safety, polypharmacy, and medication reconciliation; (5) patient and caregiver education; (6) safe discharge and transitions in care; and (7) meeting Centers for Medicare and Medicaid Services (CMS) core measures.

Essential Elements of a Quality Initiative for ACS
  • Related data were reported by the Society of Hospital Medicine Acute Coronary Syndrome Advisory Board.7

  • Abbreviations: ACS, acute coronary syndrome; CMS, Centers for Medicare and Medicaid Services; PQRI, Physician Quality Reporting Initiative.

Institutional support Commitment of time, personnel, and tools to support the initiative
Multidisciplinary team Team that focuses on quality of care for patients with ACS
Reliable metrics Reflect CMS core and applicable PQRI measures; also reportable to inform team decision making
Identify the goal Establish a measurable, achievable goal with an established timeline
Standard order sets Defined clinical pathways that support evidence‐based treatment strategies, risk stratification, and safe transitions in care
Policies that support algorithms and protocols Institution‐specific to support order sets
Education programs Targeted to clinicians and patients; should cover items addressed in order sets, algorithms, and protocols

Tools such as process flow mapping and run charts can reveal quality gaps and indicate if process improvements are leading to stated objectives. Process flow mapping makes it possible to identify and visualize quality gaps that might otherwise be hidden and to identify their source or cause. Process mapping documents discrete steps within the flow and usually requires input from multiple disciplines; this information can guide a multidisciplinary QI team when formulating interventions for process improvement.7 Figure 1 shows process flow mapping for the early identification of ST‐segment elevation myocardial infarction (STEMI) when hospitalists have open access to activate the catheterization laboratory (cath lab). The time from door‐to‐balloon is a critical factor in reducing STEMI‐related morbidity8; processes that overcome delays to percutaneous coronary intervention (PCI) and improve communication can have a direct benefit on patient outcomes.

Figure 1
Simplified process flow mapping for identifying STEMI and reducing door‐to‐balloon time. STEMI, ST‐segment elevation myocardial infarction; ECG, electrocardiogram; ED, emergency department; PCI, percutaneous coronary intervention.

A run chart is a commonly used tool which graphically depicts progress in attaining a goal over time, before and after an intervention. Figure 2a is a run chart that shows the average time to PCI following implementation of an order set designed to support the use of a risk stratification tool for the early diagnosis of STEMI. In this case, the average time to PCI is observed to decrease over time, but still lags behind the desired goal of less than 90 minutes. This run chart indicates that further work is needed to improve the process of identifying patients with STEMI. Figure 2b shows the number of eligible STEMI patients who received aspirin at discharge following implementation of a discharge order set; here, the hospital has clearly made progress toward meeting this CMS core measure.

Figure 2
A: Sample run chart documenting number of patients with STEMI having time to PCI >90 minutes. B: Sample process control chart for project monitoring successful acetylsalicylic acid (ASA) at hospital discharge. UCL, upper confidence level; LCL, lower confidence level. ASA, aspirin; PCI, percutaneous coronary intervention; STEMI, ST‐segment elevation myocardial infarction.

The following is a case study that illustrates how the implementation of standardized measures and tools can help hospitalists and other clinicians achieve quality measures in the care of a patient with ACS.

Case Study

Mary, a 68‐year‐old woman, presents to the ED with fatigue and some heartburn. She has a history of hypertension and may have had a mini stroke a few years ago. Her symptoms, which she has had on and off for the past few days, worsened considerably right before her arrival. She has been taking chewable antacids but is unsure if they have helped. Her physical exam is unremarkable. A stat electrocardiogram (ECG) shows inferior ST (part of an electrocardiogram between the QRS complex and the T wave) elevation in leads II and III, and augmented vector foot (aVF). Troponins are positive. This case can be approached from 2 perspectives.

Scenario 1

Mary arrives at a hospital that has few standardized systems or protocols for triage and transitions in care. The triage nurse recognizes the need for and obtains an ECG, but fails to alert the ED physician. When the ED physician eventually sees the patient and reviews the ECG, she immediately administers nitroglycerin and pages the cardiologist on call and the hospitalist. The hospitalist arrives first and recognizes the STEMI, but hesitates to start unfractionated or low molecular weight heparin until the cardiologist determines whether the patient will undergo PCI. The cardiologist orders PCI, the cath lab is alerted, and the patient is started on the appropriate medications; the patient does not start an aspirin until after PCI. In this scenario, several short delays amount to a significant delay of about 2 hours before the patient reaches the cath lab. In addition, although aspirin is given on day 1, it is not done on arrival. Following PCI, the patient is transferred to the coronary care unit (CCU).

Scenario 2

Mary arrives at an institution with well‐defined, institution‐specific protocols for triage and transitions in care. The triage nurse recognizes the need for and obtains an ECG; the results are immediately reviewed with the ED physician. STEMI is diagnosed and the cath lab protocol is activated; the patient receives aspirin as part of a standing order. The hospitalist meets the patient in the ED within 5 minutes and begins the protocol for unfractionated heparin and preparation for immediate PCI, allowing the ED physician to return to ED care. Simultaneously, the interventional cardiologist and cath lab are mobilized and the patient is transferred within 15 minutes. Additional appropriate medications are begun. The door‐to‐balloon time is 60 minutes, well within recommended timeframes. Following PCI, the patient is transferred to the CCU.

Measuring Performance Relative to ACS

Two agencies promulgating quality measures for hospital inpatient care are The Joint Commission (TJC) and the CMS. TJC and CMS jointly established core measures for patients with acute myocardial infarction (AMI) and these are considered key indicators of quality, evidence‐based care. As outlined in Table 3, the TJC/CMS recommendations promote, unless contraindicated, a minimum standard of care for patients with AMI.9, 10 Public reporting of institutional core measure performance has led to an intense focus on improving these metrics.

TJC/CMS Core Measures and Metrics for Acute MI
Core Measure Sample Metric
  • NOTE: All medications given unless contraindicated.

  • Related data were reported by The Joint Commission and Centers for Medicare and Medicare Services.9, 10

  • Abbreviations: ACE, angiotensin converting enzyme; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVSD, left ventricular systolic dysfunction; PCI, percutaneous coronary intervention.

Aspirin at arrival Percentage of patients receiving aspirin within 24 hours before or after hospital arrival
Aspirin at discharge Percentage of patients prescribed aspirin at hospital discharge
ACE inhibitor or ARB for LVSD Percentage of patients with LVSD prescribed an ACEI or ARB at hospital discharge
Beta blocker Percentage of patients prescribed a beta blocker at hospital discharge
Fibrinolytic medication given within 30 minutes of hospital arrival Median time to fibrinolysis
Percentage of patients given fibrinolytic medication within 30 minutes of hospital arrival
PCI received within 90 minutes of hospital arrival Median time to PCI
Percentage of patients receiving primary PCI within 90 minutes of hospital arrival
Smoking cessation counseling Percentage of patients with a history of smoking cigarettes who are counseled about smoking cessation during hospitalization

On a national level, TJC documented performance improvement from 2002 to 2008 for each of the core measures. Compliance with smoking cessation counseling improved the most, rising from 67% to almost 99%. In 2008, a combined measure of all individual core measures indicated that, overall, care of heart attack patients is of high quality. Hospitals delivered evidenced‐based care in 96.7% of the opportunities they had to provide this care. Compliance related to oral medications was also good (95%); however, a closer look at other individual measures shows that improvement is needed to reduce the time to fibrinolysis (52.4% compliance rate for 30 minutes or less) and time to primary PCI (81.6% compliance rate for 90 minutes or less).11

Financial incentives are tied to QI measures including those from CMS. At present, this system is in the pay‐for‐reporting phase, in which institutions are penalized for not reporting quality metrics for the CMS core measures. It is likely that, to further incentivize institutions to meet quality benchmarks, this will be expanded to a pay‐for‐performance system (eg, differential payments for readmissions or different payment scales based on prior performance). Public disclosure of institutional performance relative to ACS and other medical conditions is available through the HHS.gov website (www.hospitalcompare.hhs.gov), which compares performance between hospitals and provides a clear business motivation for institutions to improve and provide high quality care.

Two other reporting systems should be noted. The CMS Physician Quality Reporting Initiative (PQRI) includes physician‐related quality measures specific to ACS12 that overlap with institution‐level CMS core measures with regard to prescribing ACS medications. Payments associated with the PQRI are currently a small financial factor for hospitalists, but will likely grow as quality initiatives develop overall. The Hospital Care Quality Information From the Consumer Perspective (HCAHPS) initiative, also from CMS, strives to capture patients' perspectives on hospital care through a standardized survey. The goals are to collect data that can be used to compare hospital performance, create an incentive for QI through public disclosure of results, and increase transparency regarding the quality of hospital care.13 However, the focus is not ACS‐specific. Patients are queried about communication with hospital staff, communication about medications, and information about discharge, all areas of concern for the hospitalist in general that have been identified as areas for improvement relative to ACS.

Case Study (cont)

Scenario 1 (cont)

Mary recuperates in the CCU and is transferred to the medical floor. The hospitalist and cardiologist see her separately on rounds and each assumes the other has a reason for not starting a beta blocker; therefore, a beta blocker is not prescribed. The nurse cannot tell who is in charge and does not anticipate the day of dischargeshe is just implementing the orders as they are written. The day of discharge arrives; the nurse learns from Mary that the hospitalist will discharge her that day. The hospitalist reviews the list of ACS medications and realizes that Mary still has not started a beta blocker. He cannot reach the cardiologist before Mary's ride home arrives, so he writes a note in the discharge summary alerting the primary care physician (PCP) to consider a beta blocker at follow‐up. Because of this lack of communication and systems for tracking the implementation of guideline‐recommended therapies, Mary is discharged without a CMS core measure medication, with no assurance that this will be addressed by the PCP.

Scenario 2 (cont)

Mary recuperates in the CCU and is transferred to the medical floor. Standard post‐PCI/STEMI orders are in place according to institutional protocol. The hospitalist is able to confirm that all interventions required at admission (aspirin, beta blocker, assessment of smoking status) have occurred by reviewing a well‐structured checklist that includes easy‐to‐read visual cues. The checklist indicates that Mary was counseled about smoking cessation on day 1 of her stay in the CCU. Mary and her physicians and nurses are all aware of the target discharge date and the milestones that must be met prior to discharge (eg, echocardiogram, medication review, education, assessment of mobility, etc). Mary is instructed about each new medication and given educational materials.14 Follow‐up appointments postdischarge are made, and the discharge summary is sent electronically to the PCP. These institution‐specific protocols enhance communication overall and help the hospital meet high standards of patient care.

Special QI Issues in ACS Management for the Hospitalist

Coordination is especially important for patients with ACS because their care is so complex. Seamless transitions promote safe care as the patient moves from the ED, cath lab, recovery unit, medical floor, and discharge through the transition to primary care. Poor communication between clinicians during these transitions may result in delayed or overlooked treatment and other medical errors. Implementing an institutional system of care may overcome communication barriers and help ensure the institution meets its quality benchmarks, such as the CMS core measures. Standard order sets and protocols identify the steps and components needed to manage ACS. At admission, these measures promote early assessment of patient risk, triage to early intervention, medication reconciliation, and communication between stakeholders such as the hospitalist, cardiologist, and the cath lab.15, 16 During hospitalization, they help assure ongoing risk assessment and early consideration of discharge planning, culminating in discharge and the transition back to primary care.

A recent guideline update8 focused attention on the coordination of care between institutions and the critical importance of rapid triage for patients who need primary PCI and transfer from a non‐PCI to a PCI‐capable institution. The decision to transfer rests on multiple factors and requires rapid decision making on the part of clinicians. Time to reperfusion is shown to have a direct effect on patient outcomes. Established protocols within a non‐PCI facility can support timely transfer to a PCI‐capable facility if indicated. Factors such as the patient's mortality risk, the risk of bleeding from fibrinolytic therapy, duration of symptoms, and the time for transport to a PCI facility all must be considered. It is recognized that a regional system of STEMI care best supports collaborative efforts between institutions and community resources that support QI efforts.

Transitions in care, and particularly discharge, are areas with identified gaps in quality care17, 18 for which improvement has been pursued on an institutional level. Project BOOST (Better Outcomes for Older Adults Through Safe Transitions) seeks to improve the care of patients during the transition from inpatient to outpatient care, and focuses on elderly patients identified to be at high‐risk for adverse events during this transition.19 The goal is to improve outcomes related to 30‐day readmission rates, patient satisfaction, communication between inpatient and outpatient providers, identification of high‐risk patients who need intervention to reduce risk, and patient education about their risk for an adverse event. BOOST addresses these outcomes at an institutional level by offering resources related to project management, data collection, tools for clinicians and patients, and participating mentor institutions. These resources help an institution assess its readiness for change, identify quality gaps, promote teamwork, and guide the implementation and subsequent evaluation of process improvements. Specific tools for clinicians also support institutional goals for teamwork and communication, creating an environment for safe transitions. Both BOOST19 and the adaptable Transitions Tool from the SHM20 provide a framework for understanding processes that involve multiple departments and stakeholders, breaking complex processes into discrete parts for which quality gaps can be identified and change instituted to improve care. A checklist can also be a useful tool for ensuring specific issues are addressed during transitions in care. SHM developed a checklist for hospitalist use that lists elements of a discharge summary for patients with ACS (Table 4).21

Discharge Summary Checklist
  • Related data were reported by Halasyamani et al.17

  • Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; ECG, electrocardiogram; ECHO, echocardiogram; ETT, exercise tolerance test; INR, international normalized ratio; LDL, low‐density lipoprotein; LFTs, liver function tests; MI, myocardial infarction; NTG, nitroglycerin.

Diagnoses Elaborate on details of MI such as location, complications
Comorbidities List, including diabetes, lipids, hypertension, renal disease
Medications Note medication reconciliation, reason for not prescribing core measure medications, titration of any medications
Specific medications to address include ACE/ARB inhibitors, aspirin, beta blockers, statin, sublingual NTG, clopidogrel (include duration of therapy)
Procedures Type of stent (bare‐metal stent, drug‐eluting stent) and stent location
Complications (hematoma, transfusion)
If ECHO, note type, ejection fraction; provide copy of ECG
Follow‐up appointment(s) Primary care, cardiology, others such as cardiac rehabilitation
Follow‐up testing ETT (type, timeframe); ECHO if indicated; laboratory assessments
Code status
Activity
Diet
Wound care (eg, groin)
Treatment course Address cognitive level, discharge LDL, discharge creatinine, INR if on warfarin, LFTs if on statin
Copy all providers

Staff and patient education is also an area that can benefit from evaluation. Clinicians from multiple disciplines are stakeholders in QI and they should receive education about its purpose and goals. Usually institutions will have a QI methodology in place, and this should be conveyed to the members of the ACS team. Staff education about ACS should be tailored to each specialty, be institution‐specific, current, and comprehensive, and include methods for assessing the learner. Education should be easily available (eg, on the Internet or via an electronic format), interactive, case‐based, and mandatory. For patients, education should be available in languages other than English and identify community resources and opportunities for additional outpatient education. The value of any educational program should be assessed to measure learner participation, satisfaction, and comprehension.

Gathering metrics and generating objective evidence of change is critical to QI; quantifying improvement (or lack thereof) must be done to determine whether the changes implemented improve care and ultimately whether desired outcomes are met. Metrics should be meaningful, associated with standards of care (eg, CMS core measures), and carefully chosen to reflect current practice. CMS core measures are a good target for collecting metrics to assess an institution's performance relative to ACS (Table 3). The Specifications Manual for National and Hospital Inpatient Quality Measures10 from TJC and CMS identifies the data elements needed for reporting. Other metrics not specified as core measures are worthy of measurement because they are considered the standard of care for patients with ACS (Table 5). The metrics shown in Tables 3 and 5 assume that all patients are eligible for core‐measure or standard‐of‐care medications and procedures. Because some measures are contraindicated in some patients, it is more meaningful to measure the percentage of patients without a contraindication who receive the measure. If a measure is contraindicated, the patient's medical record must include supporting documentation indicating why a core measure was not met. To be objective and reduce bias regarding the effectiveness of QI measures, data collection is best done prospectively. If necessary, periodic assessments against performance measures (institutional, government, professional association) should be made to support timely intervention. Run charts can be particularly useful here, measuring change over time to identify trends or an intervention that supported, did not affect, or was a barrier to the desired change.

Case Study (cont)

Scenario 1 (cont)

Mary tells the hospitalist she felt the discharge process was rushed and confusing and that she was dissatisfied with her care overall. Recalling a recent review article on the process for public disclosure of patient ratings related to hospital stay, the hospitalist locates HospitalCompare.com on the Internet. He reviews results from patient satisfaction surveys that compare his institution with others in the geographic area and is surprised to discover that patients generally give his institution a poor rating as well as low marks for the quality of nursing and physicianpatient communication. He is interested in this information but is not aware of resources for further exploration.

Scenario 2 (cont)

At discharge, the hospitalist confirms with Mary that she has received smoking cessation counseling during her hospital stay; he documents this in her chart and discharge summary. The hospitalist was aware of this particular quality measure because the recent weekly score card of hospital performance, posted in the unit, reported that the hospital was not meeting its goal of 100% compliance for this CMS core measure. Among heart attack patients who were identified as smokers, only 80% of charts documented that the patient had been counseled about smoking cessation during the hospital stay. Mary says that she understands the importance of not smoking and says she will make an effort to stop.

Standard of Care Measures and Metrics for ACS
Standard of Care Measure Sample Metric
  • Abbreviations: ACS, acute coronary syndrome; LDL, low‐density lipoprotein; LVEF, left ventricular ejection fraction; PCP, primary care provider.

LDL‐cholesterol assessment Percentage of patients who have LDL cholesterol measured during hospitalization
Lipid‐lowering therapy at discharge Percentage of patients prescribed a statin at hospital discharge
Dietary consultation Percentage of patients who receive a dietary consult during hospitalization
Time to receipt of high‐risk abnormal laboratory assessments Median time to receipt of high‐risk laboratory results, eg, troponins
Cardiac risk assessment Percentage of patients who receive a cardiac risk assessment during admission
Measurement of LVEF Percentage of patients who receive a cardiac echocardiogram to measure of LVEF before discharge
Document communication with PCP Percentage of patients whose communication with the PCP was documented at discharge
Completed medication reconciliation Percentage of patients for whom medication reconciliation was documented by the time of discharge
Make 1‐week follow‐up appointment with PCP Percentage of patients for whom a 1‐week follow‐up appointment with the PCP was documented at the time of discharge
Additional Measure
Inpatient mortality

Conclusion

Each hospitalist can have an impact on ACS care systemwide. Hospitalists are on the front line of care and have a unique perspective on patients as they are transitioned through the hospital stay and on how an institution handles patient care overall. They experience firsthand the challenges presented by poor communication between providers, patients, and their families. They can offer breadth of experience and perspective when assessing processes linked to patient care and can be instrumental in ensuring each patient experiences safe transitions during the hospital stay. Hospitalists should participate in QI initiatives for ACS and should consider opportunities to take the lead on these initiatives within their institutions.

Acknowledgements

The author thanks Denise Erkkila, RPh for her editorial assistance in the preparation of this manuscript.

References
  1. Heisler M.Hospitalists and intensivists: partners in caring for the critically ill—the time has come.J Hosp Med.2010;5:13.
  2. Society of Hospital Medicine. Acute coronary syndrome.J Hosp Med.2006;1(suppl 1):23.
  3. Society of Hospital Medicine. Quality improvement.J Hosp Med.2006;1 (suppl):92.
  4. McKean S,Stein J,Maynard G, et al.Curriculum development: the venous thromboembolism quality improvement resource room.J Hosp Med.2006;1:124132.
  5. Schnipper JL,Magee M,Larsen K,Inzucchi SE,Maynard G.Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts.J Hosp Med.2008;3:6675.
  6. Schnipper JL,Ndumele CD,Liang CL,Pendergrass ML.Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial.J Hosp Med.2009;4:1627.
  7. SHM Acute Coronary Syndrome Advisory Board. A guide for effective quality improvement: improving acute coronary syndrome care for hospitalized patients. Available at: http://www.hospitalmedicine.org. 2010. Accessed July 2010.
  8. Kushner FG,Hand M,Smith SC, et al.2009focused updates: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol.year="2009"2009;54:22052241.
  9. The Joint Commission. Performance measure intiatives. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Acute+Myocardial+Infarction+Core+Measure+Set.htm. 2010. Accessed July 2010.
  10. The Joint Commission, Centers for Medicare and Medicare Services. Specifications manual for national hospital inpatient quality measures, version 2.5. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Current+NHQM+Manual.htm. 2009 November 6. Accessed July 2010.
  11. The Joint Commission. Improving America's hospitals: The Joint Commission's annual report on quality and safety 2009. Available at: http://www.jointcommission.org/Library/annual_report.2009. Accessed July 2010.
  12. Centers for Medicare and Medicare Services. Physician quality reporting initiative (PQRI). Available at: http://www.cms.hhs.gov/pqri. 2010. Accessed July 2010.
  13. Hospital Care Quality Information from the Consumer Perspective. CAHPS hospital survey. Available at: http://www.hcahpsonline.org. 2010. Accessed July 2010.
  14. Koelling TM,Johnson ML,Cody RJ,Aronson KD.Discharge education improves clinical outcomes in patients with chronic heart failure.Circulation.2005;111:179185.
  15. Bradley EH,Nallamothu BK,Herrin J, et al.National efforts to improve door‐to‐balloon time results from the Door‐to‐Balloon Alliance.J Am Coll Cardiol.2009;54:24232429.
  16. Nestler DM,Noheria A,Haro LH, et al.Sustaining improvement in door‐to‐balloon time over 4 years: the Mayo clinic ST‐elevation myocardial infarction protocol.Circ Cardiovasc Qual Outcomes.2009;2:508513.
  17. Kripalani S,Jackson AT,Schnipper JL,Coleman EA.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2:314323.
  18. Coleman EA,Berenson RA.Lost in transition: challenges and opportunities for improving the quality of transitional care.Ann Intern Med.2004;141:533536.
  19. Society of Hospital Medicine. Boosting Care Transitions Resource Room. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/RR_CareTransitions/CT_Home.cfm. 2010. Accessed July 2010.
  20. SHM ACS Transitions Workgroup. SHM ACS Transitions Tool. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/RR_ACS/html_ACS/12ClinicalTools/05_Transitions.cfm. 2010. Accessed July 2010.
  21. Halasyamani L,Kripalani S,Coleman E, et al.Transition of care for hospitalized elderly patients‐‐development of a discharge checklist for hospitalists.J Hosp Med.2006;1:354360.
References
  1. Heisler M.Hospitalists and intensivists: partners in caring for the critically ill—the time has come.J Hosp Med.2010;5:13.
  2. Society of Hospital Medicine. Acute coronary syndrome.J Hosp Med.2006;1(suppl 1):23.
  3. Society of Hospital Medicine. Quality improvement.J Hosp Med.2006;1 (suppl):92.
  4. McKean S,Stein J,Maynard G, et al.Curriculum development: the venous thromboembolism quality improvement resource room.J Hosp Med.2006;1:124132.
  5. Schnipper JL,Magee M,Larsen K,Inzucchi SE,Maynard G.Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts.J Hosp Med.2008;3:6675.
  6. Schnipper JL,Ndumele CD,Liang CL,Pendergrass ML.Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial.J Hosp Med.2009;4:1627.
  7. SHM Acute Coronary Syndrome Advisory Board. A guide for effective quality improvement: improving acute coronary syndrome care for hospitalized patients. Available at: http://www.hospitalmedicine.org. 2010. Accessed July 2010.
  8. Kushner FG,Hand M,Smith SC, et al.2009focused updates: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol.year="2009"2009;54:22052241.
  9. The Joint Commission. Performance measure intiatives. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Acute+Myocardial+Infarction+Core+Measure+Set.htm. 2010. Accessed July 2010.
  10. The Joint Commission, Centers for Medicare and Medicare Services. Specifications manual for national hospital inpatient quality measures, version 2.5. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Current+NHQM+Manual.htm. 2009 November 6. Accessed July 2010.
  11. The Joint Commission. Improving America's hospitals: The Joint Commission's annual report on quality and safety 2009. Available at: http://www.jointcommission.org/Library/annual_report.2009. Accessed July 2010.
  12. Centers for Medicare and Medicare Services. Physician quality reporting initiative (PQRI). Available at: http://www.cms.hhs.gov/pqri. 2010. Accessed July 2010.
  13. Hospital Care Quality Information from the Consumer Perspective. CAHPS hospital survey. Available at: http://www.hcahpsonline.org. 2010. Accessed July 2010.
  14. Koelling TM,Johnson ML,Cody RJ,Aronson KD.Discharge education improves clinical outcomes in patients with chronic heart failure.Circulation.2005;111:179185.
  15. Bradley EH,Nallamothu BK,Herrin J, et al.National efforts to improve door‐to‐balloon time results from the Door‐to‐Balloon Alliance.J Am Coll Cardiol.2009;54:24232429.
  16. Nestler DM,Noheria A,Haro LH, et al.Sustaining improvement in door‐to‐balloon time over 4 years: the Mayo clinic ST‐elevation myocardial infarction protocol.Circ Cardiovasc Qual Outcomes.2009;2:508513.
  17. Kripalani S,Jackson AT,Schnipper JL,Coleman EA.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2:314323.
  18. Coleman EA,Berenson RA.Lost in transition: challenges and opportunities for improving the quality of transitional care.Ann Intern Med.2004;141:533536.
  19. Society of Hospital Medicine. Boosting Care Transitions Resource Room. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/RR_CareTransitions/CT_Home.cfm. 2010. Accessed July 2010.
  20. SHM ACS Transitions Workgroup. SHM ACS Transitions Tool. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/RR_ACS/html_ACS/12ClinicalTools/05_Transitions.cfm. 2010. Accessed July 2010.
  21. Halasyamani L,Kripalani S,Coleman E, et al.Transition of care for hospitalized elderly patients‐‐development of a discharge checklist for hospitalists.J Hosp Med.2006;1:354360.
Issue
Journal of Hospital Medicine - 5(4)
Issue
Journal of Hospital Medicine - 5(4)
Page Number
S1-S7
Page Number
S1-S7
Article Type
Display Headline
The role of the hospitalist in quality improvement: Systems for improving the care of patients with acute coronary syndrome
Display Headline
The role of the hospitalist in quality improvement: Systems for improving the care of patients with acute coronary syndrome
Legacy Keywords
ACS, acute coronary syndrome, quality improvement
Legacy Keywords
ACS, acute coronary syndrome, quality improvement
Sections
Article Source
Copyright © 2010 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Associate Professor of Medicine, Director, Division of Hospital Medicine, Loyola University Stritch School of Medicine, Maywood, Illinois
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media